
<html lang="en"     class="pb-page"  data-request-id="0acc7e06-3ef3-4b3d-90c1-ed565fee523b"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2020.63.issue-23;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/acs.jmedchem.0c01246;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Optimization of the In Vivo Potency of Pyrazolopyrimidine MALT1 Protease Inhibitors by Reducing Metabolism and Increasing Potency in Whole Blood" /></meta><meta name="dc.Creator" content="Jean  Quancard" /></meta><meta name="dc.Creator" content="Oliver  Simic" /></meta><meta name="dc.Creator" content="Carole  Pissot Soldermann" /></meta><meta name="dc.Creator" content="Reiner  Aichholz" /></meta><meta name="dc.Creator" content="Markus  Blatter" /></meta><meta name="dc.Creator" content="Martin  Renatus" /></meta><meta name="dc.Creator" content="Paulus  Erbel" /></meta><meta name="dc.Creator" content="Samu  Melkko" /></meta><meta name="dc.Creator" content="Ralf  Endres" /></meta><meta name="dc.Creator" content="Mickael  Sorge" /></meta><meta name="dc.Creator" content="Laurence  Kieffer" /></meta><meta name="dc.Creator" content="Trixie  Wagner" /></meta><meta name="dc.Creator" content="Karen  Beltz" /></meta><meta name="dc.Creator" content="Paul  Mcsheehy" /></meta><meta name="dc.Creator" content="Markus  Wartmann" /></meta><meta name="dc.Creator" content="Catherine H.  Régnier" /></meta><meta name="dc.Creator" content="Thomas  Calzascia" /></meta><meta name="dc.Creator" content="Thomas  Radimerski" /></meta><meta name="dc.Creator" content="Marc  Bigaud" /></meta><meta name="dc.Creator" content="Andreas  Weiss" /></meta><meta name="dc.Creator" content="Frédéric  Bornancin" /></meta><meta name="dc.Creator" content="Achim  Schlapbach" /></meta><meta name="dc.Description" content="The paracaspase MALT1 has gained increasing interest as a target for the treatment of subsets of lymphomas as well as autoimmune diseases, and there is a need for suitable compounds to explore the ..." /></meta><meta name="Description" content="The paracaspase MALT1 has gained increasing interest as a target for the treatment of subsets of lymphomas as well as autoimmune diseases, and there is a need for suitable compounds to explore the ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 20, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c01246" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01246" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c01246" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01246" /></link>
        
    
    

<title>Optimization of the In Vivo Potency of Pyrazolopyrimidine MALT1 Protease Inhibitors by Reducing Metabolism and Increasing Potency in Whole Blood | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c01246" /></meta><meta property="og:title" content="Optimization of the In Vivo Potency of Pyrazolopyrimidine MALT1 Protease Inhibitors by Reducing Metabolism and Increasing Potency in Whole Blood" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01246/20201203/images/large/jm0c01246_0014.jpeg" /></meta><meta property="og:description" content="The paracaspase MALT1 has gained increasing interest as a target for the treatment of subsets of lymphomas as well as autoimmune diseases, and there is a need for suitable compounds to explore the therapeutic potential of this target. Here, we report the optimization of the in vivo potency of pyrazolopyrimidines, a class of highly selective allosteric MALT1 inhibitors. High doses of the initial lead compound led to tumor stasis in an activated B-cell-like (ABC) diffuse large B-cell lymphoma (DLBCL) xenograft model, but this compound suffered from a short in vivo half-life and suboptimal potency in whole blood. Guided by metabolism studies, we identified compounds with reduced metabolic clearance and increased in vivo half-life. In the second optimization step, masking one of the hydrogen-bond donors of the central urea moiety through an intramolecular interaction led to improved potency in whole blood. This was associated with improved in vivo potency in a mechanistic model of B cell activation. The optimized compound led to tumor regression in a CARD11 mutant ABC-DLBCL lymphoma xenograft model." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c01246"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01246">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c01246&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c01246&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c01246&amp;href=/doi/10.1021/acs.jmedchem.0c01246" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 23</span><span class="cit-fg-pageRange">, 14594-14608</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/23" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c01245" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c00873" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Optimization of the <i>In Vivo</i> Potency of Pyrazolopyrimidine MALT1 Protease Inhibitors by Reducing Metabolism and Increasing Potency in Whole Blood</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Jean Quancard</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jean Quancard</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Pharma AG, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#442e21252a6a3531252a27253620042a2b322536302d376a272b29"><span class="__cf_email__" data-cfemail="1a707f7b74346b6f7b74797b687e5a74756c7b686e736934797577">[email protected]</span></a>. Phone: +41-61-6968687.</span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jean++Quancard">Jean Quancard</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6324-8490" title="Orcid link">http://orcid.org/0000-0001-6324-8490</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Oliver Simic</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Oliver Simic</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Pharma AG, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Oliver++Simic">Oliver Simic</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Carole Pissot Soldermann</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Carole Pissot Soldermann</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Pharma AG, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Carole++Pissot+Soldermann">Carole Pissot Soldermann</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7497-3839" title="Orcid link">http://orcid.org/0000-0002-7497-3839</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Reiner Aichholz</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Reiner Aichholz</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Pharma AG, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Reiner++Aichholz">Reiner Aichholz</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Markus Blatter</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Markus Blatter</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Pharma AG, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Markus++Blatter">Markus Blatter</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Martin Renatus</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Martin Renatus</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Pharma AG, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Martin++Renatus">Martin Renatus</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Paulus Erbel</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Paulus Erbel</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Pharma AG, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Paulus++Erbel">Paulus Erbel</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Samu Melkko</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Samu Melkko</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Pharma AG, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Samu++Melkko">Samu Melkko</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ralf Endres</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ralf Endres</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Pharma AG, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ralf++Endres">Ralf Endres</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mickael Sorge</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mickael Sorge</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Pharma AG, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mickael++Sorge">Mickael Sorge</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Laurence Kieffer</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Laurence Kieffer</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Pharma AG, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Laurence++Kieffer">Laurence Kieffer</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Trixie Wagner</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Trixie Wagner</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Pharma AG, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Trixie++Wagner">Trixie Wagner</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Karen Beltz</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Karen Beltz</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Pharma AG, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Karen++Beltz">Karen Beltz</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Paul Mcsheehy</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Paul Mcsheehy</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Pharma AG, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Mcsheehy">Paul Mcsheehy</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Markus Wartmann</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Markus Wartmann</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Pharma AG, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Markus++Wartmann">Markus Wartmann</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Catherine H. Régnier</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Catherine H. Régnier</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Pharma AG, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Catherine+H.++R%C3%A9gnier">Catherine H. Régnier</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Thomas Calzascia</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Thomas Calzascia</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Pharma AG, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Thomas++Calzascia">Thomas Calzascia</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Thomas Radimerski</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Thomas Radimerski</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Pharma AG, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Thomas++Radimerski">Thomas Radimerski</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Marc Bigaud</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Marc Bigaud</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Pharma AG, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Marc++Bigaud">Marc Bigaud</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Andreas Weiss</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Andreas Weiss</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Pharma AG, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Andreas++Weiss">Andreas Weiss</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Frédéric Bornancin</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Frédéric Bornancin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Pharma AG, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#a2c4d0c7c6c7d0cbc18cc0cdd0ccc3ccc1cbcce2cccdd4c3d0d6cbd18cc1cdcf"><span class="__cf_email__" data-cfemail="690f1b0c0d0c1b000a470b061b0708070a00072907061f081b1d001a470a0604">[email protected]</span></a>. Phone: +41-79-4444637.</span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Fr%C3%A9d%C3%A9ric++Bornancin">Frédéric Bornancin</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Achim Schlapbach</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Achim Schlapbach</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Pharma AG, Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#50313338393d7e2333383c312032313338103e3f2631222439237e333f3d"><span class="__cf_email__" data-cfemail="bfdedcd7d6d291ccdcd7d3decfdddedcd7ffd1d0c9decdcbd6cc91dcd0d2">[email protected]</span></a>. Phone: +41-61-3244308.</span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Achim++Schlapbach">Achim Schlapbach</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01246&amp;href=/doi/10.1021%2Facs.jmedchem.0c01246" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 23</span><span class="cit-pageRange">, 14594–14608</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 20, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>17 July 2020</li><li><span class="item_label"><b>Published</b> online</span>20 November 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 10 December 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c01246" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01246</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D14594%26pageCount%3D15%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJean%2BQuancard%252C%2BOliver%2BSimic%252C%2BCarole%2BPissot%2BSoldermann%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D23%26contentID%3Dacs.jmedchem.0c01246%26title%3DOptimization%2Bof%2Bthe%2BIn%2BVivo%2BPotency%2Bof%2BPyrazolopyrimidine%2BMALT1%2BProtease%2BInhibitors%2Bby%2BReducing%2BMetabolism%2Band%2BIncreasing%2BPotency%2Bin%2BWhole%2BBlood%26numPages%3D15%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D14608%26publicationDate%3DDecember%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c01246"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2192</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">3</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c01246" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Optimization of the In Vivo Potency of Pyrazolopyrimidine MALT1 Protease Inhibitors by Reducing Metabolism and Increasing Potency in Whole Blood&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Jean&quot;,&quot;last_name&quot;:&quot;Quancard&quot;},{&quot;first_name&quot;:&quot;Oliver&quot;,&quot;last_name&quot;:&quot;Simic&quot;},{&quot;first_name&quot;:&quot;Carole&quot;,&quot;last_name&quot;:&quot;Pissot Soldermann&quot;},{&quot;first_name&quot;:&quot;Reiner&quot;,&quot;last_name&quot;:&quot;Aichholz&quot;},{&quot;first_name&quot;:&quot;Markus&quot;,&quot;last_name&quot;:&quot;Blatter&quot;},{&quot;first_name&quot;:&quot;Martin&quot;,&quot;last_name&quot;:&quot;Renatus&quot;},{&quot;first_name&quot;:&quot;Paulus&quot;,&quot;last_name&quot;:&quot;Erbel&quot;},{&quot;first_name&quot;:&quot;Samu&quot;,&quot;last_name&quot;:&quot;Melkko&quot;},{&quot;first_name&quot;:&quot;Ralf&quot;,&quot;last_name&quot;:&quot;Endres&quot;},{&quot;first_name&quot;:&quot;Mickael&quot;,&quot;last_name&quot;:&quot;Sorge&quot;},{&quot;first_name&quot;:&quot;Laurence&quot;,&quot;last_name&quot;:&quot;Kieffer&quot;},{&quot;first_name&quot;:&quot;Trixie&quot;,&quot;last_name&quot;:&quot;Wagner&quot;},{&quot;first_name&quot;:&quot;Karen&quot;,&quot;last_name&quot;:&quot;Beltz&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Mcsheehy&quot;},{&quot;first_name&quot;:&quot;Markus&quot;,&quot;last_name&quot;:&quot;Wartmann&quot;},{&quot;first_name&quot;:&quot;Catherine&quot;,&quot;last_name&quot;:&quot;H. Régnier&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;Calzascia&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;Radimerski&quot;},{&quot;first_name&quot;:&quot;Marc&quot;,&quot;last_name&quot;:&quot;Bigaud&quot;},{&quot;first_name&quot;:&quot;Andreas&quot;,&quot;last_name&quot;:&quot;Weiss&quot;},{&quot;first_name&quot;:&quot;Frédéric&quot;,&quot;last_name&quot;:&quot;Bornancin&quot;},{&quot;first_name&quot;:&quot;Achim&quot;,&quot;last_name&quot;:&quot;Schlapbach&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;20&quot;,&quot;issue&quot;:&quot;23&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;14594-14608&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c01246&quot;},&quot;abstract&quot;:&quot;The paracaspase MALT1 has gained increasing interest as a target for the treatment of subsets of lymphomas as well as autoimmune diseases, and there is a need for suitable compounds to explore the therapeutic potential of this target. Here, we report the optimization of the in vivo potency of pyrazolopyrimidines, a class of highly selective allosteric MALT1 inhibitors. High doses of the initial lead compound led to tumor stasis in an activated B-cell-like (ABC) diffuse large B-cell lymphoma (DLBCL) xenograft model, but this compound suffered from a short in vivo half-life and suboptimal potency in whole blood. Guided by metabolism studies, we identified compounds with reduced metabolic clearance and increased in vivo half-life. In the second optimization step, masking one of the hydrogen-bond donors of the central urea moiety through an intramolecular interaction led to improved potency in whole blood. This was associated with improved in vivo potency in a mechanistic model of B cell activation. The optimized&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01246&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01246" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01246&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01246" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01246&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01246" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01246&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01246&amp;href=/doi/10.1021/acs.jmedchem.0c01246" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c01246" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c01246" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01246&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c01246%26sid%3Dliteratum%253Aachs%26pmid%3D33216547%26genre%3Darticle%26aulast%3DQuancard%26date%3D2020%26atitle%3DOptimization%2Bof%2Bthe%2BIn%2BVivo%2BPotency%2Bof%2BPyrazolopyrimidine%2BMALT1%2BProtease%2BInhibitors%2Bby%2BReducing%2BMetabolism%2Band%2BIncreasing%2BPotency%2Bin%2BWhole%2BBlood%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D23%26spage%3D14594%26epage%3D14608%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292143" title="Metabolism">Metabolism</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/23" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/jmcmar.2020.63.issue-23/20201210/jmcmar.2020.63.issue-23.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01246/20201203/images/medium/jm0c01246_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01246/20201203/images/large/jm0c01246_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01246&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The paracaspase MALT1 has gained increasing interest as a target for the treatment of subsets of lymphomas as well as autoimmune diseases, and there is a need for suitable compounds to explore the therapeutic potential of this target. Here, we report the optimization of the <i>in vivo</i> potency of pyrazolopyrimidines, a class of highly selective allosteric MALT1 inhibitors. High doses of the initial lead compound led to tumor stasis in an activated B-cell-like (ABC) diffuse large B-cell lymphoma (DLBCL) xenograft model, but this compound suffered from a short <i>in vivo</i> half-life and suboptimal potency in whole blood. Guided by metabolism studies, we identified compounds with reduced metabolic clearance and increased <i>in vivo</i> half-life. In the second optimization step, masking one of the hydrogen-bond donors of the central urea moiety through an intramolecular interaction led to improved potency in whole blood. This was associated with improved <i>in vivo</i> potency in a mechanistic model of B cell activation. The optimized compound led to tumor regression in a CARD11 mutant ABC-DLBCL lymphoma xenograft model.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47736" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47736" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Targeting the proteolytic activity of MALT1 (mucosa-associated lymphoid tissue lymphoma translocated gene 1, paracaspase-1, HsPCA-Ia<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a>) has emerged as an attractive strategy for the treatment of lymphomas with oncogenic activation of the MALT1-dependent signaling pathway as well as autoimmune diseases.<a onclick="showRef(event, 'ref2 ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4 ref5">(2−5)</a> However, there are also potential concerns associated with this strategy. On the one hand, protease-inactivated MALT1 knock-in mice display reduced regulatory T cell (Treg) numbers, which is thought to drive inflammation in multiple organs and autoimmunity seen in these animals.<a onclick="showRef(event, 'ref6 ref7 ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8 ref9 ref10">(6−10)</a> The effect of MALT1 protease inhibition on reducing Treg numbers has, on the other hand, recently been suggested to potentiate efficacy of check-point immunotherapy in cancer.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11,12)</a> Overall, the therapeutic potential of MALT1 protease inhibitors remains an open question and there is a need for suitable compounds to explore the <i>in vivo</i> efficacy and safety profile of MALT1 protease inhibition. Several classes of covalent<a onclick="showRef(event, 'ref13 ref14 ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15 ref16 ref17">(13−17)</a> and noncovalent allosteric<a onclick="showRef(event, 'ref17 ref18 ref19 ref20 ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19 ref20 ref21 ref22 ref23">(17−23)</a> MALT1 protease inhibitors have been used to probe the effects of pharmacological MALT1 inhibition. In particular, the covalent inhibitor MI-2 led to decreased tumor growth of ABC-DLBCL xenographs<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a><i>in vivo.</i> Mepazine was the first allosteric inhibitor to be reported and demonstrated <i>in vivo</i> effects in ABC-DLBCL lymphomas,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> primary effusion lymphomas,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and in a model of multiple sclerosis.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Recently, we reported the highly potent and selective allosteric inhibitor <b>MLT-827</b> which has been used in several <i>in vitro</i> studies, contributing to validate the key role of MALT1 in T cells,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> myeloid cells,<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26,27)</a> and endothelial cells.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> The low solubility of this compound motivated further optimization, as described in the accompanying paper by Pissot-Soldermann et al.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(29)</a> This led to the advanced derivative <b>1</b> (<b>MLT-231</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), which induced tumor stasis in a CD79 mutant ABC-DLBCL lymphoma xenograft model. However, the required high dose of 100 mg kg<sup>–1</sup> BID and the moderate efficacy illustrated the limitations to achieve sustained MALT1 inhibition <i>in vivo</i> thus preventing progression of this series to clinical development. Here, we report on further optimization of this scaffold, to achieve high <i>in vivo</i> potency and efficacy at low doses.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01246/20201203/images/medium/jm0c01246_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01246/20201203/images/large/jm0c01246_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structure, potency, and <i>in vivo</i> efficacy of <b>MLT-231</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01246/20201203/images/large/jm0c01246_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01246&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51023" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51023" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The high dose of <b>MLT-231</b> needed for efficacy might result from two features, namely, a short <i>in vivo</i> half-life (2 h in mouse) and a suboptimal potency exemplified by the high circulating levels needed to achieve efficacy.</div><div class="NLM_p">A common strategy to prolong the <i>in vivo</i> half-life is to reduce the clearance. While the <i>in vivo</i> clearance of <b>MLT-231</b> is only moderate in mice and rats (15 and 25 mL min<sup>–1</sup> kg<sup>–1</sup>, respectively), further reduction may increase the residence time of the compound in circulation. The significant metabolic turnover of <b>MLT-231</b> in liver microsomes <i>in vitro</i> (42 and 82 μL min<sup>–1</sup> mg<sup>–1</sup> for rat and mouse, respectively) suggested a contribution of metabolism to the clearance mechanism. In addition, the higher metabolic turnover of <b>MLT-231</b> in human microsomes (114 μL min<sup>–1</sup> mg<sup>–1</sup>) suggested that reducing metabolic clearance would be needed to identify compounds with potential for clinical development. Metabolism of <b>MLT-231</b> was examined following <i>in vitro</i> incubation with either rat or human liver microsomes (see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01246/suppl_file/jm0c01246_si_001.pdf" class="ext-link">Supporting Information</a> for detailed results). Three major metabolites <b>m1, m2,</b> and <b>m4</b> could be identified from rat liver microsomes (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). Metabolite <b>m1</b> is formed by aromatic C-hydroxylation at the 5-position of the pyrazolopyrimidine moiety and subsequent <i>O</i>-glucuronidation. Oxidation and intramolecular cyclization lead to metabolite <b>m2</b> while N-oxidation at the morpholine moiety leads to metabolite <b>m4</b>. The metabolism profile identified from human liver microsomes was very similar. Two notable differences were the lower production of <b>m1</b> and <b>m2</b> in human liver microsomes and the increased level of <b>m3,</b> which is formed by <i>O</i>-glucuronidation of <b>m2</b>. For both rat and human, intramolecular cyclization and N-oxidation at the morpholine moiety appeared to be major pathways.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01246/20201203/images/medium/jm0c01246_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01246/20201203/images/large/jm0c01246_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Major metabolites of <b>MLT-231</b> identified by capillary-HPLC/MS after incubation with human or rat liver microsomes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01246/20201203/images/large/jm0c01246_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01246&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To determine the relevance of these transformations <i>in vivo</i>, the metabolism of <b>MLT-231</b> was analyzed in blood, urine, bile, kidney, and liver after i.v. administration to bile duct cannulated rats<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(30,31)</a> (see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01246/suppl_file/jm0c01246_si_001.pdf" class="ext-link">Supporting Information</a> for full details). Metabolite <b>m1</b> was the major component in bile consisting of more than 80% of the total peak area. Metabolite <b>m2</b> was the most abundant metabolite in blood while <b>m4</b> could be observed at significant levels in urine. These data confirmed that the major metabolic soft spots identified by <i>in vitro</i> incubations with microsomes were predictive for the <i>in vivo</i> situation. A tentative calculation of the mass balance for <b>MLT-231</b> suggested low levels of unchanged parent in body fluids and tissues indicating that <b>MLT-231</b> is predominantly metabolized prior to excretion.</div><div class="NLM_p">Based on this information, we embarked on modifying the compound to attenuate the major metabolic pathways. We envisioned that replacing the nitrogen atom of the morpholine by a carbon atom would not only prevent N-oxidation but also reduce the electron density of the pyrazolopyrimidine moiety, which could slow down the oxidative cyclization reaction. To quickly test this hypothesis, we made the C7-methyl analog <b>2</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Although <b>2</b> was significantly less potent than <b>MLT-231</b> on target, the <i>in vitro</i> metabolic turn-over of <b>2</b> in rat and human microsomes was significantly reduced compared to <b>MLT-231</b>. To recover the lost potency, we introduced the bulkier isopropyl group, which led to compound <b>3</b> with comparable biochemical and cellular potency as <b>MLT-231</b> while the low microsomal turn-over was maintained. We could further improve biochemical and cellular potency by introducing an additional triazole ring on the aminopyridine group, leading to compound <b>4</b>. We then compared the <i>in vivo</i> clearance and disposition properties of <b>4</b> with <b>MLT-231</b> in a rat PK cassette study (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). In agreement with the reduced <i>in vitro</i> metabolic turnover, the <i>in vivo</i> clearance of <b>4</b> was reduced compared to <b>MLT-231</b> which in turns led to a significantly longer half-life of 5.4 h.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. <i>In Vitro</i> Potency and <i>In Vitro</i> Clearance from Human (HLM), Rat (RLM), and Mouse (MLM) Liver Microsomes of Compound <b>1–4</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01246/20201203/images/medium/jm0c01246_0010.gif" alt="" id="GRAPHIC-d7e657-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01246/20201203/images/medium/jm0c01246_0011.gif" alt="" id="gr9" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Half–maximal MALT1 inhibition, as determined in a biochemical assay using recombinant MALT1 as described in ref <a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(32)</a>.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Data represent mean values of duplicate measurements.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">Half–maximal inhibition of MALT1-dependent IL-2 production in Jurkat cells measured with a reporter gene assay based on the human IL-2 promoter, as described in ref <a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a>.</p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last">Whole Blood assay.</p></div><div class="footnote" id="t1fn5"><sup><sup>e</sup></sup><p class="last">Human (HLM), Rat (RLM) and Mouse (MLM) liver microsomal clearance in μL min<sup>–1</sup> mg<sup>–1</sup>, <i>n</i> = 1.</p></div><div class="footnote" id="t1fn6"><sup><sup>f</sup></sup><p class="last">Compounds were dosed iv at 1 mg kg<sup>–1</sup> in NMP/PEG200 (1:9) in the same animals (cassette dosing). CL in mL min<sup>–1</sup> kg<sup>–1</sup>, <i>t</i><sub>1/2</sub> in h.</p></div></div><div></div></div><div class="NLM_p">The <i>in vitro</i> metabolism of <b>4</b> in rat and human liver microsomes revealed three metabolic pathways: intramolecular cyclization, aromatic C-oxidation followed by glucuronidation and N- or C-oxidation on the pyrazolopyrimidine moiety (see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01246/suppl_file/jm0c01246_si_001.pdf" class="ext-link">Supporting Information</a> for detailed results). Thus, the metabolic pathways observed for compound <b>4</b> are consistent with the metabolism of <b>MLT-231</b>. Low levels of these metabolites were observed with 91% parent compound <b>4</b> remaining in both species versus 58 and 39% for <b>MLT-231</b> in human and rat microsomes, respectively. The lower metabolic turn-over of the biotransformation study observed for <b>4</b> is in line with Clint values depicted in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>. With the good <i>in vitro</i>/<i>in vivo</i> correlation for <b>MLT-231</b> and consistency of major metabolic pathways of <b>MLT-231</b> and <b>4</b>, the Clint values were used for further compound optimization.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. <i>In Vitro</i> Potency, Lipophilicity, Plasma Protein Binding, and <i>In Vitro</i> Clearance from Human (HLM), Rat (RLM), and Mouse (MLM) Liver Microsomes of Compound <b>5–12</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01246/20201203/images/medium/jm0c01246_0012.gif" alt="" id="GRAPHIC-d7e779-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01246/20201203/images/medium/jm0c01246_0013.gif" alt="" id="gr10" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Half–maximal MALT1 inhibition, as determined in a biochemical assay using recombinant MALT1 as described in ref <a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(32)</a>.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Data represent mean values of duplicate measurements.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">Half–maximal inhibition of MALT1-dependent IL-2 production in Jurkat cells measured with a reporter gene assay based on the human IL-2 promoter.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></p></div><div class="footnote" id="t2fn4"><sup><sup>d</sup></sup><p class="last">Whole Blood assay.</p></div><div class="footnote" id="t2fn5"><sup><sup>e</sup></sup><p class="last">Human and rat plasma protein binding.</p></div><div class="footnote" id="t2fn6"><sup><sup>f</sup></sup><p class="last">Human (HLM), Rat (RLM) and Mouse (MLM) liver microsomal clearance in μL min<sup>–1</sup> mg<sup>–1</sup>, <i>n</i> = 1.</p></div></div><div></div></div><div class="NLM_p">Next, we addressed the potency of the compound, which likely also contributed to the high dose needed for efficacy. Despite a high biochemical (IC<sub>50</sub> = 9 nM) and cellular (IC<sub>50</sub> = 0.18 μM) on target potency, high total blood exposure was required for efficacy of <b>MLT-231</b><i>in vivo</i> (total exposure of 23.6 μM at peak and 0.7 μM at trough for T cell-dependent B cell responses in mice, see accompanying paper).<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(29)</a> While this may be in part accounted for by the high plasma protein binding (∼99%) of the compound, we envisioned that an assay measuring potency in a more physiologically relevant system would better predict <i>in vivo</i> potency. Because target cells, such as T and B lymphocytes, are present in blood, we established an assay measuring pathway inhibition in whole blood. In fact, human whole blood assays have long been used to optimize compounds for auto-immune diseases and proved to be excellent predictors for clinical efficacy.<a onclick="showRef(event, 'ref32 ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref32 ref33 ref34">(33−35)</a> Using a similar paradigm to the cellular assay, we could measure IL-2 production in 90% human whole blood after stimulation with a combination of PMA with an anti-CD28 antibody, which leads to full-dependency on MALT1 proteolytic function for IL-2 up-regulation.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> In this assay, <b>MLT-231</b> displayed potency of only 9 μM, hence a >800-fold loss from the biochemical potency and ∼50-fold loss from the cellular potency. While <b>4</b> was slightly more potent in whole blood (2.5 μM), the shift from the biochemical assay remained in the same range (>800).</div><div class="NLM_p">Compound <b>4</b> displayed a high log <i>P</i> value of 4. Reducing binding to blood components including plasma proteins by lowering lipophilicity is often a strategy to improve translation of biochemical potency to whole blood.<a onclick="showRef(event, 'ref33 ref35'); return false;" href="javascript:void(0);" class="ref ref33 ref35">(34,36)</a> We therefore prepared a set of derivatives with less lipophilic side chains in the 7-position of the pyrazolopyrimidine moiety (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). The potency shift from biochemical to whole blood potency (ratio WB/MALT1 IC<sub>50</sub>) was calculated to monitor the effects of these changes.</div><div class="NLM_p">The slightly less lipophilic C7-cyclopropyl derivative <b>5</b> was in the same biochemical and cellular potency range as <b>4</b> but did not lead to significant improvement of potency in whole blood. To further reduce lipophilicity, we introduced a tetrahydropyran ring leading to compound <b>6</b>, which showed a modest 3-fold loss of biochemical potency compared to <b>5.</b> The reduction of log <i>P</i> from 4 for compound <b>4</b> to 3 for compound <b>6</b> was accompanied by a reduction of plasma protein binding from greater than 99% for compound <b>4</b> to 98.8 and 97.7% for compound <b>6</b> in human and rat plasma, respectively. However, compound <b>6</b> showed a similar or higher potency shift leading to very weak activity in whole blood. These data indicated that reducing lipophilicity is not sufficient to lower the potency shift and improve performance of the compounds in whole blood. In addition, compounds <b>5–8</b> display higher <i>in vitro</i> metabolic turn over than compound <b>4</b>, in particular in rat liver microsomes, suggesting that the more polar C7 substituents may represent new metabolic weak spots or influence other metabolism pathways.</div><div class="NLM_p">Another strategy to reduce binding to blood components is to remove hydrogen-bond donors (HBD) and/or acceptors (HBA) which can interact with polar groups found in plasma proteins and other biomolecules.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(37)</a> The central urea of our scaffold constitutes a HBD–HBA–HBD motif which could contribute to binding to blood components. On one hand, previous SAR described in the accompanying paper<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(29)</a> showed that modification of the NH linked to the pyridine led to complete loss of potency. On the other hand, the NH linked to the pyrazolopyrimidine could be replaced by a carbon with a moderate 4-fold loss of potency indicating that it may not contribute strongly to binding to MALT1. This potency loss may be due to the increased flexibility of the amide compared to the urea, which is fixed in the bioactive conformation. With this in mind, we envisioned that engaging the NH linked to the pyrazolopyrimidine in an intramolecular H-bond could maintain the bioactive conformation while shielding the HBD character. This was attempted by introducing a methoxymethyl-group in the C-7 position of the pyrazolopyrimidine moiety. Despite a 6-fold loss of biochemical potency, compound <b>9</b> showed a similar whole blood potency as compound <b>4</b>. The potency shift was thus reduced to 168-fold. The loss of biochemical potency may be due to the lack of branched substituent in C-7 but the reduced potency shift suggested that this methoxymethyl-group reduced unspecific binding of the compound. Introducing an additional methyl group on the side chain led to isomers <b>10</b> and <b>11 (MLT-985)</b>, which retained this moderate potency shift and led, for the most active isomer <b>MLT-985</b>, to a high whole blood potency of 500 nM. Importantly, this methoxymethyl substituent does not impact the <i>in vitro</i> clearance of the compound which remained below 25 μL min<sup>–1</sup> mg<sup>–1</sup> in human, mouse and rat liver microsomes suggesting that metabolism is not significantly increased. When the position of the methoxy group was shifted by one carbon atom as in compounds <b>7</b> and <b>8</b>, the reduced potency shift was not observed. This may be attributed to a less favorable internal hydrogen bond that would lead to the formation of a pseudo seven-membered ring versus a pseudo six-membered ring for <b>MLT-985</b>.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(38)</a> Because <b>7</b>, <b>8</b>, and <b>MLT-985</b> have similar lipophilicity, the internal H-bond may be the major contributing factor to the reduced potency shift.</div><div class="NLM_p">To confirm this experimentally, we used NMR spectroscopy to obtain a quantitative value for hydrogen-bond strength for compounds <b>7</b> and <b>MLT-985</b> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). This can be achieved by comparing the <sup>1</sup>H NMR chemical shift of individual protic hydrogens in DMSO and CDCl<sub>3</sub>. This chemical shift change can be empirically correlated to hydrogen-bond acidity.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(39)</a> The acidity (<i>A</i>) can be calculated using the equation <i>A</i> = 0.0066 + 0.133 Δδ where Δδ is the chemical shift change (Δδ = δ(DMSO) – δ(CDCl3)). <i>A</i> can be used as a quantitative assessment of intramolecular hydrogen bonding and for NH groups, <i>A</i> < 0.05 indicates that the NH is part of a intramolecular H-bond.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(40)</a> Indeed, both intramolecular hydrogen bonding and hydrogen bonding between solute and polar solvent have a strong electron deshielding effect on its resonance. Therefore, if a strong intramolecular hydrogen bond is formed, the chemical shift of the corresponding proton will not change significantly between polar (DMSO) and nonpolar (CDCl3) solvents. The small shift (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>) and measured acidity of 0.037 for NH11 in <b>MLT-985</b> indicated a strongly hydrogen-bonded proton, whereas a larger shift was observed for NH11 in compound <b>7</b> corresponding to an acidity of 0.141. For both compounds, NH16 displayed a large shift. This confirmed that only NH11 of <b>MLT-985</b> is involved in a strong intramolecular hydrogen bond.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01246/20201203/images/medium/jm0c01246_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01246/20201203/images/large/jm0c01246_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. 1D) <sup>1</sup>H spectra of <b>MLT-985</b> (left panel) and compound <b>7</b> (right panel) in CDCl3 and DMSO. Resonances of the NH protons 11 and 16 are labeled and shift change is illustrated with black dashed arrows.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01246/20201203/images/large/jm0c01246_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01246&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Having identified this driver of whole blood potency, we prepared compound <b>12</b>, named <b>MLT-943</b>,<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(41)</a> which contains the 2-(trifluoromethyl)pyridin-4-amine substituent of <b>MLT-231</b> in R2 (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). <b>MLT-943</b> displayed similar, albeit slightly reduced potency, than <b>MLT-985</b> in the biochemical and cellular assays. Importantly, the potency shift remains similar which leads to a reasonable whole blood potency of 0.8 μM and <i>in vitro</i> metabolism is not affected.</div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> DMPK Properties of <b>MLT-985</b> and <b>MLT-943</b></h3><div class="NLM_p">Based on their promising profiles, the DMPK properties of <b>MLT-985</b> and <b>MLT-943</b> were further characterized. <b>MLT-985</b> and <b>MLT-943</b> displayed high permeability as measured in the Caco-2 assay (Papp A-B [10–6 cm/s] = 12.8 and 45.2, respectively)<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(42)</a> and showed no inhibition of the cytochrome P450 enzymes CYP3A4, CYP2C9 and CYP2D6 (IC<sub>50</sub> > 20 μM). Their moderate thermodynamic solubility (0.004 g L<sup>–1</sup> at pH 6.8) is comparable to that of <b>MLT-231</b> and an intrinsic property of this pyrazolopyrimidine scaffold.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(29)</a><b>MLT-985</b> showed a promising <i>in vivo</i> pharmacokinetic profile in both rats and mice (dosed at 1 mg kg<sup>–1</sup> intravenously (IV) and at 3 mg kg<sup>–1</sup> orally (PO)), characterized by low clearance, a terminal half-life (<i>t</i><sub>1/2</sub>) of 3.7 h in mice and 8.5 h in rats, sustained micromolar exposure levels in plasma after oral dosing, and high oral bioavailability (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). In rats, <b>MLT-943</b> displayed a similar profile. In mice, the compound showed a moderate clearance, a shorter half-life of 1.2 h and a moderate oral bioavailability of 50%. As our objective was to characterize the effects of these optimized compounds in mice xenograft models, we selected <b>MLT-985</b> for further profiling because of its superior PK profile in this species.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. PK Parameters of <b>MLT-985</b> and <b>MLT-943</b> in Sprague-Dawley Rats and Balb/C Mice</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">i.v.<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">p.o.<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center" char=".">CL</th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>1/2</sub></th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>ss</sub></th><th class="colsep0 rowsep0" align="center" char=".">AUC<sub>0–24</sub> h</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub></th><th class="colsep0 rowsep0" align="center" char="."><i>F</i></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left"><b>MLT-985</b></td><td class="colsep0 rowsep0" align="char" char=".">7</td><td class="colsep0 rowsep0" align="char" char=".">8.5</td><td class="colsep0 rowsep0" align="char" char=".">4.2</td><td class="colsep0 rowsep0" align="char" char=".">13.2</td><td class="colsep0 rowsep0" align="char" char=".">0.7</td><td class="colsep0 rowsep0" align="char" char=".">79</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><b>MLT-943</b></td><td class="colsep0 rowsep0" align="char" char="."><b>9</b></td><td class="colsep0 rowsep0" align="char" char=".">9.6</td><td class="colsep0 rowsep0" align="char" char=".">5.3</td><td class="colsep0 rowsep0" align="char" char=".">13.4</td><td class="colsep0 rowsep0" align="char" char=".">0.7</td><td class="colsep0 rowsep0" align="char" char=".">86</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse</td><td class="colsep0 rowsep0" align="left"><b>MLT-985</b></td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">3.7</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td><td class="colsep0 rowsep0" align="char" char=".">20.1</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td><td class="colsep0 rowsep0" align="char" char=".">83</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><b>MLT-943</b></td><td class="colsep0 rowsep0" align="char" char=".">28</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="char" char=".">3.0</td><td class="colsep0 rowsep0" align="char" char=".">2.3</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">50</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">i.v. admistration of 1 mg kg<sup>–1</sup> in NMP:PEG200 (30/70) for rat, NMP:Plasma (10:90) for mouse; CL: total clearance in mL min<sup>–1</sup> kg<sup>–1</sup>, <i>t</i><sub>1/2</sub>; half-life in h; <i>V</i><sub>SS</sub>: apparent volume of distribution at steady state in L kg<sup>–1</sup>.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">p.o. admistration of 3 mg kg<sup>–1</sup> in MC:Tween80:Water (0.5:0.5:99), AUC<sub>0–24 h</sub>: area under the concentration–time curve from 0 to 24 h in nM h<sup>–1</sup>, <i>C</i><sub>max</sub>: observed maximal concentration in nM, <i>F</i>: absolute oral bioavailibility in %.</p></div></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Cellular and Selectivity Profiling of <b>MLT-985</b></h3><div class="NLM_p">With its promising profile, <b>MLT-985</b> was selected for further characterization. We sought to assess the activity of <b>MLT-985</b> in cellular models of DLBCL.<a onclick="showRef(event, 'ref14 ref18'); return false;" href="javascript:void(0);" class="ref ref14 ref18">(14,18)</a> Aberrant activation of the NF-κB signaling pathway by mutations in the B-cell-receptor or the CARD11/BCL10/MALT1 (CBM) complex is a hallmark of the ABC-subtype of DLBCL.<a onclick="showRef(event, 'ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref42 ref43">(43,44)</a> We therefore profiled <b>MLT-985</b> in ABC-DLBCL cell lines harboring either activating mutations in CARD11 (OCI-Ly3), CD79A (OCI-Ly10) or CD79B (TMD8) and used BJAB germinal-center (GCB) DLBCL cells as a counter-screening model. Increasing concentrations of <b>MLT-985</b> inhibited the growth of CARD11 mutant OCI-Ly3 cells grown in soft agar, but not of the BJAB cells (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A). Importantly, in this assay <b>MLT-985</b> showed an approximately 10-fold lower EC<sub>50</sub> than <b>MLT-231</b><a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(29)</a> which is consistent with the improved potency in whole blood. Treating ABC-DLBCL cells for 24 h with <b>MLT-985</b> inhibited MALT1 protease activity in a concentration dependent manner, as evidenced by blockade of cleavage of MALT1 substrates BCL10, CYLD and RELB (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B,C). The inhibition of the CBM complex by <b>MLT-985</b> also led to decreased IRF4 levels. Potent cellular activity of <b>MLT-985</b> was further corroborated in a NF-κB reporter gene assay, a Meso Scale Discovery platform-based assay to assess inhibition of BCL10 cleavage, and a flow-cytometry assay for the detection of reactive oxygen species (ROS) (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>D). The impact of <b>MLT-985</b> on cellular ROS was assessed based on previous findings of higher baseline ROS levels in BCR-DLBLC models such as OCI-Ly3, as compared with models of the OxPhos-DLBCL subset.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(45)</a> Taken together, <b>MLT-985</b> demonstrated activity in cellular ABC-DLBCL models that is consistent with potent and selective inhibition of MALT1.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01246/20201203/images/medium/jm0c01246_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01246/20201203/images/large/jm0c01246_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. <b>MLT-985</b> suppresses growth and aberrant CARD11/BCL10/MALT1 complex signaling in ABC-DLBCL cells. (A) ABC-DLBCL (OCI-Ly3) and GCB-DLBCL (BJAB) cells were grown in soft-agar, and treated with increasing concentrations of <b>MLT-985</b> followed by imaging (image show representative fields in the individual wells, in false-color). (B) OCI-Ly3 cells were treated with increasing concentrations of <b>MLT-985</b> for 24 h followed by cell lysis for analysis of CYLD, BCL10, RELB, IRF4 by Western blotting. Levels of α-tubulin are provided as loading control. In the CYLD blot the arrow depicts appearance of full-length, uncleaved CYLD, while the arrowhead marks the position of the cleaved CYLD fragment. (C) TMD8 and OCI-Ly10 ABC-DLBCL cell lines were treated and analyzed as described above in (B). (D) IC<sub>50</sub>, EC<sub>50</sub>, or GI<sub>50</sub> values (means of at least two independent experiments except BCL10 MSD: <i>n</i> = 1) of <b>MLT-985</b> measured in the NF-kB reporter gene assay, BCL10 MSD assay, ROS inhibition assay, and resazurin-readouts of the OCI-Ly3 and BJAB soft agar growth assays, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01246/20201203/images/large/jm0c01246_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01246&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last"><b>MLT-985</b> showed excellent selectivity against a panel of 23 human proteases (all IC<sub>50</sub> values > 100 μM, <a href="/doi/suppl/10.1021/acs.jmedchem.0c01246/suppl_file/jm0c01246_si_001.pdf" class="ext-link">Table S1</a>) including cysteine proteases such as Caspase 3 and Cathepsin B, C, K, L and S which can be attributed to its allosteric mode of action.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> In addition, it showed high selectivity when tested against a standard safety panel of 25 enzymes, receptors, ion channels and transporters (IC<sub>50</sub> values > 10 μM, see <a href="/doi/suppl/10.1021/acs.jmedchem.0c01246/suppl_file/jm0c01246_si_001.pdf" class="ext-link">Supporting Information</a>). <b>MLT-985</b> did not inhibit the hERG channel (IC<sub>50</sub> > 30 μM; dofetilide binding assay).</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> <i>In Vivo</i> Pharmacology</h3><div class="NLM_p">To verify that the whole blood <i>in vitro</i> potency was predictive of <i>in vivo</i> potency, we established a short-term efficacy model that would allow for testing several compounds. We used a well-established rat model of T-dependent B cell response monitoring IgM-producing cells.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(41)</a> Four days after immunization with sheep red blood cells (SRBC), IgM producing B cells are assessed by an <i>ex vivo</i> plaque forming assay (PFA) allowing the counting of cells able to lyse sheep erythrocytes through their release of SRBC-selective IgM.<a onclick="showRef(event, 'ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref45 ref46">(46,47)</a> We used this model to compare the <i>in vivo</i> efficacy and potency of compounds <b>4</b> and <b>MLT-985</b>, which have similar biochemical potency (IC<sub>50</sub> = 0.003 μM) but differ in their whole blood potency (IC<sub>50</sub> = 2.5 vs 0.5 μM). Because <b>4</b> has a shorter <i>in vivo</i> half-life than <b>MLT-985</b> in rats (5.4 h vs 8.5 h), we used twice daily (BID) dosing for <b>4</b> and once daily (QD) dosing for <b>MLT-985</b>. As shown in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>, both compounds significantly reduced SRBC-induced IgM producing cells in a dose-dependent manner. For <b>4</b>, full inhibition was achieved at 10 mg kg<sup>–1</sup> BID and 3 mg kg<sup>–1</sup> BID could be considered as the dose required for about 50% inhibition (ED<sub>50</sub>). These doses corresponded to peak blood levels of about 7.6 and 1.5 μM, respectively, and trough blood levels of about 3.3 and 0.4 μM, respectively. A ten-fold higher potency was observed for <b>MLT-985</b> that achieved full inhibition at 3 mg kg<sup>–1</sup> QD (with peak and trough blood levels of about 2.3 and 1 μM, respectively) and ED<sub>50</sub> at 0.3 mg kg<sup>–1</sup> QD (with peak and trough blood levels of about 0.13 and 0.05 μM, respectively). <b>MLT-943</b> performed similarly in this model suggesting that this compound is suited for rat <i>in vivo</i> studies.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(41)</a></div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01246/20201203/images/medium/jm0c01246_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01246/20201203/images/large/jm0c01246_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Inhibitory effects of <b>4</b> and <b>MLT-985</b> on SRBC-induced IgM producing cells in the rat, as measured by <i>ex vivo</i> plaque forming assay. *<i>p</i> < 0.05. <sup>a</sup> Total blood concentration of <b>4</b> measured 3 or 14 h post dose. <sup>b</sup> Total blood concentration of <b>MLT-985</b> measured 3 or 24 h post dose.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01246/20201203/images/large/jm0c01246_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01246&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Next, we studied the pharmacokinetic/pharmacodynamics (PK/PD) relationship of <b>MLT-985</b> in the CD79B-mutant ABC-DLBCL xenograft model TMD8. After a single-dose at 30 mg kg<sup>–1</sup> p.o., <b>MLT-985</b> exhibited rapid absorption, which was corroborated by a rapid decrease of IL-10 production in the tumor (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A). <b>MLT-985</b> achieved a stronger effect on tumor IL-10 at a lower dose and exposure in this model compared to <b>MLT-231</b>,<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(29)</a> confirming the increased <i>in vivo</i> potency of <b>MLT-985</b>. We then tested the efficacy of <b>MLT-985</b> in the CARD11-mutant ABC-DLBCL xenograft model OCI-Ly3. We treated tumor-bearing mice with <b>MLT-985</b> in an oral QD or BID schedule at 30 mg kg<sup>–1</sup>. At day 49, <b>MLT-985</b> given at 30 mg kg<sup>–1</sup> QD led to a nonsignificant tumor growth inhibition (T/C = 32%), while BID dosing resulted in a statistically significant tumor regression of −20% (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B). The tumors continued to respond to treatment from day 49 to day 53 with the <b>MLT-985</b> QD schedule leading to approximately stasis, and the BID schedule leading to a −50% regression. Both regimens were well tolerated based on body weight (data not shown). Notably, the antitumor effect correlated with compound exposure and tumor PD modulation (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>C,D).</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01246/20201203/images/medium/jm0c01246_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01246/20201203/images/large/jm0c01246_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. PK/PD and efficacy of <b>MLT-985</b> in ABC-DLBCL xenograft models. (A) PK/PD study in TMD8 xenografts after one single oral dose (30 mg kg<sup>–1</sup>). Mean plasma concentration ± SD (blue) and % tumor IL-10 ± SD (gray) are shown (<i>n</i> = 2–3). (B) Efficacy study in OCI-Ly3 xenografts after oral administration of either vehicle control or <b>MLT-985</b> at indicated doses and schedules. Mean tumor volumes ± SEM are shown (<i>n</i> = 6; *<i>p</i> < 0.05 vs vehicle). (B) Pharmacokinetics of <b>MLT-985</b> in plasma and tumor postlast dose. Mean compound concentrations ± SD are shown (<i>n</i> = 2). <i>D.</i> MALT1-specific tumor PD read outs were analyzed postlast dose by Western blotting as indicated (<i>n</i> = 2).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01246/20201203/images/large/jm0c01246_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01246&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Chemistry</h3><div class="NLM_p">An efficient synthetic route to access compound <b>2–6</b> and <b>9</b> is shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. First, ethyl 2-(ethoxymethylene)-3-oxoate intermediates A were obtained from the corresponding commercially available β-ketoesters by reaction with triethyl orthoformiate in acetic anhydride at 135 °C. These were then cyclo-condensed with 3-chloro-1<i>H</i>-pyrazol-5-amine<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(48)</a> in EtOH at reflux temperature to give the ethyl pyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylates <b>B</b>. After saponification of the ester, the corresponding carboxylic acids <b>C</b> were converted to an intermediate isocyanate by thermal curtius rearrangement in the presence of DPPA and Et<sub>3</sub>N in dioxane, which was trapped in situ with either 2-(trifluoromethyl)pyridin-4-amine to give compounds <b>2</b> and <b>3</b>, or with aminopyridine <b>13</b> to give compounds <b>4-6</b> and <b>9</b>. Aminopyridine <b>13</b> was prepared in two steps from commercially available 2,3-dichloro-5-nitropyridine by aromatic nucleophilic substitution with 2<i>H</i>-1,2,3-triazole followed by reduction of the nitro-group by SnCl<sub>2</sub> in HCl/MeOH.</div><figure id="sch1" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01246/20201203/images/medium/jm0c01246_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01246/20201203/images/large/jm0c01246_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Routes for Inhibitors <b>2–6</b> and <b>9</b> (cf. Tables for Structures)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01246/20201203/images/large/jm0c01246_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01246&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Triethyl orthoformiate, Ac<sub>2</sub>O, 135 °C; (b) 5-chloro-1<i>H</i>-pyrazol-3-amine, EtOH, 80 °C; (c) NaOH, EtOH; (d) DPPA, Et<sub>3</sub>N, dioxane, RT then 2-(trifluoromethyl)pyridin-4-amine or <b>13,</b> 100 °C. (e) K<sub>2</sub>CO<sub>3</sub>, 2<i>H</i>-1,2,3-triazole, RT; (f) SnCl<sub>2</sub>, HCl (1.25 M) in MeOH; RT.</p></p></figure><div class="NLM_p">Examples <b>7</b>, <b>8</b>, <b>10</b>, and <b>MLT-985</b> were prepared in an analogous manner as described in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. First, β-ketoesters <b>A</b> were prepared by condensation of 3-(<i>tert</i>-butoxy)-3-oxopropanoic acid dianion with the imidazolides of corresponding commercially available carboxylic acids. In a one pot reaction, <b>A</b> were then converted to <i>tert</i>-butyl pyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylates <b>B</b> by forming the enamine intermediate with dimethylformamide-dimethylacetal at 120 °C followed by cyclo-condensation with 3-chloro-1<i>H</i>-pyrazol-5-amine in EtOH at reflux temperature. After acidic cleavage of the <i>tert</i>-butyl ester, carboxylic acids <b>C</b> were converted to an intermediate isocyanate by thermal Curtius rearrangement in the presence of DPPA and Et<sub>3</sub>N in dioxane, which was trapped in situ with aminopyridine <b>13</b> to give compounds <b>7</b>, <b>8</b>,<b>10</b>, and <b>MLT-985</b>. As 3-methoxy-2-methylpropanoic acid was used as racemate, compounds <b>7</b> and <b>8</b> were obtained by chiral separation at the final step.</div><figure id="sch2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01246/20201203/images/medium/jm0c01246_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01246/20201203/images/large/jm0c01246_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Routes for Inhibitors <b>7</b>, <b>8</b>, <b>10</b>, and <b>MLT-985</b> (cf. Tables for Structures)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01246/20201203/images/large/jm0c01246_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01246&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) CDI, 0 °C then 3-(<i>tert</i>-butoxy)-3-oxopropanoic acid, iPrMgCl, THF, RT; (f) dimethylformamide-dimethylacetal, 120 °C, then 5-chloro-1<i>H</i>-pyrazol-3-amine, EtOH, 80 °C; (g) TFA, CH<sub>2</sub>Cl<sub>2</sub>, RT; (d) DPPA, Et<sub>3</sub>N, dioxane, RT then 2-(trifluoromethyl)pyridin-4-amine or <b>13</b>, 100 °C. <b>7</b> and <b>8</b> were obtained after chiral separation of the racemate.</p></p></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63806" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63806" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">The identification of highly potent and selective MALT1 inhibitors with high <i>in vivo</i> efficacy is critical to explore the therapeutic potential of this target. Starting from an advanced lead <b>MLT-231</b>, we designed compounds with improved <i>in vivo</i> efficacy through two essential optimization steps. First, metabolism studies identified the 7-aminosubstituent as the main driver of metabolism prompting us to replace it with alkyl substituents. The resulting compound <b>4</b> displayed reduced <i>in vitro</i> metabolism as well as reduced clearance and increased half-life in rats. In the second step of the optimization, the potency in a whole blood assay measuring MALT1 pathway activation was optimized. This was achieved by introducing an intramolecular H-bond via a pseudo six-membered ring between the pyrazolopyrimidine NH and a newly introduced methoxy-group. The resulting <b>MLT-985</b> showed improved potency in whole blood as well as increased <i>in vivo</i> efficacy in a rat model of B-cell activation. It also showed improved potency in blocking proliferation of MALT1 dependent ABC-DLBCL cell lines while control GCB-DLBCL were not affected. As a result, increased PD modulation in a CD79 mutant ABC-DLBCL at lower exposures were observed. This optimized compound is the first MALT1 inhibitor to demonstrate tumor regression in a xenograft model of ABC-DLBCL lymphoma. It may therefore be useful to further explore the therapeutic potential of MALT1 inhibitors. Recently, we reported long term toxicology studies on <b>MLT-943</b>.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(41)</a> These data suggest that prolonged MALT1 protease inhibition can lead to a progressive IPEX-like pathology and highlights the risks and challenges associated with the chronic administration of MALT1 inhibitors in clinical settings.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25653" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25653" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Synthetic Procedures and Compound Characterization</h3><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> General Chemistry Information</h4><div class="NLM_p">Unless otherwise specified, all solvents and reagents were obtained from commercial suppliers and used without further drying or purification. Phase separator were obtained from Biotage: Isolute Phase separator (Part Nr: 120-1908-F for 70 mL and Part Nr: 120-1909-J for 150 mL). Normal-phase flash chromatography was performed using Merk silica gel 60 (230–400 mesh), Merck Darmstadt, Germany. <sup>1</sup>H- and <sup>13</sup>C NMR spectra were measured on Bruker spectrometers at room temperature and chemical shifts are reported in parts per million (ppm) relative to an internal solvent reference. Peaks are tabulated in the order multiplicity (s, singlet; d, doublet; t, triplet; q, quartet; quintet; m, multiplet; br, broad), coupling constant and number of protons. High-resolution mass spectra (HRMS) measurements were performed by using electrospray ionization in positive ion modus after separation by liquid chromatography (Nexera from shimadzu). The elemental composition was derived from the mass spectra acquired at the high resolution of about 30,000 on an LTQ Orbitrap XL mass spectrometer (Thermo Scientific). The high mass accuracy below 1 ppm was obtained by using a lock mass. Mass spectra (MS) and liquid chromatography mass spectra (LC–MS) were determined by using electrospray ionization in positive and negative ion modus using an Agilent 1100 series instrument. Purity of all compounds is > 95% as determined by analytical HPLC using an Agilent 1100 or 1200 series instrument and by integration of the area under the UV absorption curve at λ = 254 or 214 nm wavelenght. Rt refers to retention time.</div><div class="NLM_p last">The following conditions (A to D) were used for analytical UPLC or HPLC, if not indicated otherwise. Conditions A: Waters UPLC; column: Acquity HSS T3, 1.8 μm, 2.1 × 50 mm, at 60 °C, Eluent A: H<sub>2</sub>O + 0.05% HCOOH + 3.75 mM ammonium acetate, B: CH<sub>3</sub>CN + 0.04% HCOOH, Gradient: 5–98% B in 1.4 min, Flow: 1 mL/min. Condition B: Waters UPLC; column: Acquity HSS T3 1.8 μm, 2.1 × 50 mm, at 60 °C, Eluent A: H<sub>2</sub>O + 0.05% HCOOH + 3.75 mM ammonium acetate, B: CH<sub>3</sub>CN + 0.04% HCOOH, Gradient: 10–95% B in 1.5 min, Flow: 1 mL/min. Conditions C: Waters HPLC; column: Waters X-Bridge C18, 2.5 μm, 3 × 50 mm, at 40 °C, Eluent A: H<sub>2</sub>O + 0.1% TFA; B: CH<sub>3</sub>CN + 0.1% TFA. Gradient 10–98% B in 8.6 min hold 1.4 min, Flow: 1.4 mL/min. Condition D: Waters UPLC; column: Acquity HSS T3, 1.8 μm, 2.1 × 50 mm, at 60 °C, Eluent A: H<sub>2</sub>O + 0.05% HCOOH + 3.75 mM ammonium acetate, B: CH<sub>3</sub>CN + 0.04% HCOOH, Gradient: 5–98% B in 9.4 min, Flow: 1 mL/min.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> General Procedure 1: 2-Chloro-7-isopropylpyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylic Acid (Intermediate C, R = iPr, <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>)</h4><div class="NLM_p">Step A: Ethyl isobutyrylacetate (9.0 g, 56.9 mmol), triethyl orthoformate (18.9 mL, 114 mmol) and Ac<sub>2</sub>O (10.7 mL, 114 mmol) were stirred at 135 °C overnight. The solution was concentrated (16 mbar/60 °C) to afford ethyl 2-(ethoxymethylene)-4-methyl-3-oxopentanoate as a cis/trans mixture (11.8 g, 51.2 mmol, 90%). <i>m</i>/<i>z</i>: 215 [M + H]<sup>+</sup>, <i>R</i><sub><i>t</i></sub> = 0.93 and 0.99 min (UPLC Method A), <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): 7.84 and 7.66 (s, 1H), 4.27–4.06 (m, 4H), 3.12–3.05 (m, 1H), 1.27–1.15 (m, 6H), 1.03–0.98 (m, 6H).</div><div class="NLM_p">Step B: Ethyl 2-(ethoxymethylene)-4-methyl-3-oxopentanoate (11.8 g, 55.1 mmol) and 5-chloro-1<i>H</i>-pyrazol-3-amine (6.15 g, 52.3 mmol) in EtOH (130 mL) were stirred at 80 °C overnight. Water was added to the reaction mixture and the aqueous phase was extracted with AcOEt. The organic phase was washed with aqueous saturated NaHCO<sub>3</sub>, water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered and concentrated. The crude product was purified by flash column chromatography on silica gel (cyclohexane/AcOEt: 1/0 to 9/1) to afford ethyl 2-chloro-7-isopropylpyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylate (10.5 g, 39.3 mmol, 71%). <i>m</i>/<i>z</i>: 268–270 [M + H]<sup>+</sup>, <i>R</i><sub><i>t</i></sub> = 1.27 min (UPLC Method A), <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.80 (s, 1H), 7.00 (s, 1H), 4.42–4.35 (m, 3H), 1.51 (d, <i>J</i> = 5.1 Hz, 6H), 1.36 (t, <i>J</i> = 7.1 Hz, 3H).</div><div class="NLM_p">Step C: Ethyl 2-chloro-7-isopropylpyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylate (10.5 g, 39.3 mmol) was dissolved in EtOH (100 mL) and 2 N NaOH (39.3 mL, 79 mmol) was added. The reaction mixture was stirred at 60 °C for 3 h. EtOH was evaporated, AcOEt was added and the mixture was acidified with 1 M aqueous HCl to give a white suspension. The solid was filtered, washed with water and dried under vacuum. The resulting residue was treated with AcOEt and extracted with aqueous saturated NaHCO<sub>3</sub>. The aqueous phase was separated, acidified to pH = 2 and the precipitate filtered and washed with cold AcOEt to afford 2-chloro-7-isopropylpyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylic acid (5.8 g, 21.8 mmol, 56%). <i>m</i>/<i>z</i>: 240–242 [M + H]<sup>+</sup>, <i>R</i><sub><i>t</i></sub> = 0.83 min (UPLC Method A), <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ ppm: 13.8 (br s, 1H), 8.83 (s, 1H), 6.98 (s, 1H), 4.55 (hept, <i>J</i> = 8.9 Hz, 1H), 1.51 (d, <i>J</i> = 7.0 Hz, 6H).</div><div id="sec4_1_2_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i18" class="anchor-spacer"></div><h5 class="article-section__title" id="_i18"> 2-Chloro-7-methyl-pyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylic Acid (Intermediate C, R = Methyl, <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>)</h5><div class="NLM_p last">Colorless solid (484 mg, 90%), synthesized according to General Procedure 1. <i>m</i>/<i>z</i>: 210–212 [M – H]<sup>−</sup>, <i>R</i><sub><i>t</i></sub> = 0.65 min (UPLC Method A). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ ppm 8.92 (s, 1H), 7.01 (s, 1H), 3.07 (s, 3H) (COOH not visible).</div></div><div id="sec4_1_2_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i19" class="anchor-spacer"></div><h5 class="article-section__title" id="_i19"> 2-Chloro-7-cyclopropylpyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylic Acid (Intermediate C, R = cPr, <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>)</h5><div class="NLM_p last">Off-white solid (250 mg, 17%), prepared according to General Procedure 1. <i>m</i>/<i>z</i>: 238–240 [M + H]<sup>+</sup>, <i>R</i><sub><i>t</i></sub> = 0.69 min (UPLC Method A).</div></div><div id="sec4_1_2_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i20" class="anchor-spacer"></div><h5 class="article-section__title" id="_i20"> 2-Chloro-7-(tetrahydro-2<i>H</i>-pyran-4-yl)pyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylic Acid (Intermediate C, R = Tetrahydro-2<i>H</i>-pyran-4-yl, <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>)</h5><div class="NLM_p last">Colorless solid (1000 mg, 69%) according to General Procedure 1. <i>m</i>/<i>z</i>: 282–284 [M + H]<sup>+</sup>, <i>R</i><sub><i>t</i></sub> = 0.69 min (UPLC Method A). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ ppm 13.96 (br s, 1H), 8.85 (s, 1H), 7.01 (s, 1H), 4.02 (dd, <i>J</i> = 11.3, 4.0 Hz, 2H), 3.49–3.38 (m, 3H), 2.86–2.75 (m, 2H), 1.57 (dd, <i>J</i> = 13.0, 2.3 Hz, 2H).</div></div><div id="sec4_1_2_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i21" class="anchor-spacer"></div><h5 class="article-section__title" id="_i21"> 2-Chloro-7-(methoxy-methyl)pyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylic Acid (Intermediate C, R = Methoxymethyl, <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>)</h5><div class="NLM_p last">Yellow solid (282 mg, 62%), obtained according to General Procedure 1. <i>m</i>/<i>z</i>: 242–244 [M + H]<sup>+</sup>, <i>R</i><sub><i>t</i></sub> = 0.56 min (UPLC Method A).</div></div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 5-Chloro-6-(2<i>H</i>-1,2,3-triazol-2-yl)pyridin-3-amine, <b>13</b></h4><div class="NLM_p">Step A: To a solution of 2,3-dichloro-5-nitropyridine (1.20 g, 6.22 mmol) and K<sub>2</sub>CO<sub>3</sub> (1.43 g, 10.4 mmol) in THF (5 mL) was added 2<i>H</i>-1,2,3-triazole (0.360 mL, 6.22 mmol). The reaction mixture was stirred for overnight at RT. Because the reaction was uncomplete, additional 2<i>H</i>-1,2,3-triazole (0.300 mL, 5.18 mmol) was added and reaction mixture was stirred over 2 days at RT. Water was added and the mixture was extracted with AcOEt. The organic layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered and concentrated under vacuum. The residue taken-up in DCM, insoluble material (consisting mainly of product: 0.935 g, 4.14 mmol, 66%) was filtered off and the filtrate was evaporated. The residue was purified by flash column chromatography on silica gel (cyclohexane/AcOEt: 1/0 to 7/3) to afford additional 469 mg (2.13 mmol, 34%) of 3-chloro-5-nitro-2-(2<i>H</i>-1,2,3-triazol-2-yl)pyridine. <i>R</i><sub><i>t</i></sub> = 0.75 min (UPLC Method B), <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ ppm 9.39 (d, <i>J</i> = 2.4 Hz, 1H), 9.15 (d, <i>J</i> = 2.4 Hz, 1H), 8.33 (s, 2H).</div><div class="NLM_p last">Step B: To a solution of 3-chloro-5-nitro-2-(2<i>H</i>-1,2,3-triazol-2-yl)pyridine (500 mg, 2.22 mmol) in 1.25 M HCl in EtOH (35.5 mL, 44 mmol) at RT was added portionwise tin(II) chloride (2.1 g, 11.1 mmol). The reaction was stirred at RT for 2 h. The mixture was evaporated and residue was diluted with DCM. The mixture was basified with 1 N aqueous NaOH and phases were separated. The organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered and concentrated under vacuum. The residue was purified by flash column chromatography on silica gel (cyclohexane/AcOEt: 1/0 to 0/1) to afford 5-chloro-6-(2<i>H</i>-1,2,3-triazol-2-yl)pyridin-3-amine <b>13</b>. <i>m</i>/<i>z</i>: 196–198 [M + H]<sup>+</sup>, <i>R</i><sub><i>t</i></sub> = 0.50 min (UPLC Method B), <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ ppm 8.05 (s, 2H), 7.81 (s, 1H), 7.20 (s, 1H), 6.20 (s, 2H).</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> General Procedure 2: (<i>S</i>)-2-Chloro-7-(1-methoxyethyl)pyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylic Acid (Intermediate C (R = (<i>S</i>)-1-methoxy-ethyl, <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>)</h4><div class="NLM_p">Step A: To a solution of (<i>S</i>)-2-methoxypropanoic acid (9.0 g, 86 mmol) in THF (170 mL) at 0 °C was added CDI (15.4 g, 95 mmol) and the reaction mixture was stirred at RT for 100 min. In a separate flask, to a solution of 3-(<i>tert</i>-butoxy)-3-oxopropanoic acid (20.0 mL, 130 mmol) in THF (170 mL) at 0 °C was added dropwise 2 M isopropylmagnesium chloride in THF (125 mL, 251 mmol) and the reaction mixture was stirred for 100 min at 20 °C. Then, this solution was added dropwise to the acyl imidazole solution at 0 °C and the resulting mixture was stirred for 16 h at RT. The reaction mixture was quenched with 10% aqueous citric acid (25 mL), extracted with AcOEt, washed with aqueous saturated NaHCO<sub>3</sub>, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered and concentrated. The residue was purified by flash column chromatography on silica gel (cyclohexane/AcOEt: 100/0 to 70/30) to afford 16.1 g (76 mmol, 87%) (<i>S</i>)-<i>tert</i>-butyl 4-methoxy-3-oxopentanoate. <i>m</i>/<i>z</i>: 203 [M + H]<sup>+</sup>, <i>R</i><sub><i>t</i></sub> = 0.91 min (UPLC Method B), <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ ppm 3.85 (q, <i>J</i> = 6.8 Hz, 1H), 3.54–3.46 (m, 2H), 3.30 (s, 3H), 1.42 (s, 9H), 1.21 (d, <i>J</i> = 6.8 Hz, 3H).</div><div class="NLM_p">Step B: A mixture of 1,1-dimethoxy-<i>N</i>,<i>N</i>-dimethylmethanamine (8.48 mL, 64 mmol) and (<i>S</i>)-<i>tert</i>-butyl 4-methoxy-3-oxopentanoate (12.9 g, 64 mmol) was stirred at 120 °C for 1.5 h. Then, a solution of 5-chloro-1<i>H</i>-pyrazol-3-amine (7.5 g, 64 mmol) in EtOH (75 mL) was added and the resulting mixture was stirred 1 h at 85 °C. The reaction mixture was concentrated and the residue was purified by flash column chromatography on silica gel (cyclohexane/AcOEt: 100/0 to 70/30) to afford 13.65 g (43 mmol, 68%) of (<i>S</i>)-<i>tert</i>-butyl 2-chloro-7-(1-methoxyethyl)pyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylate. <i>m</i>/<i>z</i>: 312–314 [M + H]<sup>+</sup>, <i>R</i><sub><i>t</i></sub> = 1.30 min (UPLC Method B), <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ ppm 8.65 (s, 1H), 7.03 (s, 1H), 5.26 (q, <i>J</i> = 6.5 Hz, 1H), 3.22 (s, 3H), 1.62 (d, <i>J</i> = 6.5 Hz, 3H), 1.55 (s, 9H).</div><div class="NLM_p">Step C: To a solution of (<i>S</i>)-<i>tert</i>-butyl 2-chloro-7-(1-methoxyethyl)pyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylate (11.6 g, 37.1 mmol) in DCM (50 mL) at RT was added TFA (57 mL). The reaction mixture was stirred for 4 h and concentrated. Et<sub>2</sub>O was added to the residue and the suspension was evaporated to dryness to afford (<i>S</i>)-2-chloro-7-(1-methoxyethyl)pyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylic acid (9.8 g, 37 mmol, 100%). <i>m</i>/<i>z</i>: 256–258 [M + H]<sup>+</sup>, <i>R</i><sub><i>t</i></sub> = 0.60 min (UPLC Method B), <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ ppm 13.7 (br s, 1H), 8.74 (s, 1H), 7.04 (s, 1H), 5.40 (q, <i>J</i> = 6.6 Hz, 1H), 3.22 (s, 3H), 1.64 (d, <i>J</i> = 6.6 Hz, 3H).</div><div id="sec4_1_4_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i24" class="anchor-spacer"></div><h5 class="article-section__title" id="_i24"> (<i>R</i>)-2-Chloro-7-(1-methoxyethyl)pyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylic Acid (Intermediate C (R = (<i>R</i>)-1-Methoxy-ethyl, <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>)</h5><div class="NLM_p last">Colorless oil (1.45 g, 5.39 mmol, 93%), synthesized according to General Procedure 2. <i>m</i>/<i>z</i>: 256–258 [M + H]<sup>+</sup>, <i>R</i><sub><i>t</i></sub> = 0.63 min (UPLC Method A), <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ ppm 13.69 (br s, 1H), 8.72 (s, 1H), 7.03 (s, 1H), 5.40 (q, <i>J</i> = 6.6 Hz, 1H), 3.20 (s, 3H), 1.64 (d, <i>J</i> = 6.6 Hz, 3H).</div></div><div id="sec4_1_4_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i25" class="anchor-spacer"></div><h5 class="article-section__title" id="_i25"> 2-Chloro-7-(1-methoxypropan-2-yl)pyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylic Acid (Intermediate C (R = 1-Methoxypropan-2-yl, <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>)</h5><div class="NLM_p last">0.95 g, 2.35 mmol, 76%) according to General Procedure 2 starting from <i>tert</i>-butyl 5-methoxy-4-methyl-3-oxopentanoate. <i>m</i>/<i>z</i>: 270–272 [M + H]<sup>+</sup>, <i>R</i><sub><i>t</i></sub> = 0.79 min (UPLC Method A). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ ppm 13.91 (br s, 1H), 8.86 (s, 1H), 7.00 (s, 1H), 4.84–4.78 (m, 1H), 4.21 (t, <i>J</i> = 9.0 Hz, 1H), 3.73 (dd, <i>J</i> = 9.3, 6.6 Hz, 1H), 3.15 (s, 3H), 1.45 (d, <i>J</i> = 3H).</div></div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> General Procedure 3: (<i>S</i>)-1-(5-Chloro-6-(2<i>H</i>-1,2,3-triazol-2-yl)pyridin-3-yl)-3-(2-chloro-7-(1-methoxyethyl)pyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)urea, <b>MLT-985</b></h4><div class="NLM_p">To a solution of (<i>S</i>)-2-chloro-7-(1-methoxyethyl)pyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylic acid (2.0 g, 7.35 mmol) in 1,4-dioxane (16 mL) in a sealed vial were added DPPA (1.90 mL, 8.82 mmol) and Et<sub>3</sub>N (5.12 mL, 36.8 mmol). The yellow solution was stirred at RT for 30 min. Then, 5-chloro-6-(2<i>H</i>-1,2,3-triazol-2-yl)pyridin-3-amine (2.16 g, 11.0 mmol) was added and the reaction mixture was stirred for 2 h at 100 °C. After cooling to RT, water was added and the mixture was extracted with AcOEt, washed with aqueous saturated NaHCO<sub>3</sub>, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered and concentrated. The crude product was purified by flash column chromatography on silica gel (cyclohexane/AcOEt: 100/0 to 0/100), then the product was precipitated in MeOH and filtered to afford (<i>S</i>)-1-(5-chloro-6-(2<i>H</i>-1,2,3-triazol-2-yl)pyridin-3-yl)-3-(2-chloro-7-(1-methoxyethyl)pyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)urea as a white powder, 800 mg (7.35 mmol, 24%). <i>m</i>/<i>z</i>: 448–450 [M + H]<sup>+</sup>, <i>R</i><sub><i>t</i></sub> = 1.05 min, purity > 95% (HPLC Method B), <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ ppm 10.33 (br s, 1H), 8.95 (s, 1H), 8.60 (br s, 1H), 8.54 (d, <i>J</i> = 2.3 Hz, 1H), 8.49 (d, <i>J</i> = 2.3 Hz, 1H), 8.16 (s, 2H), 6.94 (s, 1H), 5.42 (q, <i>J</i> = 6.7 Hz, 1H), 3.33 (s, 3H), 1.59 (d, <i>J</i> = 6.7 Hz, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ ppm 153.0, 149.9, 146.3, 144.4, 141.5, 138.8, 136.8, 136.1, 127.4, 126.1, 120.2, 95.5, 72.9, 57.3, 17.4. HRMS (ESI, M + H): calcd for C<sub>17</sub>H<sub>16</sub>Cl<sub>2</sub>N<sub>9</sub>O<sub>2</sub>, 448.07985; found, 448.07993.</div><div id="sec4_1_5_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i27" class="anchor-spacer"></div><h5 class="article-section__title" id="_i27"> 1-(2-Chloro-7-methylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)-3-(2-(trifluoromethyl)pyridin-4-yl)urea, <b>2</b></h5><div class="NLM_p last">Obtained following General Procedure 3 (9.0 mg, 10%). <i>m</i>/<i>z</i>: 471–473 [M + H]<sup>+</sup>, <i>R</i><sub><i>t</i></sub> = 3.22 min, purity > 95% (UPLC Method D), <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ ppm: 9.86 (br s, 1H), 8.81 (s, 1H), 8.64 (s, 1H), 8.55 (d, <i>J</i> = 5.7 Hz, 1H), 8.06 (d, <i>J</i> = 2.2 Hz, 1H), 7.65 (dd, <i>J</i> = 5.7, 2.2 Hz, 1H), 6.93 (s, 1H), 2.66 (s, 3H). HRMS (ESI, M + H): calcd for C<sub>14</sub>H<sub>11</sub>ClF<sub>3</sub>N<sub>6</sub>O, 371.06295; found, 371.06290.</div></div><div id="sec4_1_5_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i28" class="anchor-spacer"></div><h5 class="article-section__title" id="_i28"> 1-(2-Chloro-7-isopropylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)-3-(2-(trifluoromethyl)pyridin-4-yl)urea, <b>3</b></h5><div class="NLM_p last">Synthesised according to General Procedure 3. Final purification was achieved by prep HPLC (Waters Sunfire C18 OBD, 5 μm, 30 × 100 mm, Eluent A: H<sub>2</sub>O + 0.1% TFA, B: ACN + 0.1% TFA, Gradient: 5–100% B) to give 29 mg (17%) of compound <b>3</b>. <i>m</i>/<i>z</i>: 399–401 [M + H]<sup>+</sup>, <i>R</i><sub><i>t</i></sub> = 1.08 min, purity > 95% (HPLC Method A), <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ ppm 9.85 (br s, 1H), 8.74–8.70 (m, 1H), 8.58–8.52 (m, 2H), 8.05 (d, <i>J</i> = 2.1 Hz, 1H), 7,66 (d, <i>J</i> = 6.1 Hz, 1H), 6.94 (s, 1H), 5.77 (s, 1H), 3.80 (hept, <i>J</i> = 7.0 Hz, 1H), 1.48 (d, <i>J</i> = 7.0 Hz, 6H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ ppm 153.8, 152.5, 150.7, 150.0, 148.2, 147.9, 147.2 (q), 144.7, 121.6 (q), 118.1, 114.9, 109.0, 95.1, 27.3, 17.4. HRMS (ESI, M + H): calcd for C<sub>16</sub>H<sub>15</sub>ClF<sub>3</sub>N<sub>6</sub>O, 399.09425; found, 399.09415.</div></div><div id="sec4_1_5_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i29" class="anchor-spacer"></div><h5 class="article-section__title" id="_i29"> 1-(5-Chloro-6-(2<i>H</i>-1,2,3-triazol-2-yl)pyridin-3-yl)-3-(2-chloro-7-isopropylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)urea, <b>4</b></h5><div class="NLM_p last">Synthesised according to General Procedure 3. Final purification was achieved by prep HPLC (Waters Sunfire C18 OBD, 5 μm, 30 × 100 mm, Eluent A: H<sub>2</sub>O + 0.1% TFA, B: ACN + 0.1% TFA, Gradient: 28–68% B) to give 564 mg (22%) as white solid. <i>m</i>/<i>z</i>: 432–434 [M + H]<sup>+</sup>, <i>R</i><sub><i>t</i></sub> = 1.03 min, purity > 95% (HPLC Method A), <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ ppm 9.71 (br s, 1H), 8.76 (s, 1H), 8.58 (d, <i>J</i> = 2.3 Hz, 1H), 8.56 (s, 1H), 8.44 (d, <i>J</i> = 2.3 Hz, 1H), 8.15 (s, 2H), 6.92 (s, 1H), 3.81 (m, 1H), 1.49 (d, <i>J</i> = 7.1 Hz, 6H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ ppm 153.9, 152.5, 149.8, 147.9, 144.6, 141.5, 139.0, 137.0, 136.1, 127.5, 126.0, 118.4, 95.1, 27.3, 17.5. HRMS (ESI, M + H): calcd for C<sub>17</sub>H<sub>16</sub>Cl<sub>2</sub>N<sub>9</sub>O, 432.08494; found, 432.08487.</div></div><div id="sec4_1_5_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i30" class="anchor-spacer"></div><h5 class="article-section__title" id="_i30"> 1-(5-Chloro-6-(2<i>H</i>-1,2,3-triazol-2-yl)pyridin-3-yl)-3-(2-chloro-7-cyclopropylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)urea, <b>5</b></h5><div class="NLM_p last">Obtained as an off-white solid (31 mg, 50%) according to General Procedure 3. <i>m</i>/<i>z</i>: 430–432 [M + H]<sup>+</sup>, <i>R</i><sub><i>t</i></sub> = 3.44 min, purity > 95% (HPLC Method C), <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ ppm 9.73 (br s, 1H), 8.73 (s, 1H), 8.58 (d, <i>J</i> = 2.4 Hz, 1H), 8.54 (s, 1H), 8.45 (d, <i>J</i> = 2.4 Hz, 1H), 8.14 (s, 2H), 6.88 (s, 1H), 2.40 (tt, <i>J</i> = 8.7, 5.7 Hz, 1H), 1.54 (dt, <i>J</i> = 6.5, 3.2 Hz, 2H), 1.21 (dt, <i>J</i> = 8.7, 3.2 Hz, 2H). HRMS (ESI, M + H): calcd for C<sub>17</sub>H<sub>14</sub>Cl<sub>2</sub>N<sub>9</sub>O, 430.06929; found, 430.06952.</div></div><div id="sec4_1_5_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i31" class="anchor-spacer"></div><h5 class="article-section__title" id="_i31"> 1-(5-Chloro-6-(2<i>H</i>-1,2,3-triazol-2-yl)pyridin-3-yl)-3-(2-chloro-7-(tetrahydro-2<i>H</i>-pyran-4-yl)pyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)urea, <b>6</b></h5><div class="NLM_p last">Following General Procedure 3 compound <b>6</b> was obtained as a white solid (31 mg, 12%). <i>m</i>/<i>z</i>: 472–474 [M + H]<sup>+</sup>, <i>R</i><sub><i>t</i></sub>= 3.44 min, purity > 95% (UPLC Method D), <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ ppm 9.72 (br s, 1H), 8.82 (s, 1H), 8.60 (d, <i>J</i> = 2.3 Hz, 1H), 8.59 (s, 1H), 8.45 (d, <i>J</i> = 2.3 Hz, 1H), 8.15 (s, 2H), 6.95 (s, 1H), 4.02 (dd, <i>J</i> = 10.8, 0.5 Hz, 2H), 3.83–3.73 (m, 1H), 3.46 (t, <i>J</i> = 11.6 Hz, 2H), 2.69–2.59 (m, 2H), 1.61 (d, <i>J</i> = 11.9 Hz, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ ppm 154.1, 152.7, 147.9, 147.1, 144.6, 141.5, 139.0, 137.1, 127.6, 126.0, 118.9, 95.3, 66.9, 35.2, 26.2. HRMS (ESI, M + H): calcd for C<sub>19</sub>H<sub>18</sub>Cl<sub>2</sub>N<sub>9</sub>O<sub>2</sub>, 474.09550; found, 474.09561.</div></div><div id="sec4_1_5_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i32" class="anchor-spacer"></div><h5 class="article-section__title" id="_i32"> (<i>R</i>)-1-(5-Chloro-6-(2<i>H</i>-1,2,3-triazol-2-yl)pyridin-3-yl)-3-(2-chloro-7-(1-methoxypropan-2-yl)pyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)urea, <b>7</b></h5><div class="NLM_p last">Synthesised according to General Procedure 3 followed by chiral preparative SFC, <i>R</i><sub><i>t</i></sub> = 13.27 min (71 mg, 24%). <i>m</i>/<i>z</i>: 462–464 [M + H]<sup>+</sup>, <i>R</i><sub><i>t</i></sub> = 1.04 min, purity > 95% (UPLC Method B), <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ ppm 9.79 (br s, 1H), 8.73 (s, 1H), 8.60 (s, 1H), 8.58 (d, <i>J</i> = 2.3 Hz, 1H), 8.45 (d, <i>J</i> = 2.3 Hz, 1H), 8.15 (s, 2H), 6.93 (s, 1H), 4.07 (t, <i>J</i> = 8.5 Hz, 1H), 3.98 (sext, <i>J</i> = 6.8 Hz, 1H), 3.73 (dd, <i>J</i> = 8.9, 6.1 Hz, 1H), 3.19 (s, 3H), 1.44 (d, <i>J</i> = 6.8 Hz, 3H). HRMS (ESI, M + H): calcd for C<sub>18</sub>H<sub>18</sub>Cl<sub>2</sub>N<sub>9</sub>O<sub>2</sub>, 462.09550; found, 462.09549.</div></div><div id="sec4_1_5_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i33" class="anchor-spacer"></div><h5 class="article-section__title" id="_i33"> (<i>S</i>)-1-(5-Chloro-6-(2<i>H</i>-1,2,3-triazol-2-yl)pyridin-3-yl)-3-(2-chloro-7-(1-methoxypropan-2-yl)pyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)urea, <b>8</b></h5><div class="NLM_p last">Synthesized according to General Procedure 3 followed by chiral preparative SFC, <i>R</i><sub><i>t</i></sub> = 7.11 min (70 mg, 23%). <i>m</i>/<i>z</i>: 462–464 [M + H]<sup>+</sup>, <i>R</i><sub><i>t</i></sub> = 1.04 min, purity > 95% (UPLC Method B), <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ ppm 9.79 (br s, 1H), 8.73 (s, 1H), 8.60 (s, 1H), 8.58 (d, <i>J</i> = 2.3 Hz, 1H), 8.45 (d, <i>J</i> = 2.3 Hz, 1H), 8.15 (s, 2H), 6.93 (s, 1H), 4.07 (t, <i>J</i> = 8.5 Hz, 1H), 3.98 (sext, <i>J</i> = 6.8 Hz, 1H), 3.73 (dd, <i>J</i> = 8.9, 6.1 Hz, 1H), 3.19 (s, 3H), 1.44 (d, <i>J</i> = 6.8 Hz, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ ppm 153.8, 152.2, 147.7, 146.3, 144.6, 141.5, 138.9, 137.0, 136.1, 127.5, 126.1, 119.8, 95.3, 72.3, 58.1, 33.1, 12.6. HRMS (ESI, M + H): calcd for C<sub>18</sub>H<sub>18</sub>Cl<sub>2</sub>N<sub>9</sub>O<sub>2</sub>, 462.09550; found, 462.09561.</div></div><div id="sec4_1_5_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i34" class="anchor-spacer"></div><h5 class="article-section__title" id="_i34"> 1-(5-Chloro-6-(2<i>H</i>-1,2,3-triazol-2-yl)pyridin-3-yl)-3-(2-chloro-7-(methoxymethyl)pyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)urea, <b>9</b></h5><div class="NLM_p last">Obtained as a pale yellow solid (21 mg, 13%) according to General Procedure 3. <i>m</i>/<i>z</i>: 434–436 [M + H]<sup>+</sup>, <i>R</i><sub><i>t</i></sub> = 3.31 min, purity > 95% (UPLC Method D), <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ ppm 9.97 (br s, 1H), 8.84 (s, 1H), 8.80 (br s, 1H), 8.57 (d, <i>J</i> = 2.4 Hz, 1H), 8.46 (d, <i>J</i> = 2.4 Hz, 1H), 8.16 (s, 2H), 6.97 (s, 1H), 4.98 (s, 2H), 3.39 (s, 3H). HRMS (ESI, M + H): calcd for C<sub>16</sub>H<sub>14</sub>Cl<sub>2</sub>N<sub>9</sub>O<sub>2</sub>, 434.06420; found, 434.06433.</div></div><div id="sec4_1_5_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i35" class="anchor-spacer"></div><h5 class="article-section__title" id="_i35"> (<i>R</i>)-1-(5-Chloro-6-(2<i>H</i>-1,2,3-triazol-2-yl)pyridin-3-yl)-3-(2-chloro-7-(1-methoxyethyl)pyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)urea, <b>10</b></h5><div class="NLM_p last">Synthesis according to General Procedure 3 provided 69 mg (30%) of compound <b>10</b>. <i>m</i>/<i>z</i>: 448–450 [M + H]<sup>+</sup>, <i>R</i><sub><i>t</i></sub> = 1.04 min, purity > 95% (UPLC Method A), <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ ppm 10.29 (s, 1H), 8.95 (s, 1H), 8.58 (s, 1H), 8.55 (d, <i>J</i> = 2.3 Hz, 1H), 8.49 (d, <i>J</i> = 2.3 Hz, 1H), 8.15 (s, 2H), 6.94 (s, 1H), 5.43 (q, <i>J</i> = 6.7 Hz, 1H), 3.34 (s, 3H), 1.59 (d, <i>J</i> = 6.7 Hz, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ ppm 153.0, 149.9, 146.3, 144.4, 141.5, 138.8, 136.8, 136.1, 127.4, 126.1, 120.2, 95.5, 72.9, 57.3, 17.4. HRMS (ESI, M + H): calcd for C<sub>17</sub>H<sub>16</sub>Cl<sub>2</sub>N<sub>9</sub>O<sub>2</sub>, 448.07985; found, 448.07980.</div></div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> <i>In Vitro</i> Assays</h3><div class="NLM_p">The following assays were performed as previously reported: Biochemical assay,<a onclick="showRef(event, 'ref20 ref31'); return false;" href="javascript:void(0);" class="ref ref20 ref31">(20,32)</a> IL-2 Jurkat,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> NF-kB reporter gene assay,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> BCL10 MSD assay.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> The inhibition of cellular ROS levels in OCI-Ly3 cells was measured by flow cytometry essentially as described.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(45)</a> The OCI-Ly3 and BJAB soft agar growth assays and imaging as well as resazurin-readouts are detailed in the accompanying paper by Pissot-Soldermann et al.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(29)</a></div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> Human Whole Blood IL-2 Assay</h4><div class="NLM_p last">Human whole blood was obtained from healthy volunteers by venipuncture at the Novartis Basel Health care unit (around 75 mL in 10 Monovetten Na-Heparin 7.5 mL-tubes). Age of donors ranged between 22 and 45 years. Both genders were included. Blood was kept at room temperature, protected from light, with gentle rotation for up to 5 h before use. All experimental steps performed according to “BL2” Novartis HSE guidelines. Blood from the collecting tubes was pooled into two 50 ml Falcon tubes and filtered using a 100 μm (or 70 μm)-cell strainer before transfer to new 50 mL tubes. In 2 mL-deep well plates, 180 μL of X–VIVO medium was added in column (one column for one compound to profile). Compound dilution was performed in a U-bottom plate, 90 μL of DMSO was added to the first row and 40 μL in all other wells. Then, 10 μL of compound was added to the first well of each column (10× predilution). Compounds were diluted by transferring 20 μL from the first row into the second row and repeating the process 4 times (3×-serial dilutions). 20 μL of prediluted compounds/DMSO (from U-bottom plate) were transferred to the 180 μL X–VIVO in the deep-well plate. The two filtrated blood tubes were pooled into a 100 mL reservoir and homogenized , prior to dispension into the plate. Then, 500 μL of whole blood was added to a new deep well plate and 55 μL of the X–VIVO/compound mixes were added to the blood. The deep well plates were sealed and preincubated for 1 h at 37 °C with shaking (∼600 rpm). The co-stimulation in X–VIVO medium was prepared (11×-concentrated): PMA (1100 ng/mL) /anti-CD28 (3300 ng/mL). After the preincubation time each blood sample was mixed 10-fold and 200 μL of the blood/compound mixes in duplicates were transferred to a new flat bottom plate. 20 μL of diluted stimulation was added to the blood to obtain final concentrations of PMA (100 ng/mL) /anti-CD28 (300 ng/mL). Two wells in duplicates remained unstimulated. Incubation was performed overnight at 37 °C + 5% CO<sub>2</sub>. Then, the blood plates were spun for 10 min at 470 g and 100 μL of the resulting serum was transferred, well by well, to new U-bottom plates. The plate was measured for IL-2 levels using MSD, according to the manufacturer’s protocol. For delayed measurement, a lid was sealed and the plate was frozen at −80 °C.</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> <i>In Vivo</i> Pharmacology</h3><div class="NLM_p">All animal experiments were approved by the Cantonal Veterinary Office Basel-Stadt and were conducted in accordance with the Federal Animal Protection Act and the Federal Animal Protection Order. Animal studies were conducted in accordance with Novartis Animal Care and Use Committee-approved protocols, and in line with facility Standard Operating Procedures (SOPs).</div><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> Formulations</h4><div class="NLM_p last">For pharmacology experiments, compounds were dissolved in a Microemulsion solution formulation with final composition of 17.4% w/v Cremophor RH40, 5.1% w/v Labrafil M2125 CS, 2.5% w/v Popylene glycol, 5% w/v Ethanol and 70% w/v Water. For mice, 10 mL kg<sup>–1</sup> of this solution (targeting 3 mg mL<sup>–1</sup>) were used to administer a dose of 30 mg kg<sup>–1</sup>. For rat experiments, a solution of 2, 0.6, 0.2, 0.06 mg mL<sup>–1</sup> was prepared to administer a 10, 3, 1, 0.3 mg kg<sup>–1</sup> dose, respectively, in a volume of 5 mL kg<sup>–1</sup>.</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> Rat Sheep Red Blood Cell Model</h4><div class="NLM_p last">Female albino OFA rats (IFFA CREDO, France) weighing 150–160 g were housed and used for experimentation under strict adherence to the Swiss law for animal protection (ad libitum standard diet [NAFAG890; Provimi Kliba SA]; IVC cages at 21 ± 2 °C and 55 ± 10% relative humidity; light from 6h00 to 18h00). The rats were randomized in treatment-groups (<i>n</i> = 5 each) and oral treatments started 2 days prior to immunization with 2 × 10<sup>8</sup>/mL SRBCs (0.5 mL <i>via</i> tail vein injection). Daily treatments continued for another 4 days and, on day 4 post-immunization, all rats were euthanized by CO<sub>2</sub> inhalation and the spleens were collected together with blood samples. The impact of treatments on the ability of B cells to produce SRBC-specific IgM was assessed using a classical ex vivo plaque forming assay (PFA) (Jerne and Nordin, 1963). For that, single spleen cell suspension (30 × 10<sup>6</sup>/mL) of each immunized animal was prepared and plated with fresh antigen (SRBC, 40 × 10<sup>8</sup>/mL) onto the soft agar (50 μL splenocytes + 50 μL SRBC). After an incubation for 60 min at 37 °C, 1.4 mL guinea pig complement 10% (Harlan) was added and incubation continued for another 60 min at 37 °C. During this time, B cells produce IgM antibodies specific for the SRBC, which then bind to SRBC membrane antigens and produce complement mediated lysis of the plated SRBC and subsequent formation of plaques (i.e., clear areas of hemolysis around each antibody forming cell). The numbers of hemolytic plaques, corresponding to the number of IgM producing cells in each spleen, were then counted manually. A mean number of hemolytic plaques was calculated for each treatment group (<i>n</i> = 5 each) and a percent inhibition versus vehicle controls was calculated for each treatment group. Cyclosporin A (CsA) is used as a reference compound at 6 mg kg<sup>–1</sup> p.o. QD and classically demonstrates 76–98% inhibition (mean 85.1%, ± SD 5.7) of plaque forming cells compared to the vehicle treated control group.</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> Xenograft Studies</h4><div class="NLM_p last">Subcutaneous tumors were induced by injecting TMD8 cells (5 × 10<sup>6</sup>, 50% Matrigel) or OCI-Ly3 cells (1 × 10<sup>7</sup>, 50% Matrigel) into 6–8 weeks old female SCID-bg mice (Taconic). For OCI-Ly3, developing xenografts were propagated by fragment transplantation. For PK/PD studies, treatment was started after randomizing mice into groups of <i>n</i> = 2–3 for vehicle and dose groups when the average tumor size had reached approximately 500 mm<sup>3</sup>. For efficacy studies, treatment was initiated when tumors reached a mean tumor volume of around 350 mm<sup>3</sup>. At this point, animals were randomized into different treatment groups based on similar tumour size and body weight. Tumor size was measured twice a week with a caliper. Tumor volume was calculated using the formula (length × width) <sup>3</sup> π/6 and expressed in mm<sup>3</sup>. Data are presented as mean ± SEM. Statistical analysis was performed on Δ<i>T</i><sub>Vol</sub> by comparing the treatment groups to the vehicle control group (d49) by Kruskal–Wallis followed by Dunn’s post hoc test. At indicated time points post last dose blood samples were taken and tumors were excised and snap frozen in liquid nitrogen. Concentrations of <b>MLT-985</b> in plasma and tumor were determined using ultra-high-pressure liquid chromatography/tandem MS.</div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> NMR Spectroscopy for Hydrogen-Bond Studies</h3><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> Sample Preparation</h4><div class="NLM_p last">1.0 mg of lyophilized compound <i>x</i> or <i>y</i> were dissolved in either 500 μL DMSO-<i>d</i><sub>6</sub>, or 500 μL de-acidified CDCl<sub>3</sub>, vortexed for 20 s and transferred into 5 mm SampleJet NMR sample tubes. Samples were spun down into the tube using a Hettich manual centrifuge. The tubes were closed by a tube cap and inserted into 5 mm shuttles using the automatic sample changer.</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> Data Acquisition and Resonance Assignment</h4><div class="NLM_p last">All 1D and two-dimensional (2D) data were recorded at a temperature of 300 K with a relaxation delay of 1.5 s using a Bruker 600 MHz AVANCE III spectrometer equipped with a 5 mm BBO cryo probe and a z-gradient system. For analysis, all 1D and 2D spectra obtained by <sup>1</sup>H, HSQC(edited), COSY(gradient), TOCSY(MLEV-17), HMBC, and ROESY(easy) pulssequences, were imported into the NMR workbook of ACD Spectrus 2017. 1D, HSQC, COSY and TOCSY were analyzed to obtain resonance assignment for protons and carbons of individual spin systems. Sequential connectivity assignments were achieved using 2D-HMBC and 2D-ROESY experiments. More details can be found in the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01246/suppl_file/jm0c01246_si_001.pdf" class="ext-link">Supporting Information</a>.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i45"><a href="/doi/suppl/10.1021/acs.jmedchem.0c01246" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57472" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57472" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c01246?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01246</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Selectivity data for <b>MLT-985</b>, detailed metabolism studies for <b>MLT-231</b> and compound <b>4</b>, and <sup>1</sup>H and <sup>13</sup>C data and HPLC–MS details for final compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01246/suppl_file/jm0c01246_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and biochemical potency data (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01246/suppl_file/jm0c01246_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01246/suppl_file/jm0c01246_si_001.pdf">jm0c01246_si_001.pdf (595.55 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01246/suppl_file/jm0c01246_si_002.csv">jm0c01246_si_002.csv (0.87 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c01246" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31076" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31076" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jean Quancard</span> - <span class="hlFld-Affiliation affiliation">Novartis Pharma AG, Novartis
Institutes
for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6324-8490" title="Orcid link">http://orcid.org/0000-0001-6324-8490</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#4b212e2a25653a3e2a25282a392f0b25243d2a393f223865282426"><span class="__cf_email__" data-cfemail="d8b2bdb9b6f6a9adb9b6bbb9aabc98b6b7aeb9aaacb1abf6bbb7b5">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Frédéric Bornancin</span> - <span class="hlFld-Affiliation affiliation">Novartis Pharma AG, Novartis
Institutes
for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#731501161716011a105d111c011d121d101a1d331d1c051201071a005d101c1e"><span class="__cf_email__" data-cfemail="1076627574756279733e727f627e717e73797e507e7f6671626479633e737f7d">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Achim Schlapbach</span> - <span class="hlFld-Affiliation affiliation">Novartis Pharma AG, Novartis
Institutes
for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#51303239383c7f2232393d302133303239113f3e2730232538227f323e3c"><span class="__cf_email__" data-cfemail="e0818388898dce9383888c819082818388a08e8f968192948993ce838f8d">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Oliver Simic</span> - <span class="hlFld-Affiliation affiliation">Novartis Pharma AG, Novartis
Institutes
for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carole Pissot Soldermann</span> - <span class="hlFld-Affiliation affiliation">Novartis Pharma AG, Novartis
Institutes
for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7497-3839" title="Orcid link">http://orcid.org/0000-0002-7497-3839</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Reiner Aichholz</span> - <span class="hlFld-Affiliation affiliation">Novartis Pharma AG, Novartis
Institutes
for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Markus Blatter</span> - <span class="hlFld-Affiliation affiliation">Novartis Pharma AG, Novartis
Institutes
for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martin Renatus</span> - <span class="hlFld-Affiliation affiliation">Novartis Pharma AG, Novartis
Institutes
for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paulus Erbel</span> - <span class="hlFld-Affiliation affiliation">Novartis Pharma AG, Novartis
Institutes
for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Samu Melkko</span> - <span class="hlFld-Affiliation affiliation">Novartis Pharma AG, Novartis
Institutes
for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ralf Endres</span> - <span class="hlFld-Affiliation affiliation">Novartis Pharma AG, Novartis
Institutes
for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mickael Sorge</span> - <span class="hlFld-Affiliation affiliation">Novartis Pharma AG, Novartis
Institutes
for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laurence Kieffer</span> - <span class="hlFld-Affiliation affiliation">Novartis Pharma AG, Novartis
Institutes
for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Trixie Wagner</span> - <span class="hlFld-Affiliation affiliation">Novartis Pharma AG, Novartis
Institutes
for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karen Beltz</span> - <span class="hlFld-Affiliation affiliation">Novartis Pharma AG, Novartis
Institutes
for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Mcsheehy</span> - <span class="hlFld-Affiliation affiliation">Novartis Pharma AG, Novartis
Institutes
for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span>; 
    <span>Present Address:
                        Basilea Pharmaceutica, CH-4005 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Markus Wartmann</span> - <span class="hlFld-Affiliation affiliation">Novartis Pharma AG, Novartis
Institutes
for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Catherine H. Régnier</span> - <span class="hlFld-Affiliation affiliation">Novartis Pharma AG, Novartis
Institutes
for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas Calzascia</span> - <span class="hlFld-Affiliation affiliation">Novartis Pharma AG, Novartis
Institutes
for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas Radimerski</span> - <span class="hlFld-Affiliation affiliation">Novartis Pharma AG, Novartis
Institutes
for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span>; 
    <span>Present Address:
                        Basilea Pharmaceutica, CH-4005 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marc Bigaud</span> - <span class="hlFld-Affiliation affiliation">Novartis Pharma AG, Novartis
Institutes
for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andreas Weiss</span> - <span class="hlFld-Affiliation affiliation">Novartis Pharma AG, Novartis
Institutes
for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i48">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37863" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37863" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We would like to thank Professor Tohda, Tokyo Medical and Dental University, for providing the TMD8 cell line. We thank Markus Bache, Bernard Glasser, Simon Glauser, Lilian Steiner, Estelle Ngo, Julien Scesa, Mario Centeleghe, Maureen Bardet, Danielle Boesch, Frederique Lafossas, Claire Malinverni, Cindy Schmid, Adeline Unterreiner, Corinne Vedrine, Rita Andraos-Rey, Catherine Afatsawo, Meike Lang, and Joelle Rubert for technical support.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviation</td></tr><tr><td class="NLM_term">ABC</td><td class="NLM_def"><p class="first last">activated B-cell like</p></td></tr><tr><td class="NLM_term">ABC-DLBCL</td><td class="NLM_def"><p class="first last">activated B-cell like diffuse large B-cell Lymphoma</p></td></tr><tr><td class="NLM_term">CDI</td><td class="NLM_def"><p class="first last">carbonyl diimidazole</p></td></tr><tr><td class="NLM_term">CL</td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term">Clint</td><td class="NLM_def"><p class="first last">intrinsic clearance</p></td></tr><tr><td class="NLM_term">DLBCL</td><td class="NLM_def"><p class="first last">diffuse large B-cell lymphoma</p></td></tr><tr><td class="NLM_term">DPPA</td><td class="NLM_def"><p class="first last">diphenylphosphoryl azide</p></td></tr><tr><td class="NLM_term">Et<sub>3</sub>N</td><td class="NLM_def"><p class="first last">triethylamine</p></td></tr><tr><td class="NLM_term">EtOH</td><td class="NLM_def"><p class="first last">ethanol</p></td></tr><tr><td class="NLM_term">GCB-DLBCL</td><td class="NLM_def"><p class="first last">germinal center B-cell like diffuse large B-cell lymphoma</p></td></tr><tr><td class="NLM_term">GCB</td><td class="NLM_def"><p class="first last">germinal center B-cell like</p></td></tr><tr><td class="NLM_term">HCl</td><td class="NLM_def"><p class="first last">hydrochloric acid</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver microsomes</p></td></tr><tr><td class="NLM_term">MALT1</td><td class="NLM_def"><p class="first last">mucosa-associated lymphoid tissue lymphoma translocated gene 1</p></td></tr><tr><td class="NLM_term">MC</td><td class="NLM_def"><p class="first last">methylcellulose</p></td></tr><tr><td class="NLM_term">MeOH</td><td class="NLM_def"><p class="first last">methanol</p></td></tr><tr><td class="NLM_term">MLM</td><td class="NLM_def"><p class="first last">mouse liver microsomes</p></td></tr><tr><td class="NLM_term">app</td><td class="NLM_def"><p class="first last">apparent permeability</p></td></tr><tr><td class="NLM_term">PMA</td><td class="NLM_def"><p class="first last">phorbol 12-myristate 13-acetate</p></td></tr><tr><td class="NLM_term">RLM</td><td class="NLM_def"><p class="first last">rat liver microsomes</p></td></tr><tr><td class="NLM_term">SRBC</td><td class="NLM_def"><p class="first last">sheep red blood cells</p></td></tr><tr><td class="NLM_term">SD</td><td class="NLM_def"><p class="first last">standard deviation</p></td></tr><tr><td class="NLM_term">Treg</td><td class="NLM_def"><p class="first last">regulatory T cell</p></td></tr><tr><td class="NLM_term">WB</td><td class="NLM_def"><p class="first last">whole blood</p></td></tr><tr><td class="NLM_term">CCR2</td><td class="NLM_def"><p class="first last">CC chemokine receptor 2</p></td></tr><tr><td class="NLM_term">CCL2</td><td class="NLM_def"><p class="first last">CC chemokine ligand 2</p></td></tr><tr><td class="NLM_term">CCR5</td><td class="NLM_def"><p class="first last">CC chemokine receptor 5</p></td></tr><tr><td class="NLM_term">TLC</td><td class="NLM_def"><p class="first last">thin layer chromatography</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i50">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08812" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08812" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 48 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Minina, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez, V. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berges, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berman-Frank, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beyaert, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bidle, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornancin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casanova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cazzulo, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coll, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixit, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolinar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fasel, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funk, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallois, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gevaert, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutierrez-Beltran, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hailfinger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klemenčič, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koonin, E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krappmann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linusson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machado, M. F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madeo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Megeney, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moschou, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mottram, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nyström, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osiewacz, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overall, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruland, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvesen, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smertenko, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stael, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ståhlberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suárez, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thome, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuominen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Breusegem, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Hoorn, R. A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vardi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhivotovsky, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bozhkov, P. V.</span></span> <span> </span><span class="NLM_article-title">Classification and Nomenclature of Metacaspases and Paracaspases: No More Confusion with Caspases</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">927</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2019.12.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1016%2Fj.molcel.2019.12.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=32142688" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BB3cXotFeltr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2020&pages=927&author=E.+A.+Mininaauthor=J.+Staalauthor=V.+E.+Alvarezauthor=J.+A.+Bergesauthor=I.+Berman-Frankauthor=R.+Beyaertauthor=K.+D.+Bidleauthor=F.+Bornancinauthor=M.+Casanovaauthor=J.+J.+Cazzuloauthor=C.+J.+Choiauthor=N.+S.+Collauthor=V.+M.+Dixitauthor=M.+Dolinarauthor=N.+Faselauthor=C.+Funkauthor=P.+Galloisauthor=K.+Gevaertauthor=E.+Gutierrez-Beltranauthor=S.+Hailfingerauthor=M.+Klemen%C4%8Di%C4%8Dauthor=E.+V.+Kooninauthor=D.+Krappmannauthor=A.+Linussonauthor=M.+F.+M.+Machadoauthor=F.+Madeoauthor=L.+A.+Megeneyauthor=P.+N.+Moschouauthor=J.+C.+Mottramauthor=T.+Nystr%C3%B6mauthor=H.+D.+Osiewaczauthor=C.+M.+Overallauthor=K.+C.+Pandeyauthor=J.+Rulandauthor=G.+S.+Salvesenauthor=Y.+Shiauthor=A.+Smertenkoauthor=S.+Staelauthor=J.+St%C3%A5hlbergauthor=M.+F.+Su%C3%A1rezauthor=M.+Thomeauthor=H.+Tuominenauthor=F.+Van+Breusegemauthor=R.+A.+L.+van+der+Hoornauthor=A.+Vardiauthor=B.+Zhivotovskyauthor=E.+Lamauthor=P.+V.+Bozhkov&title=Classification+and+Nomenclature+of+Metacaspases+and+Paracaspases%3A+No+More+Confusion+with+Caspases&doi=10.1016%2Fj.molcel.2019.12.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Classification and Nomenclature of Metacaspases and Paracaspases: No More Confusion with Caspases</span></div><div class="casAuthors">Minina, Elena A.; Staal, Jens; Alvarez, Vanina E.; Berges, John A.; Berman-Frank, Ilana; Beyaert, Rudi; Bidle, Kay D.; Bornancin, Frederic; Casanova, Magali; Cazzulo, Juan J.; Choi, Chang Jae; Coll, Nuria S.; Dixit, Vishva M.; Dolinar, Marko; Fasel, Nicolas; Funk, Christiane; Gallois, Patrick; Gevaert, Kris; Gutierrez-Beltran, Emilio; Hailfinger, Stephan; Klemencic, Marina; Koonin, Eugene V.; Krappmann, Daniel; Linusson, Anna; Machado, Mauricio F. M.; Madeo, Frank; Megeney, Lynn A.; Moschou, Panagiotis N.; Mottram, Jeremy C.; Nystroem, Thomas; Osiewacz, Heinz D.; Overall, Christopher M.; Pandey, Kailash C.; Ruland, Jurgen; Salvesen, Guy S.; Shi, Yigong; Smertenko, Andrei; Stael, Simon; Staahlberg, Jerry; Suarez, Maria Fernanda; Thome, Margot; Tuominen, Hannele; Van Breusegem, Frank; van der Hoorn, Renier A. L.; Vardi, Assaf; Zhivotovsky, Boris; Lam, Eric; Bozhkov, Peter V.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">927-929</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUar5FKjWwCbVg90H21EOLACvtfcHk0liD8rd-KC4GhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXotFeltr4%253D&md5=43789b5379a8cce26231f37a72fa9d22</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2019.12.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2019.12.020%26sid%3Dliteratum%253Aachs%26aulast%3DMinina%26aufirst%3DE.%2BA.%26aulast%3DStaal%26aufirst%3DJ.%26aulast%3DAlvarez%26aufirst%3DV.%2BE.%26aulast%3DBerges%26aufirst%3DJ.%2BA.%26aulast%3DBerman-Frank%26aufirst%3DI.%26aulast%3DBeyaert%26aufirst%3DR.%26aulast%3DBidle%26aufirst%3DK.%2BD.%26aulast%3DBornancin%26aufirst%3DF.%26aulast%3DCasanova%26aufirst%3DM.%26aulast%3DCazzulo%26aufirst%3DJ.%2BJ.%26aulast%3DChoi%26aufirst%3DC.%2BJ.%26aulast%3DColl%26aufirst%3DN.%2BS.%26aulast%3DDixit%26aufirst%3DV.%2BM.%26aulast%3DDolinar%26aufirst%3DM.%26aulast%3DFasel%26aufirst%3DN.%26aulast%3DFunk%26aufirst%3DC.%26aulast%3DGallois%26aufirst%3DP.%26aulast%3DGevaert%26aufirst%3DK.%26aulast%3DGutierrez-Beltran%26aufirst%3DE.%26aulast%3DHailfinger%26aufirst%3DS.%26aulast%3DKlemen%25C4%258Di%25C4%258D%26aufirst%3DM.%26aulast%3DKoonin%26aufirst%3DE.%2BV.%26aulast%3DKrappmann%26aufirst%3DD.%26aulast%3DLinusson%26aufirst%3DA.%26aulast%3DMachado%26aufirst%3DM.%2BF.%2BM.%26aulast%3DMadeo%26aufirst%3DF.%26aulast%3DMegeney%26aufirst%3DL.%2BA.%26aulast%3DMoschou%26aufirst%3DP.%2BN.%26aulast%3DMottram%26aufirst%3DJ.%2BC.%26aulast%3DNystr%25C3%25B6m%26aufirst%3DT.%26aulast%3DOsiewacz%26aufirst%3DH.%2BD.%26aulast%3DOverall%26aufirst%3DC.%2BM.%26aulast%3DPandey%26aufirst%3DK.%2BC.%26aulast%3DRuland%26aufirst%3DJ.%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DSmertenko%26aufirst%3DA.%26aulast%3DStael%26aufirst%3DS.%26aulast%3DSt%25C3%25A5hlberg%26aufirst%3DJ.%26aulast%3DSu%25C3%25A1rez%26aufirst%3DM.%2BF.%26aulast%3DThome%26aufirst%3DM.%26aulast%3DTuominen%26aufirst%3DH.%26aulast%3DVan%2BBreusegem%26aufirst%3DF.%26aulast%3Dvan%2Bder%2BHoorn%26aufirst%3DR.%2BA.%2BL.%26aulast%3DVardi%26aufirst%3DA.%26aulast%3DZhivotovsky%26aufirst%3DB.%26aulast%3DLam%26aufirst%3DE.%26aulast%3DBozhkov%26aufirst%3DP.%2BV.%26atitle%3DClassification%2520and%2520Nomenclature%2520of%2520Metacaspases%2520and%2520Paracaspases%253A%2520No%2520More%2520Confusion%2520with%2520Caspases%26jtitle%3DMol.%2520Cell%26date%3D2020%26volume%3D77%26spage%3D927%26doi%3D10.1016%2Fj.molcel.2019.12.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jaworski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thome, M.</span></span> <span> </span><span class="NLM_article-title">The Paracaspase MALT1: Biological Function and Potential for Therapeutic Inhibition</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">459</span>– <span class="NLM_lpage">473</span>, <span class="refDoi"> DOI: 10.1007/s00018-015-2059-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1007%2Fs00018-015-2059-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=26507244" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsleksLzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2016&pages=459-473&author=M.+Jaworskiauthor=M.+Thome&title=The+Paracaspase+MALT1%3A+Biological+Function+and+Potential+for+Therapeutic+Inhibition&doi=10.1007%2Fs00018-015-2059-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The paracaspase MALT1: biological function and potential for therapeutic inhibition</span></div><div class="casAuthors">Jaworski, Maike; Thome, Margot</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">459-473</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">The paracaspase MALT1 has a central role in the activation of lymphocytes and other immune cells including myeloid cells, mast cells and NK cells.  MALT1 activity is required not only for the immune response, but also for the development of natural Treg cells that keep the immune response in check.  Exaggerated MALT1 activity has been assocd. with the development of lymphoid malignancies, and recently developed MALT1 inhibitors show promising anti-tumor effects in xenograft models of diffuse large B cell lymphoma.  In this review, we provide an overview of the present understanding of MALT1's function, and discuss possibilities for its therapeutic targeting based on recently developed inhibitors and animal models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooyWY8MBt487Vg90H21EOLACvtfcHk0liydciekj9Lcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsleksLzK&md5=61a26c76efd0b36f03915071175f5ef2</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2Fs00018-015-2059-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-015-2059-z%26sid%3Dliteratum%253Aachs%26aulast%3DJaworski%26aufirst%3DM.%26aulast%3DThome%26aufirst%3DM.%26atitle%3DThe%2520Paracaspase%2520MALT1%253A%2520Biological%2520Function%2520and%2520Potential%2520for%2520Therapeutic%2520Inhibition%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2016%26volume%3D73%26spage%3D459%26epage%3D473%26doi%3D10.1007%2Fs00018-015-2059-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Demeyer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beyaert, R.</span></span> <span> </span><span class="NLM_article-title">Targeting MALT1 Proteolytic Activity in Immunity, Inflammation and Disease: Good or Bad?</span>. <i>Trends Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">135</span>– <span class="NLM_lpage">150</span>, <span class="refDoi"> DOI: 10.1016/j.molmed.2015.12.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1016%2Fj.molmed.2015.12.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=26787500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFCisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2016&pages=135-150&author=A.+Demeyerauthor=J.+Staalauthor=R.+Beyaert&title=Targeting+MALT1+Proteolytic+Activity+in+Immunity%2C+Inflammation+and+Disease%3A+Good+or+Bad%3F&doi=10.1016%2Fj.molmed.2015.12.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting MALT1 Proteolytic Activity in Immunity, Inflammation and Disease: Good or Bad?</span></div><div class="casAuthors">Demeyer, Annelies; Staal, Jens; Beyaert, Rudi</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Molecular Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">135-150</span>CODEN:
                <span class="NLM_cas:coden">TMMRCY</span>;
        ISSN:<span class="NLM_cas:issn">1471-4914</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">MALT1 is a signaling protein that plays a key role in immunity, inflammation, and lymphoid malignancies.  For a long time MALT1 was believed to function as a scaffold protein, providing an assembly platform for other signaling proteins.  This view changed dramatically when MALT1 was also found to have proteolytic activity and a capacity to fine-tune immune responses.  Preclin. studies have fostered the belief that MALT1 is a promising therapeutic target in autoimmunity and B cell lymphomas.  However, recent studies have shown that mice expressing catalytically-inactive MALT1 develop multi-organ inflammation and autoimmunity, and thus have tempered this initial enthusiasm.  We discuss recent findings, highlighting the urgent need for a better mechanistic and functional understanding of MALT1 in host defense and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq39fxtDl9_bbVg90H21EOLACvtfcHk0liydciekj9Lcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFCisQ%253D%253D&md5=0e4d984d95a32b039f29895a7cf35c95</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.molmed.2015.12.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmed.2015.12.004%26sid%3Dliteratum%253Aachs%26aulast%3DDemeyer%26aufirst%3DA.%26aulast%3DStaal%26aufirst%3DJ.%26aulast%3DBeyaert%26aufirst%3DR.%26atitle%3DTargeting%2520MALT1%2520Proteolytic%2520Activity%2520in%2520Immunity%252C%2520Inflammation%2520and%2520Disease%253A%2520Good%2520or%2520Bad%253F%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2016%26volume%3D22%26spage%3D135%26epage%3D150%26doi%3D10.1016%2Fj.molmed.2015.12.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bertossi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krappmann, D.</span></span> <span> </span><span class="NLM_article-title">MALT 1 protease: equilibrating immunity versus tolerance</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">2740</span>– <span class="NLM_lpage">2742</span>, <span class="refDoi"> DOI: 10.15252/embj.201490217</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.15252%2Fembj.201490217" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=25361604" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitFOitLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2014&pages=2740-2742&author=A.+Bertossiauthor=D.+Krappmann&title=MALT+1+protease%3A+equilibrating+immunity+versus+tolerance&doi=10.15252%2Fembj.201490217"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">MALT1 protease: equilibrating immunity versus tolerance</span></div><div class="casAuthors">Bertossi, Arianna; Krappmann, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2740-2742</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  MALT1 paracaspase links signaling cascades emanating from adaptive or innate immune receptors to the canonical NF-κB pathway.  Now, Jaworski et al (2014) investigate the physiol. role of MALT1 protease activity in mice.  Besides the expected requirement of MALT1 activity for immune activation, the study unveils a novel function for MALT1 activity for the development of peripheral tolerance.  Thus, MALT1 protease can act immunogenic or tolerogenic, and this interplay will be highly relevant for the clin. development of MALT1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqK3aFhjybmbVg90H21EOLACvtfcHk0liydciekj9Lcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitFOitLY%253D&md5=8caba6b104e52c82db7ec361d85a8770</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.15252%2Fembj.201490217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15252%252Fembj.201490217%26sid%3Dliteratum%253Aachs%26aulast%3DBertossi%26aufirst%3DA.%26aulast%3DKrappmann%26aufirst%3DD.%26atitle%3DMALT%25201%2520protease%253A%2520equilibrating%2520immunity%2520versus%2520tolerance%26jtitle%3DEMBO%2520J.%26date%3D2014%26volume%3D33%26spage%3D2740%26epage%3D2742%26doi%3D10.15252%2Fembj.201490217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fontán, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melnick, A.</span></span> <span> </span><span class="NLM_article-title">Molecular Pathways: Targeting MALT1 Paracaspase Activity in Lymphoma</span>. <i>Clin. Canc. Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">6662</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-12-3869</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1158%2F1078-0432.CCR-12-3869" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFyrtr3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=6662&author=L.+Font%C3%A1nauthor=A.+Melnick&title=Molecular+Pathways%3A+Targeting+MALT1+Paracaspase+Activity+in+Lymphoma&doi=10.1158%2F1078-0432.CCR-12-3869"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Pathways: Targeting MALT1 Paracaspase Activity in Lymphoma</span></div><div class="casAuthors">Fontan, Lorena; Melnick, Ari</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6662-6668</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  MALT1 mediates the activation of NF-κB in response to antigen receptor signaling.  MALT1, in assocn. with BCL10 and CARD11, functions as a scaffolding protein to activate the inhibitor of IκB kinase (IKK) complex.  In addn., MALT1 is a paracaspase that targets key proteins in a feedback loop mediating termination of the NF-κB response, thus promoting activation of NF-κB signaling.  Activated B-cell subtype of diffuse large B-cell lymphomas (ABC-DLBCL), which tend to be more resistant to chemotherapy, are often biol. dependent on MALT1 activity.  Newly developed MALT1 small-mol. inhibitors suppress the growth of ABC-DLBCLs in vitro and in vivo.  This review highlights the recent advances in the normal and disease-related functions of MALT1.  Furthermore, recent progress targeting MALT1 proteolytic activity raises the possibility of deploying MALT1 inhibitors for the treatment of B-cell lymphomas and perhaps autoimmune diseases that involve increased B- or T-cell receptor signaling.  Clin Cancer Res; 19(24); 6662-8. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoavbnPIV22BrVg90H21EOLACvtfcHk0liydciekj9Lcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFyrtr3E&md5=2d4762898ace23795600dc48a80b0684</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-12-3869&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-12-3869%26sid%3Dliteratum%253Aachs%26aulast%3DFont%25C3%25A1n%26aufirst%3DL.%26aulast%3DMelnick%26aufirst%3DA.%26atitle%3DMolecular%2520Pathways%253A%2520Targeting%2520MALT1%2520Paracaspase%2520Activity%2520in%2520Lymphoma%26jtitle%3DClin.%2520Canc.%2520Res.%26date%3D2013%26volume%3D19%26spage%3D6662%26doi%3D10.1158%2F1078-0432.CCR-12-3869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jaworski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsland, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gehrig, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Held, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Favre, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luther, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perroud, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golshayan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaide, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thome, M.</span></span> <span> </span><span class="NLM_article-title">Malt1 Protease Inactivation Efficiently Dampens Immune Responses but Causes Spontaneous Autoimmunity</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">2765</span>– <span class="NLM_lpage">2781</span>, <span class="refDoi"> DOI: 10.15252/embj.201488987</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.15252%2Fembj.201488987" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=25319413" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitFOitb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2014&pages=2765-2781&author=M.+Jaworskiauthor=B.+J.+Marslandauthor=J.+Gehrigauthor=W.+Heldauthor=S.+Favreauthor=S.+A.+Lutherauthor=M.+Perroudauthor=D.+Golshayanauthor=O.+Gaideauthor=M.+Thome&title=Malt1+Protease+Inactivation+Efficiently+Dampens+Immune+Responses+but+Causes+Spontaneous+Autoimmunity&doi=10.15252%2Fembj.201488987"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Malt1 protease inactivation efficiently dampens immune responses but causes spontaneous autoimmunity</span></div><div class="casAuthors">Jaworski, Maike; Marsland, Ben J.; Gehrig, Jasmine; Held, Werner; Favre, Stephanie; Luther, Sanjiv A.; Perroud, Mai; Golshayan, Dela; Gaide, Olivier; Thome, Margot</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2765-2781</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The protease activity of the paracaspase Malt1 has recently gained interest as a drug target for immunomodulation and the treatment of diffuse large B-cell lymphomas.  To address the consequences of Malt1 protease inactivation on the immune response in vivo, the authors generated knock-in mice expressing a catalytically inactive C472A mutant of Malt1 that conserves its scaffold function.  Like Malt1-deficient mice, knock-in mice had strong defects in the activation of lymphocytes, NK and dendritic cells, and the development of B1 and marginal zone B cells and were completely protected against the induction of autoimmune encephalomyelitis.  Malt1 inactivation also protected the mice from exptl. induction of colitis.  However, Malt1 knock-in mice but not Malt1-deficient mice spontaneously developed signs of autoimmune gastritis that correlated with an absence of Treg cells, an accumulation of T cells with an activated phenotype and high serum levels of IgE and IgG1.  Thus, removal of the enzymic activity of Malt1 efficiently dampens the immune response, but favors autoimmunity through impaired Treg development, which could be relevant for therapeutic Malt1-targeting strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_hW5aCqROFbVg90H21EOLACvtfcHk0lifEAYxiLaSuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitFOitb8%253D&md5=1cec30b02de338e7976638abf8f44df3</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.15252%2Fembj.201488987&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15252%252Fembj.201488987%26sid%3Dliteratum%253Aachs%26aulast%3DJaworski%26aufirst%3DM.%26aulast%3DMarsland%26aufirst%3DB.%2BJ.%26aulast%3DGehrig%26aufirst%3DJ.%26aulast%3DHeld%26aufirst%3DW.%26aulast%3DFavre%26aufirst%3DS.%26aulast%3DLuther%26aufirst%3DS.%2BA.%26aulast%3DPerroud%26aufirst%3DM.%26aulast%3DGolshayan%26aufirst%3DD.%26aulast%3DGaide%26aufirst%3DO.%26aulast%3DThome%26aufirst%3DM.%26atitle%3DMalt1%2520Protease%2520Inactivation%2520Efficiently%2520Dampens%2520Immune%2520Responses%2520but%2520Causes%2520Spontaneous%2520Autoimmunity%26jtitle%3DEMBO%2520J.%26date%3D2014%26volume%3D33%26spage%3D2765%26epage%3D2781%26doi%3D10.15252%2Fembj.201488987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gewies, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorka, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergmann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pechloff, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petermann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeltsch, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudelius, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kriegsmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weichert, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horsch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beckers, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wurst, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heikenwalder, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korn, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heissmeyer, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruland, J.</span></span> <span> </span><span class="NLM_article-title">Uncoupling Malt1 Threshold Function from Paracaspase Activity Results in Destructive Autoimmune Inflammation</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1292</span>– <span class="NLM_lpage">1305</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2014.10.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1016%2Fj.celrep.2014.10.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=25456129" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFGisbfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=1292-1305&author=A.+Gewiesauthor=O.+Gorkaauthor=H.+Bergmannauthor=K.+Pechloffauthor=F.+Petermannauthor=K.+M.+Jeltschauthor=M.+Rudeliusauthor=M.+Kriegsmannauthor=W.+Weichertauthor=M.+Horschauthor=J.+Beckersauthor=W.+Wurstauthor=M.+Heikenwalderauthor=T.+Kornauthor=V.+Heissmeyerauthor=J.+Ruland&title=Uncoupling+Malt1+Threshold+Function+from+Paracaspase+Activity+Results+in+Destructive+Autoimmune+Inflammation&doi=10.1016%2Fj.celrep.2014.10.044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Uncoupling Malt1 Threshold Function from Paracaspase Activity Results in Destructive Autoimmune Inflammation</span></div><div class="casAuthors">Gewies, Andreas; Gorka, Oliver; Bergmann, Hanna; Pechloff, Konstanze; Petermann, Franziska; Jeltsch, Katharina M.; Rudelius, Martina; Kriegsmann, Mark; Weichert, Wilko; Horsch, Marion; Beckers, Johannes; Wurst, Wolfgang; Heikenwalder, Mathias; Korn, Thomas; Heissmeyer, Vigo; Ruland, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1292-1305</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The paracaspase Malt1 is a central regulator of antigen receptor signaling that is frequently mutated in human lymphoma.  As a scaffold, it assembles protein complexes for NF-κB activation, and its proteolytic domain cleaves neg. NF-κB regulators for signal enforcement.  Still, the physiol. functions of Malt1-protease are unknown.  We demonstrate that targeted Malt1-paracaspase inactivation induces a lethal inflammatory syndrome with lymphocyte-dependent neurodegeneration in vivo.  Paracaspase activity is essential for regulatory T cell (Treg) and innate-like B cell development, but it is largely dispensable for overcoming Malt1-dependent thresholds for lymphocyte activation.  In addn. to NF-κB inhibitors, Malt1 cleaves an entire set of mRNA stability regulators, including Roquin-1, Roquin-2, and Regnase-1, and paracaspase inactivation results in excessive interferon gamma (IFNγ) prodn. by effector lymphocytes that drive pathol.  Together, our results reveal distinct threshold and modulatory functions of Malt1 that differentially control lymphocyte differentiation and activation pathways and demonstrate that selective paracaspase blockage skews systemic immunity toward destructive autoinflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraV6ZMwtgwd7Vg90H21EOLACvtfcHk0lifEAYxiLaSuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFGisbfL&md5=93d9fd5761dc85128a6c2a8460914cb7</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2014.10.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2014.10.044%26sid%3Dliteratum%253Aachs%26aulast%3DGewies%26aufirst%3DA.%26aulast%3DGorka%26aufirst%3DO.%26aulast%3DBergmann%26aufirst%3DH.%26aulast%3DPechloff%26aufirst%3DK.%26aulast%3DPetermann%26aufirst%3DF.%26aulast%3DJeltsch%26aufirst%3DK.%2BM.%26aulast%3DRudelius%26aufirst%3DM.%26aulast%3DKriegsmann%26aufirst%3DM.%26aulast%3DWeichert%26aufirst%3DW.%26aulast%3DHorsch%26aufirst%3DM.%26aulast%3DBeckers%26aufirst%3DJ.%26aulast%3DWurst%26aufirst%3DW.%26aulast%3DHeikenwalder%26aufirst%3DM.%26aulast%3DKorn%26aufirst%3DT.%26aulast%3DHeissmeyer%26aufirst%3DV.%26aulast%3DRuland%26aufirst%3DJ.%26atitle%3DUncoupling%2520Malt1%2520Threshold%2520Function%2520from%2520Paracaspase%2520Activity%2520Results%2520in%2520Destructive%2520Autoimmune%2520Inflammation%26jtitle%3DCell%2520Rep.%26date%3D2014%26volume%3D9%26spage%3D1292%26epage%3D1305%26doi%3D10.1016%2Fj.celrep.2014.10.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bornancin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renner, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Touil, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sic, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolb, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Touil-Allaoui, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rush, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, P. a.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigaud, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Junker-Walker, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burkhart, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niwa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katopodis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuesslein-Hildesheim, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weckbecker, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zenke, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinzel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traggiai, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenner, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brüstle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">St. Paul, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamurovic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rolink, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Régnier, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohashi, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calzascia, T.</span></span> <span> </span><span class="NLM_article-title">Deficiency of MALT1 Paracaspase Activity Results in Unbalanced Regulatory and Effector T and B Cell Responses Leading to Multiorgan Inflammation</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>194</i></span>,  <span class="NLM_fpage">3723</span>– <span class="NLM_lpage">3734</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.1402254</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.4049%2Fjimmunol.1402254" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=25762782" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlvVeisrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=194&publication_year=2015&pages=3723-3734&author=F.+Bornancinauthor=F.+Rennerauthor=R.+Touilauthor=H.+Sicauthor=Y.+Kolbauthor=I.+Touil-Allaouiauthor=J.+S.+Rushauthor=P.+a.+Smithauthor=M.+Bigaudauthor=U.+Junker-Walkerauthor=C.+Burkhartauthor=J.+Dawsonauthor=S.+Niwaauthor=A.+Katopodisauthor=B.+Nuesslein-Hildesheimauthor=G.+Weckbeckerauthor=G.+Zenkeauthor=B.+Kinzelauthor=E.+Traggiaiauthor=D.+Brennerauthor=A.+Br%C3%BCstleauthor=M.+St.+Paulauthor=N.+Zamurovicauthor=K.+D.+McCoyauthor=A.+Rolinkauthor=C.+H.+R%C3%A9gnierauthor=T.+W.+Makauthor=P.+S.+Ohashiauthor=D.+D.+Patelauthor=T.+Calzascia&title=Deficiency+of+MALT1+Paracaspase+Activity+Results+in+Unbalanced+Regulatory+and+Effector+T+and+B+Cell+Responses+Leading+to+Multiorgan+Inflammation&doi=10.4049%2Fjimmunol.1402254"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Deficiency of MALT1 Paracaspase Activity Results in Unbalanced Regulatory and Effector T and B Cell Responses Leading to Multiorgan Inflammation</span></div><div class="casAuthors">Bornancin, Frederic; Renner, Florian; Touil, Ratiba; Sic, Heiko; Kolb, Yeter; Touil-Allaoui, Ismahane; Rush, James S.; Smith, Paul A.; Bigaud, Marc; Junker-Walker, Ursula; Burkhart, Christoph; Dawson, Janet; Niwa, Satoru; Katopodis, Andreas; Nuesslein-Hildesheim, Barbara; Weckbecker, Gisbert; Zenke, Gerhard; Kinzel, Bernd; Traggiai, Elisabetta; Brenner, Dirk; Bruestle, Anne; St. Paul, Michael; Zamurovic, Natasa; McCoy, Kathy D.; Rolink, Antonius; Regnier, Catherine H.; Mak, Tak W.; Ohashi, Pamela S.; Patel, Dhavalkumar D.; Calzascia, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">194</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3723-3734</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">The paracaspase MALT1 plays an important role in immune receptor-driven signaling pathways leading to NF-κB activation.  MALT1 promotes signaling by acting as a scaffold, recruiting downstream signaling proteins, as well as by proteolytic cleavage of multiple substrates.  However, the relative contributions of these two different activities to T and B cell function are not well understood.  To investigate how MALT1 proteolytic activity contributes to overall immune cell regulation, we generated MALT1 protease-deficient mice (Malt1PD/PD) and compared their phenotype with that of MALT1 knockout animals (Malt1-/-).  Malt1PD/PD mice displayed defects in multiple cell types including marginal zone B cells, B1 B cells, IL-10-producing B cells, regulatory T cells, and mature T and B cells.  In general, immune defects were more pronounced in Malt1-/- animals.  Both mouse lines showed abrogated B cell responses upon immunization with T-dependent and T-independent Ags.  In vitro, inactivation of MALT1 protease activity caused reduced stimulation-induced T cell proliferation, impaired IL-2 and TNF-α prodn., as well as defective Th17 differentiation.  Consequently, Malt1PD/PD mice were protected in a Th17-dependent exptl. autoimmune encephalomyelitis model.  Surprisingly, Malt1PD/PD animals developed a multiorgan inflammatory pathol., characterized by Th1 and Th2/0 responses and enhanced IgG1 and IgE levels, which was delayed by wild-type regulatory T cell reconstitution.  We therefore propose that the pathol. characterizing Malt1PD/PD animals arises from an immune imbalance featuring pathogenic Th1- and Th2/0-skewed effector responses and reduced immunosuppressive compartments.  These data uncover a previously unappreciated key function of MALT1 protease activity in immune homeostasis and underline its relevance in human health and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8H9YU0RgmnbVg90H21EOLACvtfcHk0lgUp6tvDB--4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlvVeisrc%253D&md5=8e16455eaab8d70f0fe8cf246aeb1edc</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1402254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1402254%26sid%3Dliteratum%253Aachs%26aulast%3DBornancin%26aufirst%3DF.%26aulast%3DRenner%26aufirst%3DF.%26aulast%3DTouil%26aufirst%3DR.%26aulast%3DSic%26aufirst%3DH.%26aulast%3DKolb%26aufirst%3DY.%26aulast%3DTouil-Allaoui%26aufirst%3DI.%26aulast%3DRush%26aufirst%3DJ.%2BS.%26aulast%3DSmith%26aufirst%3DP.%2Ba.%26aulast%3DBigaud%26aufirst%3DM.%26aulast%3DJunker-Walker%26aufirst%3DU.%26aulast%3DBurkhart%26aufirst%3DC.%26aulast%3DDawson%26aufirst%3DJ.%26aulast%3DNiwa%26aufirst%3DS.%26aulast%3DKatopodis%26aufirst%3DA.%26aulast%3DNuesslein-Hildesheim%26aufirst%3DB.%26aulast%3DWeckbecker%26aufirst%3DG.%26aulast%3DZenke%26aufirst%3DG.%26aulast%3DKinzel%26aufirst%3DB.%26aulast%3DTraggiai%26aufirst%3DE.%26aulast%3DBrenner%26aufirst%3DD.%26aulast%3DBr%25C3%25BCstle%26aufirst%3DA.%26aulast%3DSt.%2BPaul%26aufirst%3DM.%26aulast%3DZamurovic%26aufirst%3DN.%26aulast%3DMcCoy%26aufirst%3DK.%2BD.%26aulast%3DRolink%26aufirst%3DA.%26aulast%3DR%25C3%25A9gnier%26aufirst%3DC.%2BH.%26aulast%3DMak%26aufirst%3DT.%2BW.%26aulast%3DOhashi%26aufirst%3DP.%2BS.%26aulast%3DPatel%26aufirst%3DD.%2BD.%26aulast%3DCalzascia%26aufirst%3DT.%26atitle%3DDeficiency%2520of%2520MALT1%2520Paracaspase%2520Activity%2520Results%2520in%2520Unbalanced%2520Regulatory%2520and%2520Effector%2520T%2520and%2520B%2520Cell%2520Responses%2520Leading%2520to%2520Multiorgan%2520Inflammation%26jtitle%3DJ.%2520Immunol.%26date%3D2015%26volume%3D194%26spage%3D3723%26epage%3D3734%26doi%3D10.4049%2Fjimmunol.1402254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beal, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dykon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ringenberg, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dare, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparcova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rickard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramanjulu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emery, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gough, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foley, K. P.</span></span> <span> </span><span class="NLM_article-title">MALT1 Protease Activity Is Required for Innate and Adaptive Immune Responses</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>, <span class="NLM_elocation-id">e0127083</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0127083</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1371%2Fjournal.pone.0127083" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=25965667" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslSju7jL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&author=J.+W.+Yuauthor=S.+Hoffmanauthor=A.+M.+Bealauthor=A.+Dykonauthor=M.+A.+Ringenbergauthor=A.+C.+Hughesauthor=L.+Dareauthor=A.+D.+Andersonauthor=J.+Fingerauthor=V.+Kasparcovaauthor=D.+Rickardauthor=S.+B.+Bergerauthor=J.+Ramanjuluauthor=J.+G.+Emeryauthor=P.+J.+Goughauthor=J.+Bertinauthor=K.+P.+Foley&title=MALT1+Protease+Activity+Is+Required+for+Innate+and+Adaptive+Immune+Responses&doi=10.1371%2Fjournal.pone.0127083"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">MALT1 protease activity is required for innate and adaptive immune responses</span></div><div class="casAuthors">Yu, Jong W.; Hoffman, Sandy; Beal, Allison M.; Dykon, Angela; Ringenberg, Michael A.; Hughes, Anna C.; Dare, Lauren; Anderson, Amber D.; Finger, Joshua; Kasparcova, Viera; Rickard, David; Berger, Scott B.; Ramanjulu, Joshi; Emery, John G.; Gough, Peter J.; Bertin, John; Foley, Kevin P.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e0127083/1-e0127083/20</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">CARMA-BCL10-MALT1 signalosomes play important roles in antigen receptor signaling and other pathways.  Previous studies have suggested that as part of this complex, MALT1 functions as both a scaffolding protein to activate NF-κB through recruitment of ubiquitin ligases, and as a protease to cleave and inactivate downstream inhibitory signaling proteins.  However, our understanding of the relative importance of these two distinct MALT1 activities has been hampered by a lack of selective MALT1 protease inhibitors with suitable pharmacol. properties.  To fully investigate the role of MALT1 protease activity, we generated mice homozygous for a protease-dead mutation in MALT1.  We found that some, but not all, MALT1 functions in immune cells were dependent upon its protease activity.  Protease-dead mice had defects in the generation of splenic marginal zone and peritoneal B1 B cells.  CD4+ and CD8+ T cells displayed decreased T cell receptor-stimulated proliferation and IL-2 prodn. while B cell receptor-stimulated proliferation was partially dependent on protease activity.  In dendritic cells, stimulation of cytokine prodn. through the Dectin-1, Dectin-2, and Mincle C-type lectin receptors was also found to be partially dependent upon protease activity.  In vivo, protease-dead mice had reduced basal Ig levels, and showed defective responses to immunization with T-dependent and T-independent antigens.  Surprisingly, despite these decreased responses, MALT1 protease-dead mice, but not MALT1 null mice, developed mixed inflammatory cell infiltrates in multiple organs, suggesting MALT1 protease activity plays a role in immune homeostasis.  These findings highlight the importance of MALT1 protease activity in multiple immune cell types, and in integrating immune responses in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmQwkA_jqS2LVg90H21EOLACvtfcHk0lgUp6tvDB--4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslSju7jL&md5=1ace6e08be2bbbcdc819e48201f968a5</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0127083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0127083%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DJ.%2BW.%26aulast%3DHoffman%26aufirst%3DS.%26aulast%3DBeal%26aufirst%3DA.%2BM.%26aulast%3DDykon%26aufirst%3DA.%26aulast%3DRingenberg%26aufirst%3DM.%2BA.%26aulast%3DHughes%26aufirst%3DA.%2BC.%26aulast%3DDare%26aufirst%3DL.%26aulast%3DAnderson%26aufirst%3DA.%2BD.%26aulast%3DFinger%26aufirst%3DJ.%26aulast%3DKasparcova%26aufirst%3DV.%26aulast%3DRickard%26aufirst%3DD.%26aulast%3DBerger%26aufirst%3DS.%2BB.%26aulast%3DRamanjulu%26aufirst%3DJ.%26aulast%3DEmery%26aufirst%3DJ.%2BG.%26aulast%3DGough%26aufirst%3DP.%2BJ.%26aulast%3DBertin%26aufirst%3DJ.%26aulast%3DFoley%26aufirst%3DK.%2BP.%26atitle%3DMALT1%2520Protease%2520Activity%2520Is%2520Required%2520for%2520Innate%2520and%2520Adaptive%2520Immune%2520Responses%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26doi%3D10.1371%2Fjournal.pone.0127083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gilis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaublomme, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venken, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhaenens, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambrecht, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coudenys, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decruy, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schryvers, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Driege, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumas, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demeyer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Muynck, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hengel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Hoorebeke, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deforce, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beyaert, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elewaut, D.</span></span> <span> </span><span class="NLM_article-title">Deletion of Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1 in Mouse T Cells Protects Against Development of Autoimmune Arthritis but Leads to Spontaneous Osteoporosis</span>. <i>Arthritis Rheumatol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">2005</span>, <span class="refDoi"> DOI: 10.1002/art.41029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1002%2Fart.41029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=31259485" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVyitb%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2019&pages=2005&author=E.+Gilisauthor=D.+Gaublommeauthor=J.+Staalauthor=K.+Venkenauthor=M.+Dhaenensauthor=S.+Lambrechtauthor=J.+Coudenysauthor=T.+Decruyauthor=N.+Schryversauthor=Y.+Driegeauthor=E.+Dumasauthor=A.+Demeyerauthor=A.+De+Muynckauthor=J.+Hengelauthor=L.+Van+Hoorebekeauthor=D.+Deforceauthor=R.+Beyaertauthor=D.+Elewaut&title=Deletion+of+Mucosa-Associated+Lymphoid+Tissue+Lymphoma+Translocation+Protein+1+in+Mouse+T+Cells+Protects+Against+Development+of+Autoimmune+Arthritis+but+Leads+to+Spontaneous+Osteoporosis&doi=10.1002%2Fart.41029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Deletion of Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1 in Mouse T Cells Protects Against Development of Autoimmune Arthritis but Leads to Spontaneous Osteoporosis</span></div><div class="casAuthors">Gilis, Elisabeth; Gaublomme, Djoere; Staal, Jens; Venken, Koen; Dhaenens, Maarten; Lambrecht, Stijn; Coudenys, Julie; Decruy, Tine; Schryvers, Nadia; Driege, Yasmine; Dumas, Emilie; Demeyer, Annelies; De Muynck, Amelie; van Hengel, Jolanda; Van Hoorebeke, Luc; Deforce, Dieter; Beyaert, Rudi; Elewaut, Dirk</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2005-2015</span>CODEN:
                <span class="NLM_cas:coden">ARRHBO</span>;
        ISSN:<span class="NLM_cas:issn">2326-5191</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The goal of this study was to examine the role of MALT-1 in exptl. animal models of rheumatoid arthritis (RA).  Methods : MALT-1 activation was assessed by measuring cleavage of the deubiquitinase CYLD in lymphocytes from mice with collagen-induced arthritis (CIA).  Furthermore, the impact of MALT-1 deficiency on arthritis was evaluated in Malt1KO mice with CIA or with collagen antibody-induced arthritis (CAIA).  Results : MALT-1 activation was obsd. in the lymphocytes of mice with CIA.  T cell-specific MALT-1 deletion in the induction phase of arthritis (incidence of arthritis, 25% in control mice vs. 0% in Malt1iTcellKO mice; P < 0.05), but not in the effector phase of arthritis, completely protected mice against the development of CIA.  Consistent with this finding, MALT-1 deficiency had no impact on CAIA, an effector phase model of RA.  Finally, mice with MALT-1 deficiency showed a spontaneous decrease in bone d. (mean ± SEM trabecular thickness, 46.3 ± 0.7 μm in control mice vs. 40 ± 1.1 μm in Malt1KO mice; P < 0.001), which was linked to the loss of Treg cells in these mice.  Conclusion : Overall, these data in murine models of RA highlight MALT-1 as a master regulator of T cell activation, which is relevant to the pathogenesis of autoimmune arthritis.  Furthermore, these findings show that MALT-1 deficiency can lead to spontaneous osteoporosis, which is assocd. with impaired Treg cell nos.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWvo9m2tRVdrVg90H21EOLACvtfcHk0lgUp6tvDB--4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVyitb%252FF&md5=d2f1d9fd8349d03f48f173c83eaac4c5</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1002%2Fart.41029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.41029%26sid%3Dliteratum%253Aachs%26aulast%3DGilis%26aufirst%3DE.%26aulast%3DGaublomme%26aufirst%3DD.%26aulast%3DStaal%26aufirst%3DJ.%26aulast%3DVenken%26aufirst%3DK.%26aulast%3DDhaenens%26aufirst%3DM.%26aulast%3DLambrecht%26aufirst%3DS.%26aulast%3DCoudenys%26aufirst%3DJ.%26aulast%3DDecruy%26aufirst%3DT.%26aulast%3DSchryvers%26aufirst%3DN.%26aulast%3DDriege%26aufirst%3DY.%26aulast%3DDumas%26aufirst%3DE.%26aulast%3DDemeyer%26aufirst%3DA.%26aulast%3DDe%2BMuynck%26aufirst%3DA.%26aulast%3DHengel%26aufirst%3DJ.%26aulast%3DVan%2BHoorebeke%26aufirst%3DL.%26aulast%3DDeforce%26aufirst%3DD.%26aulast%3DBeyaert%26aufirst%3DR.%26aulast%3DElewaut%26aufirst%3DD.%26atitle%3DDeletion%2520of%2520Mucosa-Associated%2520Lymphoid%2520Tissue%2520Lymphoma%2520Translocation%2520Protein%25201%2520in%2520Mouse%2520T%2520Cells%2520Protects%2520Against%2520Development%2520of%2520Autoimmune%2520Arthritis%2520but%2520Leads%2520to%2520Spontaneous%2520Osteoporosis%26jtitle%3DArthritis%2520Rheumatol.%26date%3D2019%26volume%3D71%26spage%3D2005%26doi%3D10.1002%2Fart.41029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span> <span> </span><span class="NLM_article-title">Malt1 Protease Is Critical in Maintaining Function of Regulatory T Cells and May Be a Therapeutic Target for Antitumor Immunity</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>202</i></span>,  <span class="NLM_fpage">3008</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.1801614</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.4049%2Fjimmunol.1801614" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=30979818" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC1MXpvF2nsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=202&publication_year=2019&pages=3008&author=L.+Chengauthor=N.+Dengauthor=N.+Yangauthor=X.+Zhaoauthor=X.+Lin&title=Malt1+Protease+Is+Critical+in+Maintaining+Function+of+Regulatory+T+Cells+and+May+Be+a+Therapeutic+Target+for+Antitumor+Immunity&doi=10.4049%2Fjimmunol.1801614"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Malt1 protease is critical in maintaining function of regulatory T cells and may be a therapeutic target for antitumor immunity</span></div><div class="casAuthors">Cheng, Liqing; Deng, Nan; Yang, Naixue; Zhao, Xueqiang; Lin, Xin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">202</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3008-3019</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">The paracaspase Malt1 is a key mol. in mediating Ag receptor-induced NF-κB activation in lymphocytes, but the role of Malt1 in the function of regulatory T (Treg) cells is still unclear.  In this article, we reported that specific deletion of Malt1 in Treg cells would lead to Scurfy-like lethal autoimmune disease, which was caused by Treg cell dysfunction but not no. loss.  Interestingly, Foxp3CreMalt1fl/C472A mice, in which Malt1 protease was specifically inactivated in Treg cells, also displayed spontaneous inflammatory disorders, with severe hair loss and skin hyperplasia.  Consistently, Foxp3CreMalt1fl/C472A mice showed enhanced antitumor response because of their decreased function and infiltration of Treg cells, as well as reduced CD8+ T cell exhaustion.  Gene expression profiling anal. revealed dysregulated expression pattern of Treg effector genes upon Malt1 deletion or its protease inactivation.  Together, our data unraveled a crit. role of Malt1, esp. its protease activity, in maintaining homeostasis and function of Treg cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyuNixqJyx5LVg90H21EOLACvtfcHk0lgi90C20_JO5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXpvF2nsbs%253D&md5=d241d288a6a191e6243e8669726138e6</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1801614&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1801614%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DL.%26aulast%3DDeng%26aufirst%3DN.%26aulast%3DYang%26aufirst%3DN.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DLin%26aufirst%3DX.%26atitle%3DMalt1%2520Protease%2520Is%2520Critical%2520in%2520Maintaining%2520Function%2520of%2520Regulatory%2520T%2520Cells%2520and%2520May%2520Be%2520a%2520Therapeutic%2520Target%2520for%2520Antitumor%2520Immunity%26jtitle%3DJ.%2520Immunol.%26date%3D2019%26volume%3D202%26spage%3D3008%26doi%3D10.4049%2Fjimmunol.1801614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di
Pilato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cadilha, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prüßmann, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nasrallah, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seruggia, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Usmani, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misale, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zappulli, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrizosa, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mani, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligorio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warner, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medoff, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marangoni, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villani, A.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mempel, T. R.</span></span> <span> </span><span class="NLM_article-title">Targeting the CBM Complex Causes Treg Cells to Prime Tumours for Immune Checkpoint Therapy</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>570</i></span>,  <span class="NLM_fpage">112</span>, <span class="refDoi"> DOI: 10.1038/s41586-019-1215-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1038%2Fs41586-019-1215-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=31092922" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC1MXpslGmurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=570&publication_year=2019&pages=112&author=M.+Di%0APilatoauthor=E.+Y.+Kimauthor=B.+L.+Cadilhaauthor=J.+N.+Pr%C3%BC%C3%9Fmannauthor=M.+N.+Nasrallahauthor=D.+Seruggiaauthor=S.+M.+Usmaniauthor=S.+Misaleauthor=V.+Zappulliauthor=E.+Carrizosaauthor=V.+Maniauthor=M.+Ligorioauthor=R.+D.+Warnerauthor=B.+D.+Medoffauthor=F.+Marangoniauthor=A.-C.+Villaniauthor=T.+R.+Mempel&title=Targeting+the+CBM+Complex+Causes+Treg+Cells+to+Prime+Tumours+for+Immune+Checkpoint+Therapy&doi=10.1038%2Fs41586-019-1215-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the CBM complex causes Treg cells to prime tumours for immune checkpoint therapy</span></div><div class="casAuthors">Di Pilato, Mauro; Kim, Edward Y.; Cadilha, Bruno L.; Prussmann, Jasper N.; Nasrallah, Mazen N.; Seruggia, Davide; Usmani, Shariq M.; Misale, Sandra; Zappulli, Valentina; Carrizosa, Esteban; Mani, Vinidhra; Ligorio, Matteo; Warner, Ross D.; Medoff, Benjamin D.; Marangoni, Francesco; Villani, Alexandra-Chloe; Mempel, Thorsten R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">570</span>
        (<span class="NLM_cas:issue">7759</span>),
    <span class="NLM_cas:pages">112-116</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Solid tumors are infiltrated by effector T cells with the potential to control or reject them, as well as by regulatory T (Treg) cells that restrict the function of effector T cells and thereby promote tumor growth.  The anti-tumor activity of effector T cells can be therapeutically unleashed, and is now being exploited for the treatment of some forms of human cancer.  However, weak tumor-assocd. inflammatory responses and the immune-suppressive function of Treg cells remain major hurdles to broader effectiveness of tumor immunotherapy.  Here we show that, after disruption of the CARMA1-BCL10-MALT1 (CBM) signalosome complex, most tumor-infiltrating Treg cells produce IFNγ, resulting in stunted tumor growth.  Notably, genetic deletion of both or even just one allele of CARMA1 (also known as Card11) in only a fraction of Treg cells-which avoided systemic autoimmunity-was sufficient to produce this anti-tumor effect, showing that it is not the mere loss of suppressive function but the gain of effector activity by Treg cells that initiates tumor control.  The prodn. of IFNγ by Treg cells was accompanied by activation of macrophages and upregulation of class I mols. of the major histocompatibility complex on tumor cells.  However, tumor cells also upregulated the expression of PD-L1, which indicates activation of adaptive immune resistance.  Consequently, blockade of PD-1 together with CARMA1 deletion caused rejection of tumors that otherwise do not respond to anti-PD-1 monotherapy.  This effect was reproduced by pharmacol. inhibition of the CBM protein MALT1.  Our results demonstrate that partial disruption of the CBM complex and induction of IFNγ secretion in the preferentially self-reactive Treg cell pool does not cause systemic autoimmunity but is sufficient to prime the tumor environment for successful immune checkpoint therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkZEjWA3fkAbVg90H21EOLACvtfcHk0lgi90C20_JO5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXpslGmurk%253D&md5=b451aabc0fc7c55c3a0796850e500485</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fs41586-019-1215-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-019-1215-2%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BPilato%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DE.%2BY.%26aulast%3DCadilha%26aufirst%3DB.%2BL.%26aulast%3DPr%25C3%25BC%25C3%259Fmann%26aufirst%3DJ.%2BN.%26aulast%3DNasrallah%26aufirst%3DM.%2BN.%26aulast%3DSeruggia%26aufirst%3DD.%26aulast%3DUsmani%26aufirst%3DS.%2BM.%26aulast%3DMisale%26aufirst%3DS.%26aulast%3DZappulli%26aufirst%3DV.%26aulast%3DCarrizosa%26aufirst%3DE.%26aulast%3DMani%26aufirst%3DV.%26aulast%3DLigorio%26aufirst%3DM.%26aulast%3DWarner%26aufirst%3DR.%2BD.%26aulast%3DMedoff%26aufirst%3DB.%2BD.%26aulast%3DMarangoni%26aufirst%3DF.%26aulast%3DVillani%26aufirst%3DA.-C.%26aulast%3DMempel%26aufirst%3DT.%2BR.%26atitle%3DTargeting%2520the%2520CBM%2520Complex%2520Causes%2520Treg%2520Cells%2520to%2520Prime%2520Tumours%2520for%2520Immune%2520Checkpoint%2520Therapy%26jtitle%3DNature%26date%3D2019%26volume%3D570%26spage%3D112%26doi%3D10.1038%2Fs41586-019-1215-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rebeaud, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hailfinger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Posevitz-Fejfar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tapernoux, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moser, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rueda, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaide, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzzardi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iancu, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rufer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fasel, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thome, M.</span></span> <span> </span><span class="NLM_article-title">The Proteolytic Activity of the Paracaspase MALT1 Is Key in T Cell Activation</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">272</span>– <span class="NLM_lpage">281</span>, <span class="refDoi"> DOI: 10.1038/ni1568</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1038%2Fni1568" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=18264101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitVOjt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=272-281&author=F.+Rebeaudauthor=S.+Hailfingerauthor=A.+Posevitz-Fejfarauthor=M.+Tapernouxauthor=R.+Moserauthor=D.+Ruedaauthor=O.+Gaideauthor=M.+Guzzardiauthor=E.+M.+Iancuauthor=N.+Ruferauthor=N.+Faselauthor=M.+Thome&title=The+Proteolytic+Activity+of+the+Paracaspase+MALT1+Is+Key+in+T+Cell+Activation&doi=10.1038%2Fni1568"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The proteolytic activity of the paracaspase MALT1 is key in T cell activation</span></div><div class="casAuthors">Rebeaud, Fabien; Hailfinger, Stephan; Posevitz-Fejfar, Anita; Tapernoux, Myriam; Moser, Roger; Rueda, Daniel; Gaide, Olivier; Guzzardi, Montserrat; Iancu, Emanuela M.; Rufer, Nathalie; Fasel, Nicolas; Thome, Margot</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">272-281</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The paracaspase MALT1 is pivotal in antigen receptor-mediated lymphocyte activation and lymphomagenesis.  MALT1 contains a caspase-like domain, but it is unknown whether this domain is proteolytically active.  Here the authors report that MALT1 had arginine-directed proteolytic activity that was activated after T cell stimulation, and they identify the signaling protein Bcl-10 as a MALT1 substrate.  Processing of Bcl-10 after Arg228 was required for T cell receptor-induced cell adhesion to fibronectin.  In contrast, MALT1 activity but not Bcl-10 cleavage was essential for optimal activation of transcription factor NF-κB and prodn. of interleukin 2.  Thus, the proteolytic activity of MALT1 is central to T cell activation, which suggests a possible target for the development of immunomodulatory or anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2kTzBRxfMGLVg90H21EOLACvtfcHk0lgi90C20_JO5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitVOjt7w%253D&md5=094b1afc1f65e8a21846b095129df581</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fni1568&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni1568%26sid%3Dliteratum%253Aachs%26aulast%3DRebeaud%26aufirst%3DF.%26aulast%3DHailfinger%26aufirst%3DS.%26aulast%3DPosevitz-Fejfar%26aufirst%3DA.%26aulast%3DTapernoux%26aufirst%3DM.%26aulast%3DMoser%26aufirst%3DR.%26aulast%3DRueda%26aufirst%3DD.%26aulast%3DGaide%26aufirst%3DO.%26aulast%3DGuzzardi%26aufirst%3DM.%26aulast%3DIancu%26aufirst%3DE.%2BM.%26aulast%3DRufer%26aufirst%3DN.%26aulast%3DFasel%26aufirst%3DN.%26aulast%3DThome%26aufirst%3DM.%26atitle%3DThe%2520Proteolytic%2520Activity%2520of%2520the%2520Paracaspase%2520MALT1%2520Is%2520Key%2520in%2520T%2520Cell%2520Activation%26jtitle%3DNat.%2520Immunol.%26date%3D2008%26volume%3D9%26spage%3D272%26epage%3D281%26doi%3D10.1038%2Fni1568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fontan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kabaleeswaran, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volpon, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osborne, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beltran, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerchietti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaknovich, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gascoyne, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Climent, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glickman, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borden, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melnick, A.</span></span> <span> </span><span class="NLM_article-title">MALT1 Small Molecule Inhibitors Specifically Suppress ABC-DLBCL In Vitro and In Vivo</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">812</span>– <span class="NLM_lpage">824</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2012.11.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1016%2Fj.ccr.2012.11.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=23238016" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVWgu7fJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=812-824&author=L.+Fontanauthor=C.+Yangauthor=V.+Kabaleeswaranauthor=L.+Volponauthor=M.+J.+Osborneauthor=E.+Beltranauthor=M.+Garciaauthor=L.+Cerchiettiauthor=R.+Shaknovichauthor=S.+N.+Yangauthor=F.+Fangauthor=R.+D.+Gascoyneauthor=J.+A.+Martinez-Climentauthor=J.+F.+Glickmanauthor=K.+Bordenauthor=H.+Wuauthor=A.+Melnick&title=MALT1+Small+Molecule+Inhibitors+Specifically+Suppress+ABC-DLBCL+In+Vitro+and+In+Vivo&doi=10.1016%2Fj.ccr.2012.11.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">MALT1 Small Molecule Inhibitors Specifically Suppress ABC-DLBCL In Vitro and In Vivo</span></div><div class="casAuthors">Fontan, Lorena; Yang, Chenghua; Kabaleeswaran, Venkataraman; Volpon, Laurent; Osborne, Michael J.; Beltran, Elena; Garcia, Monica; Cerchietti, Leandro; Shaknovich, Rita; Yang, Shao Ning; Fang, Fang; Gascoyne, Randy D.; Martinez-Climent, Jose Angel; Glickman, J. Fraser; Borden, Katherine; Wu, Hao; Melnick, Ari</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">812-824</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">MALT1 cleavage activity is linked to the pathogenesis of activated B cell-like diffuse large B cell lymphoma (ABC-DLBCL), a chemoresistant form of DLBCL.  We developed a MALT1 activity assay and identified chem. diverse MALT1 inhibitors.  A selected lead compd., MI-2, featured direct binding to MALT1 and suppression of its protease function.  MI-2 concd. within human ABC-DLBCL cells and irreversibly inhibited cleavage of MALT1 substrates.  This was accompanied by NF-κB reporter activity suppression, c-REL nuclear localization inhibition, and NF-κB target gene downregulation.  Most notably, MI-2 was nontoxic to mice, and displayed selective activity against ABC-DLBCL cell lines in vitro and xenotransplanted ABC-DLBCL tumors in vivo.  The compd. was also effective against primary human non-germinal center B cell-like DLBCLs ex vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7Pj5xKzCfyrVg90H21EOLACvtfcHk0liD5sKtPHs31g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVWgu7fJ&md5=f8a19df22430725336d5620b4ccb269a</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2012.11.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2012.11.003%26sid%3Dliteratum%253Aachs%26aulast%3DFontan%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DKabaleeswaran%26aufirst%3DV.%26aulast%3DVolpon%26aufirst%3DL.%26aulast%3DOsborne%26aufirst%3DM.%2BJ.%26aulast%3DBeltran%26aufirst%3DE.%26aulast%3DGarcia%26aufirst%3DM.%26aulast%3DCerchietti%26aufirst%3DL.%26aulast%3DShaknovich%26aufirst%3DR.%26aulast%3DYang%26aufirst%3DS.%2BN.%26aulast%3DFang%26aufirst%3DF.%26aulast%3DGascoyne%26aufirst%3DR.%2BD.%26aulast%3DMartinez-Climent%26aufirst%3DJ.%2BA.%26aulast%3DGlickman%26aufirst%3DJ.%2BF.%26aulast%3DBorden%26aufirst%3DK.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DMelnick%26aufirst%3DA.%26atitle%3DMALT1%2520Small%2520Molecule%2520Inhibitors%2520Specifically%2520Suppress%2520ABC-DLBCL%2520In%2520Vitro%2520and%2520In%2520Vivo%26jtitle%3DCancer%2520Cell%26date%3D2012%26volume%3D22%26spage%3D812%26epage%3D824%26doi%3D10.1016%2Fj.ccr.2012.11.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Structure–Activity Relationship Studies of MI-2 Analogues as MALT1 Inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">3321</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2018.04.059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1016%2Fj.bmc.2018.04.059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=29751989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC1cXptFCltrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&pages=3321&author=G.+Wuauthor=H.+Wangauthor=W.+Zhouauthor=B.+Zengauthor=W.+Moauthor=K.+Zhuauthor=R.+Liuauthor=J.+Zhouauthor=C.+Chenauthor=H.+Chen&title=Synthesis+and+Structure%E2%80%93Activity+Relationship+Studies+of+MI-2+Analogues+as+MALT1+Inhibitors&doi=10.1016%2Fj.bmc.2018.04.059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and structure-activity relationship studies of MI-2 analogues as MALT1 inhibitors</span></div><div class="casAuthors">Wu, Guolin; Wang, Haixia; Zhou, Wenhui; Zeng, Bihua; Mo, Wenhui; Zhu, Kejie; Liu, Rong; Zhou, Jia; Chen, Ceshi; Chen, Haijun</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3321-3344</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Recent studies revealed that MALT1 is a promising therapeutic target for the treatment of ABC-DLBCL.  Among several reported MALT1 inhibitors, MI-2 as an irreversible inhibitor represents a new class of ABC-DLBCL therapeutics.  Due to its inherent potential cross-reactivity, further structure-activity relationship (SAR) study is imperative.  Five focused compd. libraries based on the chem. structure of MI-2 are designed and synthesized.  The systematic SARs revealed that the side chain of 2-methoxyethoxy has little impact on the activity and can be replaced by other functionalized groups, providing new MI-2 analogs with retained or enhanced potency.  Compds. 81-83 with terminal hydroxyl group as side chain displayed enhanced activities against MALT1.  Replacement of triazole core with pyrazole is also tolerant, while structural modifications on other sites are detrimental.  These findings will facilitate further development of small-mol. MALT1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoE4dy_rlsztrVg90H21EOLACvtfcHk0liD5sKtPHs31g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXptFCltrY%253D&md5=23d5f61b7b4a1df514f98192a7a2766e</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2018.04.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2018.04.059%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DZeng%26aufirst%3DB.%26aulast%3DMo%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DH.%26atitle%3DSynthesis%2520and%2520Structure%25E2%2580%2593Activity%2520Relationship%2520Studies%2520of%2520MI-2%2520Analogues%2520as%2520MALT1%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2018%26volume%3D26%26spage%3D3321%26doi%3D10.1016%2Fj.bmc.2018.04.059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xin, B.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schimmack, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Florea, B. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der
Marel, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Driessen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krappmann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overkleeft, H. S.</span></span> <span> </span><span class="NLM_article-title">Development of New Malt1 Inhibitors and Probes</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">3312</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.03.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1016%2Fj.bmc.2016.03.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=27085674" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC28XmtVarsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=3312&author=B.-T.+Xinauthor=G.+Schimmackauthor=Y.+Duauthor=B.+I.+Floreaauthor=G.+A.+van+der%0AMarelauthor=C.+Driessenauthor=D.+Krappmannauthor=H.+S.+Overkleeft&title=Development+of+New+Malt1+Inhibitors+and+Probes&doi=10.1016%2Fj.bmc.2016.03.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Development of new Malt1 inhibitors and probes</span></div><div class="casAuthors">Xin, Bo-Tao; Schimmack, Gisela; Du, Yimeng; Florea, Bogdan I.; van der Marel, Gijsbert A.; Driessen, Christoph; Krappmann, Daniel; Overkleeft, Herman S.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3312-3329</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Mucosa-assocd. lymphoid tissue lymphoma translocation protein 1 (Malt1) is a promising therapeutic target for the treatment of activated B cell-like diffuse large B cell lymphoma (ABC-DLBCL).  Several research groups have reported on the development of Malt1 inhibitors and activity-based probes for in vitro and in situ monitoring and modulating Malt1 activity.  In this paper, the authors report on two activity-based Malt1 probes (I and II) and a focused library of 19 new Malt1 inhibitors.  The peptide-based probe I labels Malt1 in an activity-based manner.  In contrast, probe II, derived from the known covalent inhibitor MI-2, labels both wild type and catalytically inactive Cys to Ala mutant Malt1, suggesting that MI-2 inhibits Malt1 by reacting with a nucleophilic residue other than the active site cysteine.  Furthermore, two of the inhibitors (apparent IC50 3.0 μM and 2.1 μM) show good inhibitory activity against Malt1 and outperform MI-2 (apparent IC50 7.8 μM) in the competitive activity-based protein profiling assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfe_IulKpl8rVg90H21EOLACvtfcHk0liD5sKtPHs31g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmtVarsbs%253D&md5=09a86fc564cd2a438e3bcd612caa331f</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.03.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.03.035%26sid%3Dliteratum%253Aachs%26aulast%3DXin%26aufirst%3DB.-T.%26aulast%3DSchimmack%26aufirst%3DG.%26aulast%3DDu%26aufirst%3DY.%26aulast%3DFlorea%26aufirst%3DB.%2BI.%26aulast%3Dvan%2Bder%2BMarel%26aufirst%3DG.%2BA.%26aulast%3DDriessen%26aufirst%3DC.%26aulast%3DKrappmann%26aufirst%3DD.%26aulast%3DOverkleeft%26aufirst%3DH.%2BS.%26atitle%3DDevelopment%2520of%2520New%2520Malt1%2520Inhibitors%2520and%2520Probes%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D3312%26doi%3D10.1016%2Fj.bmc.2016.03.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lim, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Im, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tae, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, S.</span></span> <span> </span><span class="NLM_article-title">Identification of β-Lapachone Analogs as Novel MALT1 Inhibitors to Treat an Aggressive Subtype of Diffuse Large B-Cell Lymphoma</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">8491</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01415</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01415" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslWltrjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8491&author=S.+M.+Limauthor=Y.+Jeongauthor=S.+Leeauthor=H.+Imauthor=H.+S.+Taeauthor=B.+G.+Kimauthor=H.+D.+Parkauthor=J.+Parkauthor=S.+Hong&title=Identification+of+%CE%B2-Lapachone+Analogs+as+Novel+MALT1+Inhibitors+to+Treat+an+Aggressive+Subtype+of+Diffuse+Large+B-Cell+Lymphoma&doi=10.1021%2Facs.jmedchem.5b01415"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of β-Lapachone Analogs as Novel MALT1 Inhibitors To Treat an Aggressive Subtype of Diffuse Large B-Cell Lymphoma</span></div><div class="casAuthors">Lim, Sang Min; Jeong, Yujeong; Lee, Suhyun; Im, Honggu; Tae, Hyun Seop; Kim, Byung Gyu; Park, Hee Dong; Park, Jonghoon; Hong, Sungwoo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8491-8502</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The treatment of activated B cell-like DLBCL (ABC-DLBCL) is one of the urgent unmet medical needs because it is the most resistant DLBCL subtype to current therapies eagerly awaiting effective therapeutic strategies.  Recently, the paracaspase MALT1 has emerged as a promising therapeutic target for the treatment of ABC-DLBCL.  Herein, the authors report a new class of MALT1 inhibitors developed by high-throughput screening and structure-based drug design.  The original hit, 4-amino-1,2-naphthoquinone series inhibited MALT1 activity but suffered from poor cellular activity.  The extensive pharmacophore search led to the discovery of structurally similar β-lapachone that is a direct inhibitor of MALT1 and possesses favorable physicochem. properties.  Mol. simulation studies suggested the possibility of the formation of a covalent bond between MALT1 and β-lapachone, which was corroborated by exptl. wash-out studies.  Inspired by this, the authors explored the structure-activity relationships by incorporating electron-withdrawing substituents at C8 position of β-lapachone.  These MALT1 inhibitors exhibited potent antiproliferative activity to OCI-LY3 cell line and inhibited the cleavage of CYLD mediated MALT1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8L_xlzorpZLVg90H21EOLACvtfcHk0li6YjDJpW6tmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslWltrjI&md5=d02db14d98441839fe908f53c14fa071</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01415%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DS.%2BM.%26aulast%3DJeong%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DIm%26aufirst%3DH.%26aulast%3DTae%26aufirst%3DH.%2BS.%26aulast%3DKim%26aufirst%3DB.%2BG.%26aulast%3DPark%26aufirst%3DH.%2BD.%26aulast%3DPark%26aufirst%3DJ.%26aulast%3DHong%26aufirst%3DS.%26atitle%3DIdentification%2520of%2520%25CE%25B2-Lapachone%2520Analogs%2520as%2520Novel%2520MALT1%2520Inhibitors%2520to%2520Treat%2520an%2520Aggressive%2520Subtype%2520of%2520Diffuse%2520Large%2520B-Cell%2520Lymphoma%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8491%26doi%3D10.1021%2Facs.jmedchem.5b01415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nagel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spranger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincendeau, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grau, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raffegerst, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kloo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hlahla, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuenschwander, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peter von Kries, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hadian, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dörken, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schendel, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krappmann, D.</span></span> <span> </span><span class="NLM_article-title">Pharmacologic Inhibition of MALT1 Protease by Phenothiazines as a Therapeutic Approach for the Treatment of Aggressive ABC-DLBCL</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">825</span>– <span class="NLM_lpage">837</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2012.11.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1016%2Fj.ccr.2012.11.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=23238017" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVWns77J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=825-837&author=D.+Nagelauthor=S.+Sprangerauthor=M.+Vincendeauauthor=M.+Grauauthor=S.+Raffegerstauthor=B.+Klooauthor=D.+Hlahlaauthor=M.+Neuenschwanderauthor=J.+Peter+von+Kriesauthor=K.+Hadianauthor=B.+D%C3%B6rkenauthor=P.+Lenzauthor=G.+Lenzauthor=D.+J.+Schendelauthor=D.+Krappmann&title=Pharmacologic+Inhibition+of+MALT1+Protease+by+Phenothiazines+as+a+Therapeutic+Approach+for+the+Treatment+of+Aggressive+ABC-DLBCL&doi=10.1016%2Fj.ccr.2012.11.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacologic Inhibition of MALT1 Protease by Phenothiazines as a Therapeutic Approach for the Treatment of Aggressive ABC-DLBCL</span></div><div class="casAuthors">Nagel, Daniel; Spranger, Stefani; Vincendeau, Michelle; Grau, Michael; Raffegerst, Silke; Kloo, Bernhard; Hlahla, Daniela; Neuenschwander, Martin; von Kries, Jens Peter; Hadian, Kamyar; Doerken, Bernd; Lenz, Peter; Lenz, Georg; Schendel, Dolores J.; Krappmann, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">825-837</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Proteolytic activity of the mucosa-assocd. lymphoid tissue lymphoma translocation protein-1 (MALT1) paracaspase is required for survival of the activated B cell subtype of diffuse large B cell lymphoma (ABC-DLBCL).  We have identified distinct derivs. of medicinal active phenothiazines, namely mepazine, thioridazine, and promazine, as small mol. inhibitors of the MALT1 protease.  These phenothiazines selectively inhibit cleavage activity of recombinant and cellular MALT1 by a noncompetitive mechanism.  Consequently, the compds. inhibit anti-apoptotic NF-κB signaling and elicit toxic effects selectively on MALT1-dependent ABC-DLBCL cells in vitro and in vivo.  Our data provide a conceptual proof for a clin. application of distinct phenothiazines in the treatment of ABC-DLBCL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-pha_0UjHHLVg90H21EOLACvtfcHk0li6YjDJpW6tmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVWns77J&md5=e67e728b09fbaf08defbaf06c1258be9</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2012.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2012.11.002%26sid%3Dliteratum%253Aachs%26aulast%3DNagel%26aufirst%3DD.%26aulast%3DSpranger%26aufirst%3DS.%26aulast%3DVincendeau%26aufirst%3DM.%26aulast%3DGrau%26aufirst%3DM.%26aulast%3DRaffegerst%26aufirst%3DS.%26aulast%3DKloo%26aufirst%3DB.%26aulast%3DHlahla%26aufirst%3DD.%26aulast%3DNeuenschwander%26aufirst%3DM.%26aulast%3DPeter%2Bvon%2BKries%26aufirst%3DJ.%26aulast%3DHadian%26aufirst%3DK.%26aulast%3DD%25C3%25B6rken%26aufirst%3DB.%26aulast%3DLenz%26aufirst%3DP.%26aulast%3DLenz%26aufirst%3DG.%26aulast%3DSchendel%26aufirst%3DD.%2BJ.%26aulast%3DKrappmann%26aufirst%3DD.%26atitle%3DPharmacologic%2520Inhibition%2520of%2520MALT1%2520Protease%2520by%2520Phenothiazines%2520as%2520a%2520Therapeutic%2520Approach%2520for%2520the%2520Treatment%2520of%2520Aggressive%2520ABC-DLBCL%26jtitle%3DCancer%2520Cell%26date%3D2012%26volume%3D22%26spage%3D825%26epage%3D837%26doi%3D10.1016%2Fj.ccr.2012.11.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schlauderer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lammens, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincendeau, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eitelhuber, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhelst, S. H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kling, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chrusciel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruland, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krappmann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopfner, K.-P.</span></span> <span> </span><span class="NLM_article-title">Structural Analysis of Phenothiazine Derivatives as Allosteric Inhibitors of the MALT1 Paracaspase</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">10384</span>– <span class="NLM_lpage">10387</span>, <span class="refDoi"> DOI: 10.1002/anie.201304290</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1002%2Fanie.201304290" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1yjsb3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=10384-10387&author=F.+Schlaudererauthor=K.+Lammensauthor=D.+Nagelauthor=M.+Vincendeauauthor=A.+C.+Eitelhuberauthor=S.+H.+L.+Verhelstauthor=D.+Klingauthor=A.+Chruscielauthor=J.+Rulandauthor=D.+Krappmannauthor=K.-P.+Hopfner&title=Structural+Analysis+of+Phenothiazine+Derivatives+as+Allosteric+Inhibitors+of+the+MALT1+Paracaspase&doi=10.1002%2Fanie.201304290"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Analysis of Phenothiazine Derivatives as Allosteric Inhibitors of the MALT1 Paracaspase</span></div><div class="casAuthors">Schlauderer, Florian; Lammens, Katja; Nagel, Daniel; Vincendeau, Michelle; Eitelhuber, Andrea C.; Verhelst, Steven H. L.; Kling, Dale; Chrusciel, Al; Ruland, Juergen; Krappmann, Daniel; Hopfner, Karl-Peter</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">10384-10387</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The authors report the crystal structure of ligand-free dimeric human MALT1casp-Ig3 in complex with the tricyclic phenothiazine deriv. thioridazine.  Unexpectedly, the structure reveals that the inhibitor binds in a pocket located on the opposite to the caspase active site, in the interface between the caspase domain and the Ig3 domain connecting helix α1Ig3 of MALT1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrr2IUAVsvSQLVg90H21EOLACvtfcHk0lg3LBqBb31D6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1yjsb3O&md5=4795e1016841fd3c558b8095ff854255</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2Fanie.201304290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201304290%26sid%3Dliteratum%253Aachs%26aulast%3DSchlauderer%26aufirst%3DF.%26aulast%3DLammens%26aufirst%3DK.%26aulast%3DNagel%26aufirst%3DD.%26aulast%3DVincendeau%26aufirst%3DM.%26aulast%3DEitelhuber%26aufirst%3DA.%2BC.%26aulast%3DVerhelst%26aufirst%3DS.%2BH.%2BL.%26aulast%3DKling%26aufirst%3DD.%26aulast%3DChrusciel%26aufirst%3DA.%26aulast%3DRuland%26aufirst%3DJ.%26aulast%3DKrappmann%26aufirst%3DD.%26aulast%3DHopfner%26aufirst%3DK.-P.%26atitle%3DStructural%2520Analysis%2520of%2520Phenothiazine%2520Derivatives%2520as%2520Allosteric%2520Inhibitors%2520of%2520the%2520MALT1%2520Paracaspase%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2013%26volume%3D52%26spage%3D10384%26epage%3D10387%26doi%3D10.1002%2Fanie.201304290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schlapbach, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Revesz, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pissot Soldermann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoller, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Régnier, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornancin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radimerski, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blank, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuffenhauer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renatus, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erbel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melkko, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heng, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simic, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endres, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wartmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quancard, J.</span></span> <span> </span><span class="NLM_article-title">N-Aryl-Piperidine-4-Carboxamides as a Novel Class of Potent Inhibitors of MALT1 Proteolytic Activity</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">2153</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2018.05.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1016%2Fj.bmcl.2018.05.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=29759726" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC1cXps1Crsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=2153&author=A.+Schlapbachauthor=L.+Reveszauthor=C.+Pissot+Soldermannauthor=T.+Zollerauthor=C.+H.+R%C3%A9gnierauthor=F.+Bornancinauthor=T.+Radimerskiauthor=J.+Blankauthor=A.+Schuffenhauerauthor=M.+Renatusauthor=P.+Erbelauthor=S.+Melkkoauthor=R.+Hengauthor=O.+Simicauthor=R.+Endresauthor=M.+Wartmannauthor=J.+Quancard&title=N-Aryl-Piperidine-4-Carboxamides+as+a+Novel+Class+of+Potent+Inhibitors+of+MALT1+Proteolytic+Activity&doi=10.1016%2Fj.bmcl.2018.05.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">N-aryl-piperidine-4-carboxamides as a novel class of potent inhibitors of MALT1 proteolytic activity</span></div><div class="casAuthors">Schlapbach, Achim; Revesz, Laszlo; Pissot Soldermann, Carole; Zoller, Thomas; Regnier, Catherine H.; Bornancin, Frederic; Radimerski, Thomas; Blank, Jutta; Schuffenhauer, Ansgar; Renatus, Martin; Erbel, Paulus; Melkko, Samu; Heng, Richard; Simic, Oliver; Endres, Ralf; Wartmann, Markus; Quancard, Jean</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2153-2158</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Starting from a weak screening hit, potent and selective inhibitors of the MALT1 protease function were elaborated.  Advanced compds. displayed high potency in biochem. and cellular assays.  Compds. showed activity in a mechanistic Jurkat T cell activation assay as well as in the B-cell lymphoma line OCI-Ly3, which suggests potential use of MALT1 inhibitors in the treatment of autoimmune diseases as well as B-cell lymphomas with a dysregulated NF-κB pathway.  Initially, rat pharmacokinetic properties of this compd. series were dominated by very high clearance which could be linked to amide cleavage.  Using a rat hepatocyte assay a good in vitro-in vivo correlation could be established which led to the identification of compds. with improved PK properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4Gx09NEhsQ7Vg90H21EOLACvtfcHk0lg3LBqBb31D6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXps1Crsbc%253D&md5=f44b5e6bee523fbf3d5d692e0ce9c49c</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2018.05.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2018.05.017%26sid%3Dliteratum%253Aachs%26aulast%3DSchlapbach%26aufirst%3DA.%26aulast%3DRevesz%26aufirst%3DL.%26aulast%3DPissot%2BSoldermann%26aufirst%3DC.%26aulast%3DZoller%26aufirst%3DT.%26aulast%3DR%25C3%25A9gnier%26aufirst%3DC.%2BH.%26aulast%3DBornancin%26aufirst%3DF.%26aulast%3DRadimerski%26aufirst%3DT.%26aulast%3DBlank%26aufirst%3DJ.%26aulast%3DSchuffenhauer%26aufirst%3DA.%26aulast%3DRenatus%26aufirst%3DM.%26aulast%3DErbel%26aufirst%3DP.%26aulast%3DMelkko%26aufirst%3DS.%26aulast%3DHeng%26aufirst%3DR.%26aulast%3DSimic%26aufirst%3DO.%26aulast%3DEndres%26aufirst%3DR.%26aulast%3DWartmann%26aufirst%3DM.%26aulast%3DQuancard%26aufirst%3DJ.%26atitle%3DN-Aryl-Piperidine-4-Carboxamides%2520as%2520a%2520Novel%2520Class%2520of%2520Potent%2520Inhibitors%2520of%2520MALT1%2520Proteolytic%2520Activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D28%26spage%3D2153%26doi%3D10.1016%2Fj.bmcl.2018.05.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Quancard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fung, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renatus, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Israël, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Priatel, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blank, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viner, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blank, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlapbach, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erbel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kizhakkedathu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villard, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hersperger, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turvey, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eder, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornancin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overall, C. M.</span></span> <span> </span><span class="NLM_article-title">An Allosteric MALT1 Inhibitor Is a Molecular Corrector Rescuing Function in an Immunodeficient Patient</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">304</span>, <span class="refDoi"> DOI: 10.1038/s41589-018-0222-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1038%2Fs41589-018-0222-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=30692685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmtF2isbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2019&pages=304&author=J.+Quancardauthor=T.+Kleinauthor=S.-Y.+Fungauthor=M.+Renatusauthor=N.+Hughesauthor=L.+Isra%C3%ABlauthor=J.+J.+Priatelauthor=S.+Kangauthor=M.+A.+Blankauthor=R.+I.+Vinerauthor=J.+Blankauthor=A.+Schlapbachauthor=P.+Erbelauthor=J.+Kizhakkedathuauthor=F.+Villardauthor=R.+Herspergerauthor=S.+E.+Turveyauthor=J.+Ederauthor=F.+Bornancinauthor=C.+M.+Overall&title=An+Allosteric+MALT1+Inhibitor+Is+a+Molecular+Corrector+Rescuing+Function+in+an+Immunodeficient+Patient&doi=10.1038%2Fs41589-018-0222-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">An allosteric MALT1 inhibitor is a molecular corrector rescuing function in an immunodeficient patient</span></div><div class="casAuthors">Quancard, Jean; Klein, Theo; Fung, Shan-Yu; Renatus, Martin; Hughes, Nicola; Israel, Laura; Priatel, John J.; Kang, Sohyeong; Blank, Michael A.; Viner, Rosa I.; Blank, Jutta; Schlapbach, Achim; Erbel, Paul; Kizhakkedathu, Jayachandran; Villard, Frederic; Hersperger, Rene; Turvey, Stuart E.; Eder, Joerg; Bornancin, Frederic; Overall, Christopher M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">304-313</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">MALT1 paracaspase is central for lymphocyte antigen-dependent responses including NF-κB activation.  We discovered nanomolar, selective allosteric inhibitors of MALT1 that bind by displacing the side chain of Trp580, locking the protease in an inactive conformation.  Interestingly, we had previously identified a patient homozygous for a MALT1 Trp580-to-serine mutation who suffered from combined immunodeficiency.  We show that the loss of tryptophan weakened interactions between the paracaspase and C-terminal Ig MALT1 domains resulting in protein instability, reduced protein levels and functions.  Upon binding of allosteric inhibitors of increasing potency, we found proportionate increased stabilization of MALT1-W580S to reach that of wild-type MALT1.  With restored levels of stable MALT1 protein, the most potent of the allosteric inhibitors rescued NF-κB and JNK signaling in patient lymphocytes.  Following compd. washout, MALT1 substrate cleavage was partly recovered.  Thus, a mol. corrector rescues an enzyme deficiency by substituting for the mutated residue, inspiring new potential precision therapies to increase mutant enzyme activity in other deficiencies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoowtKlWIeaBbVg90H21EOLACvtfcHk0lib19IU2LDMKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmtF2isbo%253D&md5=923fffe83ed681c62ee0164a2d18775e</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fs41589-018-0222-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41589-018-0222-1%26sid%3Dliteratum%253Aachs%26aulast%3DQuancard%26aufirst%3DJ.%26aulast%3DKlein%26aufirst%3DT.%26aulast%3DFung%26aufirst%3DS.-Y.%26aulast%3DRenatus%26aufirst%3DM.%26aulast%3DHughes%26aufirst%3DN.%26aulast%3DIsra%25C3%25ABl%26aufirst%3DL.%26aulast%3DPriatel%26aufirst%3DJ.%2BJ.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DBlank%26aufirst%3DM.%2BA.%26aulast%3DViner%26aufirst%3DR.%2BI.%26aulast%3DBlank%26aufirst%3DJ.%26aulast%3DSchlapbach%26aufirst%3DA.%26aulast%3DErbel%26aufirst%3DP.%26aulast%3DKizhakkedathu%26aufirst%3DJ.%26aulast%3DVillard%26aufirst%3DF.%26aulast%3DHersperger%26aufirst%3DR.%26aulast%3DTurvey%26aufirst%3DS.%2BE.%26aulast%3DEder%26aufirst%3DJ.%26aulast%3DBornancin%26aufirst%3DF.%26aulast%3DOverall%26aufirst%3DC.%2BM.%26atitle%3DAn%2520Allosteric%2520MALT1%2520Inhibitor%2520Is%2520a%2520Molecular%2520Corrector%2520Rescuing%2520Function%2520in%2520an%2520Immunodeficient%2520Patient%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2019%26volume%3D15%26spage%3D304%26doi%3D10.1038%2Fs41589-018-0222-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bardet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unterreiner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malinverni, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lafossas, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vedrine, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boesch, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolb, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glück, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katopodis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renatus, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simic, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlapbach, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quancard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Régnier, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bold, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pissot-Soldermann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carballido, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovarik, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calzascia, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornancin, F.</span></span> <span> </span><span class="NLM_article-title">The T-Cell Fingerprint of MALT1 Paracaspase Revealed by Selective Inhibition</span>. <i>Immunol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">81</span>– <span class="NLM_lpage">99</span>, <span class="refDoi"> DOI: 10.1111/imcb.1018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1111%2Fimcb.1018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=29359407" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjs1Kitb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2018&pages=81-99&author=M.+Bardetauthor=A.+Unterreinerauthor=C.+Malinverniauthor=F.+Lafossasauthor=C.+Vedrineauthor=D.+Boeschauthor=Y.+Kolbauthor=D.+Kaiserauthor=A.+Gl%C3%BCckauthor=M.+A.+Schneiderauthor=A.+Katopodisauthor=M.+Renatusauthor=O.+Simicauthor=A.+Schlapbachauthor=J.+Quancardauthor=C.+H.+R%C3%A9gnierauthor=G.+Boldauthor=C.+Pissot-Soldermannauthor=J.+M.+Carballidoauthor=J.+Kovarikauthor=T.+Calzasciaauthor=F.+Bornancin&title=The+T-Cell+Fingerprint+of+MALT1+Paracaspase+Revealed+by+Selective+Inhibition&doi=10.1111%2Fimcb.1018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">The T-cell fingerprint of MALT1 paracaspase revealed by selective inhibition</span></div><div class="casAuthors">Bardet, Maureen; Unterreiner, Adeline; Malinverni, Claire; Lafossas, Frederique; Vedrine, Corinne; Boesch, Danielle; Kolb, Yeter; Kaiser, Daniel; Glueck, Anton; Schneider, Martin A.; Katopodis, Andreas; Renatus, Martin; Simic, Oliver; Schlapbach, Achim; Quancard, Jean; Regnier, Catherine H.; Bold, Guido; Pissot-Soldermann, Carole; Carballido, Jose M.; Kovarik, Jiri; Calzascia, Thomas; Bornancin, Frederic</div><div class="citationInfo"><span class="NLM_cas:title">Immunology & Cell Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">81-99</span>CODEN:
                <span class="NLM_cas:coden">ICBIEZ</span>;
        ISSN:<span class="NLM_cas:issn">1440-1711</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Australia, Ltd.</span>)
        </div><div class="casAbstract">Mucosa-assocd. lymphoid tissue lymphoma translocation protein 1 (MALT1) is essential for immune responses triggered by antigen receptors but the contribution of its paracaspase activity is not fully understood.  Here, we studied how MALT1 proteolytic function regulates T-cell activation and fate after engagement of the T-cell receptor pathway.  We show that MLT-827, a potent and selective MALT1 paracaspase inhibitor, does not prevent the initial phase of T-cell activation, in contrast to the pan-protein kinase C inhibitor AEB071.  However, MLT-827 strongly impacted cell expansion after activation.  We demonstrate this is the consequence of profound inhibition of IL-2 prodn. as well as reduced expression of the IL-2 receptor alpha subunit (CD25), resulting from defective canonical NF-κB activation and accelerated mRNA turnover mechanisms.  Accordingly, MLT-827 revealed a unique transcriptional fingerprint of MALT1 protease activity, providing evidence for broad control of T-cell signaling pathways.  Altogether, this first report with a potent and selective inhibitor elucidates how MALT1 paracaspase activity integrates several T-cell activation pathways and indirectly controls gamma-chain receptor dependent survival, to impact on T-cell expansion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcOZ3C5-LsPrVg90H21EOLACvtfcHk0lib19IU2LDMKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjs1Kitb0%253D&md5=0f35cd2ae66e3572e815eb24aacd6445</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1111%2Fimcb.1018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fimcb.1018%26sid%3Dliteratum%253Aachs%26aulast%3DBardet%26aufirst%3DM.%26aulast%3DUnterreiner%26aufirst%3DA.%26aulast%3DMalinverni%26aufirst%3DC.%26aulast%3DLafossas%26aufirst%3DF.%26aulast%3DVedrine%26aufirst%3DC.%26aulast%3DBoesch%26aufirst%3DD.%26aulast%3DKolb%26aufirst%3DY.%26aulast%3DKaiser%26aufirst%3DD.%26aulast%3DGl%25C3%25BCck%26aufirst%3DA.%26aulast%3DSchneider%26aufirst%3DM.%2BA.%26aulast%3DKatopodis%26aufirst%3DA.%26aulast%3DRenatus%26aufirst%3DM.%26aulast%3DSimic%26aufirst%3DO.%26aulast%3DSchlapbach%26aufirst%3DA.%26aulast%3DQuancard%26aufirst%3DJ.%26aulast%3DR%25C3%25A9gnier%26aufirst%3DC.%2BH.%26aulast%3DBold%26aufirst%3DG.%26aulast%3DPissot-Soldermann%26aufirst%3DC.%26aulast%3DCarballido%26aufirst%3DJ.%2BM.%26aulast%3DKovarik%26aufirst%3DJ.%26aulast%3DCalzascia%26aufirst%3DT.%26aulast%3DBornancin%26aufirst%3DF.%26atitle%3DThe%2520T-Cell%2520Fingerprint%2520of%2520MALT1%2520Paracaspase%2520Revealed%2520by%2520Selective%2520Inhibition%26jtitle%3DImmunol.%2520Cell%2520Biol.%26date%3D2018%26volume%3D96%26spage%3D81%26epage%3D99%26doi%3D10.1111%2Fimcb.1018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connolly, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philippar, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbay, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gys, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Nuffel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bekkers, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meerpoel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, J.</span></span> <span> </span><span class="NLM_article-title">Discovery and Optimization of a Series of Small-Molecule Allosteric Inhibitors of MALT1 Protease</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">126743</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2019.126743</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1016%2Fj.bmcl.2019.126743" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=31678006" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitV2hur7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2019&pages=126743&author=T.+Luauthor=P.+J.+Connollyauthor=U.+Philipparauthor=W.+Sunauthor=M.+D.+Cummingsauthor=K.+Barbayauthor=L.+Gysauthor=L.+Van+Nuffelauthor=N.+Austinauthor=M.+Bekkersauthor=F.+Shenauthor=A.+Caiauthor=R.+Attarauthor=L.+Meerpoelauthor=J.+Edwards&title=Discovery+and+Optimization+of+a+Series+of+Small-Molecule+Allosteric+Inhibitors+of+MALT1+Protease&doi=10.1016%2Fj.bmcl.2019.126743"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and optimization of a series of small-molecule allosteric inhibitors of MALT1 protease</span></div><div class="casAuthors">Lu, Tianbao; Connolly, Peter J.; Philippar, Ulrike; Sun, Weimei; Cummings, Maxwell D.; Barbay, Kent; Gys, Luc; Van Nuffel, Luc; Austin, Nigel; Bekkers, Mariette; Shen, Fang; Cai, Ann; Attar, Ricardo; Meerpoel, Lieven; Edwards, James</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">126743</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We describe a series of potent and highly selective small-mol. MALT1 inhibitors, optimized from a High-Throughput Screening hit.  Advanced analogs such as compd. 40 show high potency (IC50: 0.01 μM) in a biochem. assay measuring MALT1 enzymic activity, as well as in cellular assays: Jurkat T cell activation (0.05 μM) and IL6/10 secretion (IC50: 0.10/0.06 μM) in the TMD8 B-cell lymphoma line.  Compd. 40 also inhibited cleavage of the MALT1 substrate RelB (IC50: 0.10 μM).  Mechanistic enzymol. results suggest that these compds. bind to the known allosteric site of the protease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTRf6ZV0rc2LVg90H21EOLACvtfcHk0liQ2wuCW_Gsaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitV2hur7M&md5=47437e2ef1466412fc430fb4c64f001b</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2019.126743&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2019.126743%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DT.%26aulast%3DConnolly%26aufirst%3DP.%2BJ.%26aulast%3DPhilippar%26aufirst%3DU.%26aulast%3DSun%26aufirst%3DW.%26aulast%3DCummings%26aufirst%3DM.%2BD.%26aulast%3DBarbay%26aufirst%3DK.%26aulast%3DGys%26aufirst%3DL.%26aulast%3DVan%2BNuffel%26aufirst%3DL.%26aulast%3DAustin%26aufirst%3DN.%26aulast%3DBekkers%26aufirst%3DM.%26aulast%3DShen%26aufirst%3DF.%26aulast%3DCai%26aufirst%3DA.%26aulast%3DAttar%26aufirst%3DR.%26aulast%3DMeerpoel%26aufirst%3DL.%26aulast%3DEdwards%26aufirst%3DJ.%26atitle%3DDiscovery%2520and%2520Optimization%2520of%2520a%2520Series%2520of%2520Small-Molecule%2520Allosteric%2520Inhibitors%2520of%2520MALT1%2520Protease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26volume%3D29%26spage%3D126743%26doi%3D10.1016%2Fj.bmcl.2019.126743" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bonsignore, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Passelli, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelzer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perroud, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konrad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thurau, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stürzl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trillo-Tinoco, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Valle, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thome, M.</span></span> <span> </span><span class="NLM_article-title">A Role for MALT1 Activity in Kaposi’s Sarcoma-Associated Herpes Virus Latency and Growth of Primary Effusion Lymphoma</span>. <i>Leukemia</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">614</span>– <span class="NLM_lpage">624</span>, <span class="refDoi"> DOI: 10.1038/leu.2016.239</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1038%2Fleu.2016.239" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=27538487" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFCmsLvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2017&pages=614-624&author=L.+Bonsignoreauthor=K.+Passelliauthor=C.+Pelzerauthor=M.+Perroudauthor=A.+Konradauthor=M.+Thurauauthor=M.+St%C3%BCrzlauthor=L.+Daiauthor=J.+Trillo-Tinocoauthor=L.+Del+Valleauthor=Z.+Qinauthor=M.+Thome&title=A+Role+for+MALT1+Activity+in+Kaposi%E2%80%99s+Sarcoma-Associated+Herpes+Virus+Latency+and+Growth+of+Primary+Effusion+Lymphoma&doi=10.1038%2Fleu.2016.239"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">A role for MALT1 activity in Kaposi's sarcoma-associated herpes virus latency and growth of primary effusion lymphoma</span></div><div class="casAuthors">Bonsignore, L.; Passelli, K.; Pelzer, C.; Perroud, M.; Konrad, A.; Thurau, M.; Sturzl, M.; Dai, L.; Trillo-Tinoco, J.; Del Valle, L.; Qin, Z.; Thome, M.</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">614-624</span>CODEN:
                <span class="NLM_cas:coden">LEUKED</span>;
        ISSN:<span class="NLM_cas:issn">0887-6924</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Primary effusion lymphoma (PEL) is an incurable malignancy that develops in immunodeficient patients as a consequence of latent infection of B-cells with Kaposi's sarcoma-assocd. herpes virus (KSHV).  Malignant growth of KSHV-infected B cells requires the activity of the transcription factor nuclear factor (NF)-κB, which controls maintenance of viral latency and suppression of the viral lytic program.  Here we show that the KSHV proteins K13 and K15 promote NF-κB activation via the protease mucosa-assocd. lymphoid tissue lymphoma translocation protein-1 (MALT1), a key driver of NF-κB activation in lymphocytes.  Inhibition of the MALT1 protease activity induced a switch from the latent to the lytic stage of viral infection, and led to reduced growth and survival of PEL cell lines in vitro and in a xenograft model.  These results demonstrate a key role for the proteolytic activity of MALT1 in PEL, and provide a rationale for the pharmacol. targeting of MALT1 in PEL therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo33QiWBC8muLVg90H21EOLACvtfcHk0liQ2wuCW_Gsaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFCmsLvL&md5=6e8b34ef0b128505ace6df24f413e723</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fleu.2016.239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fleu.2016.239%26sid%3Dliteratum%253Aachs%26aulast%3DBonsignore%26aufirst%3DL.%26aulast%3DPasselli%26aufirst%3DK.%26aulast%3DPelzer%26aufirst%3DC.%26aulast%3DPerroud%26aufirst%3DM.%26aulast%3DKonrad%26aufirst%3DA.%26aulast%3DThurau%26aufirst%3DM.%26aulast%3DSt%25C3%25BCrzl%26aufirst%3DM.%26aulast%3DDai%26aufirst%3DL.%26aulast%3DTrillo-Tinoco%26aufirst%3DJ.%26aulast%3DDel%2BValle%26aufirst%3DL.%26aulast%3DQin%26aufirst%3DZ.%26aulast%3DThome%26aufirst%3DM.%26atitle%3DA%2520Role%2520for%2520MALT1%2520Activity%2520in%2520Kaposi%25E2%2580%2599s%2520Sarcoma-Associated%2520Herpes%2520Virus%2520Latency%2520and%2520Growth%2520of%2520Primary%2520Effusion%2520Lymphoma%26jtitle%3DLeukemia%26date%3D2017%26volume%3D31%26spage%3D614%26epage%3D624%26doi%3D10.1038%2Fleu.2016.239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mc
Guire, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elton, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wieghofer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demeyer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krappmann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prinz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beyaert, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Loo, G.</span></span> <span> </span><span class="NLM_article-title">Pharmacological Inhibition of MALT1 Protease Activity Protects Mice in a Mouse Model of Multiple Sclerosis</span>. <i>J. Neuroinflammation</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">124</span>, <span class="refDoi"> DOI: 10.1186/1742-2094-11-124</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1186%2F1742-2094-11-124" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=25043939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A280%3ADC%252BC2cbktFGiuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2014&pages=124&author=C.+Mc%0AGuireauthor=L.+Eltonauthor=P.+Wieghoferauthor=J.+Staalauthor=S.+Voetauthor=A.+Demeyerauthor=D.+Nagelauthor=D.+Krappmannauthor=M.+Prinzauthor=R.+Beyaertauthor=G.+van+Loo&title=Pharmacological+Inhibition+of+MALT1+Protease+Activity+Protects+Mice+in+a+Mouse+Model+of+Multiple+Sclerosis&doi=10.1186%2F1742-2094-11-124"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological inhibition of MALT1 protease activity protects mice in a mouse model of multiple sclerosis</span></div><div class="casAuthors">Mc Guire Conor; Elton Lynn; Wieghofer Peter; Staal Jens; Voet Sofie; Demeyer Annelies; Nagel Daniel; Krappmann Daniel; Prinz Marco; van Loo Geert; Beyaert Rudi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neuroinflammation</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">124</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The paracaspase mucosa-associated lymphoid tissue lymphoma translocation protein 1 (MALT1) is crucial for lymphocyte activation through signaling to the transcription factor NF-κB.  Besides functioning as a scaffold signaling protein, MALT1 also acts as a cysteine protease that specifically cleaves a number of substrates and contributes to specific T cell receptor-induced gene expression.  Recently, small molecule inhibitors of MALT1 proteolytic activity were identified and shown to have promising anticancer properties in subtypes of B cell lymphoma.  However, information on the therapeutic potential of small compound inhibitors that target MALT1 protease activity in autoimmunity is still lacking.  METHODS:  The present study aimed to elucidate whether MALT1 protease inhibitors are also useful in the treatment of lymphocyte-mediated autoimmune pathologies such as multiple sclerosis (MS).  For this, we studied the therapeutic potential of a recently identified inhibitor of MALT1 protease activity, the phenothiazine derivative mepazine, in the context of experimental autoimmune encephalomyelitis (EAE), the main animal model for MS.  RESULTS:  We demonstrate that administration of mepazine prophylactically or after disease onset, can attenuate EAE.  Importantly, while complete absence of MALT1 affects the differentiation of regulatory T (Treg) cells in vivo, the MALT1 protease inhibitor mepazine did not affect Treg development.  CONCLUSIONS:  Altogether, these data indicate that small molecule inhibitors of MALT1 not only hold great promise for the treatment of B cell lymphomas but also for autoimmune disorders such as MS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ8MHZfJVcqDXp3bfzSLaX5fW6udTcc2eZLbw8uBNBSM7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cbktFGiuw%253D%253D&md5=c9ab918a4d0dfeb999b9b965df49245f</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1186%2F1742-2094-11-124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1742-2094-11-124%26sid%3Dliteratum%253Aachs%26aulast%3DMc%2BGuire%26aufirst%3DC.%26aulast%3DElton%26aufirst%3DL.%26aulast%3DWieghofer%26aufirst%3DP.%26aulast%3DStaal%26aufirst%3DJ.%26aulast%3DVoet%26aufirst%3DS.%26aulast%3DDemeyer%26aufirst%3DA.%26aulast%3DNagel%26aufirst%3DD.%26aulast%3DKrappmann%26aufirst%3DD.%26aulast%3DPrinz%26aufirst%3DM.%26aulast%3DBeyaert%26aufirst%3DR.%26aulast%3Dvan%2BLoo%26aufirst%3DG.%26atitle%3DPharmacological%2520Inhibition%2520of%2520MALT1%2520Protease%2520Activity%2520Protects%2520Mice%2520in%2520a%2520Mouse%2520Model%2520of%2520Multiple%2520Sclerosis%26jtitle%3DJ.%2520Neuroinflammation%26date%3D2014%26volume%3D11%26spage%3D124%26doi%3D10.1186%2F1742-2094-11-124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Unterreiner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoehr, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huppertz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calzascia, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farady, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornancin, F.</span></span> <span> </span><span class="NLM_article-title">Selective MALT1 Paracaspase Inhibition Does Not Block TNF-α Production Downstream of TLR4 in Myeloid Cells</span>. <i>Immunol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>192</i></span>,  <span class="NLM_fpage">48</span>– <span class="NLM_lpage">51</span>, <span class="refDoi"> DOI: 10.1016/j.imlet.2017.10.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1016%2Fj.imlet.2017.10.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=29079202" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslehur%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=192&publication_year=2017&pages=48-51&author=A.+Unterreinerauthor=N.+Stoehrauthor=C.+Huppertzauthor=T.+Calzasciaauthor=C.+J.+Faradyauthor=F.+Bornancin&title=Selective+MALT1+Paracaspase+Inhibition+Does+Not+Block+TNF-%CE%B1+Production+Downstream+of+TLR4+in+Myeloid+Cells&doi=10.1016%2Fj.imlet.2017.10.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Selective MALT1 paracaspase inhibition does not block TNF-α production downstream of TLR4 in myeloid cells</span></div><div class="casAuthors">Unterreiner, Adeline; Stoehr, Natacha; Huppertz, Christine; Calzascia, Thomas; Farady, Christopher J.; Bornancin, Frederic</div><div class="citationInfo"><span class="NLM_cas:title">Immunology Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">192</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">48-51</span>CODEN:
                <span class="NLM_cas:coden">IMLED6</span>;
        ISSN:<span class="NLM_cas:issn">0165-2478</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The paracaspase MALT1 controls signaling downstream of several cell surface receptors, particularly in immune cells.  A no. of studies have suggested that targeting MALT1, and notably its paracaspase activity, could be beneficial to the treatment of pathol. conditions, such as lymphoma and autoimmune diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGou613LsB6AbLVg90H21EOLACvtfcHk0lhzK9BG5gdkzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslehur%252FN&md5=6b5c36781915e5134597235d31e922cd</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.imlet.2017.10.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.imlet.2017.10.009%26sid%3Dliteratum%253Aachs%26aulast%3DUnterreiner%26aufirst%3DA.%26aulast%3DStoehr%26aufirst%3DN.%26aulast%3DHuppertz%26aufirst%3DC.%26aulast%3DCalzascia%26aufirst%3DT.%26aulast%3DFarady%26aufirst%3DC.%2BJ.%26aulast%3DBornancin%26aufirst%3DF.%26atitle%3DSelective%2520MALT1%2520Paracaspase%2520Inhibition%2520Does%2520Not%2520Block%2520TNF-%25CE%25B1%2520Production%2520Downstream%2520of%2520TLR4%2520in%2520Myeloid%2520Cells%26jtitle%3DImmunol.%2520Lett.%26date%3D2017%26volume%3D192%26spage%3D48%26epage%3D51%26doi%3D10.1016%2Fj.imlet.2017.10.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Unterreiner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Touil, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anastasi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubois, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niwa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calzascia, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornancin, F.</span></span> <span> </span><span class="NLM_article-title">Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity</span>. <i>J. Visualized Exp.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>143</i></span>, <span class="NLM_elocation-id">e58439</span> <span class="refDoi"> DOI: 10.3791/58439</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.3791%2F58439" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2019&author=A.+Unterreinerauthor=R.+Touilauthor=D.+Anastasiauthor=N.+Duboisauthor=S.+Niwaauthor=T.+Calzasciaauthor=F.+Bornancin&title=Myeloid+Innate+Signaling+Pathway+Regulation+by+MALT1+Paracaspase+Activity&doi=10.3791%2F58439"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.3791%2F58439&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3791%252F58439%26sid%3Dliteratum%253Aachs%26aulast%3DUnterreiner%26aufirst%3DA.%26aulast%3DTouil%26aufirst%3DR.%26aulast%3DAnastasi%26aufirst%3DD.%26aulast%3DDubois%26aufirst%3DN.%26aulast%3DNiwa%26aufirst%3DS.%26aulast%3DCalzascia%26aufirst%3DT.%26aulast%3DBornancin%26aufirst%3DF.%26atitle%3DMyeloid%2520Innate%2520Signaling%2520Pathway%2520Regulation%2520by%2520MALT1%2520Paracaspase%2520Activity%26jtitle%3DJ.%2520Visualized%2520Exp.%26date%3D2019%26volume%3D143%26doi%3D10.3791%2F58439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falcon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soutar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornancin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xin, H.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, M.</span></span> <span> </span><span class="NLM_article-title">Pharmacological Inhibition of MALT1 Protease Activity Suppresses Endothelial Activation via Enhancing MCPIP1 Expression</span>. <i>Cell. Signalling</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">1</span>, <span class="refDoi"> DOI: 10.1016/j.cellsig.2018.05.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1016%2Fj.cellsig.2018.05.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=29913212" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1Sjsb7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2018&pages=1&author=Y.+Liauthor=S.+Huangauthor=X.+Huangauthor=X.+Liauthor=A.+Falconauthor=A.+Soutarauthor=F.+Bornancinauthor=Z.+Jiangauthor=H.-B.+Xinauthor=M.+Fu&title=Pharmacological+Inhibition+of+MALT1+Protease+Activity+Suppresses+Endothelial+Activation+via+Enhancing+MCPIP1+Expression&doi=10.1016%2Fj.cellsig.2018.05.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological inhibition of MALT1 protease activity suppresses endothelial activation via enhancing MCPIP1 expression</span></div><div class="casAuthors">Li, Yong; Huang, Shengping; Huang, Xuan; Li, Xiuzhen; Falcon, Adrian; Soutar, Adele; Bornancin, Frederic; Jiang, Zhisheng; Xin, Hong-Bo; Fu, Mingui</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-8</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Mucosa assocd. lymphoid tissue lymphoma translocation protein 1 (MALT1) is not only an intracellular signaling scaffold protein but also a paracaspase that plays a key role in the signal transduction and cellular activation of lymphocytes and macrophages.  However, its role in endothelial cells remains unknown.  Here we report that pharmacol. inhibition of MALT1 protease activity strongly suppresses endothelial activation via enhancing MCPIP1 expression.  Treatment with MALT1 protease inhibitors selectively inhibited TNFα-induced VCAM-1 expression in HUVECs and LPS-induced VCAM-1 expression in mice.  In addn., Inhibition of MALT1 protease activity also significantly inhibited TNFα-induced adhesion of THP-1 monocytic cells to HUVECs.  To explore the mechanisms, MALT1 inhibitors does not affect the activation of NF-κB signaling pathway in HUVEC.  However, they can stabilize MCPIP1 protein and significantly enhance MCPIP1 protein level in endothelial cells.  These results suggest that MALT1 paracaspase also targets MCPIP1 and degrade MCPIP1 protein in endothelial cells similar as it does in immune cells.  Taken together, the study suggest inhibition of MALT1 protease activity may represent a new strategy for prevention/therapy of vascular inflammatory diseases such as atherosclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqp7Blhcs5L87Vg90H21EOLACvtfcHk0lhzK9BG5gdkzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1Sjsb7I&md5=61c26f4ecc693856853894769ee3c4b9</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2018.05.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2018.05.009%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DFalcon%26aufirst%3DA.%26aulast%3DSoutar%26aufirst%3DA.%26aulast%3DBornancin%26aufirst%3DF.%26aulast%3DJiang%26aufirst%3DZ.%26aulast%3DXin%26aufirst%3DH.-B.%26aulast%3DFu%26aufirst%3DM.%26atitle%3DPharmacological%2520Inhibition%2520of%2520MALT1%2520Protease%2520Activity%2520Suppresses%2520Endothelial%2520Activation%2520via%2520Enhancing%2520MCPIP1%2520Expression%26jtitle%3DCell.%2520Signalling%26date%3D2018%26volume%3D50%26spage%3D1%26doi%3D10.1016%2Fj.cellsig.2018.05.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soldermann, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simic, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renatus, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erbel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melkko, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wartmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biguad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McSheehy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endres, R.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Discovery of Potent, Highly Selective, and In Vivo Efficacious, Allosteric MALT1 Inhibitors by Iterative Scaffold Morphing</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c01245</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c01245" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=C.+P.+Soldermannauthor=O.+Simicauthor=M.+Renatusauthor=P.+Erbelauthor=S.+Melkkoauthor=M.+Wartmannauthor=M.+Biguadauthor=A.+Weissauthor=P.+McSheehyauthor=R.+Endres&title=Discovery+of+Potent%2C+Highly+Selective%2C+and+In+Vivo+Efficacious%2C+Allosteric+MALT1+Inhibitors+by+Iterative+Scaffold+Morphing&doi=10.1021%2Facs.jmedchem.0c01245"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c01245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c01245%26sid%3Dliteratum%253Aachs%26aulast%3DSoldermann%26aufirst%3DC.%2BP.%26aulast%3DSimic%26aufirst%3DO.%26aulast%3DRenatus%26aufirst%3DM.%26aulast%3DErbel%26aufirst%3DP.%26aulast%3DMelkko%26aufirst%3DS.%26aulast%3DWartmann%26aufirst%3DM.%26aulast%3DBiguad%26aufirst%3DM.%26aulast%3DWeiss%26aufirst%3DA.%26aulast%3DMcSheehy%26aufirst%3DP.%26aulast%3DEndres%26aufirst%3DR.%26atitle%3DDiscovery%2520of%2520Potent%252C%2520Highly%2520Selective%252C%2520and%2520In%2520Vivo%2520Efficacious%252C%2520Allosteric%2520MALT1%2520Inhibitors%2520by%2520Iterative%2520Scaffold%2520Morphing%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26doi%3D10.1021%2Facs.jmedchem.0c01245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tønsberg, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holm, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjerregaard, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boll, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müllertz, A.</span></span> <span> </span><span class="NLM_article-title">An Updated and Simplified Method for Bile Duct Cannulation of Rats</span>. <i>Lab. Anim.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">373</span>, <span class="refDoi"> DOI: 10.1258/la.2010.010010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1258%2Fla.2010.010010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=20736319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A280%3ADC%252BC3cflsF2qsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2010&pages=373&author=H.+T%C3%B8nsbergauthor=R.+Holmauthor=T.+G.+Bjerregaardauthor=J.+B.+Bollauthor=J.+Jacobsenauthor=A.+M%C3%BCllertz&title=An+Updated+and+Simplified+Method+for+Bile+Duct+Cannulation+of+Rats&doi=10.1258%2Fla.2010.010010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">An updated and simplified method for bile duct cannulation of rats</span></div><div class="casAuthors">Tonsberg H; Holm R; Bjerregaard T G; Boll J B; Jacobsen J; Mullertz A</div><div class="citationInfo"><span class="NLM_cas:title">Laboratory animals</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">373-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The single bile duct cannulated rat model was used for short-term intestinal absorption studies.  Rats were randomly assigned to three groups: (A) bile duct cannulated, (B) control laparotomy and (C) no treatment.  The body weight and health of the rats were monitored before and until day 5 after surgery, while bile flow was measured in group A on day 2.  On the fifth day, tail vein blood was harvested, and alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase and total bilirubin were quantified.  Analysis of variance showed no significant difference between the groups for these parameters.  This study demonstrated the suitability of a surgical rat model feasible for evaluation of the impact of bile in pharmacokinetic studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQVEpieDyv8RCM8MEzWGjS9fW6udTcc2eYr8r1qDy51fLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cflsF2qsg%253D%253D&md5=23ead010e248040508699af28ec3a445</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1258%2Fla.2010.010010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1258%252Fla.2010.010010%26sid%3Dliteratum%253Aachs%26aulast%3DT%25C3%25B8nsberg%26aufirst%3DH.%26aulast%3DHolm%26aufirst%3DR.%26aulast%3DBjerregaard%26aufirst%3DT.%2BG.%26aulast%3DBoll%26aufirst%3DJ.%2BB.%26aulast%3DJacobsen%26aufirst%3DJ.%26aulast%3DM%25C3%25BCllertz%26aufirst%3DA.%26atitle%3DAn%2520Updated%2520and%2520Simplified%2520Method%2520for%2520Bile%2520Duct%2520Cannulation%2520of%2520Rats%26jtitle%3DLab.%2520Anim.%26date%3D2010%26volume%3D44%26spage%3D373%26doi%3D10.1258%2Fla.2010.010010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bachir-Cherif, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blum, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braendli-Baiocco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaput, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duran Pacheco, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flint, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haiker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoflack, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Justies, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neff, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Starke, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steiner, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tournillac, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ubeaud-Séquier, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuler, F.</span></span> <span> </span><span class="NLM_article-title">Characterization of Post-Surgical Alterations in the Bile Duct-Cannulated Rat</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">701</span>, <span class="refDoi"> DOI: 10.3109/00498254.2011.565819</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.3109%2F00498254.2011.565819" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=21521079" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosFaltb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2011&pages=701&author=D.+Bachir-Cherifauthor=D.+Blumauthor=A.+Braendli-Baioccoauthor=E.+Chaputauthor=G.+C.+Duran+Pachecoauthor=N.+Flintauthor=M.+Haikerauthor=J.-C.+Hoflackauthor=N.+Justiesauthor=R.+Neffauthor=V.+Starkeauthor=G.+Steinerauthor=C.+A.+Tournillacauthor=T.+Singerauthor=G.+Ubeaud-S%C3%A9quierauthor=F.+Schuler&title=Characterization+of+Post-Surgical+Alterations+in+the+Bile+Duct-Cannulated+Rat&doi=10.3109%2F00498254.2011.565819"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of post-surgical alterations in the bile duct-cannulated rat</span></div><div class="casAuthors">Bachir-Cherif, Dalila; Blum, Denise; Braendli-Baiocco, Annamaria; Chaput, Evelyne; Duran Pacheco, Gonzalo Christiano; Flint, Nicholas; Haiker, Monika; Hoflack, Jean-Christophe; Justies, Nicole; Neff, Rachel; Starke, Volkmar; Steiner, Guido; Tournillac, Charles Alexandre; Singer, Thomas; Ubeaud-Seequier, Genevieeve; Schuler, Franz</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">701-711</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">The bile duct-cannulated (BDC) rat is a std. animal model used in ADME expts.  The aim of this study was to investigate post-surgical alterations that are relevant to ADME investigations in BDC rats compared with sham- and non-operated animals.  Water and food intake was reduced in the animals' post-surgery.  This led to a lower body wt. in operated animals.  In BDC animals, aspartate aminotransferase (AST) levels in plasma were transiently elevated and total bile acid levels were reduced.  Alpha1-acid glycoprotein (AGP) in plasma and the concn. of bile components in bile were elevated.  Histopathol. showed inflammation in the area of the cannulation between the liver and the small intestine.  A microarray-based gene expression and RTq-PCR anal. identified altered expression for several genes involved in drug disposition including the down-regulation of cytochrome P 450 enzymes.  This led to reduced cytochrome P 450 content in the liver and lower metabolic activity in microsomes from BDC and sham-operated rats compared with naive animals.  The results of the study suggest that the post-surgical inflammation leads to physiol. changes relevant for drug absorption and disposition.  These alterations should be accounted for in the interpretation of ADME studies in BDC animals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLIqpij33b9LVg90H21EOLACvtfcHk0lgRH4PcQT_d6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosFaltb0%253D&md5=a5c018db9611f037476bd29bc859a2e3</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.3109%2F00498254.2011.565819&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00498254.2011.565819%26sid%3Dliteratum%253Aachs%26aulast%3DBachir-Cherif%26aufirst%3DD.%26aulast%3DBlum%26aufirst%3DD.%26aulast%3DBraendli-Baiocco%26aufirst%3DA.%26aulast%3DChaput%26aufirst%3DE.%26aulast%3DDuran%2BPacheco%26aufirst%3DG.%2BC.%26aulast%3DFlint%26aufirst%3DN.%26aulast%3DHaiker%26aufirst%3DM.%26aulast%3DHoflack%26aufirst%3DJ.-C.%26aulast%3DJusties%26aufirst%3DN.%26aulast%3DNeff%26aufirst%3DR.%26aulast%3DStarke%26aufirst%3DV.%26aulast%3DSteiner%26aufirst%3DG.%26aulast%3DTournillac%26aufirst%3DC.%2BA.%26aulast%3DSinger%26aufirst%3DT.%26aulast%3DUbeaud-S%25C3%25A9quier%26aufirst%3DG.%26aulast%3DSchuler%26aufirst%3DF.%26atitle%3DCharacterization%2520of%2520Post-Surgical%2520Alterations%2520in%2520the%2520Bile%2520Duct-Cannulated%2520Rat%26jtitle%3DXenobiotica%26date%3D2011%26volume%3D41%26spage%3D701%26doi%3D10.3109%2F00498254.2011.565819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wiesmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leder, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blank, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernardi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melkko, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decock, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Arcy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villard, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erbel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freuler, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolay, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alves, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornancin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renatus, M.</span></span> <span> </span><span class="NLM_article-title">Structural Determinants of MALT1 Protease Activity</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>419</i></span>,  <span class="NLM_fpage">4</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2012.02.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1016%2Fj.jmb.2012.02.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=22366302" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC38Xkt1Ghur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=419&publication_year=2012&pages=4&author=C.+Wiesmannauthor=L.+Lederauthor=J.+Blankauthor=A.+Bernardiauthor=S.+Melkkoauthor=A.+Decockauthor=A.+D%E2%80%99Arcyauthor=F.+Villardauthor=P.+Erbelauthor=N.+Hughesauthor=F.+Freulerauthor=R.+Nikolayauthor=J.+Alvesauthor=F.+Bornancinauthor=M.+Renatus&title=Structural+Determinants+of+MALT1+Protease+Activity&doi=10.1016%2Fj.jmb.2012.02.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Determinants of MALT1 Protease Activity</span></div><div class="casAuthors">Wiesmann, Christian; Leder, Lukas; Blank, Jutta; Bernardi, Anna; Melkko, Samu; Decock, Arnaud; D'Arcy, Allan; Villard, Frederic; Erbel, Paulus; Hughes, Nicola; Freuler, Felix; Nikolay, Rainer; Alves, Juliano; Bornancin, Frederic; Renatus, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">419</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">4-21</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The formation of the CBM (CARD11-BCL10-MALT1) complex is pivotal for antigen-receptor-mediated activation of the transcription factor NF-κB.  Signaling is dependent on MALT1 (mucosa-assocd. lymphoid tissue lymphoma translocation protein 1), which not only acts as a scaffolding protein but also possesses proteolytic activity mediated by its caspase-like domain.  It remained unclear how the CBM activates MALT1.  Here, we provide biochem. and structural evidence that MALT1 activation is dependent on its dimerization and show that mutations at the dimer interface abrogate activity in cells.  The unliganded protease presents itself in a dimeric yet inactive state and undergoes substantial conformational changes upon substrate binding.  These structural changes also affect the conformation of the C-terminal Ig-like domain, a domain that is required for MALT1 activity.  Binding to the active site is coupled to a relative movement of caspase and Ig-like domains.  MALT1 binding partners thus may have the potential of tuning MALT1 protease activity without binding directly to the caspase domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDaYh5EEjXC7Vg90H21EOLACvtfcHk0lgRH4PcQT_d6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xkt1Ghur0%253D&md5=a35adbc547fadbe5353ee2d1c2dad767</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2012.02.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2012.02.018%26sid%3Dliteratum%253Aachs%26aulast%3DWiesmann%26aufirst%3DC.%26aulast%3DLeder%26aufirst%3DL.%26aulast%3DBlank%26aufirst%3DJ.%26aulast%3DBernardi%26aufirst%3DA.%26aulast%3DMelkko%26aufirst%3DS.%26aulast%3DDecock%26aufirst%3DA.%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DA.%26aulast%3DVillard%26aufirst%3DF.%26aulast%3DErbel%26aufirst%3DP.%26aulast%3DHughes%26aufirst%3DN.%26aulast%3DFreuler%26aufirst%3DF.%26aulast%3DNikolay%26aufirst%3DR.%26aulast%3DAlves%26aufirst%3DJ.%26aulast%3DBornancin%26aufirst%3DF.%26aulast%3DRenatus%26aufirst%3DM.%26atitle%3DStructural%2520Determinants%2520of%2520MALT1%2520Protease%2520Activity%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2012%26volume%3D419%26spage%3D4%26doi%3D10.1016%2Fj.jmb.2012.02.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Padilla, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhagirath, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiao, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldstein, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hermann, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy-Smith, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuglstatter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowrie, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luk, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owens, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O-Yang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Railkar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoenfeld, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slade, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steiner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, Y.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villaseñor, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wanner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, M. C.</span></span> <span> </span><span class="NLM_article-title">Pyrrolopyrazines as Selective Spleen Tyrosine Kinase Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">1677</span>, <span class="refDoi"> DOI: 10.1021/jm301720p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301720p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFaqurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=1677&author=F.+Padillaauthor=N.+Bhagirathauthor=S.+Chenauthor=E.+Chiaoauthor=D.+M.+Goldsteinauthor=J.+C.+Hermannauthor=J.+Hsuauthor=J.+J.+Kennedy-Smithauthor=A.+Kuglstatterauthor=C.+Liaoauthor=W.+Liuauthor=L.+E.+Lowrieauthor=K.+C.+Lukauthor=S.+M.+Lynchauthor=J.+Menkeauthor=L.+Niuauthor=T.+D.+Owensauthor=C.+O-Yangauthor=A.+Railkarauthor=R.+C.+Schoenfeldauthor=M.+Sladeauthor=S.+Steinerauthor=Y.-C.+Tanauthor=A.+G.+Villase%C3%B1orauthor=C.+Wangauthor=J.+Wannerauthor=W.+Xieauthor=D.+Xuauthor=X.+Zhangauthor=M.+Zhouauthor=M.+C.+Lucas&title=Pyrrolopyrazines+as+Selective+Spleen+Tyrosine+Kinase+Inhibitors&doi=10.1021%2Fjm301720p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrrolopyrazines as Selective Spleen Tyrosine Kinase Inhibitors</span></div><div class="casAuthors">Padilla, Fernando; Bhagirath, Niala; Chen, Shaoqing; Chiao, Eric; Goldstein, David M.; Hermann, Johannes C.; Hsu, Jonathan; Kennedy-Smith, Joshua J.; Kuglstatter, Andreas; Liao, Cheng; Liu, Wenjian; Lowrie, Lee E., Jr.; Luk, Kin Chun; Lynch, Stephen M.; Menke, John; Niu, Linghao; Owens, Timothy D.; O-Yang, Counde; Railkar, Aruna; Schoenfeld, Ryan C.; Slade, Michelle; Steiner, Sandra; Tan, Yun-Chou; Villasenor, Armando G.; Wang, Ce; Wanner, Jutta; Xie, Wenwei; Xu, Daigen; Zhang, Xiaohu; Zhou, Mingyan; Lucas, Matthew C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1677-1692</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors describe the discovery of several pyrrolopyrazines as potent and selective Syk inhibitors and the efforts that eventually led to the desired improvements in physicochem. properties and human whole blood potencies.  Ultimately, the mouse model revealed unexpected toxicity of compd. I that precluded the further advancement of this series.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPn6yiWDGRMbVg90H21EOLACvtfcHk0lgFOX7vWmaU6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFaqurs%253D&md5=2ab3e28de06e6300547d2a474bd14aef</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm301720p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301720p%26sid%3Dliteratum%253Aachs%26aulast%3DPadilla%26aufirst%3DF.%26aulast%3DBhagirath%26aufirst%3DN.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DChiao%26aufirst%3DE.%26aulast%3DGoldstein%26aufirst%3DD.%2BM.%26aulast%3DHermann%26aufirst%3DJ.%2BC.%26aulast%3DHsu%26aufirst%3DJ.%26aulast%3DKennedy-Smith%26aufirst%3DJ.%2BJ.%26aulast%3DKuglstatter%26aufirst%3DA.%26aulast%3DLiao%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DLowrie%26aufirst%3DL.%2BE.%26aulast%3DLuk%26aufirst%3DK.%2BC.%26aulast%3DLynch%26aufirst%3DS.%2BM.%26aulast%3DMenke%26aufirst%3DJ.%26aulast%3DNiu%26aufirst%3DL.%26aulast%3DOwens%26aufirst%3DT.%2BD.%26aulast%3DO-Yang%26aufirst%3DC.%26aulast%3DRailkar%26aufirst%3DA.%26aulast%3DSchoenfeld%26aufirst%3DR.%2BC.%26aulast%3DSlade%26aufirst%3DM.%26aulast%3DSteiner%26aufirst%3DS.%26aulast%3DTan%26aufirst%3DY.-C.%26aulast%3DVillase%25C3%25B1or%26aufirst%3DA.%2BG.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DWanner%26aufirst%3DJ.%26aulast%3DXie%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DM.%26aulast%3DLucas%26aufirst%3DM.%2BC.%26atitle%3DPyrrolopyrazines%2520as%2520Selective%2520Spleen%2520Tyrosine%2520Kinase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D1677%26doi%3D10.1021%2Fjm301720p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kubiak, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rothbauer, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laufer, S.</span></span> <span> </span><span class="NLM_article-title">From Enzyme to Whole Blood: Sequential Screening Procedure for Identification and Evaluation of P38 MAPK Inhibitors</span>. <i>Methods Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>1360</i></span>,  <span class="NLM_fpage">123</span>, <span class="refDoi"> DOI: 10.1007/978-1-4939-3073-9_10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1007%2F978-1-4939-3073-9_10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=26501907" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC2sXntVenu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1360&publication_year=2016&pages=123&author=S.+M.+Bauerauthor=J.+M.+Kubiakauthor=U.+Rothbauerauthor=S.+Laufer&title=From+Enzyme+to+Whole+Blood%3A+Sequential+Screening+Procedure+for+Identification+and+Evaluation+of+P38+MAPK+Inhibitors&doi=10.1007%2F978-1-4939-3073-9_10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">From Enzyme to Whole Blood: Sequential Screening Procedure for Identification and Evaluation of p38 MAPK Inhibitors</span></div><div class="casAuthors">Bauer, Silke M.; Kubiak, Jakub M.; Rothbauer, Ulrich; Laufer, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">1360</span>
        (<span class="NLM_cas:issue">Kinase Screening and Profiling</span>),
    <span class="NLM_cas:pages">123-148</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1940-6029</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">P38 mitogen-activated protein kinase (MAPK) is a pivotal enzyme in the biosynthesis of pro-inflammatory cytokines like IL-1 and TNF.  Therefore, the success of anti-cytokine therapy for treatment of inflammatory processes qualified p38-MAPK as a solid target in drug research concerning chronic inflammatory diseases including infectious vascular, neurobiol., and autoimmune disorders.  However, the discovery of new kinase inhibitors is limited by the need for a high biol. activity combined with restricted activity to the target enzyme or pathway interaction.  As a consequence, no p38 MAPK inhibitor has been introduced to the market so far, although several p38 inhibitors have proceeded into clin. trials.  The development of novel inhibitor types and optimization of already known structural classes of MAPK inhibitors require appropriate testing systems reaching across these crucial parameters.  As a new approach, we describe the sequential arrangement of three testing systems custom-tailored to the requirements of drug discovery programs with focus on p38 inhibition.  Integrated anal. of the obtained results enables a concerted step-by-step selection of tested mols. in order to screen a compd. library for the most suitable inhibitor.  First, evaluation of the inhibitor's activity on the isolated p38 MAPK enzyme via an ELISA assay gives a first idea about the inhibitory potency of the mol.  Moreover, structure-activity relationships can be elucidated when comparing mols. within inhibitor series.  Second, screening in living cells via a p38 substrate-specific MK2-EGFP translocation assay supplies further information about efficacy, but provides also a first notion concerning selectivity and toxicity.  Third, efficacy is evaluated more specifically in vivo in LPS-stimulated human whole blood with regard to in vivo parameters, e.g., pharmacokinetic characteristics like plasma protein binding and cellular permeability.  These three testing systems complement one another synergistically by providing a high overlap and predictability.  Clear advantages of all presented systems are their realizability in an academic environment as well as their applicability for high-throughput screenings on a larger scale.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzgA7iA4wN77Vg90H21EOLACvtfcHk0lgFOX7vWmaU6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXntVenu7Y%253D&md5=3b170d3e07e05e52d383d2acf1525b02</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1007%2F978-1-4939-3073-9_10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-4939-3073-9_10%26sid%3Dliteratum%253Aachs%26aulast%3DBauer%26aufirst%3DS.%2BM.%26aulast%3DKubiak%26aufirst%3DJ.%2BM.%26aulast%3DRothbauer%26aufirst%3DU.%26aulast%3DLaufer%26aufirst%3DS.%26atitle%3DFrom%2520Enzyme%2520to%2520Whole%2520Blood%253A%2520Sequential%2520Screening%2520Procedure%2520for%2520Identification%2520and%2520Evaluation%2520of%2520P38%2520MAPK%2520Inhibitors%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2016%26volume%3D1360%26spage%3D123%26doi%3D10.1007%2F978-1-4939-3073-9_10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brandt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bendfeldt, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinke, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radbruch, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Worm, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumgrass, R.</span></span> <span> </span><span class="NLM_article-title">Whole Blood Flow Cytometric Measurement of NFATc1 and IL-2 Expression to Analyze Cyclosporine a-Mediated Effects in T Cells</span>. <i>Cytometry, Part A</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>77A</i></span>,  <span class="NLM_fpage">607</span>, <span class="refDoi"> DOI: 10.1002/cyto.a.20928</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1002%2Fcyto.a.20928" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpvVemurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77A&publication_year=2010&pages=607&author=C.+Brandtauthor=P.+Limanauthor=H.+Bendfeldtauthor=K.+Muellerauthor=P.+Reinkeauthor=A.+Radbruchauthor=M.+Wormauthor=R.+Baumgrass&title=Whole+Blood+Flow+Cytometric+Measurement+of+NFATc1+and+IL-2+Expression+to+Analyze+Cyclosporine+a-Mediated+Effects+in+T+Cells&doi=10.1002%2Fcyto.a.20928"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Whole blood flow cytometric measurement of and IL-2 expression to analyze cyclosporine A-mediated effects in T cells</span></div><div class="casAuthors">Brandt, Claudia; Liman, Peter; Bendfeldt, Hanna; Mueller, Karin; Reinke, Petra; Radbruch, Andreas; Worm, Margitta; Baumgrass, Ria</div><div class="citationInfo"><span class="NLM_cas:title">Cytometry, Part A</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">77A</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">607-613</span>CODEN:
                <span class="NLM_cas:coden">CPAYAV</span>;
        ISSN:<span class="NLM_cas:issn">1552-4922</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The calcineurin inhibitor Cyclosporine A (CsA) is one of the crucial immunosuppressive drugs given after organ transplantation.  The small therapeutic window of CsA generates the dilemma that efficient and toxic drug doses differ only slightly.  Moreover, these threshold concns. differ considerably between individuals; therefore, functional assays are urgently needed.  We explored whether the transcription factor NFATc1, a direct as well as indirect target of CsA, can be used as a potential biomarker to det. the individual immunosuppressive activity of CsA.  First, in isolated human T cells we showed that flow cytometry is practicable to measure NFATc1, the most abundant NFATc isoform in activated T cells.  Second, for whole blood we developed a flow cytometric assay to det. in parallel the inducible transcription factor NFATc1 and the cytokine IL-2 in stimulated T cells.  We found that added CsA inhibits both the expression of NFATc1 and IL-2 in T cells of stimulated whole blood samples with IC50 values of 200 and 150 nM, resp.  The intra- and inter-assay variability was low, and clin. practicability was good.  Further expts. have to demonstrate whether the parallel cytometric measurement of NFATc1 and IL-2 in whole blood is a good predictor of individual CsA efficacy and toxicity in CsA-treated patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjl8BYYi4cGrVg90H21EOLACvtfcHk0lj0RykubE58mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpvVemurc%253D&md5=f20fa76c51d5e1a5b261ec1bd777b3e7</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1002%2Fcyto.a.20928&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcyto.a.20928%26sid%3Dliteratum%253Aachs%26aulast%3DBrandt%26aufirst%3DC.%26aulast%3DLiman%26aufirst%3DP.%26aulast%3DBendfeldt%26aufirst%3DH.%26aulast%3DMueller%26aufirst%3DK.%26aulast%3DReinke%26aufirst%3DP.%26aulast%3DRadbruch%26aufirst%3DA.%26aulast%3DWorm%26aufirst%3DM.%26aulast%3DBaumgrass%26aufirst%3DR.%26atitle%3DWhole%2520Blood%2520Flow%2520Cytometric%2520Measurement%2520of%2520NFATc1%2520and%2520IL-2%2520Expression%2520to%2520Analyze%2520Cyclosporine%2520a-Mediated%2520Effects%2520in%2520T%2520Cells%26jtitle%3DCytometry%252C%2520Part%2520A%26date%3D2010%26volume%3D77A%26spage%3D607%26doi%3D10.1002%2Fcyto.a.20928" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wentsch, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayer-Wrangowski, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storch, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niess, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koeberle, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grütter, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boeckler, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rauh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laufer, S. A.</span></span> <span> </span><span class="NLM_article-title">Dibenzosuberones as P38 Mitogen-Activated Protein Kinase Inhibitors with Low ATP Competitiveness and Outstanding Whole Blood Activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">241</span>, <span class="refDoi"> DOI: 10.1021/jm301539x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301539x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvFWiurzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=241&author=S.+Fischerauthor=H.+K.+Wentschauthor=S.+C.+Mayer-Wrangowskiauthor=M.+Zimmermannauthor=S.+M.+Bauerauthor=K.+Storchauthor=R.+Niessauthor=S.+C.+Koeberleauthor=C.+Gr%C3%BCtterauthor=F.+M.+Boecklerauthor=D.+Rauhauthor=S.+A.+Laufer&title=Dibenzosuberones+as+P38+Mitogen-Activated+Protein+Kinase+Inhibitors+with+Low+ATP+Competitiveness+and+Outstanding+Whole+Blood+Activity&doi=10.1021%2Fjm301539x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Dibenzosuberones as p38 Mitogen-Activated Protein Kinase Inhibitors with Low ATP Competitiveness and Outstanding Whole Blood Activity</span></div><div class="casAuthors">Fischer, Stefan; Wentsch, Heike K.; Mayer-Wrangowski, Svenja C.; Zimmermann, Markus; Bauer, Silke M.; Storch, Kirsten; Niess, Raimund; Koeberle, Solveigh C.; Gruetter, Christian; Boeckler, Frank M.; Rauh, Daniel; Laufer, Stefan A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">241-253</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">P38α mitogen-activated protein (MAP) kinase is a main target in drug research concerning inflammatory diseases.  Nevertheless, no inhibitor of p38α MAP kinase has been introduced to the market.  This might be attributed to the fact that there is no inhibitor which combines outstanding activity in biol. systems and selectivity.  Herein an approach to the development of such inhibitors on the basis of the highly selective mol. probe Skepinone-L (I) is described.  Introduction of a "deep pocket" moiety addressing the DFG motif led to an increased activity of the compds.  Hydrophilic moieties, addressing the solvent-exposed area adjacent to hydrophilic region II, conserved a high activity of the compds. in a whole blood assay.  Combined with their outstanding selectivity and low ATP competitiveness, these inhibitors are very interesting candidates for use in biol. systems and in therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbi31syvBEYrVg90H21EOLACvtfcHk0lj0RykubE58mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvFWiurzP&md5=bfce0ba26af365a1d218095e54ba169f</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm301539x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301539x%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DS.%26aulast%3DWentsch%26aufirst%3DH.%2BK.%26aulast%3DMayer-Wrangowski%26aufirst%3DS.%2BC.%26aulast%3DZimmermann%26aufirst%3DM.%26aulast%3DBauer%26aufirst%3DS.%2BM.%26aulast%3DStorch%26aufirst%3DK.%26aulast%3DNiess%26aufirst%3DR.%26aulast%3DKoeberle%26aufirst%3DS.%2BC.%26aulast%3DGr%25C3%25BCtter%26aufirst%3DC.%26aulast%3DBoeckler%26aufirst%3DF.%2BM.%26aulast%3DRauh%26aufirst%3DD.%26aulast%3DLaufer%26aufirst%3DS.%2BA.%26atitle%3DDibenzosuberones%2520as%2520P38%2520Mitogen-Activated%2520Protein%2520Kinase%2520Inhibitors%2520with%2520Low%2520ATP%2520Competitiveness%2520and%2520Outstanding%2520Whole%2520Blood%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D241%26doi%3D10.1021%2Fjm301539x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leach, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cosgrove, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenny, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruston, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacFaul, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colclough, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Law, B.</span></span> <span> </span><span class="NLM_article-title">Matched Molecular Pairs as a Guide in the Optimization of Pharmaceutical Properties; a Study of Aqueous Solubility, Plasma Protein Binding and Oral Exposure</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">6672</span>, <span class="refDoi"> DOI: 10.1021/jm0605233</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0605233" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtV2gtLnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6672&author=A.+G.+Leachauthor=H.+D.+Jonesauthor=D.+A.+Cosgroveauthor=P.+W.+Kennyauthor=L.+Rustonauthor=P.+MacFaulauthor=J.+M.+Woodauthor=N.+Colcloughauthor=B.+Law&title=Matched+Molecular+Pairs+as+a+Guide+in+the+Optimization+of+Pharmaceutical+Properties%3B+a+Study+of+Aqueous+Solubility%2C+Plasma+Protein+Binding+and+Oral+Exposure&doi=10.1021%2Fjm0605233"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Matched Molecular Pairs as a Guide in the Optimization of Pharmaceutical Properties; a Study of Aqueous Solubility, Plasma Protein Binding and Oral Exposure</span></div><div class="casAuthors">Leach, Andrew G.; Jones, Huw D.; Cosgrove, David A.; Kenny, Peter W.; Ruston, Linette; MacFaul, Philip; Wood, J. Matthew; Colclough, Nicola; Law, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6672-6682</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">By identifying every pair of mols. that differ only by a particular, well-defined, structural transformation in a database of measured properties and computing the corresponding change in property, we obtain an overview of the effect that structural change has upon the property and set an expectation for what will happen when that transformation is applied elsewhere.  The mean change indicates the expected magnitude of the change in the property and the no. of cases in which the property increases give the probability that the structural transformation will cause the property to increase.  Outliers indicate potential ways of avoiding the general trend.  Comparing to changes in lipophilicity highlights structural transformations that have unusual effects, some of which can be explained by conformational changes.  In this paper, we focus upon the effects on aq. soly., plasma protein binding and oral exposure of adding substituents to arom. rings and methylating heteroatoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcyrloR79Oq7Vg90H21EOLACvtfcHk0lj0RykubE58mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtV2gtLnO&md5=2c143b424aee3ddb6c34616aff699ee0</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm0605233&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0605233%26sid%3Dliteratum%253Aachs%26aulast%3DLeach%26aufirst%3DA.%2BG.%26aulast%3DJones%26aufirst%3DH.%2BD.%26aulast%3DCosgrove%26aufirst%3DD.%2BA.%26aulast%3DKenny%26aufirst%3DP.%2BW.%26aulast%3DRuston%26aufirst%3DL.%26aulast%3DMacFaul%26aufirst%3DP.%26aulast%3DWood%26aufirst%3DJ.%2BM.%26aulast%3DColclough%26aufirst%3DN.%26aulast%3DLaw%26aufirst%3DB.%26atitle%3DMatched%2520Molecular%2520Pairs%2520as%2520a%2520Guide%2520in%2520the%2520Optimization%2520of%2520Pharmaceutical%2520Properties%253B%2520a%2520Study%2520of%2520Aqueous%2520Solubility%252C%2520Plasma%2520Protein%2520Binding%2520and%2520Oral%2520Exposure%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6672%26doi%3D10.1021%2Fjm0605233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohr, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, M.</span></span> <span> </span><span class="NLM_article-title">Intramolecular Hydrogen Bonding in Medicinal Chemistry</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2601</span>, <span class="refDoi"> DOI: 10.1021/jm100087s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100087s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC3cXit1Clur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2601&author=B.+Kuhnauthor=P.+Mohrauthor=M.+Stahl&title=Intramolecular+Hydrogen+Bonding+in+Medicinal+Chemistry&doi=10.1021%2Fjm100087s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Intramolecular Hydrogen Bonding in Medicinal Chemistry</span></div><div class="casAuthors">Kuhn, Bernd; Mohr, Peter; Stahl, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2601-2611</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The formation of intramol. hydrogen bonds has a very pronounced effect on mol. structure and properties.  We study both aspects in detail with the aim of enabling a more rational use of this class of interactions in medicinal chem.  On the basis of exhaustive searches in crystal structure databases, we derive propensities for intramol. hydrogen bond formation of five- to eight-membered ring systems of relevance in drug discovery.  A no. of motifs, several of which are clearly underutilized in drug discovery, are analyzed in more detail by comparing small mol. and protein-ligand X-ray structures.  To investigate effects on physicochem. properties, sets of closely related structures with and without the ability to form intramol. hydrogen bonds were designed, synthesized, and characterized with respect to membrane permeability, water soly., and lipophilicity.  We find that changes in these properties depend on a subtle balance between the strength of the hydrogen bond interaction, geometry of the newly formed ring system, and the relative energies of the open and closed conformations in polar and unpolar environments.  A no. of general guidelines for medicinal chemists emerge from this study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdaV7tFRU4k7Vg90H21EOLACvtfcHk0lgLPubSftC_OA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXit1Clur8%253D&md5=b9b6865dfcc9bdf7796d15218f6e8ff2</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm100087s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100087s%26sid%3Dliteratum%253Aachs%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DMohr%26aufirst%3DP.%26aulast%3DStahl%26aufirst%3DM.%26atitle%3DIntramolecular%2520Hydrogen%2520Bonding%2520in%2520Medicinal%2520Chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2601%26doi%3D10.1021%2Fjm100087s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byrne, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffiths, L.</span></span> <span> </span><span class="NLM_article-title">NMR Method for the Determination of Solute Hydrogen Bond Acidity</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">3389</span>, <span class="refDoi"> DOI: 10.1021/jo052631n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo052631n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BD28XivF2qt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2006&pages=3389&author=M.+H.+Abrahamauthor=R.+J.+Abrahamauthor=J.+Byrneauthor=L.+Griffiths&title=NMR+Method+for+the+Determination+of+Solute+Hydrogen+Bond+Acidity&doi=10.1021%2Fjo052631n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">NMR Method for the Determination of Solute Hydrogen Bond Acidity</span></div><div class="casAuthors">Abraham, Michael H.; Abraham, Raymond J.; Byrne, Jonathan; Griffiths, Lee</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3389-3394</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">It is shown that the difference in the 1H NMR chem. shift of a protic hydrogen in DMSO and CDCl3 solvents is directly related to the overall, or summation, hydrogen bond acidity for a wide range of solutes.  This provides a new and direct method of measuring the hydrogen bond acidity.  For 54 compds., the obsd. shifts for 72 protic hydrogens could be correlated to the Abraham solute hydrogen bond acidity parameter, A, with a correlation coeff. squared, R2, of 0.938 and a std. deviation, SD, of 0.054 units in A.  A training equation that used half the data could predict A values for the remaining data with an av. error of 0.001 and a std. deviation, SD, of 0.053 units, thus demonstrating the predictive power of the method.  Unlike any previous method for the detn. of solute hydrogen bond acidities, the NMR method allows the detn. of A values for individual protic hydrogens in multifunctional solutes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjlb-QytDX37Vg90H21EOLACvtfcHk0lgLPubSftC_OA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XivF2qt7s%253D&md5=6c74f59a2aba5d0ac75d2bbb842c97ea</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjo052631n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo052631n%26sid%3Dliteratum%253Aachs%26aulast%3DAbraham%26aufirst%3DM.%2BH.%26aulast%3DAbraham%26aufirst%3DR.%2BJ.%26aulast%3DByrne%26aufirst%3DJ.%26aulast%3DGriffiths%26aufirst%3DL.%26atitle%3DNMR%2520Method%2520for%2520the%2520Determination%2520of%2520Solute%2520Hydrogen%2520Bond%2520Acidity%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2006%26volume%3D71%26spage%3D3389%26doi%3D10.1021%2Fjo052631n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acree, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aliev, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leo, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whaley, W. L.</span></span> <span> </span><span class="NLM_article-title">An NMR Method for the Quantitative Assessment of Intramolecular Hydrogen Bonding; Application to Physicochemical, Environmental, and Biochemical Properties</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">11075</span>, <span class="refDoi"> DOI: 10.1021/jo502080p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo502080p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVensLrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2014&pages=11075&author=M.+H.+Abrahamauthor=R.+J.+Abrahamauthor=W.+E.+Acreeauthor=A.+E.+Alievauthor=A.+J.+Leoauthor=W.+L.+Whaley&title=An+NMR+Method+for+the+Quantitative+Assessment+of+Intramolecular+Hydrogen+Bonding%3B+Application+to+Physicochemical%2C+Environmental%2C+and+Biochemical+Properties&doi=10.1021%2Fjo502080p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">An NMR Method for the Quantitative Assessment of Intramolecular Hydrogen Bonding; Application to Physicochemical, Environmental, and Biochemical Properties</span></div><div class="casAuthors">Abraham, Michael H.; Abraham, Raymond J.; Acree, William E.; Aliev, Abil E.; Leo, Al J.; Whaley, William L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">11075-11083</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">1H NMR chem. shifts have been obtained in the solvents deuterochloroform and DMSO.  The difference in the chem. shifts of an OH or NH group in these two solvents, Δδ = δ(DMSO) - δ(CDCl3), can be converted into the hydrogen bond acidity, A, of the group using the equation A = 0.0065 + 0.133Δδ.  The NMR A value, ANMR, can be used as a quant. assessment of intramol. hydrogen bonding.  We list values of Δδ and ANMR for 55 compds. contg. an OH group and 60 compds. with an NH group.  For the hydroxy compds., if A > 0.5 then the OH group is not part of an intramol. hydrogen bond, but if A < 0.1 then the OH group forms part of an intramol. hydrogen bond.  For NH compds., if A > 0.16 the NH group is not part of an intramol. hydrogen bond, and if A < 0.05 the NH group is part of an intramol. hydrogen bond.  No comparison compds. are needed, and the method is extremely simple.  We further show how it is possible to relate intramol. hydrogen bonding to the actual effect on values of a no. of physicochem., environmental, and biochem. properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpS3GZXQi7robVg90H21EOLACvtfcHk0lgLPubSftC_OA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVensLrM&md5=b5e9948a04237fadb3b4fc3237bde8b1</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjo502080p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo502080p%26sid%3Dliteratum%253Aachs%26aulast%3DAbraham%26aufirst%3DM.%2BH.%26aulast%3DAbraham%26aufirst%3DR.%2BJ.%26aulast%3DAcree%26aufirst%3DW.%2BE.%26aulast%3DAliev%26aufirst%3DA.%2BE.%26aulast%3DLeo%26aufirst%3DA.%2BJ.%26aulast%3DWhaley%26aufirst%3DW.%2BL.%26atitle%3DAn%2520NMR%2520Method%2520for%2520the%2520Quantitative%2520Assessment%2520of%2520Intramolecular%2520Hydrogen%2520Bonding%253B%2520Application%2520to%2520Physicochemical%252C%2520Environmental%252C%2520and%2520Biochemical%2520Properties%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2014%26volume%3D79%26spage%3D11075%26doi%3D10.1021%2Fjo502080p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Junker, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tritto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutter, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubic-Schneider, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niwa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlapbach, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigaud, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beerli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Littlewood-Evans, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudolph, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laisney, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ledieu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beltz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quancard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornancin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamurovic Ribrioux, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calzascia, T.</span></span> <span> </span><span class="NLM_article-title">Pharmacological Inhibition of MALT1 Protease Leads to a Progressive IPEX-Like Pathology</span>. <i>Front. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">745</span>, <span class="refDoi"> DOI: 10.3389/fimmu.2020.00745</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.3389%2Ffimmu.2020.00745" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=32425939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitVWns7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=745&author=K.+Martinauthor=U.+Junkerauthor=E.+Trittoauthor=E.+Sutterauthor=T.+Rubic-Schneiderauthor=H.+Morganauthor=S.+Niwaauthor=J.+Liauthor=A.+Schlapbachauthor=D.+Walkerauthor=M.+Bigaudauthor=C.+Beerliauthor=A.+Littlewood-Evansauthor=B.+Rudolphauthor=M.+Laisneyauthor=D.+Ledieuauthor=K.+Beltzauthor=J.+Quancardauthor=F.+Bornancinauthor=N.+Zamurovic+Ribriouxauthor=T.+Calzascia&title=Pharmacological+Inhibition+of+MALT1+Protease+Leads+to+a+Progressive+IPEX-Like+Pathology&doi=10.3389%2Ffimmu.2020.00745"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological inhibition of MALT1 protease leads to a progressive IPEX-like pathology</span></div><div class="casAuthors">Martin, Kea; Junker, Ursula; Tritto, Elaine; Sutter, Esther; Rubic-Schneider, Tina; Morgan, Hannah; Saba, Ingrid; Lu, Jinghua; Bhattacharya, Abhisek; Tai, Xuguang; Guinter, Terry I.; Engelhardt, Britta; Alag, Amala; Rojano, Mirelle; Ashe, Jennifer M.; Hanada, Ken-Ichi; Yang, James C.; Sun, Peter D.; Singer, Alfred</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Immunology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">745</span>CODEN:
                <span class="NLM_cas:coden">FIRMCW</span>;
        ISSN:<span class="NLM_cas:issn">1664-3224</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Genetic disruption or short-term pharmacol. inhibition of MALT1 protease is effective in several preclin. models of autoimmunity and B cell malignancies.  Despite these protective effects, the severe redn. in regulatory T cells (Tregs) and the assocd. IPEX-like pathol. occurring upon congenital disruption of the MALT1 protease in mice has raised concerns about the long-term safety of MALT1 inhibition.  Here we describe the results of a series of toxicol. studies in rat and dog species using MLT-943, a novel potent and selective MALT1 protease inhibitor.  While MLT943 effectively prevented T cell-dependent B cell immune responses and reduced joint inflammation in the collagen-induced arthritis rat pharmacol. model, in both preclin. species, pharmacol. inhibition of MALT1 was assocd. with a rapid and dosedependent redn. in Tregs and resulted in the progressive appearance of immune abnormalities and clin. signs of an IPEX-like pathol.  At the 13-wk time point, rats displayed severe intestinal inflammation assocd. with mast cell activation, high serum IgE levels, systemic T cell activation and mononuclear cell infiltration in multiple tissues.  Importantly, using thymectomized rats we demonstrated that MALT1 protease inhibition affects peripheral Treg frequency independently of effects on thymic Treg output and development.  Our data confirm the therapeutic potential of MALT1 protease inhibitors but highlight the safety risks and challenges to consider before potential application of such inhibitors into the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqyqdJM-CkubVg90H21EOLACvtfcHk0lhdO3r0ezRNMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitVWns7vJ&md5=8fa2e57b2111b45c0a6dda682e40e378</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.3389%2Ffimmu.2020.00745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffimmu.2020.00745%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DK.%26aulast%3DJunker%26aufirst%3DU.%26aulast%3DTritto%26aufirst%3DE.%26aulast%3DSutter%26aufirst%3DE.%26aulast%3DRubic-Schneider%26aufirst%3DT.%26aulast%3DMorgan%26aufirst%3DH.%26aulast%3DNiwa%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DSchlapbach%26aufirst%3DA.%26aulast%3DWalker%26aufirst%3DD.%26aulast%3DBigaud%26aufirst%3DM.%26aulast%3DBeerli%26aufirst%3DC.%26aulast%3DLittlewood-Evans%26aufirst%3DA.%26aulast%3DRudolph%26aufirst%3DB.%26aulast%3DLaisney%26aufirst%3DM.%26aulast%3DLedieu%26aufirst%3DD.%26aulast%3DBeltz%26aufirst%3DK.%26aulast%3DQuancard%26aufirst%3DJ.%26aulast%3DBornancin%26aufirst%3DF.%26aulast%3DZamurovic%2BRibrioux%26aufirst%3DN.%26aulast%3DCalzascia%26aufirst%3DT.%26atitle%3DPharmacological%2520Inhibition%2520of%2520MALT1%2520Protease%2520Leads%2520to%2520a%2520Progressive%2520IPEX-Like%2520Pathology%26jtitle%3DFront.%2520Immunol.%26date%3D2020%26volume%3D11%26spage%3D745%26doi%3D10.3389%2Ffimmu.2020.00745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van
Breemen, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span> <span> </span><span class="NLM_article-title">Caco-2 Cell Permeability Assays to Measure Drug Absorption</span>. <i>Expet Opin. Drug Metabol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">175</span>, <span class="refDoi"> DOI: 10.1517/17425255.1.2.175</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1517%2F17425255.1.2.175" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=16922635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVKltLbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2005&pages=175&author=R.+B.+Van%0ABreemenauthor=Y.+Li&title=Caco-2+Cell+Permeability+Assays+to+Measure+Drug+Absorption&doi=10.1517%2F17425255.1.2.175"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Caco-2 cell permeability assays to measure drug absorption</span></div><div class="casAuthors">van Breemen, Richard B.; Li, Yongmei</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">175-185</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Caco-2 cells are a human colon epithelial cancer cell line used as a model of human intestinal absorption of drugs and other compds.  When cultured as a monolayer, Caco-2 cells differentiate to form tight junctions between cells to serve as a model of paracellular movement of compds. across the mono-layer.  In addn., Caco-2 cells express transporter proteins, efflux proteins, and Phase II conjugation enzymes to model a variety of transcellular pathways as well as metabolic transformation of test substances.  In many respects, the Caco-2 cell monolayer mimics the human intestinal epithelium.  One of the functional differences between normal cells and Caco-2 cells is the lack of expression of the cytochrome P 450 isoenzymes and in particular, CYP3A4, which is normally expressed at high levels in the intestine.  However, Caco-2 cells may be induced to express higher levels of CYP3A4 by treatment with vitamin D3.  Caco-2 cell monolayers are usually cultured on semipermeable plastic supports that may be fitted into the wells of multi-well culture plates.  Test compds. are then added to either the apical or basolateral sides of the monolayer.  After incubation for various lengths of time, aliquots of the buffer in opposite chambers are removed for the detn. of the concn. of test compds. and the computation of the rates of permeability for each compd. (called the apparent permeability coeffs.).  Although radiolabeled compds. were used in the original Caco-2 cells monolayer assays, radio-labeled compds. have been replaced in most labs. by the use of liq. chromatog.-mass spectrometry (LC-MS) and LC-tandem mass spectrometry (LC-MS-MS).  Mass spectrometry not only eliminates the need for radiolabeled compds., but permits the simultaneous measurement of multiple compds.  The measurement of multiple compds. per assay reduces the no. of incubations that need to be carried out, thereby increasing the throughput of the expts.  Furthermore, LC-MS and LC-MS-MS add another dimension to Caco-2 assays by facilitating the investigation of the metab. of compds. by Caco-2 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcV-AZvy78ILVg90H21EOLACvtfcHk0lhdO3r0ezRNMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVKltLbK&md5=7bd0b875ffa9c840f904bab6513b7e3f</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1517%2F17425255.1.2.175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425255.1.2.175%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BBreemen%26aufirst%3DR.%2BB.%26aulast%3DLi%26aufirst%3DY.%26atitle%3DCaco-2%2520Cell%2520Permeability%2520Assays%2520to%2520Measure%2520Drug%2520Absorption%26jtitle%3DExpet%2520Opin.%2520Drug%2520Metabol.%2520Toxicol.%26date%3D2005%26volume%3D1%26spage%3D175%26doi%3D10.1517%2F17425255.1.2.175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lenz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngo, V. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">George, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dave, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenwald, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ott, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller-Hermelink, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gascoyne, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connors, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rimsza, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaffe, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delabie, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smeland, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staudt, L. M.</span></span> <span> </span><span class="NLM_article-title">Oncogenic CARD11 Mutations in Human Diffuse Large B Cell Lymphoma</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>319</i></span>,  <span class="NLM_fpage">1676</span>– <span class="NLM_lpage">1679</span>, <span class="refDoi"> DOI: 10.1126/science.1153629</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1126%2Fscience.1153629" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=18323416" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjsVamtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=319&publication_year=2008&pages=1676-1679&author=G.+Lenzauthor=R.+E.+Davisauthor=V.+N.+Ngoauthor=L.+Lamauthor=T.+C.+Georgeauthor=G.+W.+Wrightauthor=S.+S.+Daveauthor=H.+Zhaoauthor=W.+Xuauthor=A.+Rosenwaldauthor=G.+Ottauthor=H.+K.+Muller-Hermelinkauthor=R.+D.+Gascoyneauthor=J.+M.+Connorsauthor=L.+M.+Rimszaauthor=E.+Campoauthor=E.+S.+Jaffeauthor=J.+Delabieauthor=E.+B.+Smelandauthor=R.+I.+Fisherauthor=W.+C.+Chanauthor=L.+M.+Staudt&title=Oncogenic+CARD11+Mutations+in+Human+Diffuse+Large+B+Cell+Lymphoma&doi=10.1126%2Fscience.1153629"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Oncogenic CARD11 Mutations in Human Diffuse Large B Cell Lymphoma</span></div><div class="casAuthors">Lenz, Georg; Davis, R. Eric; Ngo, Vu N.; Lam, Lloyd; George, Thaddeus C.; Wright, George W.; Dave, Sandeep S.; Zhao, Hong; Xu, Weihong; Rosenwald, Andreas; Ott, German; Muller-Hermelink, Hans Konrad; Gascoyne, Randy D.; Connors, Joseph M.; Rimsza, Lisa M.; Campo, Elias; Jaffe, Elaine S.; Delabie, Jan; Smeland, Erlend B.; Fisher, Richard I.; Chan, Wing C.; Staudt, Louis M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">319</span>
        (<span class="NLM_cas:issue">5870</span>),
    <span class="NLM_cas:pages">1676-1679</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Diffuse large B cell lymphoma (DLBCL) is the most common form of non-Hodgkin's lymphoma.  In the least curable (ABC) subtype of DLBCL, survival of the malignant cells is dependent on constitutive activation of the nuclear factor-κB (NF-κB) signaling pathway.  In normal B cells, antigen receptor-induced NF-κB activation requires CARD11, a cytoplasmic scaffolding protein.  To det. whether CARD11 contributes to tumorigenesis, we sequenced the CARD11 gene in human DLBCL tumors.  We detected missense mutations in 7 of 73 ABC DLBCL biopsies (9.6%), all within exons encoding the coiled-coil domain.  Exptl. introduction of CARD11 coiled-coil domain mutants into lymphoma cell lines resulted in constitutive NF-κB activation and enhanced NF-κB activity upon antigen receptor stimulation.  These results demonstrate that CARD11 is a bona fide oncogene in DLBCL, providing a genetic rationale for the development of pharmacol. inhibitors of the CARD11 pathway for DLBCL therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaK7D2i-dr9bVg90H21EOLACvtfcHk0lhdO3r0ezRNMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjsVamtbg%253D&md5=207cb84e62aa402dd2032ae842a97033</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1126%2Fscience.1153629&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1153629%26sid%3Dliteratum%253Aachs%26aulast%3DLenz%26aufirst%3DG.%26aulast%3DDavis%26aufirst%3DR.%2BE.%26aulast%3DNgo%26aufirst%3DV.%2BN.%26aulast%3DLam%26aufirst%3DL.%26aulast%3DGeorge%26aufirst%3DT.%2BC.%26aulast%3DWright%26aufirst%3DG.%2BW.%26aulast%3DDave%26aufirst%3DS.%2BS.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DRosenwald%26aufirst%3DA.%26aulast%3DOtt%26aufirst%3DG.%26aulast%3DMuller-Hermelink%26aufirst%3DH.%2BK.%26aulast%3DGascoyne%26aufirst%3DR.%2BD.%26aulast%3DConnors%26aufirst%3DJ.%2BM.%26aulast%3DRimsza%26aufirst%3DL.%2BM.%26aulast%3DCampo%26aufirst%3DE.%26aulast%3DJaffe%26aufirst%3DE.%2BS.%26aulast%3DDelabie%26aufirst%3DJ.%26aulast%3DSmeland%26aufirst%3DE.%2BB.%26aulast%3DFisher%26aufirst%3DR.%2BI.%26aulast%3DChan%26aufirst%3DW.%2BC.%26aulast%3DStaudt%26aufirst%3DL.%2BM.%26atitle%3DOncogenic%2520CARD11%2520Mutations%2520in%2520Human%2520Diffuse%2520Large%2520B%2520Cell%2520Lymphoma%26jtitle%3DScience%26date%3D2008%26volume%3D319%26spage%3D1676%26epage%3D1679%26doi%3D10.1126%2Fscience.1153629" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davis, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngo, V. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romesser, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohlhammer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamy, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaffer, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J.-k.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenwald, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ott, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller-Hermelink, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gascoyne, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connors, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rimsza, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaffe, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delabie, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smeland, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braziel, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tubbs, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weisenburger, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staudt, L. M.</span></span> <span> </span><span class="NLM_article-title">Chronic Active B-Cell-Receptor Signalling in Diffuse Large B-Cell Lymphoma</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>463</i></span>,  <span class="NLM_fpage">88</span>– <span class="NLM_lpage">92</span>, <span class="refDoi"> DOI: 10.1038/nature08638</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1038%2Fnature08638" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=20054396" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhvFCitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=463&publication_year=2010&pages=88-92&author=R.+E.+Davisauthor=V.+N.+Ngoauthor=G.+Lenzauthor=P.+Tolarauthor=R.+M.+Youngauthor=P.+B.+Romesserauthor=H.+Kohlhammerauthor=L.+Lamyauthor=H.+Zhaoauthor=Y.+Yangauthor=W.+Xuauthor=A.+L.+Shafferauthor=G.+Wrightauthor=W.+Xiaoauthor=J.+Powellauthor=J.-k.+Jiangauthor=C.+J.+Thomasauthor=A.+Rosenwaldauthor=G.+Ottauthor=H.+K.+Muller-Hermelinkauthor=R.+D.+Gascoyneauthor=J.+M.+Connorsauthor=N.+A.+Johnsonauthor=L.+M.+Rimszaauthor=E.+Campoauthor=E.+S.+Jaffeauthor=W.+H.+Wilsonauthor=J.+Delabieauthor=E.+B.+Smelandauthor=R.+I.+Fisherauthor=R.+M.+Brazielauthor=R.+R.+Tubbsauthor=J.+R.+Cookauthor=D.+D.+Weisenburgerauthor=W.+C.+Chanauthor=S.+K.+Pierceauthor=L.+M.+Staudt&title=Chronic+Active+B-Cell-Receptor+Signalling+in+Diffuse+Large+B-Cell+Lymphoma&doi=10.1038%2Fnature08638"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma</span></div><div class="casAuthors">Davis, R. Eric; Ngo, Vu N.; Lenz, Georg; Tolar, Pavel; Young, Ryan M.; Romesser, Paul B.; Kohlhammer, Holger; Lamy, Laurence; Zhao, Hong; Yang, Yandan; Xu, Weihong; Shaffer, Arthur L.; Wright, George; Xiao, Wenming; Powell, John; Jiang, Jian-kang; Thomas, Craig J.; Rosenwald, Andreas; Ott, German; Muller-Hermelink, Hans Konrad; Gascoyne, Randy D.; Connors, Joseph M.; Johnson, Nathalie A.; Rimsza, Lisa M.; Campo, Elias; Jaffe, Elaine S.; Wilson, Wyndham H.; Delabie, Jan; Smeland, Erlend B.; Fisher, Richard I.; Braziel, Rita M.; Tubbs, Raymond R.; Cook, J. R.; Weisenburger, Dennis D.; Chan, Wing C.; Pierce, Susan K.; Staudt, Louis M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">463</span>
        (<span class="NLM_cas:issue">7277</span>),
    <span class="NLM_cas:pages">88-92</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A role for B-cell-receptor (BCR) signaling in lymphomagenesis has been inferred by studying Ig genes in human lymphomas and by engineering mouse models, but genetic and functional evidence for its oncogenic role in human lymphomas is needed.  Here the authors describe a form of chronic active' BCR signaling that is required for cell survival in the activated B-cell-like (ABC) subtype of diffuse large B-cell lymphoma (DLBCL).  The signaling adaptor CARD11 is required for constitutive NF-κB pathway activity and survival in ABC DLBCL.  Roughly 10% of ABC DLBCLs have mutant CARD11 isoforms that activate NF-κB, but the mechanism that engages wild-type CARD11 in other ABC DLBCLs was unknown.  An RNA interference genetic screen revealed that a BCR signaling component, Bruton's tyrosine kinase, is essential for the survival of ABC DLBCLs with wild-type CARD11.  In addn., knockdown of proximal BCR subunits (IgM, Ig-κ, CD79A and CD79B) killed ABC DLBCLs with wild-type CARD11 but not other lymphomas.  The BCRs in these ABC DLBCLs formed prominent clusters in the plasma membrane with low diffusion, similarly to BCRs in antigen-stimulated normal B cells.  Somatic mutations affecting the immunoreceptor tyrosine-based activation motif (ITAM) signaling modules of CD79B and CD79A were detected frequently in ABC DLBCL biopsy samples but rarely in other DLBCLs and never in Burkitt's lymphoma or mucosa-assocd. lymphoid tissue lymphoma.  In 18% of ABC DLBCLs, one functionally crit. residue of CD79B, the first ITAM tyrosine, was mutated.  These mutations increased surface BCR expression and attenuated Lyn kinase, a feedback inhibitor of BCR signaling.  These findings establish chronic active BCR signaling as a new pathogenetic mechanism in ABC DLBCL, suggesting several therapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzlT4q2Ie4lrVg90H21EOLACvtfcHk0ljXtGycJQWbHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhvFCitw%253D%253D&md5=86d4bdf7f9af3fbe120d5b9175389e5a</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fnature08638&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08638%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DR.%2BE.%26aulast%3DNgo%26aufirst%3DV.%2BN.%26aulast%3DLenz%26aufirst%3DG.%26aulast%3DTolar%26aufirst%3DP.%26aulast%3DYoung%26aufirst%3DR.%2BM.%26aulast%3DRomesser%26aufirst%3DP.%2BB.%26aulast%3DKohlhammer%26aufirst%3DH.%26aulast%3DLamy%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DShaffer%26aufirst%3DA.%2BL.%26aulast%3DWright%26aufirst%3DG.%26aulast%3DXiao%26aufirst%3DW.%26aulast%3DPowell%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DJ.-k.%26aulast%3DThomas%26aufirst%3DC.%2BJ.%26aulast%3DRosenwald%26aufirst%3DA.%26aulast%3DOtt%26aufirst%3DG.%26aulast%3DMuller-Hermelink%26aufirst%3DH.%2BK.%26aulast%3DGascoyne%26aufirst%3DR.%2BD.%26aulast%3DConnors%26aufirst%3DJ.%2BM.%26aulast%3DJohnson%26aufirst%3DN.%2BA.%26aulast%3DRimsza%26aufirst%3DL.%2BM.%26aulast%3DCampo%26aufirst%3DE.%26aulast%3DJaffe%26aufirst%3DE.%2BS.%26aulast%3DWilson%26aufirst%3DW.%2BH.%26aulast%3DDelabie%26aufirst%3DJ.%26aulast%3DSmeland%26aufirst%3DE.%2BB.%26aulast%3DFisher%26aufirst%3DR.%2BI.%26aulast%3DBraziel%26aufirst%3DR.%2BM.%26aulast%3DTubbs%26aufirst%3DR.%2BR.%26aulast%3DCook%26aufirst%3DJ.%2BR.%26aulast%3DWeisenburger%26aufirst%3DD.%2BD.%26aulast%3DChan%26aufirst%3DW.%2BC.%26aulast%3DPierce%26aufirst%3DS.%2BK.%26aulast%3DStaudt%26aufirst%3DL.%2BM.%26atitle%3DChronic%2520Active%2520B-Cell-Receptor%2520Signalling%2520in%2520Diffuse%2520Large%2520B-Cell%2520Lymphoma%26jtitle%3DNature%26date%3D2010%26volume%3D463%26spage%3D88%26epage%3D92%26doi%3D10.1038%2Fnature08638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Caro, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kishan, A. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norberg, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanley, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapuy, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ficarro, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polak, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tondera, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gounarides, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marto, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shipp, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danial, N. N.</span></span> <span> </span><span class="NLM_article-title">Metabolic Signatures Uncover Distinct Targets in Molecular Subsets of Diffuse Large B Cell Lymphoma</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">547</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2012.08.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1016%2Fj.ccr.2012.08.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=23079663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFWitbbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=547&author=P.+Caroauthor=A.+U.+Kishanauthor=E.+Norbergauthor=I.+A.+Stanleyauthor=B.+Chapuyauthor=S.+B.+Ficarroauthor=K.+Polakauthor=D.+Tonderaauthor=J.+Gounaridesauthor=H.+Yinauthor=F.+Zhouauthor=M.+R.+Greenauthor=L.+Chenauthor=S.+Montiauthor=J.+A.+Martoauthor=M.+A.+Shippauthor=N.+N.+Danial&title=Metabolic+Signatures+Uncover+Distinct+Targets+in+Molecular+Subsets+of+Diffuse+Large+B+Cell+Lymphoma&doi=10.1016%2Fj.ccr.2012.08.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic Signatures Uncover Distinct Targets in Molecular Subsets of Diffuse Large B Cell Lymphoma</span></div><div class="casAuthors">Caro, Pilar; Kishan, Amar U.; Norberg, Erik; Stanley, Illana A.; Chapuy, Bjoern; Ficarro, Scott B.; Polak, Klaudia; Tondera, Daniel; Gounarides, John; Yin, Hong; Zhou, Feng; Green, Michael R.; Chen, Linfeng; Monti, Stefano; Marto, Jarrod A.; Shipp, Margaret A.; Danial, Nika N.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">547-560</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Mol. signatures have identified several subsets of diffuse large B cell lymphoma (DLBCL) and rational targets within the B cell receptor (BCR) signaling axis.  The OxPhos-DLBCL subset, which harbors the signature of genes involved in mitochondrial metab., is insensitive to inhibition of BCR survival signaling but is functionally undefined.  We show that, compared with BCR-DLBCLs, OxPhos-DLBCLs display enhanced mitochondrial energy transduction, greater incorporation of nutrient-derived carbons into the tricarboxylic acid cycle, and increased glutathione levels.  Moreover, perturbation of the fatty acid oxidn. program and glutathione synthesis proved selectively toxic to this tumor subset.  Our anal. provides evidence for distinct metabolic fingerprints and assocd. survival mechanisms in DLBCL and may have therapeutic implications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFccRUow25JbVg90H21EOLACvtfcHk0ljXtGycJQWbHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFWitbbO&md5=cc9e0ced5202e9e61ec7ee3baf4d7306</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2012.08.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2012.08.014%26sid%3Dliteratum%253Aachs%26aulast%3DCaro%26aufirst%3DP.%26aulast%3DKishan%26aufirst%3DA.%2BU.%26aulast%3DNorberg%26aufirst%3DE.%26aulast%3DStanley%26aufirst%3DI.%2BA.%26aulast%3DChapuy%26aufirst%3DB.%26aulast%3DFicarro%26aufirst%3DS.%2BB.%26aulast%3DPolak%26aufirst%3DK.%26aulast%3DTondera%26aufirst%3DD.%26aulast%3DGounarides%26aufirst%3DJ.%26aulast%3DYin%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DF.%26aulast%3DGreen%26aufirst%3DM.%2BR.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DMonti%26aufirst%3DS.%26aulast%3DMarto%26aufirst%3DJ.%2BA.%26aulast%3DShipp%26aufirst%3DM.%2BA.%26aulast%3DDanial%26aufirst%3DN.%2BN.%26atitle%3DMetabolic%2520Signatures%2520Uncover%2520Distinct%2520Targets%2520in%2520Molecular%2520Subsets%2520of%2520Diffuse%2520Large%2520B%2520Cell%2520Lymphoma%26jtitle%3DCancer%2520Cell%26date%3D2012%26volume%3D22%26spage%3D547%26doi%3D10.1016%2Fj.ccr.2012.08.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jerne, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nordin, A. A.</span></span> <span> </span><span class="NLM_article-title">Plaque Formation in Agar by Single Antibody-Producing Cells</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1963</span>,  <span class="NLM_volume"><i>140</i></span>,  <span class="NLM_fpage">405</span>, <span class="refDoi"> DOI: 10.1126/science.140.3565.405</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1126%2Fscience.140.3565.405" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=13957684" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=1963&pages=405&author=N.+K.+Jerneauthor=A.+A.+Nordin&title=Plaque+Formation+in+Agar+by+Single+Antibody-Producing+Cells&doi=10.1126%2Fscience.140.3565.405"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1126%2Fscience.140.3565.405&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.140.3565.405%26sid%3Dliteratum%253Aachs%26aulast%3DJerne%26aufirst%3DN.%2BK.%26aulast%3DNordin%26aufirst%3DA.%2BA.%26atitle%3DPlaque%2520Formation%2520in%2520Agar%2520by%2520Single%2520Antibody-Producing%2520Cells%26jtitle%3DScience%26date%3D1963%26volume%3D140%26spage%3D405%26doi%3D10.1126%2Fscience.140.3565.405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ladics, G. S.</span></span> <span> </span><span class="NLM_article-title">Primary Immune Response to Sheep Red Blood Cells (SRBC) as the Conventional T-Cell Dependent Antibody Response (TDAR) Test</span>. <i>J. Immunot.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">149</span>, <span class="refDoi"> DOI: 10.1080/15476910701337357</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1080%2F15476910701337357" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=18958723" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2007&pages=149&author=G.+S.+Ladics&title=Primary+Immune+Response+to+Sheep+Red+Blood+Cells+%28SRBC%29+as+the+Conventional+T-Cell+Dependent+Antibody+Response+%28TDAR%29+Test&doi=10.1080%2F15476910701337357"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1080%2F15476910701337357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F15476910701337357%26sid%3Dliteratum%253Aachs%26aulast%3DLadics%26aufirst%3DG.%2BS.%26atitle%3DPrimary%2520Immune%2520Response%2520to%2520Sheep%2520Red%2520Blood%2520Cells%2520%2528SRBC%2529%2520as%2520the%2520Conventional%2520T-Cell%2520Dependent%2520Antibody%2520Response%2520%2528TDAR%2529%2520Test%26jtitle%3DJ.%2520Immunot.%26date%3D2007%26volume%3D4%26spage%3D149%26doi%3D10.1080%2F15476910701337357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Finlay, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lloyd, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaccaro, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kover, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhave, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prol, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huynh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhandaru, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caringal, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimarco, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harper, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conder, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levesque, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atwal, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wexler, R.</span></span> <span> </span><span class="NLM_article-title">Discovery of ((S)-5-(Methoxymethyl)-7-(1-Methyl-1 H -Indol-2-Yl)-2- (Trifluoromethyl)-4,7-Dihydropyrazolo[1,5- a ]Pyrimidin-6-Yl)((S)-2-(3- Methylisoxazol-5-Yl)Pyrrolidin-1-Yl)Methanone as a Potent and Selective I Kur Inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">3036</span>, <span class="refDoi"> DOI: 10.1021/jm201386u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201386u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs1OisLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=3036&author=H.+J.+Finlayauthor=J.+Lloydauthor=W.+Vaccaroauthor=A.+Koverauthor=L.+Yanauthor=G.+Bhaveauthor=J.+Prolauthor=T.+Huynhauthor=R.+Bhandaruauthor=Y.+Caringalauthor=J.+Dimarcoauthor=J.+Ganauthor=T.+Harperauthor=C.+Huangauthor=M.+L.+Conderauthor=H.+Sunauthor=P.+Levesqueauthor=M.+Blanarauthor=K.+Atwalauthor=R.+Wexler&title=Discovery+of+%28%28S%29-5-%28Methoxymethyl%29-7-%281-Methyl-1+H+-Indol-2-Yl%29-2-+%28Trifluoromethyl%29-4%2C7-Dihydropyrazolo%5B1%2C5-+a+%5DPyrimidin-6-Yl%29%28%28S%29-2-%283-+Methylisoxazol-5-Yl%29Pyrrolidin-1-Yl%29Methanone+as+a+Potent+and+Selective+I+Kur+Inhibitor&doi=10.1021%2Fjm201386u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of ((S)-5-(methoxymethyl)-7-(1-methyl-1H-indol-2-yl)-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-a]pyrimidin-6-yl)((S)-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone As a Potent and Selective IKur Inhibitor</span></div><div class="casAuthors">Finlay, Heather J.; Lloyd, John; Vaccaro, Wayne; Kover, Alexander; Yan, Lin; Bhave, Gauri; Prol, Joseph; Huynh, Tram; Bhandaru, Rao; Caringal, Yolanda; DiMarco, John; Gan, Jinping; Harper, Tim; Huang, Christine; Conder, Mary Lee; Sun, Huabin; Levesque, Paul; Blanar, Michael; Atwal, Karnail; Wexler, Ruth</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3036-3048</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Previously disclosed dihydropyrazolopyrimidines are potent and selective blockers of IKur current.  A potential liability with this chemotype is the formation of a reactive metabolite which demonstrated covalent binding to protein in vitro.  When substituted at the 2 or 3 position, this template yielded potent IKur inhibitors, with selectivity over hERG which did not form reactive metabolites.  Subsequent optimization for potency and PK properties lead to the discovery of ((S)-5-(methoxymethyl)-7-(1-methyl-1H-indol-2-yl)-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-a]pyrimidin-6-yl)((S)-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone I, with an acceptable PK profile in preclin. species and potent efficacy in the preclin. rabbit atrial effective refractory period (AERP) model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBQ3O-MOGeKbVg90H21EOLACvtfcHk0lifnkxb2BL6TQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs1OisLY%253D&md5=6c70b62774028a29fb53a65e987e50fe</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm201386u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201386u%26sid%3Dliteratum%253Aachs%26aulast%3DFinlay%26aufirst%3DH.%2BJ.%26aulast%3DLloyd%26aufirst%3DJ.%26aulast%3DVaccaro%26aufirst%3DW.%26aulast%3DKover%26aufirst%3DA.%26aulast%3DYan%26aufirst%3DL.%26aulast%3DBhave%26aufirst%3DG.%26aulast%3DProl%26aufirst%3DJ.%26aulast%3DHuynh%26aufirst%3DT.%26aulast%3DBhandaru%26aufirst%3DR.%26aulast%3DCaringal%26aufirst%3DY.%26aulast%3DDimarco%26aufirst%3DJ.%26aulast%3DGan%26aufirst%3DJ.%26aulast%3DHarper%26aufirst%3DT.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DConder%26aufirst%3DM.%2BL.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DLevesque%26aufirst%3DP.%26aulast%3DBlanar%26aufirst%3DM.%26aulast%3DAtwal%26aufirst%3DK.%26aulast%3DWexler%26aufirst%3DR.%26atitle%3DDiscovery%2520of%2520%2528%2528S%2529-5-%2528Methoxymethyl%2529-7-%25281-Methyl-1%2520H%2520-Indol-2-Yl%2529-2-%2520%2528Trifluoromethyl%2529-4%252C7-Dihydropyrazolo%255B1%252C5-%2520a%2520%255DPyrimidin-6-Yl%2529%2528%2528S%2529-2-%25283-%2520Methylisoxazol-5-Yl%2529Pyrrolidin-1-Yl%2529Methanone%2520as%2520a%2520Potent%2520and%2520Selective%2520I%2520Kur%2520Inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D3036%26doi%3D10.1021%2Fjm201386u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref48':['cit48'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 3 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Xuewu Liang, Chenxia Sun, Chunpu Li, Haolan Yu, Xiaohui Wei, Xuyi Liu, Wei Bao, Yuqiang Shi, Xiaochen Sun, Mirzadavlat Khamrakulov, Chenghua Yang, <span class="NLM_string-name hlFld-ContribAuthor">Hong Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of Novel Fused Heteroaromatics-Based MALT1 Inhibitors by High-Throughput Screening to Treat B Cell Lymphoma. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (13)
                                     , 9217-9237. <a href="https://doi.org/10.1021/acs.jmedchem.1c00466" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00466</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00466&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00466%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252BNovel%252BFused%252BHeteroaromatics-Based%252BMALT1%252BInhibitors%252Bby%252BHigh-Throughput%252BScreening%252Bto%252BTreat%252BB%252BCell%252BLymphoma%26aulast%3DLiang%26aufirst%3DXuewu%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D15032021%26date%3D28062021%26volume%3D64%26issue%3D13%26spage%3D9217%26epage%3D9237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenwu  Liu</span>, <span class="hlFld-ContribAuthor ">Xin  Liu</span>, <span class="hlFld-ContribAuthor ">Liting  Tian</span>, <span class="hlFld-ContribAuthor ">Yaping  Gao</span>, <span class="hlFld-ContribAuthor ">Wenjie  Liu</span>, <span class="hlFld-ContribAuthor ">Huanhua  Chen</span>, <span class="hlFld-ContribAuthor ">Xiaowen  Jiang</span>, <span class="hlFld-ContribAuthor ">Zihua  Xu</span>, <span class="hlFld-ContribAuthor ">Huaiwei  Ding</span>, <span class="hlFld-ContribAuthor ">Qingchun  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of harmine derivatives as potent GSK-3β/DYRK1A dual inhibitors for the treatment of Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>222 </em>, 113554. <a href="https://doi.org/10.1016/j.ejmech.2021.113554" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113554</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113554&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113554%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bharmine%252Bderivatives%252Bas%252Bpotent%252BGSK-3%2525CE%2525B2%25252FDYRK1A%252Bdual%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%252527s%252Bdisease%26aulast%3DLiu%26aufirst%3DWenwu%26date%3D2021%26volume%3D222%26spage%3D113554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Isabel  Hamp</span>, <span class="hlFld-ContribAuthor ">Thomas J.  O’Neill</span>, <span class="hlFld-ContribAuthor ">Oliver  Plettenburg</span>, <span class="hlFld-ContribAuthor ">Daniel  Krappmann</span>. </span><span class="cited-content_cbyCitation_article-title">A patent review of MALT1 inhibitors (2013-present). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2021,</strong> <em>77 </em>, 1-18. <a href="https://doi.org/10.1080/13543776.2021.1951703" title="DOI URL">https://doi.org/10.1080/13543776.2021.1951703</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2021.1951703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2021.1951703%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DA%252Bpatent%252Breview%252Bof%252BMALT1%252Binhibitors%252B%2525282013-present%252529%26aulast%3DHamp%26aufirst%3DIsabel%26date%3D2021%26date%3D2021%26volume%3D77%26spage%3D1%26epage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01246/20201203/images/medium/jm0c01246_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01246/20201203/images/large/jm0c01246_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01246&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01246/20201203/images/medium/jm0c01246_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01246/20201203/images/large/jm0c01246_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structure, potency, and <i>in vivo</i> efficacy of <b>MLT-231</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01246/20201203/images/large/jm0c01246_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01246&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01246/20201203/images/medium/jm0c01246_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01246/20201203/images/large/jm0c01246_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Major metabolites of <b>MLT-231</b> identified by capillary-HPLC/MS after incubation with human or rat liver microsomes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01246/20201203/images/large/jm0c01246_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01246&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01246/20201203/images/medium/jm0c01246_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01246/20201203/images/large/jm0c01246_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. 1D) <sup>1</sup>H spectra of <b>MLT-985</b> (left panel) and compound <b>7</b> (right panel) in CDCl3 and DMSO. Resonances of the NH protons 11 and 16 are labeled and shift change is illustrated with black dashed arrows.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01246/20201203/images/large/jm0c01246_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01246&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01246/20201203/images/medium/jm0c01246_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01246/20201203/images/large/jm0c01246_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. <b>MLT-985</b> suppresses growth and aberrant CARD11/BCL10/MALT1 complex signaling in ABC-DLBCL cells. (A) ABC-DLBCL (OCI-Ly3) and GCB-DLBCL (BJAB) cells were grown in soft-agar, and treated with increasing concentrations of <b>MLT-985</b> followed by imaging (image show representative fields in the individual wells, in false-color). (B) OCI-Ly3 cells were treated with increasing concentrations of <b>MLT-985</b> for 24 h followed by cell lysis for analysis of CYLD, BCL10, RELB, IRF4 by Western blotting. Levels of α-tubulin are provided as loading control. In the CYLD blot the arrow depicts appearance of full-length, uncleaved CYLD, while the arrowhead marks the position of the cleaved CYLD fragment. (C) TMD8 and OCI-Ly10 ABC-DLBCL cell lines were treated and analyzed as described above in (B). (D) IC<sub>50</sub>, EC<sub>50</sub>, or GI<sub>50</sub> values (means of at least two independent experiments except BCL10 MSD: <i>n</i> = 1) of <b>MLT-985</b> measured in the NF-kB reporter gene assay, BCL10 MSD assay, ROS inhibition assay, and resazurin-readouts of the OCI-Ly3 and BJAB soft agar growth assays, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01246/20201203/images/large/jm0c01246_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01246&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01246/20201203/images/medium/jm0c01246_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01246/20201203/images/large/jm0c01246_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Inhibitory effects of <b>4</b> and <b>MLT-985</b> on SRBC-induced IgM producing cells in the rat, as measured by <i>ex vivo</i> plaque forming assay. *<i>p</i> < 0.05. <sup>a</sup> Total blood concentration of <b>4</b> measured 3 or 14 h post dose. <sup>b</sup> Total blood concentration of <b>MLT-985</b> measured 3 or 24 h post dose.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01246/20201203/images/large/jm0c01246_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01246&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01246/20201203/images/medium/jm0c01246_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01246/20201203/images/large/jm0c01246_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. PK/PD and efficacy of <b>MLT-985</b> in ABC-DLBCL xenograft models. (A) PK/PD study in TMD8 xenografts after one single oral dose (30 mg kg<sup>–1</sup>). Mean plasma concentration ± SD (blue) and % tumor IL-10 ± SD (gray) are shown (<i>n</i> = 2–3). (B) Efficacy study in OCI-Ly3 xenografts after oral administration of either vehicle control or <b>MLT-985</b> at indicated doses and schedules. Mean tumor volumes ± SEM are shown (<i>n</i> = 6; *<i>p</i> < 0.05 vs vehicle). (B) Pharmacokinetics of <b>MLT-985</b> in plasma and tumor postlast dose. Mean compound concentrations ± SD are shown (<i>n</i> = 2). <i>D.</i> MALT1-specific tumor PD read outs were analyzed postlast dose by Western blotting as indicated (<i>n</i> = 2).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01246/20201203/images/large/jm0c01246_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01246&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01246/20201203/images/medium/jm0c01246_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01246/20201203/images/large/jm0c01246_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Routes for Inhibitors <b>2–6</b> and <b>9</b> (cf. Tables for Structures)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01246/20201203/images/large/jm0c01246_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01246&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Triethyl orthoformiate, Ac<sub>2</sub>O, 135 °C; (b) 5-chloro-1<i>H</i>-pyrazol-3-amine, EtOH, 80 °C; (c) NaOH, EtOH; (d) DPPA, Et<sub>3</sub>N, dioxane, RT then 2-(trifluoromethyl)pyridin-4-amine or <b>13,</b> 100 °C. (e) K<sub>2</sub>CO<sub>3</sub>, 2<i>H</i>-1,2,3-triazole, RT; (f) SnCl<sub>2</sub>, HCl (1.25 M) in MeOH; RT.</p></p></figure><figure data-id="sch2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01246/20201203/images/medium/jm0c01246_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01246/20201203/images/large/jm0c01246_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Routes for Inhibitors <b>7</b>, <b>8</b>, <b>10</b>, and <b>MLT-985</b> (cf. Tables for Structures)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01246/20201203/images/large/jm0c01246_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01246&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) CDI, 0 °C then 3-(<i>tert</i>-butoxy)-3-oxopropanoic acid, iPrMgCl, THF, RT; (f) dimethylformamide-dimethylacetal, 120 °C, then 5-chloro-1<i>H</i>-pyrazol-3-amine, EtOH, 80 °C; (g) TFA, CH<sub>2</sub>Cl<sub>2</sub>, RT; (d) DPPA, Et<sub>3</sub>N, dioxane, RT then 2-(trifluoromethyl)pyridin-4-amine or <b>13</b>, 100 °C. <b>7</b> and <b>8</b> were obtained after chiral separation of the racemate.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i50">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75265" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75265" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 48 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Minina, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvarez, V. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berges, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berman-Frank, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beyaert, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bidle, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornancin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casanova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cazzulo, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coll, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixit, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolinar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fasel, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funk, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallois, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gevaert, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutierrez-Beltran, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hailfinger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klemenčič, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koonin, E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krappmann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linusson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machado, M. F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madeo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Megeney, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moschou, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mottram, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nyström, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osiewacz, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overall, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruland, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvesen, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smertenko, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stael, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ståhlberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suárez, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thome, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuominen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Breusegem, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Hoorn, R. A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vardi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhivotovsky, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bozhkov, P. V.</span></span> <span> </span><span class="NLM_article-title">Classification and Nomenclature of Metacaspases and Paracaspases: No More Confusion with Caspases</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">927</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2019.12.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1016%2Fj.molcel.2019.12.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=32142688" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BB3cXotFeltr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2020&pages=927&author=E.+A.+Mininaauthor=J.+Staalauthor=V.+E.+Alvarezauthor=J.+A.+Bergesauthor=I.+Berman-Frankauthor=R.+Beyaertauthor=K.+D.+Bidleauthor=F.+Bornancinauthor=M.+Casanovaauthor=J.+J.+Cazzuloauthor=C.+J.+Choiauthor=N.+S.+Collauthor=V.+M.+Dixitauthor=M.+Dolinarauthor=N.+Faselauthor=C.+Funkauthor=P.+Galloisauthor=K.+Gevaertauthor=E.+Gutierrez-Beltranauthor=S.+Hailfingerauthor=M.+Klemen%C4%8Di%C4%8Dauthor=E.+V.+Kooninauthor=D.+Krappmannauthor=A.+Linussonauthor=M.+F.+M.+Machadoauthor=F.+Madeoauthor=L.+A.+Megeneyauthor=P.+N.+Moschouauthor=J.+C.+Mottramauthor=T.+Nystr%C3%B6mauthor=H.+D.+Osiewaczauthor=C.+M.+Overallauthor=K.+C.+Pandeyauthor=J.+Rulandauthor=G.+S.+Salvesenauthor=Y.+Shiauthor=A.+Smertenkoauthor=S.+Staelauthor=J.+St%C3%A5hlbergauthor=M.+F.+Su%C3%A1rezauthor=M.+Thomeauthor=H.+Tuominenauthor=F.+Van+Breusegemauthor=R.+A.+L.+van+der+Hoornauthor=A.+Vardiauthor=B.+Zhivotovskyauthor=E.+Lamauthor=P.+V.+Bozhkov&title=Classification+and+Nomenclature+of+Metacaspases+and+Paracaspases%3A+No+More+Confusion+with+Caspases&doi=10.1016%2Fj.molcel.2019.12.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Classification and Nomenclature of Metacaspases and Paracaspases: No More Confusion with Caspases</span></div><div class="casAuthors">Minina, Elena A.; Staal, Jens; Alvarez, Vanina E.; Berges, John A.; Berman-Frank, Ilana; Beyaert, Rudi; Bidle, Kay D.; Bornancin, Frederic; Casanova, Magali; Cazzulo, Juan J.; Choi, Chang Jae; Coll, Nuria S.; Dixit, Vishva M.; Dolinar, Marko; Fasel, Nicolas; Funk, Christiane; Gallois, Patrick; Gevaert, Kris; Gutierrez-Beltran, Emilio; Hailfinger, Stephan; Klemencic, Marina; Koonin, Eugene V.; Krappmann, Daniel; Linusson, Anna; Machado, Mauricio F. M.; Madeo, Frank; Megeney, Lynn A.; Moschou, Panagiotis N.; Mottram, Jeremy C.; Nystroem, Thomas; Osiewacz, Heinz D.; Overall, Christopher M.; Pandey, Kailash C.; Ruland, Jurgen; Salvesen, Guy S.; Shi, Yigong; Smertenko, Andrei; Stael, Simon; Staahlberg, Jerry; Suarez, Maria Fernanda; Thome, Margot; Tuominen, Hannele; Van Breusegem, Frank; van der Hoorn, Renier A. L.; Vardi, Assaf; Zhivotovsky, Boris; Lam, Eric; Bozhkov, Peter V.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">927-929</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUar5FKjWwCbVg90H21EOLACvtfcHk0ligmddevApabA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXotFeltr4%253D&md5=43789b5379a8cce26231f37a72fa9d22</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2019.12.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2019.12.020%26sid%3Dliteratum%253Aachs%26aulast%3DMinina%26aufirst%3DE.%2BA.%26aulast%3DStaal%26aufirst%3DJ.%26aulast%3DAlvarez%26aufirst%3DV.%2BE.%26aulast%3DBerges%26aufirst%3DJ.%2BA.%26aulast%3DBerman-Frank%26aufirst%3DI.%26aulast%3DBeyaert%26aufirst%3DR.%26aulast%3DBidle%26aufirst%3DK.%2BD.%26aulast%3DBornancin%26aufirst%3DF.%26aulast%3DCasanova%26aufirst%3DM.%26aulast%3DCazzulo%26aufirst%3DJ.%2BJ.%26aulast%3DChoi%26aufirst%3DC.%2BJ.%26aulast%3DColl%26aufirst%3DN.%2BS.%26aulast%3DDixit%26aufirst%3DV.%2BM.%26aulast%3DDolinar%26aufirst%3DM.%26aulast%3DFasel%26aufirst%3DN.%26aulast%3DFunk%26aufirst%3DC.%26aulast%3DGallois%26aufirst%3DP.%26aulast%3DGevaert%26aufirst%3DK.%26aulast%3DGutierrez-Beltran%26aufirst%3DE.%26aulast%3DHailfinger%26aufirst%3DS.%26aulast%3DKlemen%25C4%258Di%25C4%258D%26aufirst%3DM.%26aulast%3DKoonin%26aufirst%3DE.%2BV.%26aulast%3DKrappmann%26aufirst%3DD.%26aulast%3DLinusson%26aufirst%3DA.%26aulast%3DMachado%26aufirst%3DM.%2BF.%2BM.%26aulast%3DMadeo%26aufirst%3DF.%26aulast%3DMegeney%26aufirst%3DL.%2BA.%26aulast%3DMoschou%26aufirst%3DP.%2BN.%26aulast%3DMottram%26aufirst%3DJ.%2BC.%26aulast%3DNystr%25C3%25B6m%26aufirst%3DT.%26aulast%3DOsiewacz%26aufirst%3DH.%2BD.%26aulast%3DOverall%26aufirst%3DC.%2BM.%26aulast%3DPandey%26aufirst%3DK.%2BC.%26aulast%3DRuland%26aufirst%3DJ.%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DSmertenko%26aufirst%3DA.%26aulast%3DStael%26aufirst%3DS.%26aulast%3DSt%25C3%25A5hlberg%26aufirst%3DJ.%26aulast%3DSu%25C3%25A1rez%26aufirst%3DM.%2BF.%26aulast%3DThome%26aufirst%3DM.%26aulast%3DTuominen%26aufirst%3DH.%26aulast%3DVan%2BBreusegem%26aufirst%3DF.%26aulast%3Dvan%2Bder%2BHoorn%26aufirst%3DR.%2BA.%2BL.%26aulast%3DVardi%26aufirst%3DA.%26aulast%3DZhivotovsky%26aufirst%3DB.%26aulast%3DLam%26aufirst%3DE.%26aulast%3DBozhkov%26aufirst%3DP.%2BV.%26atitle%3DClassification%2520and%2520Nomenclature%2520of%2520Metacaspases%2520and%2520Paracaspases%253A%2520No%2520More%2520Confusion%2520with%2520Caspases%26jtitle%3DMol.%2520Cell%26date%3D2020%26volume%3D77%26spage%3D927%26doi%3D10.1016%2Fj.molcel.2019.12.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jaworski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thome, M.</span></span> <span> </span><span class="NLM_article-title">The Paracaspase MALT1: Biological Function and Potential for Therapeutic Inhibition</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">459</span>– <span class="NLM_lpage">473</span>, <span class="refDoi"> DOI: 10.1007/s00018-015-2059-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1007%2Fs00018-015-2059-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=26507244" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsleksLzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2016&pages=459-473&author=M.+Jaworskiauthor=M.+Thome&title=The+Paracaspase+MALT1%3A+Biological+Function+and+Potential+for+Therapeutic+Inhibition&doi=10.1007%2Fs00018-015-2059-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The paracaspase MALT1: biological function and potential for therapeutic inhibition</span></div><div class="casAuthors">Jaworski, Maike; Thome, Margot</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">459-473</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">The paracaspase MALT1 has a central role in the activation of lymphocytes and other immune cells including myeloid cells, mast cells and NK cells.  MALT1 activity is required not only for the immune response, but also for the development of natural Treg cells that keep the immune response in check.  Exaggerated MALT1 activity has been assocd. with the development of lymphoid malignancies, and recently developed MALT1 inhibitors show promising anti-tumor effects in xenograft models of diffuse large B cell lymphoma.  In this review, we provide an overview of the present understanding of MALT1's function, and discuss possibilities for its therapeutic targeting based on recently developed inhibitors and animal models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooyWY8MBt487Vg90H21EOLACvtfcHk0liP-ScofNemiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsleksLzK&md5=61a26c76efd0b36f03915071175f5ef2</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2Fs00018-015-2059-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-015-2059-z%26sid%3Dliteratum%253Aachs%26aulast%3DJaworski%26aufirst%3DM.%26aulast%3DThome%26aufirst%3DM.%26atitle%3DThe%2520Paracaspase%2520MALT1%253A%2520Biological%2520Function%2520and%2520Potential%2520for%2520Therapeutic%2520Inhibition%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2016%26volume%3D73%26spage%3D459%26epage%3D473%26doi%3D10.1007%2Fs00018-015-2059-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Demeyer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beyaert, R.</span></span> <span> </span><span class="NLM_article-title">Targeting MALT1 Proteolytic Activity in Immunity, Inflammation and Disease: Good or Bad?</span>. <i>Trends Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">135</span>– <span class="NLM_lpage">150</span>, <span class="refDoi"> DOI: 10.1016/j.molmed.2015.12.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1016%2Fj.molmed.2015.12.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=26787500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFCisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2016&pages=135-150&author=A.+Demeyerauthor=J.+Staalauthor=R.+Beyaert&title=Targeting+MALT1+Proteolytic+Activity+in+Immunity%2C+Inflammation+and+Disease%3A+Good+or+Bad%3F&doi=10.1016%2Fj.molmed.2015.12.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting MALT1 Proteolytic Activity in Immunity, Inflammation and Disease: Good or Bad?</span></div><div class="casAuthors">Demeyer, Annelies; Staal, Jens; Beyaert, Rudi</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Molecular Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">135-150</span>CODEN:
                <span class="NLM_cas:coden">TMMRCY</span>;
        ISSN:<span class="NLM_cas:issn">1471-4914</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">MALT1 is a signaling protein that plays a key role in immunity, inflammation, and lymphoid malignancies.  For a long time MALT1 was believed to function as a scaffold protein, providing an assembly platform for other signaling proteins.  This view changed dramatically when MALT1 was also found to have proteolytic activity and a capacity to fine-tune immune responses.  Preclin. studies have fostered the belief that MALT1 is a promising therapeutic target in autoimmunity and B cell lymphomas.  However, recent studies have shown that mice expressing catalytically-inactive MALT1 develop multi-organ inflammation and autoimmunity, and thus have tempered this initial enthusiasm.  We discuss recent findings, highlighting the urgent need for a better mechanistic and functional understanding of MALT1 in host defense and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq39fxtDl9_bbVg90H21EOLACvtfcHk0liP-ScofNemiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFCisQ%253D%253D&md5=0e4d984d95a32b039f29895a7cf35c95</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.molmed.2015.12.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmed.2015.12.004%26sid%3Dliteratum%253Aachs%26aulast%3DDemeyer%26aufirst%3DA.%26aulast%3DStaal%26aufirst%3DJ.%26aulast%3DBeyaert%26aufirst%3DR.%26atitle%3DTargeting%2520MALT1%2520Proteolytic%2520Activity%2520in%2520Immunity%252C%2520Inflammation%2520and%2520Disease%253A%2520Good%2520or%2520Bad%253F%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2016%26volume%3D22%26spage%3D135%26epage%3D150%26doi%3D10.1016%2Fj.molmed.2015.12.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bertossi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krappmann, D.</span></span> <span> </span><span class="NLM_article-title">MALT 1 protease: equilibrating immunity versus tolerance</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">2740</span>– <span class="NLM_lpage">2742</span>, <span class="refDoi"> DOI: 10.15252/embj.201490217</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.15252%2Fembj.201490217" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=25361604" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitFOitLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2014&pages=2740-2742&author=A.+Bertossiauthor=D.+Krappmann&title=MALT+1+protease%3A+equilibrating+immunity+versus+tolerance&doi=10.15252%2Fembj.201490217"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">MALT1 protease: equilibrating immunity versus tolerance</span></div><div class="casAuthors">Bertossi, Arianna; Krappmann, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2740-2742</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  MALT1 paracaspase links signaling cascades emanating from adaptive or innate immune receptors to the canonical NF-κB pathway.  Now, Jaworski et al (2014) investigate the physiol. role of MALT1 protease activity in mice.  Besides the expected requirement of MALT1 activity for immune activation, the study unveils a novel function for MALT1 activity for the development of peripheral tolerance.  Thus, MALT1 protease can act immunogenic or tolerogenic, and this interplay will be highly relevant for the clin. development of MALT1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqK3aFhjybmbVg90H21EOLACvtfcHk0lgfwsw5AjUSSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitFOitLY%253D&md5=8caba6b104e52c82db7ec361d85a8770</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.15252%2Fembj.201490217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15252%252Fembj.201490217%26sid%3Dliteratum%253Aachs%26aulast%3DBertossi%26aufirst%3DA.%26aulast%3DKrappmann%26aufirst%3DD.%26atitle%3DMALT%25201%2520protease%253A%2520equilibrating%2520immunity%2520versus%2520tolerance%26jtitle%3DEMBO%2520J.%26date%3D2014%26volume%3D33%26spage%3D2740%26epage%3D2742%26doi%3D10.15252%2Fembj.201490217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fontán, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melnick, A.</span></span> <span> </span><span class="NLM_article-title">Molecular Pathways: Targeting MALT1 Paracaspase Activity in Lymphoma</span>. <i>Clin. Canc. Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">6662</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-12-3869</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1158%2F1078-0432.CCR-12-3869" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFyrtr3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=6662&author=L.+Font%C3%A1nauthor=A.+Melnick&title=Molecular+Pathways%3A+Targeting+MALT1+Paracaspase+Activity+in+Lymphoma&doi=10.1158%2F1078-0432.CCR-12-3869"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Pathways: Targeting MALT1 Paracaspase Activity in Lymphoma</span></div><div class="casAuthors">Fontan, Lorena; Melnick, Ari</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6662-6668</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  MALT1 mediates the activation of NF-κB in response to antigen receptor signaling.  MALT1, in assocn. with BCL10 and CARD11, functions as a scaffolding protein to activate the inhibitor of IκB kinase (IKK) complex.  In addn., MALT1 is a paracaspase that targets key proteins in a feedback loop mediating termination of the NF-κB response, thus promoting activation of NF-κB signaling.  Activated B-cell subtype of diffuse large B-cell lymphomas (ABC-DLBCL), which tend to be more resistant to chemotherapy, are often biol. dependent on MALT1 activity.  Newly developed MALT1 small-mol. inhibitors suppress the growth of ABC-DLBCLs in vitro and in vivo.  This review highlights the recent advances in the normal and disease-related functions of MALT1.  Furthermore, recent progress targeting MALT1 proteolytic activity raises the possibility of deploying MALT1 inhibitors for the treatment of B-cell lymphomas and perhaps autoimmune diseases that involve increased B- or T-cell receptor signaling.  Clin Cancer Res; 19(24); 6662-8. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoavbnPIV22BrVg90H21EOLACvtfcHk0lgfwsw5AjUSSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFyrtr3E&md5=2d4762898ace23795600dc48a80b0684</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-12-3869&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-12-3869%26sid%3Dliteratum%253Aachs%26aulast%3DFont%25C3%25A1n%26aufirst%3DL.%26aulast%3DMelnick%26aufirst%3DA.%26atitle%3DMolecular%2520Pathways%253A%2520Targeting%2520MALT1%2520Paracaspase%2520Activity%2520in%2520Lymphoma%26jtitle%3DClin.%2520Canc.%2520Res.%26date%3D2013%26volume%3D19%26spage%3D6662%26doi%3D10.1158%2F1078-0432.CCR-12-3869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jaworski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsland, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gehrig, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Held, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Favre, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luther, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perroud, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golshayan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaide, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thome, M.</span></span> <span> </span><span class="NLM_article-title">Malt1 Protease Inactivation Efficiently Dampens Immune Responses but Causes Spontaneous Autoimmunity</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">2765</span>– <span class="NLM_lpage">2781</span>, <span class="refDoi"> DOI: 10.15252/embj.201488987</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.15252%2Fembj.201488987" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=25319413" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitFOitb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2014&pages=2765-2781&author=M.+Jaworskiauthor=B.+J.+Marslandauthor=J.+Gehrigauthor=W.+Heldauthor=S.+Favreauthor=S.+A.+Lutherauthor=M.+Perroudauthor=D.+Golshayanauthor=O.+Gaideauthor=M.+Thome&title=Malt1+Protease+Inactivation+Efficiently+Dampens+Immune+Responses+but+Causes+Spontaneous+Autoimmunity&doi=10.15252%2Fembj.201488987"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Malt1 protease inactivation efficiently dampens immune responses but causes spontaneous autoimmunity</span></div><div class="casAuthors">Jaworski, Maike; Marsland, Ben J.; Gehrig, Jasmine; Held, Werner; Favre, Stephanie; Luther, Sanjiv A.; Perroud, Mai; Golshayan, Dela; Gaide, Olivier; Thome, Margot</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2765-2781</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The protease activity of the paracaspase Malt1 has recently gained interest as a drug target for immunomodulation and the treatment of diffuse large B-cell lymphomas.  To address the consequences of Malt1 protease inactivation on the immune response in vivo, the authors generated knock-in mice expressing a catalytically inactive C472A mutant of Malt1 that conserves its scaffold function.  Like Malt1-deficient mice, knock-in mice had strong defects in the activation of lymphocytes, NK and dendritic cells, and the development of B1 and marginal zone B cells and were completely protected against the induction of autoimmune encephalomyelitis.  Malt1 inactivation also protected the mice from exptl. induction of colitis.  However, Malt1 knock-in mice but not Malt1-deficient mice spontaneously developed signs of autoimmune gastritis that correlated with an absence of Treg cells, an accumulation of T cells with an activated phenotype and high serum levels of IgE and IgG1.  Thus, removal of the enzymic activity of Malt1 efficiently dampens the immune response, but favors autoimmunity through impaired Treg development, which could be relevant for therapeutic Malt1-targeting strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_hW5aCqROFbVg90H21EOLACvtfcHk0lgfwsw5AjUSSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitFOitb8%253D&md5=1cec30b02de338e7976638abf8f44df3</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.15252%2Fembj.201488987&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15252%252Fembj.201488987%26sid%3Dliteratum%253Aachs%26aulast%3DJaworski%26aufirst%3DM.%26aulast%3DMarsland%26aufirst%3DB.%2BJ.%26aulast%3DGehrig%26aufirst%3DJ.%26aulast%3DHeld%26aufirst%3DW.%26aulast%3DFavre%26aufirst%3DS.%26aulast%3DLuther%26aufirst%3DS.%2BA.%26aulast%3DPerroud%26aufirst%3DM.%26aulast%3DGolshayan%26aufirst%3DD.%26aulast%3DGaide%26aufirst%3DO.%26aulast%3DThome%26aufirst%3DM.%26atitle%3DMalt1%2520Protease%2520Inactivation%2520Efficiently%2520Dampens%2520Immune%2520Responses%2520but%2520Causes%2520Spontaneous%2520Autoimmunity%26jtitle%3DEMBO%2520J.%26date%3D2014%26volume%3D33%26spage%3D2765%26epage%3D2781%26doi%3D10.15252%2Fembj.201488987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gewies, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorka, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergmann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pechloff, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petermann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeltsch, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudelius, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kriegsmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weichert, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horsch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beckers, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wurst, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heikenwalder, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korn, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heissmeyer, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruland, J.</span></span> <span> </span><span class="NLM_article-title">Uncoupling Malt1 Threshold Function from Paracaspase Activity Results in Destructive Autoimmune Inflammation</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1292</span>– <span class="NLM_lpage">1305</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2014.10.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1016%2Fj.celrep.2014.10.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=25456129" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFGisbfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=1292-1305&author=A.+Gewiesauthor=O.+Gorkaauthor=H.+Bergmannauthor=K.+Pechloffauthor=F.+Petermannauthor=K.+M.+Jeltschauthor=M.+Rudeliusauthor=M.+Kriegsmannauthor=W.+Weichertauthor=M.+Horschauthor=J.+Beckersauthor=W.+Wurstauthor=M.+Heikenwalderauthor=T.+Kornauthor=V.+Heissmeyerauthor=J.+Ruland&title=Uncoupling+Malt1+Threshold+Function+from+Paracaspase+Activity+Results+in+Destructive+Autoimmune+Inflammation&doi=10.1016%2Fj.celrep.2014.10.044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Uncoupling Malt1 Threshold Function from Paracaspase Activity Results in Destructive Autoimmune Inflammation</span></div><div class="casAuthors">Gewies, Andreas; Gorka, Oliver; Bergmann, Hanna; Pechloff, Konstanze; Petermann, Franziska; Jeltsch, Katharina M.; Rudelius, Martina; Kriegsmann, Mark; Weichert, Wilko; Horsch, Marion; Beckers, Johannes; Wurst, Wolfgang; Heikenwalder, Mathias; Korn, Thomas; Heissmeyer, Vigo; Ruland, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1292-1305</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The paracaspase Malt1 is a central regulator of antigen receptor signaling that is frequently mutated in human lymphoma.  As a scaffold, it assembles protein complexes for NF-κB activation, and its proteolytic domain cleaves neg. NF-κB regulators for signal enforcement.  Still, the physiol. functions of Malt1-protease are unknown.  We demonstrate that targeted Malt1-paracaspase inactivation induces a lethal inflammatory syndrome with lymphocyte-dependent neurodegeneration in vivo.  Paracaspase activity is essential for regulatory T cell (Treg) and innate-like B cell development, but it is largely dispensable for overcoming Malt1-dependent thresholds for lymphocyte activation.  In addn. to NF-κB inhibitors, Malt1 cleaves an entire set of mRNA stability regulators, including Roquin-1, Roquin-2, and Regnase-1, and paracaspase inactivation results in excessive interferon gamma (IFNγ) prodn. by effector lymphocytes that drive pathol.  Together, our results reveal distinct threshold and modulatory functions of Malt1 that differentially control lymphocyte differentiation and activation pathways and demonstrate that selective paracaspase blockage skews systemic immunity toward destructive autoinflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraV6ZMwtgwd7Vg90H21EOLACvtfcHk0ljSIWlbGx4pYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFGisbfL&md5=93d9fd5761dc85128a6c2a8460914cb7</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2014.10.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2014.10.044%26sid%3Dliteratum%253Aachs%26aulast%3DGewies%26aufirst%3DA.%26aulast%3DGorka%26aufirst%3DO.%26aulast%3DBergmann%26aufirst%3DH.%26aulast%3DPechloff%26aufirst%3DK.%26aulast%3DPetermann%26aufirst%3DF.%26aulast%3DJeltsch%26aufirst%3DK.%2BM.%26aulast%3DRudelius%26aufirst%3DM.%26aulast%3DKriegsmann%26aufirst%3DM.%26aulast%3DWeichert%26aufirst%3DW.%26aulast%3DHorsch%26aufirst%3DM.%26aulast%3DBeckers%26aufirst%3DJ.%26aulast%3DWurst%26aufirst%3DW.%26aulast%3DHeikenwalder%26aufirst%3DM.%26aulast%3DKorn%26aufirst%3DT.%26aulast%3DHeissmeyer%26aufirst%3DV.%26aulast%3DRuland%26aufirst%3DJ.%26atitle%3DUncoupling%2520Malt1%2520Threshold%2520Function%2520from%2520Paracaspase%2520Activity%2520Results%2520in%2520Destructive%2520Autoimmune%2520Inflammation%26jtitle%3DCell%2520Rep.%26date%3D2014%26volume%3D9%26spage%3D1292%26epage%3D1305%26doi%3D10.1016%2Fj.celrep.2014.10.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bornancin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renner, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Touil, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sic, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolb, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Touil-Allaoui, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rush, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, P. a.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigaud, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Junker-Walker, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burkhart, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niwa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katopodis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuesslein-Hildesheim, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weckbecker, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zenke, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinzel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traggiai, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenner, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brüstle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">St. Paul, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamurovic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rolink, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Régnier, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohashi, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calzascia, T.</span></span> <span> </span><span class="NLM_article-title">Deficiency of MALT1 Paracaspase Activity Results in Unbalanced Regulatory and Effector T and B Cell Responses Leading to Multiorgan Inflammation</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>194</i></span>,  <span class="NLM_fpage">3723</span>– <span class="NLM_lpage">3734</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.1402254</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.4049%2Fjimmunol.1402254" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=25762782" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlvVeisrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=194&publication_year=2015&pages=3723-3734&author=F.+Bornancinauthor=F.+Rennerauthor=R.+Touilauthor=H.+Sicauthor=Y.+Kolbauthor=I.+Touil-Allaouiauthor=J.+S.+Rushauthor=P.+a.+Smithauthor=M.+Bigaudauthor=U.+Junker-Walkerauthor=C.+Burkhartauthor=J.+Dawsonauthor=S.+Niwaauthor=A.+Katopodisauthor=B.+Nuesslein-Hildesheimauthor=G.+Weckbeckerauthor=G.+Zenkeauthor=B.+Kinzelauthor=E.+Traggiaiauthor=D.+Brennerauthor=A.+Br%C3%BCstleauthor=M.+St.+Paulauthor=N.+Zamurovicauthor=K.+D.+McCoyauthor=A.+Rolinkauthor=C.+H.+R%C3%A9gnierauthor=T.+W.+Makauthor=P.+S.+Ohashiauthor=D.+D.+Patelauthor=T.+Calzascia&title=Deficiency+of+MALT1+Paracaspase+Activity+Results+in+Unbalanced+Regulatory+and+Effector+T+and+B+Cell+Responses+Leading+to+Multiorgan+Inflammation&doi=10.4049%2Fjimmunol.1402254"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Deficiency of MALT1 Paracaspase Activity Results in Unbalanced Regulatory and Effector T and B Cell Responses Leading to Multiorgan Inflammation</span></div><div class="casAuthors">Bornancin, Frederic; Renner, Florian; Touil, Ratiba; Sic, Heiko; Kolb, Yeter; Touil-Allaoui, Ismahane; Rush, James S.; Smith, Paul A.; Bigaud, Marc; Junker-Walker, Ursula; Burkhart, Christoph; Dawson, Janet; Niwa, Satoru; Katopodis, Andreas; Nuesslein-Hildesheim, Barbara; Weckbecker, Gisbert; Zenke, Gerhard; Kinzel, Bernd; Traggiai, Elisabetta; Brenner, Dirk; Bruestle, Anne; St. Paul, Michael; Zamurovic, Natasa; McCoy, Kathy D.; Rolink, Antonius; Regnier, Catherine H.; Mak, Tak W.; Ohashi, Pamela S.; Patel, Dhavalkumar D.; Calzascia, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">194</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3723-3734</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">The paracaspase MALT1 plays an important role in immune receptor-driven signaling pathways leading to NF-κB activation.  MALT1 promotes signaling by acting as a scaffold, recruiting downstream signaling proteins, as well as by proteolytic cleavage of multiple substrates.  However, the relative contributions of these two different activities to T and B cell function are not well understood.  To investigate how MALT1 proteolytic activity contributes to overall immune cell regulation, we generated MALT1 protease-deficient mice (Malt1PD/PD) and compared their phenotype with that of MALT1 knockout animals (Malt1-/-).  Malt1PD/PD mice displayed defects in multiple cell types including marginal zone B cells, B1 B cells, IL-10-producing B cells, regulatory T cells, and mature T and B cells.  In general, immune defects were more pronounced in Malt1-/- animals.  Both mouse lines showed abrogated B cell responses upon immunization with T-dependent and T-independent Ags.  In vitro, inactivation of MALT1 protease activity caused reduced stimulation-induced T cell proliferation, impaired IL-2 and TNF-α prodn., as well as defective Th17 differentiation.  Consequently, Malt1PD/PD mice were protected in a Th17-dependent exptl. autoimmune encephalomyelitis model.  Surprisingly, Malt1PD/PD animals developed a multiorgan inflammatory pathol., characterized by Th1 and Th2/0 responses and enhanced IgG1 and IgE levels, which was delayed by wild-type regulatory T cell reconstitution.  We therefore propose that the pathol. characterizing Malt1PD/PD animals arises from an immune imbalance featuring pathogenic Th1- and Th2/0-skewed effector responses and reduced immunosuppressive compartments.  These data uncover a previously unappreciated key function of MALT1 protease activity in immune homeostasis and underline its relevance in human health and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8H9YU0RgmnbVg90H21EOLACvtfcHk0ljSIWlbGx4pYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlvVeisrc%253D&md5=8e16455eaab8d70f0fe8cf246aeb1edc</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1402254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1402254%26sid%3Dliteratum%253Aachs%26aulast%3DBornancin%26aufirst%3DF.%26aulast%3DRenner%26aufirst%3DF.%26aulast%3DTouil%26aufirst%3DR.%26aulast%3DSic%26aufirst%3DH.%26aulast%3DKolb%26aufirst%3DY.%26aulast%3DTouil-Allaoui%26aufirst%3DI.%26aulast%3DRush%26aufirst%3DJ.%2BS.%26aulast%3DSmith%26aufirst%3DP.%2Ba.%26aulast%3DBigaud%26aufirst%3DM.%26aulast%3DJunker-Walker%26aufirst%3DU.%26aulast%3DBurkhart%26aufirst%3DC.%26aulast%3DDawson%26aufirst%3DJ.%26aulast%3DNiwa%26aufirst%3DS.%26aulast%3DKatopodis%26aufirst%3DA.%26aulast%3DNuesslein-Hildesheim%26aufirst%3DB.%26aulast%3DWeckbecker%26aufirst%3DG.%26aulast%3DZenke%26aufirst%3DG.%26aulast%3DKinzel%26aufirst%3DB.%26aulast%3DTraggiai%26aufirst%3DE.%26aulast%3DBrenner%26aufirst%3DD.%26aulast%3DBr%25C3%25BCstle%26aufirst%3DA.%26aulast%3DSt.%2BPaul%26aufirst%3DM.%26aulast%3DZamurovic%26aufirst%3DN.%26aulast%3DMcCoy%26aufirst%3DK.%2BD.%26aulast%3DRolink%26aufirst%3DA.%26aulast%3DR%25C3%25A9gnier%26aufirst%3DC.%2BH.%26aulast%3DMak%26aufirst%3DT.%2BW.%26aulast%3DOhashi%26aufirst%3DP.%2BS.%26aulast%3DPatel%26aufirst%3DD.%2BD.%26aulast%3DCalzascia%26aufirst%3DT.%26atitle%3DDeficiency%2520of%2520MALT1%2520Paracaspase%2520Activity%2520Results%2520in%2520Unbalanced%2520Regulatory%2520and%2520Effector%2520T%2520and%2520B%2520Cell%2520Responses%2520Leading%2520to%2520Multiorgan%2520Inflammation%26jtitle%3DJ.%2520Immunol.%26date%3D2015%26volume%3D194%26spage%3D3723%26epage%3D3734%26doi%3D10.4049%2Fjimmunol.1402254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beal, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dykon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ringenberg, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dare, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparcova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rickard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramanjulu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emery, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gough, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foley, K. P.</span></span> <span> </span><span class="NLM_article-title">MALT1 Protease Activity Is Required for Innate and Adaptive Immune Responses</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>, <span class="NLM_elocation-id">e0127083</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0127083</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1371%2Fjournal.pone.0127083" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=25965667" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslSju7jL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&author=J.+W.+Yuauthor=S.+Hoffmanauthor=A.+M.+Bealauthor=A.+Dykonauthor=M.+A.+Ringenbergauthor=A.+C.+Hughesauthor=L.+Dareauthor=A.+D.+Andersonauthor=J.+Fingerauthor=V.+Kasparcovaauthor=D.+Rickardauthor=S.+B.+Bergerauthor=J.+Ramanjuluauthor=J.+G.+Emeryauthor=P.+J.+Goughauthor=J.+Bertinauthor=K.+P.+Foley&title=MALT1+Protease+Activity+Is+Required+for+Innate+and+Adaptive+Immune+Responses&doi=10.1371%2Fjournal.pone.0127083"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">MALT1 protease activity is required for innate and adaptive immune responses</span></div><div class="casAuthors">Yu, Jong W.; Hoffman, Sandy; Beal, Allison M.; Dykon, Angela; Ringenberg, Michael A.; Hughes, Anna C.; Dare, Lauren; Anderson, Amber D.; Finger, Joshua; Kasparcova, Viera; Rickard, David; Berger, Scott B.; Ramanjulu, Joshi; Emery, John G.; Gough, Peter J.; Bertin, John; Foley, Kevin P.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e0127083/1-e0127083/20</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">CARMA-BCL10-MALT1 signalosomes play important roles in antigen receptor signaling and other pathways.  Previous studies have suggested that as part of this complex, MALT1 functions as both a scaffolding protein to activate NF-κB through recruitment of ubiquitin ligases, and as a protease to cleave and inactivate downstream inhibitory signaling proteins.  However, our understanding of the relative importance of these two distinct MALT1 activities has been hampered by a lack of selective MALT1 protease inhibitors with suitable pharmacol. properties.  To fully investigate the role of MALT1 protease activity, we generated mice homozygous for a protease-dead mutation in MALT1.  We found that some, but not all, MALT1 functions in immune cells were dependent upon its protease activity.  Protease-dead mice had defects in the generation of splenic marginal zone and peritoneal B1 B cells.  CD4+ and CD8+ T cells displayed decreased T cell receptor-stimulated proliferation and IL-2 prodn. while B cell receptor-stimulated proliferation was partially dependent on protease activity.  In dendritic cells, stimulation of cytokine prodn. through the Dectin-1, Dectin-2, and Mincle C-type lectin receptors was also found to be partially dependent upon protease activity.  In vivo, protease-dead mice had reduced basal Ig levels, and showed defective responses to immunization with T-dependent and T-independent antigens.  Surprisingly, despite these decreased responses, MALT1 protease-dead mice, but not MALT1 null mice, developed mixed inflammatory cell infiltrates in multiple organs, suggesting MALT1 protease activity plays a role in immune homeostasis.  These findings highlight the importance of MALT1 protease activity in multiple immune cell types, and in integrating immune responses in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmQwkA_jqS2LVg90H21EOLACvtfcHk0ljSIWlbGx4pYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslSju7jL&md5=1ace6e08be2bbbcdc819e48201f968a5</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0127083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0127083%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DJ.%2BW.%26aulast%3DHoffman%26aufirst%3DS.%26aulast%3DBeal%26aufirst%3DA.%2BM.%26aulast%3DDykon%26aufirst%3DA.%26aulast%3DRingenberg%26aufirst%3DM.%2BA.%26aulast%3DHughes%26aufirst%3DA.%2BC.%26aulast%3DDare%26aufirst%3DL.%26aulast%3DAnderson%26aufirst%3DA.%2BD.%26aulast%3DFinger%26aufirst%3DJ.%26aulast%3DKasparcova%26aufirst%3DV.%26aulast%3DRickard%26aufirst%3DD.%26aulast%3DBerger%26aufirst%3DS.%2BB.%26aulast%3DRamanjulu%26aufirst%3DJ.%26aulast%3DEmery%26aufirst%3DJ.%2BG.%26aulast%3DGough%26aufirst%3DP.%2BJ.%26aulast%3DBertin%26aufirst%3DJ.%26aulast%3DFoley%26aufirst%3DK.%2BP.%26atitle%3DMALT1%2520Protease%2520Activity%2520Is%2520Required%2520for%2520Innate%2520and%2520Adaptive%2520Immune%2520Responses%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26doi%3D10.1371%2Fjournal.pone.0127083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gilis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaublomme, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venken, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhaenens, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambrecht, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coudenys, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decruy, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schryvers, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Driege, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumas, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demeyer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Muynck, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hengel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Hoorebeke, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deforce, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beyaert, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elewaut, D.</span></span> <span> </span><span class="NLM_article-title">Deletion of Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1 in Mouse T Cells Protects Against Development of Autoimmune Arthritis but Leads to Spontaneous Osteoporosis</span>. <i>Arthritis Rheumatol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">2005</span>, <span class="refDoi"> DOI: 10.1002/art.41029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1002%2Fart.41029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=31259485" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVyitb%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2019&pages=2005&author=E.+Gilisauthor=D.+Gaublommeauthor=J.+Staalauthor=K.+Venkenauthor=M.+Dhaenensauthor=S.+Lambrechtauthor=J.+Coudenysauthor=T.+Decruyauthor=N.+Schryversauthor=Y.+Driegeauthor=E.+Dumasauthor=A.+Demeyerauthor=A.+De+Muynckauthor=J.+Hengelauthor=L.+Van+Hoorebekeauthor=D.+Deforceauthor=R.+Beyaertauthor=D.+Elewaut&title=Deletion+of+Mucosa-Associated+Lymphoid+Tissue+Lymphoma+Translocation+Protein+1+in+Mouse+T+Cells+Protects+Against+Development+of+Autoimmune+Arthritis+but+Leads+to+Spontaneous+Osteoporosis&doi=10.1002%2Fart.41029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Deletion of Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1 in Mouse T Cells Protects Against Development of Autoimmune Arthritis but Leads to Spontaneous Osteoporosis</span></div><div class="casAuthors">Gilis, Elisabeth; Gaublomme, Djoere; Staal, Jens; Venken, Koen; Dhaenens, Maarten; Lambrecht, Stijn; Coudenys, Julie; Decruy, Tine; Schryvers, Nadia; Driege, Yasmine; Dumas, Emilie; Demeyer, Annelies; De Muynck, Amelie; van Hengel, Jolanda; Van Hoorebeke, Luc; Deforce, Dieter; Beyaert, Rudi; Elewaut, Dirk</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2005-2015</span>CODEN:
                <span class="NLM_cas:coden">ARRHBO</span>;
        ISSN:<span class="NLM_cas:issn">2326-5191</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The goal of this study was to examine the role of MALT-1 in exptl. animal models of rheumatoid arthritis (RA).  Methods : MALT-1 activation was assessed by measuring cleavage of the deubiquitinase CYLD in lymphocytes from mice with collagen-induced arthritis (CIA).  Furthermore, the impact of MALT-1 deficiency on arthritis was evaluated in Malt1KO mice with CIA or with collagen antibody-induced arthritis (CAIA).  Results : MALT-1 activation was obsd. in the lymphocytes of mice with CIA.  T cell-specific MALT-1 deletion in the induction phase of arthritis (incidence of arthritis, 25% in control mice vs. 0% in Malt1iTcellKO mice; P < 0.05), but not in the effector phase of arthritis, completely protected mice against the development of CIA.  Consistent with this finding, MALT-1 deficiency had no impact on CAIA, an effector phase model of RA.  Finally, mice with MALT-1 deficiency showed a spontaneous decrease in bone d. (mean ± SEM trabecular thickness, 46.3 ± 0.7 μm in control mice vs. 40 ± 1.1 μm in Malt1KO mice; P < 0.001), which was linked to the loss of Treg cells in these mice.  Conclusion : Overall, these data in murine models of RA highlight MALT-1 as a master regulator of T cell activation, which is relevant to the pathogenesis of autoimmune arthritis.  Furthermore, these findings show that MALT-1 deficiency can lead to spontaneous osteoporosis, which is assocd. with impaired Treg cell nos.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWvo9m2tRVdrVg90H21EOLACvtfcHk0linkFXVfWiqSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVyitb%252FF&md5=d2f1d9fd8349d03f48f173c83eaac4c5</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1002%2Fart.41029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.41029%26sid%3Dliteratum%253Aachs%26aulast%3DGilis%26aufirst%3DE.%26aulast%3DGaublomme%26aufirst%3DD.%26aulast%3DStaal%26aufirst%3DJ.%26aulast%3DVenken%26aufirst%3DK.%26aulast%3DDhaenens%26aufirst%3DM.%26aulast%3DLambrecht%26aufirst%3DS.%26aulast%3DCoudenys%26aufirst%3DJ.%26aulast%3DDecruy%26aufirst%3DT.%26aulast%3DSchryvers%26aufirst%3DN.%26aulast%3DDriege%26aufirst%3DY.%26aulast%3DDumas%26aufirst%3DE.%26aulast%3DDemeyer%26aufirst%3DA.%26aulast%3DDe%2BMuynck%26aufirst%3DA.%26aulast%3DHengel%26aufirst%3DJ.%26aulast%3DVan%2BHoorebeke%26aufirst%3DL.%26aulast%3DDeforce%26aufirst%3DD.%26aulast%3DBeyaert%26aufirst%3DR.%26aulast%3DElewaut%26aufirst%3DD.%26atitle%3DDeletion%2520of%2520Mucosa-Associated%2520Lymphoid%2520Tissue%2520Lymphoma%2520Translocation%2520Protein%25201%2520in%2520Mouse%2520T%2520Cells%2520Protects%2520Against%2520Development%2520of%2520Autoimmune%2520Arthritis%2520but%2520Leads%2520to%2520Spontaneous%2520Osteoporosis%26jtitle%3DArthritis%2520Rheumatol.%26date%3D2019%26volume%3D71%26spage%3D2005%26doi%3D10.1002%2Fart.41029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span> <span> </span><span class="NLM_article-title">Malt1 Protease Is Critical in Maintaining Function of Regulatory T Cells and May Be a Therapeutic Target for Antitumor Immunity</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>202</i></span>,  <span class="NLM_fpage">3008</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.1801614</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.4049%2Fjimmunol.1801614" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=30979818" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC1MXpvF2nsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=202&publication_year=2019&pages=3008&author=L.+Chengauthor=N.+Dengauthor=N.+Yangauthor=X.+Zhaoauthor=X.+Lin&title=Malt1+Protease+Is+Critical+in+Maintaining+Function+of+Regulatory+T+Cells+and+May+Be+a+Therapeutic+Target+for+Antitumor+Immunity&doi=10.4049%2Fjimmunol.1801614"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Malt1 protease is critical in maintaining function of regulatory T cells and may be a therapeutic target for antitumor immunity</span></div><div class="casAuthors">Cheng, Liqing; Deng, Nan; Yang, Naixue; Zhao, Xueqiang; Lin, Xin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">202</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3008-3019</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">The paracaspase Malt1 is a key mol. in mediating Ag receptor-induced NF-κB activation in lymphocytes, but the role of Malt1 in the function of regulatory T (Treg) cells is still unclear.  In this article, we reported that specific deletion of Malt1 in Treg cells would lead to Scurfy-like lethal autoimmune disease, which was caused by Treg cell dysfunction but not no. loss.  Interestingly, Foxp3CreMalt1fl/C472A mice, in which Malt1 protease was specifically inactivated in Treg cells, also displayed spontaneous inflammatory disorders, with severe hair loss and skin hyperplasia.  Consistently, Foxp3CreMalt1fl/C472A mice showed enhanced antitumor response because of their decreased function and infiltration of Treg cells, as well as reduced CD8+ T cell exhaustion.  Gene expression profiling anal. revealed dysregulated expression pattern of Treg effector genes upon Malt1 deletion or its protease inactivation.  Together, our data unraveled a crit. role of Malt1, esp. its protease activity, in maintaining homeostasis and function of Treg cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyuNixqJyx5LVg90H21EOLACvtfcHk0linkFXVfWiqSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXpvF2nsbs%253D&md5=d241d288a6a191e6243e8669726138e6</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1801614&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1801614%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DL.%26aulast%3DDeng%26aufirst%3DN.%26aulast%3DYang%26aufirst%3DN.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DLin%26aufirst%3DX.%26atitle%3DMalt1%2520Protease%2520Is%2520Critical%2520in%2520Maintaining%2520Function%2520of%2520Regulatory%2520T%2520Cells%2520and%2520May%2520Be%2520a%2520Therapeutic%2520Target%2520for%2520Antitumor%2520Immunity%26jtitle%3DJ.%2520Immunol.%26date%3D2019%26volume%3D202%26spage%3D3008%26doi%3D10.4049%2Fjimmunol.1801614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di
Pilato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cadilha, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prüßmann, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nasrallah, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seruggia, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Usmani, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misale, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zappulli, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrizosa, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mani, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligorio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warner, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medoff, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marangoni, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villani, A.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mempel, T. R.</span></span> <span> </span><span class="NLM_article-title">Targeting the CBM Complex Causes Treg Cells to Prime Tumours for Immune Checkpoint Therapy</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>570</i></span>,  <span class="NLM_fpage">112</span>, <span class="refDoi"> DOI: 10.1038/s41586-019-1215-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1038%2Fs41586-019-1215-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=31092922" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC1MXpslGmurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=570&publication_year=2019&pages=112&author=M.+Di%0APilatoauthor=E.+Y.+Kimauthor=B.+L.+Cadilhaauthor=J.+N.+Pr%C3%BC%C3%9Fmannauthor=M.+N.+Nasrallahauthor=D.+Seruggiaauthor=S.+M.+Usmaniauthor=S.+Misaleauthor=V.+Zappulliauthor=E.+Carrizosaauthor=V.+Maniauthor=M.+Ligorioauthor=R.+D.+Warnerauthor=B.+D.+Medoffauthor=F.+Marangoniauthor=A.-C.+Villaniauthor=T.+R.+Mempel&title=Targeting+the+CBM+Complex+Causes+Treg+Cells+to+Prime+Tumours+for+Immune+Checkpoint+Therapy&doi=10.1038%2Fs41586-019-1215-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the CBM complex causes Treg cells to prime tumours for immune checkpoint therapy</span></div><div class="casAuthors">Di Pilato, Mauro; Kim, Edward Y.; Cadilha, Bruno L.; Prussmann, Jasper N.; Nasrallah, Mazen N.; Seruggia, Davide; Usmani, Shariq M.; Misale, Sandra; Zappulli, Valentina; Carrizosa, Esteban; Mani, Vinidhra; Ligorio, Matteo; Warner, Ross D.; Medoff, Benjamin D.; Marangoni, Francesco; Villani, Alexandra-Chloe; Mempel, Thorsten R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">570</span>
        (<span class="NLM_cas:issue">7759</span>),
    <span class="NLM_cas:pages">112-116</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Solid tumors are infiltrated by effector T cells with the potential to control or reject them, as well as by regulatory T (Treg) cells that restrict the function of effector T cells and thereby promote tumor growth.  The anti-tumor activity of effector T cells can be therapeutically unleashed, and is now being exploited for the treatment of some forms of human cancer.  However, weak tumor-assocd. inflammatory responses and the immune-suppressive function of Treg cells remain major hurdles to broader effectiveness of tumor immunotherapy.  Here we show that, after disruption of the CARMA1-BCL10-MALT1 (CBM) signalosome complex, most tumor-infiltrating Treg cells produce IFNγ, resulting in stunted tumor growth.  Notably, genetic deletion of both or even just one allele of CARMA1 (also known as Card11) in only a fraction of Treg cells-which avoided systemic autoimmunity-was sufficient to produce this anti-tumor effect, showing that it is not the mere loss of suppressive function but the gain of effector activity by Treg cells that initiates tumor control.  The prodn. of IFNγ by Treg cells was accompanied by activation of macrophages and upregulation of class I mols. of the major histocompatibility complex on tumor cells.  However, tumor cells also upregulated the expression of PD-L1, which indicates activation of adaptive immune resistance.  Consequently, blockade of PD-1 together with CARMA1 deletion caused rejection of tumors that otherwise do not respond to anti-PD-1 monotherapy.  This effect was reproduced by pharmacol. inhibition of the CBM protein MALT1.  Our results demonstrate that partial disruption of the CBM complex and induction of IFNγ secretion in the preferentially self-reactive Treg cell pool does not cause systemic autoimmunity but is sufficient to prime the tumor environment for successful immune checkpoint therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkZEjWA3fkAbVg90H21EOLACvtfcHk0ljHMbF8wzPt0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXpslGmurk%253D&md5=b451aabc0fc7c55c3a0796850e500485</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fs41586-019-1215-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-019-1215-2%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BPilato%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DE.%2BY.%26aulast%3DCadilha%26aufirst%3DB.%2BL.%26aulast%3DPr%25C3%25BC%25C3%259Fmann%26aufirst%3DJ.%2BN.%26aulast%3DNasrallah%26aufirst%3DM.%2BN.%26aulast%3DSeruggia%26aufirst%3DD.%26aulast%3DUsmani%26aufirst%3DS.%2BM.%26aulast%3DMisale%26aufirst%3DS.%26aulast%3DZappulli%26aufirst%3DV.%26aulast%3DCarrizosa%26aufirst%3DE.%26aulast%3DMani%26aufirst%3DV.%26aulast%3DLigorio%26aufirst%3DM.%26aulast%3DWarner%26aufirst%3DR.%2BD.%26aulast%3DMedoff%26aufirst%3DB.%2BD.%26aulast%3DMarangoni%26aufirst%3DF.%26aulast%3DVillani%26aufirst%3DA.-C.%26aulast%3DMempel%26aufirst%3DT.%2BR.%26atitle%3DTargeting%2520the%2520CBM%2520Complex%2520Causes%2520Treg%2520Cells%2520to%2520Prime%2520Tumours%2520for%2520Immune%2520Checkpoint%2520Therapy%26jtitle%3DNature%26date%3D2019%26volume%3D570%26spage%3D112%26doi%3D10.1038%2Fs41586-019-1215-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rebeaud, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hailfinger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Posevitz-Fejfar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tapernoux, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moser, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rueda, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaide, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzzardi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iancu, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rufer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fasel, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thome, M.</span></span> <span> </span><span class="NLM_article-title">The Proteolytic Activity of the Paracaspase MALT1 Is Key in T Cell Activation</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">272</span>– <span class="NLM_lpage">281</span>, <span class="refDoi"> DOI: 10.1038/ni1568</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1038%2Fni1568" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=18264101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitVOjt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=272-281&author=F.+Rebeaudauthor=S.+Hailfingerauthor=A.+Posevitz-Fejfarauthor=M.+Tapernouxauthor=R.+Moserauthor=D.+Ruedaauthor=O.+Gaideauthor=M.+Guzzardiauthor=E.+M.+Iancuauthor=N.+Ruferauthor=N.+Faselauthor=M.+Thome&title=The+Proteolytic+Activity+of+the+Paracaspase+MALT1+Is+Key+in+T+Cell+Activation&doi=10.1038%2Fni1568"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The proteolytic activity of the paracaspase MALT1 is key in T cell activation</span></div><div class="casAuthors">Rebeaud, Fabien; Hailfinger, Stephan; Posevitz-Fejfar, Anita; Tapernoux, Myriam; Moser, Roger; Rueda, Daniel; Gaide, Olivier; Guzzardi, Montserrat; Iancu, Emanuela M.; Rufer, Nathalie; Fasel, Nicolas; Thome, Margot</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">272-281</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The paracaspase MALT1 is pivotal in antigen receptor-mediated lymphocyte activation and lymphomagenesis.  MALT1 contains a caspase-like domain, but it is unknown whether this domain is proteolytically active.  Here the authors report that MALT1 had arginine-directed proteolytic activity that was activated after T cell stimulation, and they identify the signaling protein Bcl-10 as a MALT1 substrate.  Processing of Bcl-10 after Arg228 was required for T cell receptor-induced cell adhesion to fibronectin.  In contrast, MALT1 activity but not Bcl-10 cleavage was essential for optimal activation of transcription factor NF-κB and prodn. of interleukin 2.  Thus, the proteolytic activity of MALT1 is central to T cell activation, which suggests a possible target for the development of immunomodulatory or anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2kTzBRxfMGLVg90H21EOLACvtfcHk0ljbMl6Da_FtSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitVOjt7w%253D&md5=094b1afc1f65e8a21846b095129df581</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fni1568&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni1568%26sid%3Dliteratum%253Aachs%26aulast%3DRebeaud%26aufirst%3DF.%26aulast%3DHailfinger%26aufirst%3DS.%26aulast%3DPosevitz-Fejfar%26aufirst%3DA.%26aulast%3DTapernoux%26aufirst%3DM.%26aulast%3DMoser%26aufirst%3DR.%26aulast%3DRueda%26aufirst%3DD.%26aulast%3DGaide%26aufirst%3DO.%26aulast%3DGuzzardi%26aufirst%3DM.%26aulast%3DIancu%26aufirst%3DE.%2BM.%26aulast%3DRufer%26aufirst%3DN.%26aulast%3DFasel%26aufirst%3DN.%26aulast%3DThome%26aufirst%3DM.%26atitle%3DThe%2520Proteolytic%2520Activity%2520of%2520the%2520Paracaspase%2520MALT1%2520Is%2520Key%2520in%2520T%2520Cell%2520Activation%26jtitle%3DNat.%2520Immunol.%26date%3D2008%26volume%3D9%26spage%3D272%26epage%3D281%26doi%3D10.1038%2Fni1568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fontan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kabaleeswaran, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volpon, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osborne, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beltran, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerchietti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaknovich, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gascoyne, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Climent, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glickman, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borden, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melnick, A.</span></span> <span> </span><span class="NLM_article-title">MALT1 Small Molecule Inhibitors Specifically Suppress ABC-DLBCL In Vitro and In Vivo</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">812</span>– <span class="NLM_lpage">824</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2012.11.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1016%2Fj.ccr.2012.11.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=23238016" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVWgu7fJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=812-824&author=L.+Fontanauthor=C.+Yangauthor=V.+Kabaleeswaranauthor=L.+Volponauthor=M.+J.+Osborneauthor=E.+Beltranauthor=M.+Garciaauthor=L.+Cerchiettiauthor=R.+Shaknovichauthor=S.+N.+Yangauthor=F.+Fangauthor=R.+D.+Gascoyneauthor=J.+A.+Martinez-Climentauthor=J.+F.+Glickmanauthor=K.+Bordenauthor=H.+Wuauthor=A.+Melnick&title=MALT1+Small+Molecule+Inhibitors+Specifically+Suppress+ABC-DLBCL+In+Vitro+and+In+Vivo&doi=10.1016%2Fj.ccr.2012.11.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">MALT1 Small Molecule Inhibitors Specifically Suppress ABC-DLBCL In Vitro and In Vivo</span></div><div class="casAuthors">Fontan, Lorena; Yang, Chenghua; Kabaleeswaran, Venkataraman; Volpon, Laurent; Osborne, Michael J.; Beltran, Elena; Garcia, Monica; Cerchietti, Leandro; Shaknovich, Rita; Yang, Shao Ning; Fang, Fang; Gascoyne, Randy D.; Martinez-Climent, Jose Angel; Glickman, J. Fraser; Borden, Katherine; Wu, Hao; Melnick, Ari</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">812-824</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">MALT1 cleavage activity is linked to the pathogenesis of activated B cell-like diffuse large B cell lymphoma (ABC-DLBCL), a chemoresistant form of DLBCL.  We developed a MALT1 activity assay and identified chem. diverse MALT1 inhibitors.  A selected lead compd., MI-2, featured direct binding to MALT1 and suppression of its protease function.  MI-2 concd. within human ABC-DLBCL cells and irreversibly inhibited cleavage of MALT1 substrates.  This was accompanied by NF-κB reporter activity suppression, c-REL nuclear localization inhibition, and NF-κB target gene downregulation.  Most notably, MI-2 was nontoxic to mice, and displayed selective activity against ABC-DLBCL cell lines in vitro and xenotransplanted ABC-DLBCL tumors in vivo.  The compd. was also effective against primary human non-germinal center B cell-like DLBCLs ex vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7Pj5xKzCfyrVg90H21EOLACvtfcHk0ljbMl6Da_FtSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVWgu7fJ&md5=f8a19df22430725336d5620b4ccb269a</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2012.11.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2012.11.003%26sid%3Dliteratum%253Aachs%26aulast%3DFontan%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DKabaleeswaran%26aufirst%3DV.%26aulast%3DVolpon%26aufirst%3DL.%26aulast%3DOsborne%26aufirst%3DM.%2BJ.%26aulast%3DBeltran%26aufirst%3DE.%26aulast%3DGarcia%26aufirst%3DM.%26aulast%3DCerchietti%26aufirst%3DL.%26aulast%3DShaknovich%26aufirst%3DR.%26aulast%3DYang%26aufirst%3DS.%2BN.%26aulast%3DFang%26aufirst%3DF.%26aulast%3DGascoyne%26aufirst%3DR.%2BD.%26aulast%3DMartinez-Climent%26aufirst%3DJ.%2BA.%26aulast%3DGlickman%26aufirst%3DJ.%2BF.%26aulast%3DBorden%26aufirst%3DK.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DMelnick%26aufirst%3DA.%26atitle%3DMALT1%2520Small%2520Molecule%2520Inhibitors%2520Specifically%2520Suppress%2520ABC-DLBCL%2520In%2520Vitro%2520and%2520In%2520Vivo%26jtitle%3DCancer%2520Cell%26date%3D2012%26volume%3D22%26spage%3D812%26epage%3D824%26doi%3D10.1016%2Fj.ccr.2012.11.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Structure–Activity Relationship Studies of MI-2 Analogues as MALT1 Inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">3321</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2018.04.059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1016%2Fj.bmc.2018.04.059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=29751989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC1cXptFCltrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&pages=3321&author=G.+Wuauthor=H.+Wangauthor=W.+Zhouauthor=B.+Zengauthor=W.+Moauthor=K.+Zhuauthor=R.+Liuauthor=J.+Zhouauthor=C.+Chenauthor=H.+Chen&title=Synthesis+and+Structure%E2%80%93Activity+Relationship+Studies+of+MI-2+Analogues+as+MALT1+Inhibitors&doi=10.1016%2Fj.bmc.2018.04.059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and structure-activity relationship studies of MI-2 analogues as MALT1 inhibitors</span></div><div class="casAuthors">Wu, Guolin; Wang, Haixia; Zhou, Wenhui; Zeng, Bihua; Mo, Wenhui; Zhu, Kejie; Liu, Rong; Zhou, Jia; Chen, Ceshi; Chen, Haijun</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3321-3344</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Recent studies revealed that MALT1 is a promising therapeutic target for the treatment of ABC-DLBCL.  Among several reported MALT1 inhibitors, MI-2 as an irreversible inhibitor represents a new class of ABC-DLBCL therapeutics.  Due to its inherent potential cross-reactivity, further structure-activity relationship (SAR) study is imperative.  Five focused compd. libraries based on the chem. structure of MI-2 are designed and synthesized.  The systematic SARs revealed that the side chain of 2-methoxyethoxy has little impact on the activity and can be replaced by other functionalized groups, providing new MI-2 analogs with retained or enhanced potency.  Compds. 81-83 with terminal hydroxyl group as side chain displayed enhanced activities against MALT1.  Replacement of triazole core with pyrazole is also tolerant, while structural modifications on other sites are detrimental.  These findings will facilitate further development of small-mol. MALT1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoE4dy_rlsztrVg90H21EOLACvtfcHk0ljbMl6Da_FtSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXptFCltrY%253D&md5=23d5f61b7b4a1df514f98192a7a2766e</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2018.04.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2018.04.059%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DZeng%26aufirst%3DB.%26aulast%3DMo%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DH.%26atitle%3DSynthesis%2520and%2520Structure%25E2%2580%2593Activity%2520Relationship%2520Studies%2520of%2520MI-2%2520Analogues%2520as%2520MALT1%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2018%26volume%3D26%26spage%3D3321%26doi%3D10.1016%2Fj.bmc.2018.04.059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xin, B.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schimmack, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Florea, B. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der
Marel, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Driessen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krappmann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overkleeft, H. S.</span></span> <span> </span><span class="NLM_article-title">Development of New Malt1 Inhibitors and Probes</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">3312</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.03.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1016%2Fj.bmc.2016.03.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=27085674" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC28XmtVarsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=3312&author=B.-T.+Xinauthor=G.+Schimmackauthor=Y.+Duauthor=B.+I.+Floreaauthor=G.+A.+van+der%0AMarelauthor=C.+Driessenauthor=D.+Krappmannauthor=H.+S.+Overkleeft&title=Development+of+New+Malt1+Inhibitors+and+Probes&doi=10.1016%2Fj.bmc.2016.03.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Development of new Malt1 inhibitors and probes</span></div><div class="casAuthors">Xin, Bo-Tao; Schimmack, Gisela; Du, Yimeng; Florea, Bogdan I.; van der Marel, Gijsbert A.; Driessen, Christoph; Krappmann, Daniel; Overkleeft, Herman S.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3312-3329</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Mucosa-assocd. lymphoid tissue lymphoma translocation protein 1 (Malt1) is a promising therapeutic target for the treatment of activated B cell-like diffuse large B cell lymphoma (ABC-DLBCL).  Several research groups have reported on the development of Malt1 inhibitors and activity-based probes for in vitro and in situ monitoring and modulating Malt1 activity.  In this paper, the authors report on two activity-based Malt1 probes (I and II) and a focused library of 19 new Malt1 inhibitors.  The peptide-based probe I labels Malt1 in an activity-based manner.  In contrast, probe II, derived from the known covalent inhibitor MI-2, labels both wild type and catalytically inactive Cys to Ala mutant Malt1, suggesting that MI-2 inhibits Malt1 by reacting with a nucleophilic residue other than the active site cysteine.  Furthermore, two of the inhibitors (apparent IC50 3.0 μM and 2.1 μM) show good inhibitory activity against Malt1 and outperform MI-2 (apparent IC50 7.8 μM) in the competitive activity-based protein profiling assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfe_IulKpl8rVg90H21EOLACvtfcHk0lhFekhsgdSbtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmtVarsbs%253D&md5=09a86fc564cd2a438e3bcd612caa331f</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.03.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.03.035%26sid%3Dliteratum%253Aachs%26aulast%3DXin%26aufirst%3DB.-T.%26aulast%3DSchimmack%26aufirst%3DG.%26aulast%3DDu%26aufirst%3DY.%26aulast%3DFlorea%26aufirst%3DB.%2BI.%26aulast%3Dvan%2Bder%2BMarel%26aufirst%3DG.%2BA.%26aulast%3DDriessen%26aufirst%3DC.%26aulast%3DKrappmann%26aufirst%3DD.%26aulast%3DOverkleeft%26aufirst%3DH.%2BS.%26atitle%3DDevelopment%2520of%2520New%2520Malt1%2520Inhibitors%2520and%2520Probes%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D3312%26doi%3D10.1016%2Fj.bmc.2016.03.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lim, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Im, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tae, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, S.</span></span> <span> </span><span class="NLM_article-title">Identification of β-Lapachone Analogs as Novel MALT1 Inhibitors to Treat an Aggressive Subtype of Diffuse Large B-Cell Lymphoma</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">8491</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01415</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01415" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslWltrjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8491&author=S.+M.+Limauthor=Y.+Jeongauthor=S.+Leeauthor=H.+Imauthor=H.+S.+Taeauthor=B.+G.+Kimauthor=H.+D.+Parkauthor=J.+Parkauthor=S.+Hong&title=Identification+of+%CE%B2-Lapachone+Analogs+as+Novel+MALT1+Inhibitors+to+Treat+an+Aggressive+Subtype+of+Diffuse+Large+B-Cell+Lymphoma&doi=10.1021%2Facs.jmedchem.5b01415"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of β-Lapachone Analogs as Novel MALT1 Inhibitors To Treat an Aggressive Subtype of Diffuse Large B-Cell Lymphoma</span></div><div class="casAuthors">Lim, Sang Min; Jeong, Yujeong; Lee, Suhyun; Im, Honggu; Tae, Hyun Seop; Kim, Byung Gyu; Park, Hee Dong; Park, Jonghoon; Hong, Sungwoo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8491-8502</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The treatment of activated B cell-like DLBCL (ABC-DLBCL) is one of the urgent unmet medical needs because it is the most resistant DLBCL subtype to current therapies eagerly awaiting effective therapeutic strategies.  Recently, the paracaspase MALT1 has emerged as a promising therapeutic target for the treatment of ABC-DLBCL.  Herein, the authors report a new class of MALT1 inhibitors developed by high-throughput screening and structure-based drug design.  The original hit, 4-amino-1,2-naphthoquinone series inhibited MALT1 activity but suffered from poor cellular activity.  The extensive pharmacophore search led to the discovery of structurally similar β-lapachone that is a direct inhibitor of MALT1 and possesses favorable physicochem. properties.  Mol. simulation studies suggested the possibility of the formation of a covalent bond between MALT1 and β-lapachone, which was corroborated by exptl. wash-out studies.  Inspired by this, the authors explored the structure-activity relationships by incorporating electron-withdrawing substituents at C8 position of β-lapachone.  These MALT1 inhibitors exhibited potent antiproliferative activity to OCI-LY3 cell line and inhibited the cleavage of CYLD mediated MALT1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8L_xlzorpZLVg90H21EOLACvtfcHk0lhFekhsgdSbtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslWltrjI&md5=d02db14d98441839fe908f53c14fa071</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01415%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DS.%2BM.%26aulast%3DJeong%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DIm%26aufirst%3DH.%26aulast%3DTae%26aufirst%3DH.%2BS.%26aulast%3DKim%26aufirst%3DB.%2BG.%26aulast%3DPark%26aufirst%3DH.%2BD.%26aulast%3DPark%26aufirst%3DJ.%26aulast%3DHong%26aufirst%3DS.%26atitle%3DIdentification%2520of%2520%25CE%25B2-Lapachone%2520Analogs%2520as%2520Novel%2520MALT1%2520Inhibitors%2520to%2520Treat%2520an%2520Aggressive%2520Subtype%2520of%2520Diffuse%2520Large%2520B-Cell%2520Lymphoma%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8491%26doi%3D10.1021%2Facs.jmedchem.5b01415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nagel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spranger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincendeau, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grau, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raffegerst, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kloo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hlahla, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuenschwander, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peter von Kries, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hadian, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dörken, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schendel, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krappmann, D.</span></span> <span> </span><span class="NLM_article-title">Pharmacologic Inhibition of MALT1 Protease by Phenothiazines as a Therapeutic Approach for the Treatment of Aggressive ABC-DLBCL</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">825</span>– <span class="NLM_lpage">837</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2012.11.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1016%2Fj.ccr.2012.11.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=23238017" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVWns77J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=825-837&author=D.+Nagelauthor=S.+Sprangerauthor=M.+Vincendeauauthor=M.+Grauauthor=S.+Raffegerstauthor=B.+Klooauthor=D.+Hlahlaauthor=M.+Neuenschwanderauthor=J.+Peter+von+Kriesauthor=K.+Hadianauthor=B.+D%C3%B6rkenauthor=P.+Lenzauthor=G.+Lenzauthor=D.+J.+Schendelauthor=D.+Krappmann&title=Pharmacologic+Inhibition+of+MALT1+Protease+by+Phenothiazines+as+a+Therapeutic+Approach+for+the+Treatment+of+Aggressive+ABC-DLBCL&doi=10.1016%2Fj.ccr.2012.11.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacologic Inhibition of MALT1 Protease by Phenothiazines as a Therapeutic Approach for the Treatment of Aggressive ABC-DLBCL</span></div><div class="casAuthors">Nagel, Daniel; Spranger, Stefani; Vincendeau, Michelle; Grau, Michael; Raffegerst, Silke; Kloo, Bernhard; Hlahla, Daniela; Neuenschwander, Martin; von Kries, Jens Peter; Hadian, Kamyar; Doerken, Bernd; Lenz, Peter; Lenz, Georg; Schendel, Dolores J.; Krappmann, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">825-837</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Proteolytic activity of the mucosa-assocd. lymphoid tissue lymphoma translocation protein-1 (MALT1) paracaspase is required for survival of the activated B cell subtype of diffuse large B cell lymphoma (ABC-DLBCL).  We have identified distinct derivs. of medicinal active phenothiazines, namely mepazine, thioridazine, and promazine, as small mol. inhibitors of the MALT1 protease.  These phenothiazines selectively inhibit cleavage activity of recombinant and cellular MALT1 by a noncompetitive mechanism.  Consequently, the compds. inhibit anti-apoptotic NF-κB signaling and elicit toxic effects selectively on MALT1-dependent ABC-DLBCL cells in vitro and in vivo.  Our data provide a conceptual proof for a clin. application of distinct phenothiazines in the treatment of ABC-DLBCL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-pha_0UjHHLVg90H21EOLACvtfcHk0ljNHhojJFO5ZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVWns77J&md5=e67e728b09fbaf08defbaf06c1258be9</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2012.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2012.11.002%26sid%3Dliteratum%253Aachs%26aulast%3DNagel%26aufirst%3DD.%26aulast%3DSpranger%26aufirst%3DS.%26aulast%3DVincendeau%26aufirst%3DM.%26aulast%3DGrau%26aufirst%3DM.%26aulast%3DRaffegerst%26aufirst%3DS.%26aulast%3DKloo%26aufirst%3DB.%26aulast%3DHlahla%26aufirst%3DD.%26aulast%3DNeuenschwander%26aufirst%3DM.%26aulast%3DPeter%2Bvon%2BKries%26aufirst%3DJ.%26aulast%3DHadian%26aufirst%3DK.%26aulast%3DD%25C3%25B6rken%26aufirst%3DB.%26aulast%3DLenz%26aufirst%3DP.%26aulast%3DLenz%26aufirst%3DG.%26aulast%3DSchendel%26aufirst%3DD.%2BJ.%26aulast%3DKrappmann%26aufirst%3DD.%26atitle%3DPharmacologic%2520Inhibition%2520of%2520MALT1%2520Protease%2520by%2520Phenothiazines%2520as%2520a%2520Therapeutic%2520Approach%2520for%2520the%2520Treatment%2520of%2520Aggressive%2520ABC-DLBCL%26jtitle%3DCancer%2520Cell%26date%3D2012%26volume%3D22%26spage%3D825%26epage%3D837%26doi%3D10.1016%2Fj.ccr.2012.11.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schlauderer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lammens, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincendeau, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eitelhuber, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhelst, S. H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kling, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chrusciel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruland, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krappmann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopfner, K.-P.</span></span> <span> </span><span class="NLM_article-title">Structural Analysis of Phenothiazine Derivatives as Allosteric Inhibitors of the MALT1 Paracaspase</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">10384</span>– <span class="NLM_lpage">10387</span>, <span class="refDoi"> DOI: 10.1002/anie.201304290</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1002%2Fanie.201304290" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1yjsb3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=10384-10387&author=F.+Schlaudererauthor=K.+Lammensauthor=D.+Nagelauthor=M.+Vincendeauauthor=A.+C.+Eitelhuberauthor=S.+H.+L.+Verhelstauthor=D.+Klingauthor=A.+Chruscielauthor=J.+Rulandauthor=D.+Krappmannauthor=K.-P.+Hopfner&title=Structural+Analysis+of+Phenothiazine+Derivatives+as+Allosteric+Inhibitors+of+the+MALT1+Paracaspase&doi=10.1002%2Fanie.201304290"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Analysis of Phenothiazine Derivatives as Allosteric Inhibitors of the MALT1 Paracaspase</span></div><div class="casAuthors">Schlauderer, Florian; Lammens, Katja; Nagel, Daniel; Vincendeau, Michelle; Eitelhuber, Andrea C.; Verhelst, Steven H. L.; Kling, Dale; Chrusciel, Al; Ruland, Juergen; Krappmann, Daniel; Hopfner, Karl-Peter</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">10384-10387</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The authors report the crystal structure of ligand-free dimeric human MALT1casp-Ig3 in complex with the tricyclic phenothiazine deriv. thioridazine.  Unexpectedly, the structure reveals that the inhibitor binds in a pocket located on the opposite to the caspase active site, in the interface between the caspase domain and the Ig3 domain connecting helix α1Ig3 of MALT1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrr2IUAVsvSQLVg90H21EOLACvtfcHk0ljNHhojJFO5ZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1yjsb3O&md5=4795e1016841fd3c558b8095ff854255</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2Fanie.201304290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201304290%26sid%3Dliteratum%253Aachs%26aulast%3DSchlauderer%26aufirst%3DF.%26aulast%3DLammens%26aufirst%3DK.%26aulast%3DNagel%26aufirst%3DD.%26aulast%3DVincendeau%26aufirst%3DM.%26aulast%3DEitelhuber%26aufirst%3DA.%2BC.%26aulast%3DVerhelst%26aufirst%3DS.%2BH.%2BL.%26aulast%3DKling%26aufirst%3DD.%26aulast%3DChrusciel%26aufirst%3DA.%26aulast%3DRuland%26aufirst%3DJ.%26aulast%3DKrappmann%26aufirst%3DD.%26aulast%3DHopfner%26aufirst%3DK.-P.%26atitle%3DStructural%2520Analysis%2520of%2520Phenothiazine%2520Derivatives%2520as%2520Allosteric%2520Inhibitors%2520of%2520the%2520MALT1%2520Paracaspase%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2013%26volume%3D52%26spage%3D10384%26epage%3D10387%26doi%3D10.1002%2Fanie.201304290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schlapbach, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Revesz, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pissot Soldermann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoller, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Régnier, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornancin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radimerski, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blank, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuffenhauer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renatus, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erbel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melkko, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heng, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simic, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endres, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wartmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quancard, J.</span></span> <span> </span><span class="NLM_article-title">N-Aryl-Piperidine-4-Carboxamides as a Novel Class of Potent Inhibitors of MALT1 Proteolytic Activity</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">2153</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2018.05.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1016%2Fj.bmcl.2018.05.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=29759726" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC1cXps1Crsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=2153&author=A.+Schlapbachauthor=L.+Reveszauthor=C.+Pissot+Soldermannauthor=T.+Zollerauthor=C.+H.+R%C3%A9gnierauthor=F.+Bornancinauthor=T.+Radimerskiauthor=J.+Blankauthor=A.+Schuffenhauerauthor=M.+Renatusauthor=P.+Erbelauthor=S.+Melkkoauthor=R.+Hengauthor=O.+Simicauthor=R.+Endresauthor=M.+Wartmannauthor=J.+Quancard&title=N-Aryl-Piperidine-4-Carboxamides+as+a+Novel+Class+of+Potent+Inhibitors+of+MALT1+Proteolytic+Activity&doi=10.1016%2Fj.bmcl.2018.05.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">N-aryl-piperidine-4-carboxamides as a novel class of potent inhibitors of MALT1 proteolytic activity</span></div><div class="casAuthors">Schlapbach, Achim; Revesz, Laszlo; Pissot Soldermann, Carole; Zoller, Thomas; Regnier, Catherine H.; Bornancin, Frederic; Radimerski, Thomas; Blank, Jutta; Schuffenhauer, Ansgar; Renatus, Martin; Erbel, Paulus; Melkko, Samu; Heng, Richard; Simic, Oliver; Endres, Ralf; Wartmann, Markus; Quancard, Jean</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2153-2158</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Starting from a weak screening hit, potent and selective inhibitors of the MALT1 protease function were elaborated.  Advanced compds. displayed high potency in biochem. and cellular assays.  Compds. showed activity in a mechanistic Jurkat T cell activation assay as well as in the B-cell lymphoma line OCI-Ly3, which suggests potential use of MALT1 inhibitors in the treatment of autoimmune diseases as well as B-cell lymphomas with a dysregulated NF-κB pathway.  Initially, rat pharmacokinetic properties of this compd. series were dominated by very high clearance which could be linked to amide cleavage.  Using a rat hepatocyte assay a good in vitro-in vivo correlation could be established which led to the identification of compds. with improved PK properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4Gx09NEhsQ7Vg90H21EOLACvtfcHk0ljNHhojJFO5ZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXps1Crsbc%253D&md5=f44b5e6bee523fbf3d5d692e0ce9c49c</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2018.05.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2018.05.017%26sid%3Dliteratum%253Aachs%26aulast%3DSchlapbach%26aufirst%3DA.%26aulast%3DRevesz%26aufirst%3DL.%26aulast%3DPissot%2BSoldermann%26aufirst%3DC.%26aulast%3DZoller%26aufirst%3DT.%26aulast%3DR%25C3%25A9gnier%26aufirst%3DC.%2BH.%26aulast%3DBornancin%26aufirst%3DF.%26aulast%3DRadimerski%26aufirst%3DT.%26aulast%3DBlank%26aufirst%3DJ.%26aulast%3DSchuffenhauer%26aufirst%3DA.%26aulast%3DRenatus%26aufirst%3DM.%26aulast%3DErbel%26aufirst%3DP.%26aulast%3DMelkko%26aufirst%3DS.%26aulast%3DHeng%26aufirst%3DR.%26aulast%3DSimic%26aufirst%3DO.%26aulast%3DEndres%26aufirst%3DR.%26aulast%3DWartmann%26aufirst%3DM.%26aulast%3DQuancard%26aufirst%3DJ.%26atitle%3DN-Aryl-Piperidine-4-Carboxamides%2520as%2520a%2520Novel%2520Class%2520of%2520Potent%2520Inhibitors%2520of%2520MALT1%2520Proteolytic%2520Activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D28%26spage%3D2153%26doi%3D10.1016%2Fj.bmcl.2018.05.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Quancard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fung, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renatus, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Israël, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Priatel, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blank, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viner, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blank, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlapbach, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erbel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kizhakkedathu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villard, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hersperger, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turvey, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eder, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornancin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overall, C. M.</span></span> <span> </span><span class="NLM_article-title">An Allosteric MALT1 Inhibitor Is a Molecular Corrector Rescuing Function in an Immunodeficient Patient</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">304</span>, <span class="refDoi"> DOI: 10.1038/s41589-018-0222-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1038%2Fs41589-018-0222-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=30692685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmtF2isbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2019&pages=304&author=J.+Quancardauthor=T.+Kleinauthor=S.-Y.+Fungauthor=M.+Renatusauthor=N.+Hughesauthor=L.+Isra%C3%ABlauthor=J.+J.+Priatelauthor=S.+Kangauthor=M.+A.+Blankauthor=R.+I.+Vinerauthor=J.+Blankauthor=A.+Schlapbachauthor=P.+Erbelauthor=J.+Kizhakkedathuauthor=F.+Villardauthor=R.+Herspergerauthor=S.+E.+Turveyauthor=J.+Ederauthor=F.+Bornancinauthor=C.+M.+Overall&title=An+Allosteric+MALT1+Inhibitor+Is+a+Molecular+Corrector+Rescuing+Function+in+an+Immunodeficient+Patient&doi=10.1038%2Fs41589-018-0222-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">An allosteric MALT1 inhibitor is a molecular corrector rescuing function in an immunodeficient patient</span></div><div class="casAuthors">Quancard, Jean; Klein, Theo; Fung, Shan-Yu; Renatus, Martin; Hughes, Nicola; Israel, Laura; Priatel, John J.; Kang, Sohyeong; Blank, Michael A.; Viner, Rosa I.; Blank, Jutta; Schlapbach, Achim; Erbel, Paul; Kizhakkedathu, Jayachandran; Villard, Frederic; Hersperger, Rene; Turvey, Stuart E.; Eder, Joerg; Bornancin, Frederic; Overall, Christopher M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">304-313</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">MALT1 paracaspase is central for lymphocyte antigen-dependent responses including NF-κB activation.  We discovered nanomolar, selective allosteric inhibitors of MALT1 that bind by displacing the side chain of Trp580, locking the protease in an inactive conformation.  Interestingly, we had previously identified a patient homozygous for a MALT1 Trp580-to-serine mutation who suffered from combined immunodeficiency.  We show that the loss of tryptophan weakened interactions between the paracaspase and C-terminal Ig MALT1 domains resulting in protein instability, reduced protein levels and functions.  Upon binding of allosteric inhibitors of increasing potency, we found proportionate increased stabilization of MALT1-W580S to reach that of wild-type MALT1.  With restored levels of stable MALT1 protein, the most potent of the allosteric inhibitors rescued NF-κB and JNK signaling in patient lymphocytes.  Following compd. washout, MALT1 substrate cleavage was partly recovered.  Thus, a mol. corrector rescues an enzyme deficiency by substituting for the mutated residue, inspiring new potential precision therapies to increase mutant enzyme activity in other deficiencies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoowtKlWIeaBbVg90H21EOLACvtfcHk0lhcC3P-xtOujA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmtF2isbo%253D&md5=923fffe83ed681c62ee0164a2d18775e</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fs41589-018-0222-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41589-018-0222-1%26sid%3Dliteratum%253Aachs%26aulast%3DQuancard%26aufirst%3DJ.%26aulast%3DKlein%26aufirst%3DT.%26aulast%3DFung%26aufirst%3DS.-Y.%26aulast%3DRenatus%26aufirst%3DM.%26aulast%3DHughes%26aufirst%3DN.%26aulast%3DIsra%25C3%25ABl%26aufirst%3DL.%26aulast%3DPriatel%26aufirst%3DJ.%2BJ.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DBlank%26aufirst%3DM.%2BA.%26aulast%3DViner%26aufirst%3DR.%2BI.%26aulast%3DBlank%26aufirst%3DJ.%26aulast%3DSchlapbach%26aufirst%3DA.%26aulast%3DErbel%26aufirst%3DP.%26aulast%3DKizhakkedathu%26aufirst%3DJ.%26aulast%3DVillard%26aufirst%3DF.%26aulast%3DHersperger%26aufirst%3DR.%26aulast%3DTurvey%26aufirst%3DS.%2BE.%26aulast%3DEder%26aufirst%3DJ.%26aulast%3DBornancin%26aufirst%3DF.%26aulast%3DOverall%26aufirst%3DC.%2BM.%26atitle%3DAn%2520Allosteric%2520MALT1%2520Inhibitor%2520Is%2520a%2520Molecular%2520Corrector%2520Rescuing%2520Function%2520in%2520an%2520Immunodeficient%2520Patient%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2019%26volume%3D15%26spage%3D304%26doi%3D10.1038%2Fs41589-018-0222-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bardet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unterreiner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malinverni, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lafossas, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vedrine, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boesch, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolb, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glück, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katopodis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renatus, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simic, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlapbach, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quancard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Régnier, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bold, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pissot-Soldermann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carballido, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovarik, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calzascia, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornancin, F.</span></span> <span> </span><span class="NLM_article-title">The T-Cell Fingerprint of MALT1 Paracaspase Revealed by Selective Inhibition</span>. <i>Immunol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">81</span>– <span class="NLM_lpage">99</span>, <span class="refDoi"> DOI: 10.1111/imcb.1018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1111%2Fimcb.1018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=29359407" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjs1Kitb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2018&pages=81-99&author=M.+Bardetauthor=A.+Unterreinerauthor=C.+Malinverniauthor=F.+Lafossasauthor=C.+Vedrineauthor=D.+Boeschauthor=Y.+Kolbauthor=D.+Kaiserauthor=A.+Gl%C3%BCckauthor=M.+A.+Schneiderauthor=A.+Katopodisauthor=M.+Renatusauthor=O.+Simicauthor=A.+Schlapbachauthor=J.+Quancardauthor=C.+H.+R%C3%A9gnierauthor=G.+Boldauthor=C.+Pissot-Soldermannauthor=J.+M.+Carballidoauthor=J.+Kovarikauthor=T.+Calzasciaauthor=F.+Bornancin&title=The+T-Cell+Fingerprint+of+MALT1+Paracaspase+Revealed+by+Selective+Inhibition&doi=10.1111%2Fimcb.1018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">The T-cell fingerprint of MALT1 paracaspase revealed by selective inhibition</span></div><div class="casAuthors">Bardet, Maureen; Unterreiner, Adeline; Malinverni, Claire; Lafossas, Frederique; Vedrine, Corinne; Boesch, Danielle; Kolb, Yeter; Kaiser, Daniel; Glueck, Anton; Schneider, Martin A.; Katopodis, Andreas; Renatus, Martin; Simic, Oliver; Schlapbach, Achim; Quancard, Jean; Regnier, Catherine H.; Bold, Guido; Pissot-Soldermann, Carole; Carballido, Jose M.; Kovarik, Jiri; Calzascia, Thomas; Bornancin, Frederic</div><div class="citationInfo"><span class="NLM_cas:title">Immunology & Cell Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">81-99</span>CODEN:
                <span class="NLM_cas:coden">ICBIEZ</span>;
        ISSN:<span class="NLM_cas:issn">1440-1711</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Australia, Ltd.</span>)
        </div><div class="casAbstract">Mucosa-assocd. lymphoid tissue lymphoma translocation protein 1 (MALT1) is essential for immune responses triggered by antigen receptors but the contribution of its paracaspase activity is not fully understood.  Here, we studied how MALT1 proteolytic function regulates T-cell activation and fate after engagement of the T-cell receptor pathway.  We show that MLT-827, a potent and selective MALT1 paracaspase inhibitor, does not prevent the initial phase of T-cell activation, in contrast to the pan-protein kinase C inhibitor AEB071.  However, MLT-827 strongly impacted cell expansion after activation.  We demonstrate this is the consequence of profound inhibition of IL-2 prodn. as well as reduced expression of the IL-2 receptor alpha subunit (CD25), resulting from defective canonical NF-κB activation and accelerated mRNA turnover mechanisms.  Accordingly, MLT-827 revealed a unique transcriptional fingerprint of MALT1 protease activity, providing evidence for broad control of T-cell signaling pathways.  Altogether, this first report with a potent and selective inhibitor elucidates how MALT1 paracaspase activity integrates several T-cell activation pathways and indirectly controls gamma-chain receptor dependent survival, to impact on T-cell expansion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcOZ3C5-LsPrVg90H21EOLACvtfcHk0lhcC3P-xtOujA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjs1Kitb0%253D&md5=0f35cd2ae66e3572e815eb24aacd6445</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1111%2Fimcb.1018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fimcb.1018%26sid%3Dliteratum%253Aachs%26aulast%3DBardet%26aufirst%3DM.%26aulast%3DUnterreiner%26aufirst%3DA.%26aulast%3DMalinverni%26aufirst%3DC.%26aulast%3DLafossas%26aufirst%3DF.%26aulast%3DVedrine%26aufirst%3DC.%26aulast%3DBoesch%26aufirst%3DD.%26aulast%3DKolb%26aufirst%3DY.%26aulast%3DKaiser%26aufirst%3DD.%26aulast%3DGl%25C3%25BCck%26aufirst%3DA.%26aulast%3DSchneider%26aufirst%3DM.%2BA.%26aulast%3DKatopodis%26aufirst%3DA.%26aulast%3DRenatus%26aufirst%3DM.%26aulast%3DSimic%26aufirst%3DO.%26aulast%3DSchlapbach%26aufirst%3DA.%26aulast%3DQuancard%26aufirst%3DJ.%26aulast%3DR%25C3%25A9gnier%26aufirst%3DC.%2BH.%26aulast%3DBold%26aufirst%3DG.%26aulast%3DPissot-Soldermann%26aufirst%3DC.%26aulast%3DCarballido%26aufirst%3DJ.%2BM.%26aulast%3DKovarik%26aufirst%3DJ.%26aulast%3DCalzascia%26aufirst%3DT.%26aulast%3DBornancin%26aufirst%3DF.%26atitle%3DThe%2520T-Cell%2520Fingerprint%2520of%2520MALT1%2520Paracaspase%2520Revealed%2520by%2520Selective%2520Inhibition%26jtitle%3DImmunol.%2520Cell%2520Biol.%26date%3D2018%26volume%3D96%26spage%3D81%26epage%3D99%26doi%3D10.1111%2Fimcb.1018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connolly, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philippar, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbay, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gys, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Nuffel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bekkers, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meerpoel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, J.</span></span> <span> </span><span class="NLM_article-title">Discovery and Optimization of a Series of Small-Molecule Allosteric Inhibitors of MALT1 Protease</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">126743</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2019.126743</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1016%2Fj.bmcl.2019.126743" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=31678006" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitV2hur7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2019&pages=126743&author=T.+Luauthor=P.+J.+Connollyauthor=U.+Philipparauthor=W.+Sunauthor=M.+D.+Cummingsauthor=K.+Barbayauthor=L.+Gysauthor=L.+Van+Nuffelauthor=N.+Austinauthor=M.+Bekkersauthor=F.+Shenauthor=A.+Caiauthor=R.+Attarauthor=L.+Meerpoelauthor=J.+Edwards&title=Discovery+and+Optimization+of+a+Series+of+Small-Molecule+Allosteric+Inhibitors+of+MALT1+Protease&doi=10.1016%2Fj.bmcl.2019.126743"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and optimization of a series of small-molecule allosteric inhibitors of MALT1 protease</span></div><div class="casAuthors">Lu, Tianbao; Connolly, Peter J.; Philippar, Ulrike; Sun, Weimei; Cummings, Maxwell D.; Barbay, Kent; Gys, Luc; Van Nuffel, Luc; Austin, Nigel; Bekkers, Mariette; Shen, Fang; Cai, Ann; Attar, Ricardo; Meerpoel, Lieven; Edwards, James</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">126743</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We describe a series of potent and highly selective small-mol. MALT1 inhibitors, optimized from a High-Throughput Screening hit.  Advanced analogs such as compd. 40 show high potency (IC50: 0.01 μM) in a biochem. assay measuring MALT1 enzymic activity, as well as in cellular assays: Jurkat T cell activation (0.05 μM) and IL6/10 secretion (IC50: 0.10/0.06 μM) in the TMD8 B-cell lymphoma line.  Compd. 40 also inhibited cleavage of the MALT1 substrate RelB (IC50: 0.10 μM).  Mechanistic enzymol. results suggest that these compds. bind to the known allosteric site of the protease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTRf6ZV0rc2LVg90H21EOLACvtfcHk0liX1xjQKM_4vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitV2hur7M&md5=47437e2ef1466412fc430fb4c64f001b</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2019.126743&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2019.126743%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DT.%26aulast%3DConnolly%26aufirst%3DP.%2BJ.%26aulast%3DPhilippar%26aufirst%3DU.%26aulast%3DSun%26aufirst%3DW.%26aulast%3DCummings%26aufirst%3DM.%2BD.%26aulast%3DBarbay%26aufirst%3DK.%26aulast%3DGys%26aufirst%3DL.%26aulast%3DVan%2BNuffel%26aufirst%3DL.%26aulast%3DAustin%26aufirst%3DN.%26aulast%3DBekkers%26aufirst%3DM.%26aulast%3DShen%26aufirst%3DF.%26aulast%3DCai%26aufirst%3DA.%26aulast%3DAttar%26aufirst%3DR.%26aulast%3DMeerpoel%26aufirst%3DL.%26aulast%3DEdwards%26aufirst%3DJ.%26atitle%3DDiscovery%2520and%2520Optimization%2520of%2520a%2520Series%2520of%2520Small-Molecule%2520Allosteric%2520Inhibitors%2520of%2520MALT1%2520Protease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26volume%3D29%26spage%3D126743%26doi%3D10.1016%2Fj.bmcl.2019.126743" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bonsignore, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Passelli, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelzer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perroud, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konrad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thurau, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stürzl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trillo-Tinoco, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Valle, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thome, M.</span></span> <span> </span><span class="NLM_article-title">A Role for MALT1 Activity in Kaposi’s Sarcoma-Associated Herpes Virus Latency and Growth of Primary Effusion Lymphoma</span>. <i>Leukemia</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">614</span>– <span class="NLM_lpage">624</span>, <span class="refDoi"> DOI: 10.1038/leu.2016.239</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1038%2Fleu.2016.239" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=27538487" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFCmsLvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2017&pages=614-624&author=L.+Bonsignoreauthor=K.+Passelliauthor=C.+Pelzerauthor=M.+Perroudauthor=A.+Konradauthor=M.+Thurauauthor=M.+St%C3%BCrzlauthor=L.+Daiauthor=J.+Trillo-Tinocoauthor=L.+Del+Valleauthor=Z.+Qinauthor=M.+Thome&title=A+Role+for+MALT1+Activity+in+Kaposi%E2%80%99s+Sarcoma-Associated+Herpes+Virus+Latency+and+Growth+of+Primary+Effusion+Lymphoma&doi=10.1038%2Fleu.2016.239"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">A role for MALT1 activity in Kaposi's sarcoma-associated herpes virus latency and growth of primary effusion lymphoma</span></div><div class="casAuthors">Bonsignore, L.; Passelli, K.; Pelzer, C.; Perroud, M.; Konrad, A.; Thurau, M.; Sturzl, M.; Dai, L.; Trillo-Tinoco, J.; Del Valle, L.; Qin, Z.; Thome, M.</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">614-624</span>CODEN:
                <span class="NLM_cas:coden">LEUKED</span>;
        ISSN:<span class="NLM_cas:issn">0887-6924</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Primary effusion lymphoma (PEL) is an incurable malignancy that develops in immunodeficient patients as a consequence of latent infection of B-cells with Kaposi's sarcoma-assocd. herpes virus (KSHV).  Malignant growth of KSHV-infected B cells requires the activity of the transcription factor nuclear factor (NF)-κB, which controls maintenance of viral latency and suppression of the viral lytic program.  Here we show that the KSHV proteins K13 and K15 promote NF-κB activation via the protease mucosa-assocd. lymphoid tissue lymphoma translocation protein-1 (MALT1), a key driver of NF-κB activation in lymphocytes.  Inhibition of the MALT1 protease activity induced a switch from the latent to the lytic stage of viral infection, and led to reduced growth and survival of PEL cell lines in vitro and in a xenograft model.  These results demonstrate a key role for the proteolytic activity of MALT1 in PEL, and provide a rationale for the pharmacol. targeting of MALT1 in PEL therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo33QiWBC8muLVg90H21EOLACvtfcHk0liX1xjQKM_4vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFCmsLvL&md5=6e8b34ef0b128505ace6df24f413e723</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fleu.2016.239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fleu.2016.239%26sid%3Dliteratum%253Aachs%26aulast%3DBonsignore%26aufirst%3DL.%26aulast%3DPasselli%26aufirst%3DK.%26aulast%3DPelzer%26aufirst%3DC.%26aulast%3DPerroud%26aufirst%3DM.%26aulast%3DKonrad%26aufirst%3DA.%26aulast%3DThurau%26aufirst%3DM.%26aulast%3DSt%25C3%25BCrzl%26aufirst%3DM.%26aulast%3DDai%26aufirst%3DL.%26aulast%3DTrillo-Tinoco%26aufirst%3DJ.%26aulast%3DDel%2BValle%26aufirst%3DL.%26aulast%3DQin%26aufirst%3DZ.%26aulast%3DThome%26aufirst%3DM.%26atitle%3DA%2520Role%2520for%2520MALT1%2520Activity%2520in%2520Kaposi%25E2%2580%2599s%2520Sarcoma-Associated%2520Herpes%2520Virus%2520Latency%2520and%2520Growth%2520of%2520Primary%2520Effusion%2520Lymphoma%26jtitle%3DLeukemia%26date%3D2017%26volume%3D31%26spage%3D614%26epage%3D624%26doi%3D10.1038%2Fleu.2016.239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mc
Guire, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elton, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wieghofer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demeyer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krappmann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prinz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beyaert, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Loo, G.</span></span> <span> </span><span class="NLM_article-title">Pharmacological Inhibition of MALT1 Protease Activity Protects Mice in a Mouse Model of Multiple Sclerosis</span>. <i>J. Neuroinflammation</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">124</span>, <span class="refDoi"> DOI: 10.1186/1742-2094-11-124</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1186%2F1742-2094-11-124" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=25043939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A280%3ADC%252BC2cbktFGiuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2014&pages=124&author=C.+Mc%0AGuireauthor=L.+Eltonauthor=P.+Wieghoferauthor=J.+Staalauthor=S.+Voetauthor=A.+Demeyerauthor=D.+Nagelauthor=D.+Krappmannauthor=M.+Prinzauthor=R.+Beyaertauthor=G.+van+Loo&title=Pharmacological+Inhibition+of+MALT1+Protease+Activity+Protects+Mice+in+a+Mouse+Model+of+Multiple+Sclerosis&doi=10.1186%2F1742-2094-11-124"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological inhibition of MALT1 protease activity protects mice in a mouse model of multiple sclerosis</span></div><div class="casAuthors">Mc Guire Conor; Elton Lynn; Wieghofer Peter; Staal Jens; Voet Sofie; Demeyer Annelies; Nagel Daniel; Krappmann Daniel; Prinz Marco; van Loo Geert; Beyaert Rudi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neuroinflammation</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">124</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The paracaspase mucosa-associated lymphoid tissue lymphoma translocation protein 1 (MALT1) is crucial for lymphocyte activation through signaling to the transcription factor NF-κB.  Besides functioning as a scaffold signaling protein, MALT1 also acts as a cysteine protease that specifically cleaves a number of substrates and contributes to specific T cell receptor-induced gene expression.  Recently, small molecule inhibitors of MALT1 proteolytic activity were identified and shown to have promising anticancer properties in subtypes of B cell lymphoma.  However, information on the therapeutic potential of small compound inhibitors that target MALT1 protease activity in autoimmunity is still lacking.  METHODS:  The present study aimed to elucidate whether MALT1 protease inhibitors are also useful in the treatment of lymphocyte-mediated autoimmune pathologies such as multiple sclerosis (MS).  For this, we studied the therapeutic potential of a recently identified inhibitor of MALT1 protease activity, the phenothiazine derivative mepazine, in the context of experimental autoimmune encephalomyelitis (EAE), the main animal model for MS.  RESULTS:  We demonstrate that administration of mepazine prophylactically or after disease onset, can attenuate EAE.  Importantly, while complete absence of MALT1 affects the differentiation of regulatory T (Treg) cells in vivo, the MALT1 protease inhibitor mepazine did not affect Treg development.  CONCLUSIONS:  Altogether, these data indicate that small molecule inhibitors of MALT1 not only hold great promise for the treatment of B cell lymphomas but also for autoimmune disorders such as MS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ8MHZfJVcqDXp3bfzSLaX5fW6udTcc2ebGnvqCtVJP8rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cbktFGiuw%253D%253D&md5=c9ab918a4d0dfeb999b9b965df49245f</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1186%2F1742-2094-11-124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1742-2094-11-124%26sid%3Dliteratum%253Aachs%26aulast%3DMc%2BGuire%26aufirst%3DC.%26aulast%3DElton%26aufirst%3DL.%26aulast%3DWieghofer%26aufirst%3DP.%26aulast%3DStaal%26aufirst%3DJ.%26aulast%3DVoet%26aufirst%3DS.%26aulast%3DDemeyer%26aufirst%3DA.%26aulast%3DNagel%26aufirst%3DD.%26aulast%3DKrappmann%26aufirst%3DD.%26aulast%3DPrinz%26aufirst%3DM.%26aulast%3DBeyaert%26aufirst%3DR.%26aulast%3Dvan%2BLoo%26aufirst%3DG.%26atitle%3DPharmacological%2520Inhibition%2520of%2520MALT1%2520Protease%2520Activity%2520Protects%2520Mice%2520in%2520a%2520Mouse%2520Model%2520of%2520Multiple%2520Sclerosis%26jtitle%3DJ.%2520Neuroinflammation%26date%3D2014%26volume%3D11%26spage%3D124%26doi%3D10.1186%2F1742-2094-11-124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Unterreiner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoehr, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huppertz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calzascia, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farady, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornancin, F.</span></span> <span> </span><span class="NLM_article-title">Selective MALT1 Paracaspase Inhibition Does Not Block TNF-α Production Downstream of TLR4 in Myeloid Cells</span>. <i>Immunol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>192</i></span>,  <span class="NLM_fpage">48</span>– <span class="NLM_lpage">51</span>, <span class="refDoi"> DOI: 10.1016/j.imlet.2017.10.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1016%2Fj.imlet.2017.10.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=29079202" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslehur%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=192&publication_year=2017&pages=48-51&author=A.+Unterreinerauthor=N.+Stoehrauthor=C.+Huppertzauthor=T.+Calzasciaauthor=C.+J.+Faradyauthor=F.+Bornancin&title=Selective+MALT1+Paracaspase+Inhibition+Does+Not+Block+TNF-%CE%B1+Production+Downstream+of+TLR4+in+Myeloid+Cells&doi=10.1016%2Fj.imlet.2017.10.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Selective MALT1 paracaspase inhibition does not block TNF-α production downstream of TLR4 in myeloid cells</span></div><div class="casAuthors">Unterreiner, Adeline; Stoehr, Natacha; Huppertz, Christine; Calzascia, Thomas; Farady, Christopher J.; Bornancin, Frederic</div><div class="citationInfo"><span class="NLM_cas:title">Immunology Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">192</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">48-51</span>CODEN:
                <span class="NLM_cas:coden">IMLED6</span>;
        ISSN:<span class="NLM_cas:issn">0165-2478</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The paracaspase MALT1 controls signaling downstream of several cell surface receptors, particularly in immune cells.  A no. of studies have suggested that targeting MALT1, and notably its paracaspase activity, could be beneficial to the treatment of pathol. conditions, such as lymphoma and autoimmune diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGou613LsB6AbLVg90H21EOLACvtfcHk0lgd-Oal4RATiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslehur%252FN&md5=6b5c36781915e5134597235d31e922cd</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.imlet.2017.10.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.imlet.2017.10.009%26sid%3Dliteratum%253Aachs%26aulast%3DUnterreiner%26aufirst%3DA.%26aulast%3DStoehr%26aufirst%3DN.%26aulast%3DHuppertz%26aufirst%3DC.%26aulast%3DCalzascia%26aufirst%3DT.%26aulast%3DFarady%26aufirst%3DC.%2BJ.%26aulast%3DBornancin%26aufirst%3DF.%26atitle%3DSelective%2520MALT1%2520Paracaspase%2520Inhibition%2520Does%2520Not%2520Block%2520TNF-%25CE%25B1%2520Production%2520Downstream%2520of%2520TLR4%2520in%2520Myeloid%2520Cells%26jtitle%3DImmunol.%2520Lett.%26date%3D2017%26volume%3D192%26spage%3D48%26epage%3D51%26doi%3D10.1016%2Fj.imlet.2017.10.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Unterreiner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Touil, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anastasi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubois, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niwa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calzascia, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornancin, F.</span></span> <span> </span><span class="NLM_article-title">Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity</span>. <i>J. Visualized Exp.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>143</i></span>, <span class="NLM_elocation-id">e58439</span> <span class="refDoi"> DOI: 10.3791/58439</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.3791%2F58439" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2019&author=A.+Unterreinerauthor=R.+Touilauthor=D.+Anastasiauthor=N.+Duboisauthor=S.+Niwaauthor=T.+Calzasciaauthor=F.+Bornancin&title=Myeloid+Innate+Signaling+Pathway+Regulation+by+MALT1+Paracaspase+Activity&doi=10.3791%2F58439"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.3791%2F58439&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3791%252F58439%26sid%3Dliteratum%253Aachs%26aulast%3DUnterreiner%26aufirst%3DA.%26aulast%3DTouil%26aufirst%3DR.%26aulast%3DAnastasi%26aufirst%3DD.%26aulast%3DDubois%26aufirst%3DN.%26aulast%3DNiwa%26aufirst%3DS.%26aulast%3DCalzascia%26aufirst%3DT.%26aulast%3DBornancin%26aufirst%3DF.%26atitle%3DMyeloid%2520Innate%2520Signaling%2520Pathway%2520Regulation%2520by%2520MALT1%2520Paracaspase%2520Activity%26jtitle%3DJ.%2520Visualized%2520Exp.%26date%3D2019%26volume%3D143%26doi%3D10.3791%2F58439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falcon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soutar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornancin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xin, H.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, M.</span></span> <span> </span><span class="NLM_article-title">Pharmacological Inhibition of MALT1 Protease Activity Suppresses Endothelial Activation via Enhancing MCPIP1 Expression</span>. <i>Cell. Signalling</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">1</span>, <span class="refDoi"> DOI: 10.1016/j.cellsig.2018.05.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1016%2Fj.cellsig.2018.05.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=29913212" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1Sjsb7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2018&pages=1&author=Y.+Liauthor=S.+Huangauthor=X.+Huangauthor=X.+Liauthor=A.+Falconauthor=A.+Soutarauthor=F.+Bornancinauthor=Z.+Jiangauthor=H.-B.+Xinauthor=M.+Fu&title=Pharmacological+Inhibition+of+MALT1+Protease+Activity+Suppresses+Endothelial+Activation+via+Enhancing+MCPIP1+Expression&doi=10.1016%2Fj.cellsig.2018.05.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological inhibition of MALT1 protease activity suppresses endothelial activation via enhancing MCPIP1 expression</span></div><div class="casAuthors">Li, Yong; Huang, Shengping; Huang, Xuan; Li, Xiuzhen; Falcon, Adrian; Soutar, Adele; Bornancin, Frederic; Jiang, Zhisheng; Xin, Hong-Bo; Fu, Mingui</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-8</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Mucosa assocd. lymphoid tissue lymphoma translocation protein 1 (MALT1) is not only an intracellular signaling scaffold protein but also a paracaspase that plays a key role in the signal transduction and cellular activation of lymphocytes and macrophages.  However, its role in endothelial cells remains unknown.  Here we report that pharmacol. inhibition of MALT1 protease activity strongly suppresses endothelial activation via enhancing MCPIP1 expression.  Treatment with MALT1 protease inhibitors selectively inhibited TNFα-induced VCAM-1 expression in HUVECs and LPS-induced VCAM-1 expression in mice.  In addn., Inhibition of MALT1 protease activity also significantly inhibited TNFα-induced adhesion of THP-1 monocytic cells to HUVECs.  To explore the mechanisms, MALT1 inhibitors does not affect the activation of NF-κB signaling pathway in HUVEC.  However, they can stabilize MCPIP1 protein and significantly enhance MCPIP1 protein level in endothelial cells.  These results suggest that MALT1 paracaspase also targets MCPIP1 and degrade MCPIP1 protein in endothelial cells similar as it does in immune cells.  Taken together, the study suggest inhibition of MALT1 protease activity may represent a new strategy for prevention/therapy of vascular inflammatory diseases such as atherosclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqp7Blhcs5L87Vg90H21EOLACvtfcHk0lgd-Oal4RATiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1Sjsb7I&md5=61c26f4ecc693856853894769ee3c4b9</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2018.05.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2018.05.009%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DFalcon%26aufirst%3DA.%26aulast%3DSoutar%26aufirst%3DA.%26aulast%3DBornancin%26aufirst%3DF.%26aulast%3DJiang%26aufirst%3DZ.%26aulast%3DXin%26aufirst%3DH.-B.%26aulast%3DFu%26aufirst%3DM.%26atitle%3DPharmacological%2520Inhibition%2520of%2520MALT1%2520Protease%2520Activity%2520Suppresses%2520Endothelial%2520Activation%2520via%2520Enhancing%2520MCPIP1%2520Expression%26jtitle%3DCell.%2520Signalling%26date%3D2018%26volume%3D50%26spage%3D1%26doi%3D10.1016%2Fj.cellsig.2018.05.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soldermann, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simic, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renatus, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erbel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melkko, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wartmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biguad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McSheehy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endres, R.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Discovery of Potent, Highly Selective, and In Vivo Efficacious, Allosteric MALT1 Inhibitors by Iterative Scaffold Morphing</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c01245</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c01245" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=C.+P.+Soldermannauthor=O.+Simicauthor=M.+Renatusauthor=P.+Erbelauthor=S.+Melkkoauthor=M.+Wartmannauthor=M.+Biguadauthor=A.+Weissauthor=P.+McSheehyauthor=R.+Endres&title=Discovery+of+Potent%2C+Highly+Selective%2C+and+In+Vivo+Efficacious%2C+Allosteric+MALT1+Inhibitors+by+Iterative+Scaffold+Morphing&doi=10.1021%2Facs.jmedchem.0c01245"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c01245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c01245%26sid%3Dliteratum%253Aachs%26aulast%3DSoldermann%26aufirst%3DC.%2BP.%26aulast%3DSimic%26aufirst%3DO.%26aulast%3DRenatus%26aufirst%3DM.%26aulast%3DErbel%26aufirst%3DP.%26aulast%3DMelkko%26aufirst%3DS.%26aulast%3DWartmann%26aufirst%3DM.%26aulast%3DBiguad%26aufirst%3DM.%26aulast%3DWeiss%26aufirst%3DA.%26aulast%3DMcSheehy%26aufirst%3DP.%26aulast%3DEndres%26aufirst%3DR.%26atitle%3DDiscovery%2520of%2520Potent%252C%2520Highly%2520Selective%252C%2520and%2520In%2520Vivo%2520Efficacious%252C%2520Allosteric%2520MALT1%2520Inhibitors%2520by%2520Iterative%2520Scaffold%2520Morphing%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26doi%3D10.1021%2Facs.jmedchem.0c01245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tønsberg, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holm, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjerregaard, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boll, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müllertz, A.</span></span> <span> </span><span class="NLM_article-title">An Updated and Simplified Method for Bile Duct Cannulation of Rats</span>. <i>Lab. Anim.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">373</span>, <span class="refDoi"> DOI: 10.1258/la.2010.010010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1258%2Fla.2010.010010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=20736319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A280%3ADC%252BC3cflsF2qsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2010&pages=373&author=H.+T%C3%B8nsbergauthor=R.+Holmauthor=T.+G.+Bjerregaardauthor=J.+B.+Bollauthor=J.+Jacobsenauthor=A.+M%C3%BCllertz&title=An+Updated+and+Simplified+Method+for+Bile+Duct+Cannulation+of+Rats&doi=10.1258%2Fla.2010.010010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">An updated and simplified method for bile duct cannulation of rats</span></div><div class="casAuthors">Tonsberg H; Holm R; Bjerregaard T G; Boll J B; Jacobsen J; Mullertz A</div><div class="citationInfo"><span class="NLM_cas:title">Laboratory animals</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">373-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The single bile duct cannulated rat model was used for short-term intestinal absorption studies.  Rats were randomly assigned to three groups: (A) bile duct cannulated, (B) control laparotomy and (C) no treatment.  The body weight and health of the rats were monitored before and until day 5 after surgery, while bile flow was measured in group A on day 2.  On the fifth day, tail vein blood was harvested, and alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase and total bilirubin were quantified.  Analysis of variance showed no significant difference between the groups for these parameters.  This study demonstrated the suitability of a surgical rat model feasible for evaluation of the impact of bile in pharmacokinetic studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQVEpieDyv8RCM8MEzWGjS9fW6udTcc2eYAV-4VyFd8S7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cflsF2qsg%253D%253D&md5=23ead010e248040508699af28ec3a445</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1258%2Fla.2010.010010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1258%252Fla.2010.010010%26sid%3Dliteratum%253Aachs%26aulast%3DT%25C3%25B8nsberg%26aufirst%3DH.%26aulast%3DHolm%26aufirst%3DR.%26aulast%3DBjerregaard%26aufirst%3DT.%2BG.%26aulast%3DBoll%26aufirst%3DJ.%2BB.%26aulast%3DJacobsen%26aufirst%3DJ.%26aulast%3DM%25C3%25BCllertz%26aufirst%3DA.%26atitle%3DAn%2520Updated%2520and%2520Simplified%2520Method%2520for%2520Bile%2520Duct%2520Cannulation%2520of%2520Rats%26jtitle%3DLab.%2520Anim.%26date%3D2010%26volume%3D44%26spage%3D373%26doi%3D10.1258%2Fla.2010.010010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bachir-Cherif, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blum, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braendli-Baiocco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaput, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duran Pacheco, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flint, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haiker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoflack, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Justies, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neff, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Starke, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steiner, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tournillac, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ubeaud-Séquier, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuler, F.</span></span> <span> </span><span class="NLM_article-title">Characterization of Post-Surgical Alterations in the Bile Duct-Cannulated Rat</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">701</span>, <span class="refDoi"> DOI: 10.3109/00498254.2011.565819</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.3109%2F00498254.2011.565819" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=21521079" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosFaltb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2011&pages=701&author=D.+Bachir-Cherifauthor=D.+Blumauthor=A.+Braendli-Baioccoauthor=E.+Chaputauthor=G.+C.+Duran+Pachecoauthor=N.+Flintauthor=M.+Haikerauthor=J.-C.+Hoflackauthor=N.+Justiesauthor=R.+Neffauthor=V.+Starkeauthor=G.+Steinerauthor=C.+A.+Tournillacauthor=T.+Singerauthor=G.+Ubeaud-S%C3%A9quierauthor=F.+Schuler&title=Characterization+of+Post-Surgical+Alterations+in+the+Bile+Duct-Cannulated+Rat&doi=10.3109%2F00498254.2011.565819"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of post-surgical alterations in the bile duct-cannulated rat</span></div><div class="casAuthors">Bachir-Cherif, Dalila; Blum, Denise; Braendli-Baiocco, Annamaria; Chaput, Evelyne; Duran Pacheco, Gonzalo Christiano; Flint, Nicholas; Haiker, Monika; Hoflack, Jean-Christophe; Justies, Nicole; Neff, Rachel; Starke, Volkmar; Steiner, Guido; Tournillac, Charles Alexandre; Singer, Thomas; Ubeaud-Seequier, Genevieeve; Schuler, Franz</div><div class="citationInfo"><span class="NLM_cas:title">Xenobiotica</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">701-711</span>CODEN:
                <span class="NLM_cas:coden">XENOBH</span>;
        ISSN:<span class="NLM_cas:issn">0049-8254</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">The bile duct-cannulated (BDC) rat is a std. animal model used in ADME expts.  The aim of this study was to investigate post-surgical alterations that are relevant to ADME investigations in BDC rats compared with sham- and non-operated animals.  Water and food intake was reduced in the animals' post-surgery.  This led to a lower body wt. in operated animals.  In BDC animals, aspartate aminotransferase (AST) levels in plasma were transiently elevated and total bile acid levels were reduced.  Alpha1-acid glycoprotein (AGP) in plasma and the concn. of bile components in bile were elevated.  Histopathol. showed inflammation in the area of the cannulation between the liver and the small intestine.  A microarray-based gene expression and RTq-PCR anal. identified altered expression for several genes involved in drug disposition including the down-regulation of cytochrome P 450 enzymes.  This led to reduced cytochrome P 450 content in the liver and lower metabolic activity in microsomes from BDC and sham-operated rats compared with naive animals.  The results of the study suggest that the post-surgical inflammation leads to physiol. changes relevant for drug absorption and disposition.  These alterations should be accounted for in the interpretation of ADME studies in BDC animals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLIqpij33b9LVg90H21EOLACvtfcHk0ljKXqOGZBmUJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosFaltb0%253D&md5=a5c018db9611f037476bd29bc859a2e3</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.3109%2F00498254.2011.565819&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00498254.2011.565819%26sid%3Dliteratum%253Aachs%26aulast%3DBachir-Cherif%26aufirst%3DD.%26aulast%3DBlum%26aufirst%3DD.%26aulast%3DBraendli-Baiocco%26aufirst%3DA.%26aulast%3DChaput%26aufirst%3DE.%26aulast%3DDuran%2BPacheco%26aufirst%3DG.%2BC.%26aulast%3DFlint%26aufirst%3DN.%26aulast%3DHaiker%26aufirst%3DM.%26aulast%3DHoflack%26aufirst%3DJ.-C.%26aulast%3DJusties%26aufirst%3DN.%26aulast%3DNeff%26aufirst%3DR.%26aulast%3DStarke%26aufirst%3DV.%26aulast%3DSteiner%26aufirst%3DG.%26aulast%3DTournillac%26aufirst%3DC.%2BA.%26aulast%3DSinger%26aufirst%3DT.%26aulast%3DUbeaud-S%25C3%25A9quier%26aufirst%3DG.%26aulast%3DSchuler%26aufirst%3DF.%26atitle%3DCharacterization%2520of%2520Post-Surgical%2520Alterations%2520in%2520the%2520Bile%2520Duct-Cannulated%2520Rat%26jtitle%3DXenobiotica%26date%3D2011%26volume%3D41%26spage%3D701%26doi%3D10.3109%2F00498254.2011.565819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wiesmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leder, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blank, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernardi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melkko, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decock, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Arcy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villard, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erbel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freuler, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolay, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alves, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornancin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renatus, M.</span></span> <span> </span><span class="NLM_article-title">Structural Determinants of MALT1 Protease Activity</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>419</i></span>,  <span class="NLM_fpage">4</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2012.02.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1016%2Fj.jmb.2012.02.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=22366302" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC38Xkt1Ghur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=419&publication_year=2012&pages=4&author=C.+Wiesmannauthor=L.+Lederauthor=J.+Blankauthor=A.+Bernardiauthor=S.+Melkkoauthor=A.+Decockauthor=A.+D%E2%80%99Arcyauthor=F.+Villardauthor=P.+Erbelauthor=N.+Hughesauthor=F.+Freulerauthor=R.+Nikolayauthor=J.+Alvesauthor=F.+Bornancinauthor=M.+Renatus&title=Structural+Determinants+of+MALT1+Protease+Activity&doi=10.1016%2Fj.jmb.2012.02.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Determinants of MALT1 Protease Activity</span></div><div class="casAuthors">Wiesmann, Christian; Leder, Lukas; Blank, Jutta; Bernardi, Anna; Melkko, Samu; Decock, Arnaud; D'Arcy, Allan; Villard, Frederic; Erbel, Paulus; Hughes, Nicola; Freuler, Felix; Nikolay, Rainer; Alves, Juliano; Bornancin, Frederic; Renatus, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">419</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">4-21</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The formation of the CBM (CARD11-BCL10-MALT1) complex is pivotal for antigen-receptor-mediated activation of the transcription factor NF-κB.  Signaling is dependent on MALT1 (mucosa-assocd. lymphoid tissue lymphoma translocation protein 1), which not only acts as a scaffolding protein but also possesses proteolytic activity mediated by its caspase-like domain.  It remained unclear how the CBM activates MALT1.  Here, we provide biochem. and structural evidence that MALT1 activation is dependent on its dimerization and show that mutations at the dimer interface abrogate activity in cells.  The unliganded protease presents itself in a dimeric yet inactive state and undergoes substantial conformational changes upon substrate binding.  These structural changes also affect the conformation of the C-terminal Ig-like domain, a domain that is required for MALT1 activity.  Binding to the active site is coupled to a relative movement of caspase and Ig-like domains.  MALT1 binding partners thus may have the potential of tuning MALT1 protease activity without binding directly to the caspase domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDaYh5EEjXC7Vg90H21EOLACvtfcHk0ljKXqOGZBmUJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xkt1Ghur0%253D&md5=a35adbc547fadbe5353ee2d1c2dad767</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2012.02.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2012.02.018%26sid%3Dliteratum%253Aachs%26aulast%3DWiesmann%26aufirst%3DC.%26aulast%3DLeder%26aufirst%3DL.%26aulast%3DBlank%26aufirst%3DJ.%26aulast%3DBernardi%26aufirst%3DA.%26aulast%3DMelkko%26aufirst%3DS.%26aulast%3DDecock%26aufirst%3DA.%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DA.%26aulast%3DVillard%26aufirst%3DF.%26aulast%3DErbel%26aufirst%3DP.%26aulast%3DHughes%26aufirst%3DN.%26aulast%3DFreuler%26aufirst%3DF.%26aulast%3DNikolay%26aufirst%3DR.%26aulast%3DAlves%26aufirst%3DJ.%26aulast%3DBornancin%26aufirst%3DF.%26aulast%3DRenatus%26aufirst%3DM.%26atitle%3DStructural%2520Determinants%2520of%2520MALT1%2520Protease%2520Activity%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2012%26volume%3D419%26spage%3D4%26doi%3D10.1016%2Fj.jmb.2012.02.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Padilla, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhagirath, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiao, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldstein, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hermann, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy-Smith, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuglstatter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowrie, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luk, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owens, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O-Yang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Railkar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoenfeld, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slade, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steiner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, Y.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villaseñor, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wanner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, M. C.</span></span> <span> </span><span class="NLM_article-title">Pyrrolopyrazines as Selective Spleen Tyrosine Kinase Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">1677</span>, <span class="refDoi"> DOI: 10.1021/jm301720p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301720p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFaqurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=1677&author=F.+Padillaauthor=N.+Bhagirathauthor=S.+Chenauthor=E.+Chiaoauthor=D.+M.+Goldsteinauthor=J.+C.+Hermannauthor=J.+Hsuauthor=J.+J.+Kennedy-Smithauthor=A.+Kuglstatterauthor=C.+Liaoauthor=W.+Liuauthor=L.+E.+Lowrieauthor=K.+C.+Lukauthor=S.+M.+Lynchauthor=J.+Menkeauthor=L.+Niuauthor=T.+D.+Owensauthor=C.+O-Yangauthor=A.+Railkarauthor=R.+C.+Schoenfeldauthor=M.+Sladeauthor=S.+Steinerauthor=Y.-C.+Tanauthor=A.+G.+Villase%C3%B1orauthor=C.+Wangauthor=J.+Wannerauthor=W.+Xieauthor=D.+Xuauthor=X.+Zhangauthor=M.+Zhouauthor=M.+C.+Lucas&title=Pyrrolopyrazines+as+Selective+Spleen+Tyrosine+Kinase+Inhibitors&doi=10.1021%2Fjm301720p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrrolopyrazines as Selective Spleen Tyrosine Kinase Inhibitors</span></div><div class="casAuthors">Padilla, Fernando; Bhagirath, Niala; Chen, Shaoqing; Chiao, Eric; Goldstein, David M.; Hermann, Johannes C.; Hsu, Jonathan; Kennedy-Smith, Joshua J.; Kuglstatter, Andreas; Liao, Cheng; Liu, Wenjian; Lowrie, Lee E., Jr.; Luk, Kin Chun; Lynch, Stephen M.; Menke, John; Niu, Linghao; Owens, Timothy D.; O-Yang, Counde; Railkar, Aruna; Schoenfeld, Ryan C.; Slade, Michelle; Steiner, Sandra; Tan, Yun-Chou; Villasenor, Armando G.; Wang, Ce; Wanner, Jutta; Xie, Wenwei; Xu, Daigen; Zhang, Xiaohu; Zhou, Mingyan; Lucas, Matthew C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1677-1692</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors describe the discovery of several pyrrolopyrazines as potent and selective Syk inhibitors and the efforts that eventually led to the desired improvements in physicochem. properties and human whole blood potencies.  Ultimately, the mouse model revealed unexpected toxicity of compd. I that precluded the further advancement of this series.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPn6yiWDGRMbVg90H21EOLACvtfcHk0ljYUZ9ZawGhAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFaqurs%253D&md5=2ab3e28de06e6300547d2a474bd14aef</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm301720p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301720p%26sid%3Dliteratum%253Aachs%26aulast%3DPadilla%26aufirst%3DF.%26aulast%3DBhagirath%26aufirst%3DN.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DChiao%26aufirst%3DE.%26aulast%3DGoldstein%26aufirst%3DD.%2BM.%26aulast%3DHermann%26aufirst%3DJ.%2BC.%26aulast%3DHsu%26aufirst%3DJ.%26aulast%3DKennedy-Smith%26aufirst%3DJ.%2BJ.%26aulast%3DKuglstatter%26aufirst%3DA.%26aulast%3DLiao%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DLowrie%26aufirst%3DL.%2BE.%26aulast%3DLuk%26aufirst%3DK.%2BC.%26aulast%3DLynch%26aufirst%3DS.%2BM.%26aulast%3DMenke%26aufirst%3DJ.%26aulast%3DNiu%26aufirst%3DL.%26aulast%3DOwens%26aufirst%3DT.%2BD.%26aulast%3DO-Yang%26aufirst%3DC.%26aulast%3DRailkar%26aufirst%3DA.%26aulast%3DSchoenfeld%26aufirst%3DR.%2BC.%26aulast%3DSlade%26aufirst%3DM.%26aulast%3DSteiner%26aufirst%3DS.%26aulast%3DTan%26aufirst%3DY.-C.%26aulast%3DVillase%25C3%25B1or%26aufirst%3DA.%2BG.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DWanner%26aufirst%3DJ.%26aulast%3DXie%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DM.%26aulast%3DLucas%26aufirst%3DM.%2BC.%26atitle%3DPyrrolopyrazines%2520as%2520Selective%2520Spleen%2520Tyrosine%2520Kinase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D1677%26doi%3D10.1021%2Fjm301720p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kubiak, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rothbauer, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laufer, S.</span></span> <span> </span><span class="NLM_article-title">From Enzyme to Whole Blood: Sequential Screening Procedure for Identification and Evaluation of P38 MAPK Inhibitors</span>. <i>Methods Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>1360</i></span>,  <span class="NLM_fpage">123</span>, <span class="refDoi"> DOI: 10.1007/978-1-4939-3073-9_10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1007%2F978-1-4939-3073-9_10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=26501907" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC2sXntVenu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1360&publication_year=2016&pages=123&author=S.+M.+Bauerauthor=J.+M.+Kubiakauthor=U.+Rothbauerauthor=S.+Laufer&title=From+Enzyme+to+Whole+Blood%3A+Sequential+Screening+Procedure+for+Identification+and+Evaluation+of+P38+MAPK+Inhibitors&doi=10.1007%2F978-1-4939-3073-9_10"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">From Enzyme to Whole Blood: Sequential Screening Procedure for Identification and Evaluation of p38 MAPK Inhibitors</span></div><div class="casAuthors">Bauer, Silke M.; Kubiak, Jakub M.; Rothbauer, Ulrich; Laufer, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">1360</span>
        (<span class="NLM_cas:issue">Kinase Screening and Profiling</span>),
    <span class="NLM_cas:pages">123-148</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1940-6029</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">P38 mitogen-activated protein kinase (MAPK) is a pivotal enzyme in the biosynthesis of pro-inflammatory cytokines like IL-1 and TNF.  Therefore, the success of anti-cytokine therapy for treatment of inflammatory processes qualified p38-MAPK as a solid target in drug research concerning chronic inflammatory diseases including infectious vascular, neurobiol., and autoimmune disorders.  However, the discovery of new kinase inhibitors is limited by the need for a high biol. activity combined with restricted activity to the target enzyme or pathway interaction.  As a consequence, no p38 MAPK inhibitor has been introduced to the market so far, although several p38 inhibitors have proceeded into clin. trials.  The development of novel inhibitor types and optimization of already known structural classes of MAPK inhibitors require appropriate testing systems reaching across these crucial parameters.  As a new approach, we describe the sequential arrangement of three testing systems custom-tailored to the requirements of drug discovery programs with focus on p38 inhibition.  Integrated anal. of the obtained results enables a concerted step-by-step selection of tested mols. in order to screen a compd. library for the most suitable inhibitor.  First, evaluation of the inhibitor's activity on the isolated p38 MAPK enzyme via an ELISA assay gives a first idea about the inhibitory potency of the mol.  Moreover, structure-activity relationships can be elucidated when comparing mols. within inhibitor series.  Second, screening in living cells via a p38 substrate-specific MK2-EGFP translocation assay supplies further information about efficacy, but provides also a first notion concerning selectivity and toxicity.  Third, efficacy is evaluated more specifically in vivo in LPS-stimulated human whole blood with regard to in vivo parameters, e.g., pharmacokinetic characteristics like plasma protein binding and cellular permeability.  These three testing systems complement one another synergistically by providing a high overlap and predictability.  Clear advantages of all presented systems are their realizability in an academic environment as well as their applicability for high-throughput screenings on a larger scale.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzgA7iA4wN77Vg90H21EOLACvtfcHk0ljYUZ9ZawGhAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXntVenu7Y%253D&md5=3b170d3e07e05e52d383d2acf1525b02</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1007%2F978-1-4939-3073-9_10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-4939-3073-9_10%26sid%3Dliteratum%253Aachs%26aulast%3DBauer%26aufirst%3DS.%2BM.%26aulast%3DKubiak%26aufirst%3DJ.%2BM.%26aulast%3DRothbauer%26aufirst%3DU.%26aulast%3DLaufer%26aufirst%3DS.%26atitle%3DFrom%2520Enzyme%2520to%2520Whole%2520Blood%253A%2520Sequential%2520Screening%2520Procedure%2520for%2520Identification%2520and%2520Evaluation%2520of%2520P38%2520MAPK%2520Inhibitors%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2016%26volume%3D1360%26spage%3D123%26doi%3D10.1007%2F978-1-4939-3073-9_10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brandt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bendfeldt, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinke, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radbruch, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Worm, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumgrass, R.</span></span> <span> </span><span class="NLM_article-title">Whole Blood Flow Cytometric Measurement of NFATc1 and IL-2 Expression to Analyze Cyclosporine a-Mediated Effects in T Cells</span>. <i>Cytometry, Part A</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>77A</i></span>,  <span class="NLM_fpage">607</span>, <span class="refDoi"> DOI: 10.1002/cyto.a.20928</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1002%2Fcyto.a.20928" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpvVemurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77A&publication_year=2010&pages=607&author=C.+Brandtauthor=P.+Limanauthor=H.+Bendfeldtauthor=K.+Muellerauthor=P.+Reinkeauthor=A.+Radbruchauthor=M.+Wormauthor=R.+Baumgrass&title=Whole+Blood+Flow+Cytometric+Measurement+of+NFATc1+and+IL-2+Expression+to+Analyze+Cyclosporine+a-Mediated+Effects+in+T+Cells&doi=10.1002%2Fcyto.a.20928"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Whole blood flow cytometric measurement of and IL-2 expression to analyze cyclosporine A-mediated effects in T cells</span></div><div class="casAuthors">Brandt, Claudia; Liman, Peter; Bendfeldt, Hanna; Mueller, Karin; Reinke, Petra; Radbruch, Andreas; Worm, Margitta; Baumgrass, Ria</div><div class="citationInfo"><span class="NLM_cas:title">Cytometry, Part A</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">77A</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">607-613</span>CODEN:
                <span class="NLM_cas:coden">CPAYAV</span>;
        ISSN:<span class="NLM_cas:issn">1552-4922</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The calcineurin inhibitor Cyclosporine A (CsA) is one of the crucial immunosuppressive drugs given after organ transplantation.  The small therapeutic window of CsA generates the dilemma that efficient and toxic drug doses differ only slightly.  Moreover, these threshold concns. differ considerably between individuals; therefore, functional assays are urgently needed.  We explored whether the transcription factor NFATc1, a direct as well as indirect target of CsA, can be used as a potential biomarker to det. the individual immunosuppressive activity of CsA.  First, in isolated human T cells we showed that flow cytometry is practicable to measure NFATc1, the most abundant NFATc isoform in activated T cells.  Second, for whole blood we developed a flow cytometric assay to det. in parallel the inducible transcription factor NFATc1 and the cytokine IL-2 in stimulated T cells.  We found that added CsA inhibits both the expression of NFATc1 and IL-2 in T cells of stimulated whole blood samples with IC50 values of 200 and 150 nM, resp.  The intra- and inter-assay variability was low, and clin. practicability was good.  Further expts. have to demonstrate whether the parallel cytometric measurement of NFATc1 and IL-2 in whole blood is a good predictor of individual CsA efficacy and toxicity in CsA-treated patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjl8BYYi4cGrVg90H21EOLACvtfcHk0ljYUZ9ZawGhAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpvVemurc%253D&md5=f20fa76c51d5e1a5b261ec1bd777b3e7</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1002%2Fcyto.a.20928&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcyto.a.20928%26sid%3Dliteratum%253Aachs%26aulast%3DBrandt%26aufirst%3DC.%26aulast%3DLiman%26aufirst%3DP.%26aulast%3DBendfeldt%26aufirst%3DH.%26aulast%3DMueller%26aufirst%3DK.%26aulast%3DReinke%26aufirst%3DP.%26aulast%3DRadbruch%26aufirst%3DA.%26aulast%3DWorm%26aufirst%3DM.%26aulast%3DBaumgrass%26aufirst%3DR.%26atitle%3DWhole%2520Blood%2520Flow%2520Cytometric%2520Measurement%2520of%2520NFATc1%2520and%2520IL-2%2520Expression%2520to%2520Analyze%2520Cyclosporine%2520a-Mediated%2520Effects%2520in%2520T%2520Cells%26jtitle%3DCytometry%252C%2520Part%2520A%26date%3D2010%26volume%3D77A%26spage%3D607%26doi%3D10.1002%2Fcyto.a.20928" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wentsch, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayer-Wrangowski, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storch, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niess, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koeberle, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grütter, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boeckler, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rauh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laufer, S. A.</span></span> <span> </span><span class="NLM_article-title">Dibenzosuberones as P38 Mitogen-Activated Protein Kinase Inhibitors with Low ATP Competitiveness and Outstanding Whole Blood Activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">241</span>, <span class="refDoi"> DOI: 10.1021/jm301539x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301539x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvFWiurzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=241&author=S.+Fischerauthor=H.+K.+Wentschauthor=S.+C.+Mayer-Wrangowskiauthor=M.+Zimmermannauthor=S.+M.+Bauerauthor=K.+Storchauthor=R.+Niessauthor=S.+C.+Koeberleauthor=C.+Gr%C3%BCtterauthor=F.+M.+Boecklerauthor=D.+Rauhauthor=S.+A.+Laufer&title=Dibenzosuberones+as+P38+Mitogen-Activated+Protein+Kinase+Inhibitors+with+Low+ATP+Competitiveness+and+Outstanding+Whole+Blood+Activity&doi=10.1021%2Fjm301539x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Dibenzosuberones as p38 Mitogen-Activated Protein Kinase Inhibitors with Low ATP Competitiveness and Outstanding Whole Blood Activity</span></div><div class="casAuthors">Fischer, Stefan; Wentsch, Heike K.; Mayer-Wrangowski, Svenja C.; Zimmermann, Markus; Bauer, Silke M.; Storch, Kirsten; Niess, Raimund; Koeberle, Solveigh C.; Gruetter, Christian; Boeckler, Frank M.; Rauh, Daniel; Laufer, Stefan A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">241-253</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">P38α mitogen-activated protein (MAP) kinase is a main target in drug research concerning inflammatory diseases.  Nevertheless, no inhibitor of p38α MAP kinase has been introduced to the market.  This might be attributed to the fact that there is no inhibitor which combines outstanding activity in biol. systems and selectivity.  Herein an approach to the development of such inhibitors on the basis of the highly selective mol. probe Skepinone-L (I) is described.  Introduction of a "deep pocket" moiety addressing the DFG motif led to an increased activity of the compds.  Hydrophilic moieties, addressing the solvent-exposed area adjacent to hydrophilic region II, conserved a high activity of the compds. in a whole blood assay.  Combined with their outstanding selectivity and low ATP competitiveness, these inhibitors are very interesting candidates for use in biol. systems and in therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbi31syvBEYrVg90H21EOLACvtfcHk0ljhY8Bq7rmX2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvFWiurzP&md5=bfce0ba26af365a1d218095e54ba169f</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm301539x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301539x%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DS.%26aulast%3DWentsch%26aufirst%3DH.%2BK.%26aulast%3DMayer-Wrangowski%26aufirst%3DS.%2BC.%26aulast%3DZimmermann%26aufirst%3DM.%26aulast%3DBauer%26aufirst%3DS.%2BM.%26aulast%3DStorch%26aufirst%3DK.%26aulast%3DNiess%26aufirst%3DR.%26aulast%3DKoeberle%26aufirst%3DS.%2BC.%26aulast%3DGr%25C3%25BCtter%26aufirst%3DC.%26aulast%3DBoeckler%26aufirst%3DF.%2BM.%26aulast%3DRauh%26aufirst%3DD.%26aulast%3DLaufer%26aufirst%3DS.%2BA.%26atitle%3DDibenzosuberones%2520as%2520P38%2520Mitogen-Activated%2520Protein%2520Kinase%2520Inhibitors%2520with%2520Low%2520ATP%2520Competitiveness%2520and%2520Outstanding%2520Whole%2520Blood%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D241%26doi%3D10.1021%2Fjm301539x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leach, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cosgrove, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenny, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruston, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacFaul, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colclough, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Law, B.</span></span> <span> </span><span class="NLM_article-title">Matched Molecular Pairs as a Guide in the Optimization of Pharmaceutical Properties; a Study of Aqueous Solubility, Plasma Protein Binding and Oral Exposure</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">6672</span>, <span class="refDoi"> DOI: 10.1021/jm0605233</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0605233" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtV2gtLnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6672&author=A.+G.+Leachauthor=H.+D.+Jonesauthor=D.+A.+Cosgroveauthor=P.+W.+Kennyauthor=L.+Rustonauthor=P.+MacFaulauthor=J.+M.+Woodauthor=N.+Colcloughauthor=B.+Law&title=Matched+Molecular+Pairs+as+a+Guide+in+the+Optimization+of+Pharmaceutical+Properties%3B+a+Study+of+Aqueous+Solubility%2C+Plasma+Protein+Binding+and+Oral+Exposure&doi=10.1021%2Fjm0605233"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Matched Molecular Pairs as a Guide in the Optimization of Pharmaceutical Properties; a Study of Aqueous Solubility, Plasma Protein Binding and Oral Exposure</span></div><div class="casAuthors">Leach, Andrew G.; Jones, Huw D.; Cosgrove, David A.; Kenny, Peter W.; Ruston, Linette; MacFaul, Philip; Wood, J. Matthew; Colclough, Nicola; Law, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6672-6682</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">By identifying every pair of mols. that differ only by a particular, well-defined, structural transformation in a database of measured properties and computing the corresponding change in property, we obtain an overview of the effect that structural change has upon the property and set an expectation for what will happen when that transformation is applied elsewhere.  The mean change indicates the expected magnitude of the change in the property and the no. of cases in which the property increases give the probability that the structural transformation will cause the property to increase.  Outliers indicate potential ways of avoiding the general trend.  Comparing to changes in lipophilicity highlights structural transformations that have unusual effects, some of which can be explained by conformational changes.  In this paper, we focus upon the effects on aq. soly., plasma protein binding and oral exposure of adding substituents to arom. rings and methylating heteroatoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcyrloR79Oq7Vg90H21EOLACvtfcHk0ljhY8Bq7rmX2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtV2gtLnO&md5=2c143b424aee3ddb6c34616aff699ee0</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm0605233&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0605233%26sid%3Dliteratum%253Aachs%26aulast%3DLeach%26aufirst%3DA.%2BG.%26aulast%3DJones%26aufirst%3DH.%2BD.%26aulast%3DCosgrove%26aufirst%3DD.%2BA.%26aulast%3DKenny%26aufirst%3DP.%2BW.%26aulast%3DRuston%26aufirst%3DL.%26aulast%3DMacFaul%26aufirst%3DP.%26aulast%3DWood%26aufirst%3DJ.%2BM.%26aulast%3DColclough%26aufirst%3DN.%26aulast%3DLaw%26aufirst%3DB.%26atitle%3DMatched%2520Molecular%2520Pairs%2520as%2520a%2520Guide%2520in%2520the%2520Optimization%2520of%2520Pharmaceutical%2520Properties%253B%2520a%2520Study%2520of%2520Aqueous%2520Solubility%252C%2520Plasma%2520Protein%2520Binding%2520and%2520Oral%2520Exposure%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6672%26doi%3D10.1021%2Fjm0605233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohr, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, M.</span></span> <span> </span><span class="NLM_article-title">Intramolecular Hydrogen Bonding in Medicinal Chemistry</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2601</span>, <span class="refDoi"> DOI: 10.1021/jm100087s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100087s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC3cXit1Clur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2601&author=B.+Kuhnauthor=P.+Mohrauthor=M.+Stahl&title=Intramolecular+Hydrogen+Bonding+in+Medicinal+Chemistry&doi=10.1021%2Fjm100087s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Intramolecular Hydrogen Bonding in Medicinal Chemistry</span></div><div class="casAuthors">Kuhn, Bernd; Mohr, Peter; Stahl, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2601-2611</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The formation of intramol. hydrogen bonds has a very pronounced effect on mol. structure and properties.  We study both aspects in detail with the aim of enabling a more rational use of this class of interactions in medicinal chem.  On the basis of exhaustive searches in crystal structure databases, we derive propensities for intramol. hydrogen bond formation of five- to eight-membered ring systems of relevance in drug discovery.  A no. of motifs, several of which are clearly underutilized in drug discovery, are analyzed in more detail by comparing small mol. and protein-ligand X-ray structures.  To investigate effects on physicochem. properties, sets of closely related structures with and without the ability to form intramol. hydrogen bonds were designed, synthesized, and characterized with respect to membrane permeability, water soly., and lipophilicity.  We find that changes in these properties depend on a subtle balance between the strength of the hydrogen bond interaction, geometry of the newly formed ring system, and the relative energies of the open and closed conformations in polar and unpolar environments.  A no. of general guidelines for medicinal chemists emerge from this study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdaV7tFRU4k7Vg90H21EOLACvtfcHk0lh0c2YpB0l-qQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXit1Clur8%253D&md5=b9b6865dfcc9bdf7796d15218f6e8ff2</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm100087s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100087s%26sid%3Dliteratum%253Aachs%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DMohr%26aufirst%3DP.%26aulast%3DStahl%26aufirst%3DM.%26atitle%3DIntramolecular%2520Hydrogen%2520Bonding%2520in%2520Medicinal%2520Chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2601%26doi%3D10.1021%2Fjm100087s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byrne, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffiths, L.</span></span> <span> </span><span class="NLM_article-title">NMR Method for the Determination of Solute Hydrogen Bond Acidity</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">3389</span>, <span class="refDoi"> DOI: 10.1021/jo052631n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo052631n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BD28XivF2qt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2006&pages=3389&author=M.+H.+Abrahamauthor=R.+J.+Abrahamauthor=J.+Byrneauthor=L.+Griffiths&title=NMR+Method+for+the+Determination+of+Solute+Hydrogen+Bond+Acidity&doi=10.1021%2Fjo052631n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">NMR Method for the Determination of Solute Hydrogen Bond Acidity</span></div><div class="casAuthors">Abraham, Michael H.; Abraham, Raymond J.; Byrne, Jonathan; Griffiths, Lee</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3389-3394</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">It is shown that the difference in the 1H NMR chem. shift of a protic hydrogen in DMSO and CDCl3 solvents is directly related to the overall, or summation, hydrogen bond acidity for a wide range of solutes.  This provides a new and direct method of measuring the hydrogen bond acidity.  For 54 compds., the obsd. shifts for 72 protic hydrogens could be correlated to the Abraham solute hydrogen bond acidity parameter, A, with a correlation coeff. squared, R2, of 0.938 and a std. deviation, SD, of 0.054 units in A.  A training equation that used half the data could predict A values for the remaining data with an av. error of 0.001 and a std. deviation, SD, of 0.053 units, thus demonstrating the predictive power of the method.  Unlike any previous method for the detn. of solute hydrogen bond acidities, the NMR method allows the detn. of A values for individual protic hydrogens in multifunctional solutes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjlb-QytDX37Vg90H21EOLACvtfcHk0lh0c2YpB0l-qQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XivF2qt7s%253D&md5=6c74f59a2aba5d0ac75d2bbb842c97ea</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjo052631n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo052631n%26sid%3Dliteratum%253Aachs%26aulast%3DAbraham%26aufirst%3DM.%2BH.%26aulast%3DAbraham%26aufirst%3DR.%2BJ.%26aulast%3DByrne%26aufirst%3DJ.%26aulast%3DGriffiths%26aufirst%3DL.%26atitle%3DNMR%2520Method%2520for%2520the%2520Determination%2520of%2520Solute%2520Hydrogen%2520Bond%2520Acidity%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2006%26volume%3D71%26spage%3D3389%26doi%3D10.1021%2Fjo052631n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acree, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aliev, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leo, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whaley, W. L.</span></span> <span> </span><span class="NLM_article-title">An NMR Method for the Quantitative Assessment of Intramolecular Hydrogen Bonding; Application to Physicochemical, Environmental, and Biochemical Properties</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">11075</span>, <span class="refDoi"> DOI: 10.1021/jo502080p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo502080p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVensLrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2014&pages=11075&author=M.+H.+Abrahamauthor=R.+J.+Abrahamauthor=W.+E.+Acreeauthor=A.+E.+Alievauthor=A.+J.+Leoauthor=W.+L.+Whaley&title=An+NMR+Method+for+the+Quantitative+Assessment+of+Intramolecular+Hydrogen+Bonding%3B+Application+to+Physicochemical%2C+Environmental%2C+and+Biochemical+Properties&doi=10.1021%2Fjo502080p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">An NMR Method for the Quantitative Assessment of Intramolecular Hydrogen Bonding; Application to Physicochemical, Environmental, and Biochemical Properties</span></div><div class="casAuthors">Abraham, Michael H.; Abraham, Raymond J.; Acree, William E.; Aliev, Abil E.; Leo, Al J.; Whaley, William L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">11075-11083</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">1H NMR chem. shifts have been obtained in the solvents deuterochloroform and DMSO.  The difference in the chem. shifts of an OH or NH group in these two solvents, Δδ = δ(DMSO) - δ(CDCl3), can be converted into the hydrogen bond acidity, A, of the group using the equation A = 0.0065 + 0.133Δδ.  The NMR A value, ANMR, can be used as a quant. assessment of intramol. hydrogen bonding.  We list values of Δδ and ANMR for 55 compds. contg. an OH group and 60 compds. with an NH group.  For the hydroxy compds., if A > 0.5 then the OH group is not part of an intramol. hydrogen bond, but if A < 0.1 then the OH group forms part of an intramol. hydrogen bond.  For NH compds., if A > 0.16 the NH group is not part of an intramol. hydrogen bond, and if A < 0.05 the NH group is part of an intramol. hydrogen bond.  No comparison compds. are needed, and the method is extremely simple.  We further show how it is possible to relate intramol. hydrogen bonding to the actual effect on values of a no. of physicochem., environmental, and biochem. properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpS3GZXQi7robVg90H21EOLACvtfcHk0lh0c2YpB0l-qQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVensLrM&md5=b5e9948a04237fadb3b4fc3237bde8b1</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjo502080p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo502080p%26sid%3Dliteratum%253Aachs%26aulast%3DAbraham%26aufirst%3DM.%2BH.%26aulast%3DAbraham%26aufirst%3DR.%2BJ.%26aulast%3DAcree%26aufirst%3DW.%2BE.%26aulast%3DAliev%26aufirst%3DA.%2BE.%26aulast%3DLeo%26aufirst%3DA.%2BJ.%26aulast%3DWhaley%26aufirst%3DW.%2BL.%26atitle%3DAn%2520NMR%2520Method%2520for%2520the%2520Quantitative%2520Assessment%2520of%2520Intramolecular%2520Hydrogen%2520Bonding%253B%2520Application%2520to%2520Physicochemical%252C%2520Environmental%252C%2520and%2520Biochemical%2520Properties%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2014%26volume%3D79%26spage%3D11075%26doi%3D10.1021%2Fjo502080p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Junker, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tritto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutter, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubic-Schneider, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niwa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlapbach, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigaud, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beerli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Littlewood-Evans, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudolph, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laisney, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ledieu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beltz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quancard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornancin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamurovic Ribrioux, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calzascia, T.</span></span> <span> </span><span class="NLM_article-title">Pharmacological Inhibition of MALT1 Protease Leads to a Progressive IPEX-Like Pathology</span>. <i>Front. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">745</span>, <span class="refDoi"> DOI: 10.3389/fimmu.2020.00745</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.3389%2Ffimmu.2020.00745" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=32425939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitVWns7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=745&author=K.+Martinauthor=U.+Junkerauthor=E.+Trittoauthor=E.+Sutterauthor=T.+Rubic-Schneiderauthor=H.+Morganauthor=S.+Niwaauthor=J.+Liauthor=A.+Schlapbachauthor=D.+Walkerauthor=M.+Bigaudauthor=C.+Beerliauthor=A.+Littlewood-Evansauthor=B.+Rudolphauthor=M.+Laisneyauthor=D.+Ledieuauthor=K.+Beltzauthor=J.+Quancardauthor=F.+Bornancinauthor=N.+Zamurovic+Ribriouxauthor=T.+Calzascia&title=Pharmacological+Inhibition+of+MALT1+Protease+Leads+to+a+Progressive+IPEX-Like+Pathology&doi=10.3389%2Ffimmu.2020.00745"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological inhibition of MALT1 protease leads to a progressive IPEX-like pathology</span></div><div class="casAuthors">Martin, Kea; Junker, Ursula; Tritto, Elaine; Sutter, Esther; Rubic-Schneider, Tina; Morgan, Hannah; Saba, Ingrid; Lu, Jinghua; Bhattacharya, Abhisek; Tai, Xuguang; Guinter, Terry I.; Engelhardt, Britta; Alag, Amala; Rojano, Mirelle; Ashe, Jennifer M.; Hanada, Ken-Ichi; Yang, James C.; Sun, Peter D.; Singer, Alfred</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Immunology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">745</span>CODEN:
                <span class="NLM_cas:coden">FIRMCW</span>;
        ISSN:<span class="NLM_cas:issn">1664-3224</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Genetic disruption or short-term pharmacol. inhibition of MALT1 protease is effective in several preclin. models of autoimmunity and B cell malignancies.  Despite these protective effects, the severe redn. in regulatory T cells (Tregs) and the assocd. IPEX-like pathol. occurring upon congenital disruption of the MALT1 protease in mice has raised concerns about the long-term safety of MALT1 inhibition.  Here we describe the results of a series of toxicol. studies in rat and dog species using MLT-943, a novel potent and selective MALT1 protease inhibitor.  While MLT943 effectively prevented T cell-dependent B cell immune responses and reduced joint inflammation in the collagen-induced arthritis rat pharmacol. model, in both preclin. species, pharmacol. inhibition of MALT1 was assocd. with a rapid and dosedependent redn. in Tregs and resulted in the progressive appearance of immune abnormalities and clin. signs of an IPEX-like pathol.  At the 13-wk time point, rats displayed severe intestinal inflammation assocd. with mast cell activation, high serum IgE levels, systemic T cell activation and mononuclear cell infiltration in multiple tissues.  Importantly, using thymectomized rats we demonstrated that MALT1 protease inhibition affects peripheral Treg frequency independently of effects on thymic Treg output and development.  Our data confirm the therapeutic potential of MALT1 protease inhibitors but highlight the safety risks and challenges to consider before potential application of such inhibitors into the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqyqdJM-CkubVg90H21EOLACvtfcHk0lh0c2YpB0l-qQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitVWns7vJ&md5=8fa2e57b2111b45c0a6dda682e40e378</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.3389%2Ffimmu.2020.00745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffimmu.2020.00745%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DK.%26aulast%3DJunker%26aufirst%3DU.%26aulast%3DTritto%26aufirst%3DE.%26aulast%3DSutter%26aufirst%3DE.%26aulast%3DRubic-Schneider%26aufirst%3DT.%26aulast%3DMorgan%26aufirst%3DH.%26aulast%3DNiwa%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DSchlapbach%26aufirst%3DA.%26aulast%3DWalker%26aufirst%3DD.%26aulast%3DBigaud%26aufirst%3DM.%26aulast%3DBeerli%26aufirst%3DC.%26aulast%3DLittlewood-Evans%26aufirst%3DA.%26aulast%3DRudolph%26aufirst%3DB.%26aulast%3DLaisney%26aufirst%3DM.%26aulast%3DLedieu%26aufirst%3DD.%26aulast%3DBeltz%26aufirst%3DK.%26aulast%3DQuancard%26aufirst%3DJ.%26aulast%3DBornancin%26aufirst%3DF.%26aulast%3DZamurovic%2BRibrioux%26aufirst%3DN.%26aulast%3DCalzascia%26aufirst%3DT.%26atitle%3DPharmacological%2520Inhibition%2520of%2520MALT1%2520Protease%2520Leads%2520to%2520a%2520Progressive%2520IPEX-Like%2520Pathology%26jtitle%3DFront.%2520Immunol.%26date%3D2020%26volume%3D11%26spage%3D745%26doi%3D10.3389%2Ffimmu.2020.00745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van
Breemen, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span> <span> </span><span class="NLM_article-title">Caco-2 Cell Permeability Assays to Measure Drug Absorption</span>. <i>Expet Opin. Drug Metabol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">175</span>, <span class="refDoi"> DOI: 10.1517/17425255.1.2.175</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1517%2F17425255.1.2.175" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=16922635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVKltLbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2005&pages=175&author=R.+B.+Van%0ABreemenauthor=Y.+Li&title=Caco-2+Cell+Permeability+Assays+to+Measure+Drug+Absorption&doi=10.1517%2F17425255.1.2.175"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Caco-2 cell permeability assays to measure drug absorption</span></div><div class="casAuthors">van Breemen, Richard B.; Li, Yongmei</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">175-185</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Caco-2 cells are a human colon epithelial cancer cell line used as a model of human intestinal absorption of drugs and other compds.  When cultured as a monolayer, Caco-2 cells differentiate to form tight junctions between cells to serve as a model of paracellular movement of compds. across the mono-layer.  In addn., Caco-2 cells express transporter proteins, efflux proteins, and Phase II conjugation enzymes to model a variety of transcellular pathways as well as metabolic transformation of test substances.  In many respects, the Caco-2 cell monolayer mimics the human intestinal epithelium.  One of the functional differences between normal cells and Caco-2 cells is the lack of expression of the cytochrome P 450 isoenzymes and in particular, CYP3A4, which is normally expressed at high levels in the intestine.  However, Caco-2 cells may be induced to express higher levels of CYP3A4 by treatment with vitamin D3.  Caco-2 cell monolayers are usually cultured on semipermeable plastic supports that may be fitted into the wells of multi-well culture plates.  Test compds. are then added to either the apical or basolateral sides of the monolayer.  After incubation for various lengths of time, aliquots of the buffer in opposite chambers are removed for the detn. of the concn. of test compds. and the computation of the rates of permeability for each compd. (called the apparent permeability coeffs.).  Although radiolabeled compds. were used in the original Caco-2 cells monolayer assays, radio-labeled compds. have been replaced in most labs. by the use of liq. chromatog.-mass spectrometry (LC-MS) and LC-tandem mass spectrometry (LC-MS-MS).  Mass spectrometry not only eliminates the need for radiolabeled compds., but permits the simultaneous measurement of multiple compds.  The measurement of multiple compds. per assay reduces the no. of incubations that need to be carried out, thereby increasing the throughput of the expts.  Furthermore, LC-MS and LC-MS-MS add another dimension to Caco-2 assays by facilitating the investigation of the metab. of compds. by Caco-2 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcV-AZvy78ILVg90H21EOLACvtfcHk0ljgLJVFryc8dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVKltLbK&md5=7bd0b875ffa9c840f904bab6513b7e3f</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1517%2F17425255.1.2.175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425255.1.2.175%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BBreemen%26aufirst%3DR.%2BB.%26aulast%3DLi%26aufirst%3DY.%26atitle%3DCaco-2%2520Cell%2520Permeability%2520Assays%2520to%2520Measure%2520Drug%2520Absorption%26jtitle%3DExpet%2520Opin.%2520Drug%2520Metabol.%2520Toxicol.%26date%3D2005%26volume%3D1%26spage%3D175%26doi%3D10.1517%2F17425255.1.2.175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lenz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngo, V. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">George, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dave, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenwald, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ott, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller-Hermelink, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gascoyne, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connors, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rimsza, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaffe, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delabie, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smeland, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staudt, L. M.</span></span> <span> </span><span class="NLM_article-title">Oncogenic CARD11 Mutations in Human Diffuse Large B Cell Lymphoma</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>319</i></span>,  <span class="NLM_fpage">1676</span>– <span class="NLM_lpage">1679</span>, <span class="refDoi"> DOI: 10.1126/science.1153629</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1126%2Fscience.1153629" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=18323416" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjsVamtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=319&publication_year=2008&pages=1676-1679&author=G.+Lenzauthor=R.+E.+Davisauthor=V.+N.+Ngoauthor=L.+Lamauthor=T.+C.+Georgeauthor=G.+W.+Wrightauthor=S.+S.+Daveauthor=H.+Zhaoauthor=W.+Xuauthor=A.+Rosenwaldauthor=G.+Ottauthor=H.+K.+Muller-Hermelinkauthor=R.+D.+Gascoyneauthor=J.+M.+Connorsauthor=L.+M.+Rimszaauthor=E.+Campoauthor=E.+S.+Jaffeauthor=J.+Delabieauthor=E.+B.+Smelandauthor=R.+I.+Fisherauthor=W.+C.+Chanauthor=L.+M.+Staudt&title=Oncogenic+CARD11+Mutations+in+Human+Diffuse+Large+B+Cell+Lymphoma&doi=10.1126%2Fscience.1153629"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Oncogenic CARD11 Mutations in Human Diffuse Large B Cell Lymphoma</span></div><div class="casAuthors">Lenz, Georg; Davis, R. Eric; Ngo, Vu N.; Lam, Lloyd; George, Thaddeus C.; Wright, George W.; Dave, Sandeep S.; Zhao, Hong; Xu, Weihong; Rosenwald, Andreas; Ott, German; Muller-Hermelink, Hans Konrad; Gascoyne, Randy D.; Connors, Joseph M.; Rimsza, Lisa M.; Campo, Elias; Jaffe, Elaine S.; Delabie, Jan; Smeland, Erlend B.; Fisher, Richard I.; Chan, Wing C.; Staudt, Louis M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">319</span>
        (<span class="NLM_cas:issue">5870</span>),
    <span class="NLM_cas:pages">1676-1679</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Diffuse large B cell lymphoma (DLBCL) is the most common form of non-Hodgkin's lymphoma.  In the least curable (ABC) subtype of DLBCL, survival of the malignant cells is dependent on constitutive activation of the nuclear factor-κB (NF-κB) signaling pathway.  In normal B cells, antigen receptor-induced NF-κB activation requires CARD11, a cytoplasmic scaffolding protein.  To det. whether CARD11 contributes to tumorigenesis, we sequenced the CARD11 gene in human DLBCL tumors.  We detected missense mutations in 7 of 73 ABC DLBCL biopsies (9.6%), all within exons encoding the coiled-coil domain.  Exptl. introduction of CARD11 coiled-coil domain mutants into lymphoma cell lines resulted in constitutive NF-κB activation and enhanced NF-κB activity upon antigen receptor stimulation.  These results demonstrate that CARD11 is a bona fide oncogene in DLBCL, providing a genetic rationale for the development of pharmacol. inhibitors of the CARD11 pathway for DLBCL therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaK7D2i-dr9bVg90H21EOLACvtfcHk0ljgLJVFryc8dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjsVamtbg%253D&md5=207cb84e62aa402dd2032ae842a97033</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1126%2Fscience.1153629&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1153629%26sid%3Dliteratum%253Aachs%26aulast%3DLenz%26aufirst%3DG.%26aulast%3DDavis%26aufirst%3DR.%2BE.%26aulast%3DNgo%26aufirst%3DV.%2BN.%26aulast%3DLam%26aufirst%3DL.%26aulast%3DGeorge%26aufirst%3DT.%2BC.%26aulast%3DWright%26aufirst%3DG.%2BW.%26aulast%3DDave%26aufirst%3DS.%2BS.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DRosenwald%26aufirst%3DA.%26aulast%3DOtt%26aufirst%3DG.%26aulast%3DMuller-Hermelink%26aufirst%3DH.%2BK.%26aulast%3DGascoyne%26aufirst%3DR.%2BD.%26aulast%3DConnors%26aufirst%3DJ.%2BM.%26aulast%3DRimsza%26aufirst%3DL.%2BM.%26aulast%3DCampo%26aufirst%3DE.%26aulast%3DJaffe%26aufirst%3DE.%2BS.%26aulast%3DDelabie%26aufirst%3DJ.%26aulast%3DSmeland%26aufirst%3DE.%2BB.%26aulast%3DFisher%26aufirst%3DR.%2BI.%26aulast%3DChan%26aufirst%3DW.%2BC.%26aulast%3DStaudt%26aufirst%3DL.%2BM.%26atitle%3DOncogenic%2520CARD11%2520Mutations%2520in%2520Human%2520Diffuse%2520Large%2520B%2520Cell%2520Lymphoma%26jtitle%3DScience%26date%3D2008%26volume%3D319%26spage%3D1676%26epage%3D1679%26doi%3D10.1126%2Fscience.1153629" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davis, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngo, V. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romesser, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohlhammer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamy, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaffer, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J.-k.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenwald, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ott, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller-Hermelink, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gascoyne, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connors, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rimsza, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaffe, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delabie, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smeland, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braziel, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tubbs, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weisenburger, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staudt, L. M.</span></span> <span> </span><span class="NLM_article-title">Chronic Active B-Cell-Receptor Signalling in Diffuse Large B-Cell Lymphoma</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>463</i></span>,  <span class="NLM_fpage">88</span>– <span class="NLM_lpage">92</span>, <span class="refDoi"> DOI: 10.1038/nature08638</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1038%2Fnature08638" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=20054396" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhvFCitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=463&publication_year=2010&pages=88-92&author=R.+E.+Davisauthor=V.+N.+Ngoauthor=G.+Lenzauthor=P.+Tolarauthor=R.+M.+Youngauthor=P.+B.+Romesserauthor=H.+Kohlhammerauthor=L.+Lamyauthor=H.+Zhaoauthor=Y.+Yangauthor=W.+Xuauthor=A.+L.+Shafferauthor=G.+Wrightauthor=W.+Xiaoauthor=J.+Powellauthor=J.-k.+Jiangauthor=C.+J.+Thomasauthor=A.+Rosenwaldauthor=G.+Ottauthor=H.+K.+Muller-Hermelinkauthor=R.+D.+Gascoyneauthor=J.+M.+Connorsauthor=N.+A.+Johnsonauthor=L.+M.+Rimszaauthor=E.+Campoauthor=E.+S.+Jaffeauthor=W.+H.+Wilsonauthor=J.+Delabieauthor=E.+B.+Smelandauthor=R.+I.+Fisherauthor=R.+M.+Brazielauthor=R.+R.+Tubbsauthor=J.+R.+Cookauthor=D.+D.+Weisenburgerauthor=W.+C.+Chanauthor=S.+K.+Pierceauthor=L.+M.+Staudt&title=Chronic+Active+B-Cell-Receptor+Signalling+in+Diffuse+Large+B-Cell+Lymphoma&doi=10.1038%2Fnature08638"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma</span></div><div class="casAuthors">Davis, R. Eric; Ngo, Vu N.; Lenz, Georg; Tolar, Pavel; Young, Ryan M.; Romesser, Paul B.; Kohlhammer, Holger; Lamy, Laurence; Zhao, Hong; Yang, Yandan; Xu, Weihong; Shaffer, Arthur L.; Wright, George; Xiao, Wenming; Powell, John; Jiang, Jian-kang; Thomas, Craig J.; Rosenwald, Andreas; Ott, German; Muller-Hermelink, Hans Konrad; Gascoyne, Randy D.; Connors, Joseph M.; Johnson, Nathalie A.; Rimsza, Lisa M.; Campo, Elias; Jaffe, Elaine S.; Wilson, Wyndham H.; Delabie, Jan; Smeland, Erlend B.; Fisher, Richard I.; Braziel, Rita M.; Tubbs, Raymond R.; Cook, J. R.; Weisenburger, Dennis D.; Chan, Wing C.; Pierce, Susan K.; Staudt, Louis M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">463</span>
        (<span class="NLM_cas:issue">7277</span>),
    <span class="NLM_cas:pages">88-92</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A role for B-cell-receptor (BCR) signaling in lymphomagenesis has been inferred by studying Ig genes in human lymphomas and by engineering mouse models, but genetic and functional evidence for its oncogenic role in human lymphomas is needed.  Here the authors describe a form of chronic active' BCR signaling that is required for cell survival in the activated B-cell-like (ABC) subtype of diffuse large B-cell lymphoma (DLBCL).  The signaling adaptor CARD11 is required for constitutive NF-κB pathway activity and survival in ABC DLBCL.  Roughly 10% of ABC DLBCLs have mutant CARD11 isoforms that activate NF-κB, but the mechanism that engages wild-type CARD11 in other ABC DLBCLs was unknown.  An RNA interference genetic screen revealed that a BCR signaling component, Bruton's tyrosine kinase, is essential for the survival of ABC DLBCLs with wild-type CARD11.  In addn., knockdown of proximal BCR subunits (IgM, Ig-κ, CD79A and CD79B) killed ABC DLBCLs with wild-type CARD11 but not other lymphomas.  The BCRs in these ABC DLBCLs formed prominent clusters in the plasma membrane with low diffusion, similarly to BCRs in antigen-stimulated normal B cells.  Somatic mutations affecting the immunoreceptor tyrosine-based activation motif (ITAM) signaling modules of CD79B and CD79A were detected frequently in ABC DLBCL biopsy samples but rarely in other DLBCLs and never in Burkitt's lymphoma or mucosa-assocd. lymphoid tissue lymphoma.  In 18% of ABC DLBCLs, one functionally crit. residue of CD79B, the first ITAM tyrosine, was mutated.  These mutations increased surface BCR expression and attenuated Lyn kinase, a feedback inhibitor of BCR signaling.  These findings establish chronic active BCR signaling as a new pathogenetic mechanism in ABC DLBCL, suggesting several therapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzlT4q2Ie4lrVg90H21EOLACvtfcHk0liXj7p8y-ZQ9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhvFCitw%253D%253D&md5=86d4bdf7f9af3fbe120d5b9175389e5a</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fnature08638&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08638%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DR.%2BE.%26aulast%3DNgo%26aufirst%3DV.%2BN.%26aulast%3DLenz%26aufirst%3DG.%26aulast%3DTolar%26aufirst%3DP.%26aulast%3DYoung%26aufirst%3DR.%2BM.%26aulast%3DRomesser%26aufirst%3DP.%2BB.%26aulast%3DKohlhammer%26aufirst%3DH.%26aulast%3DLamy%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DShaffer%26aufirst%3DA.%2BL.%26aulast%3DWright%26aufirst%3DG.%26aulast%3DXiao%26aufirst%3DW.%26aulast%3DPowell%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DJ.-k.%26aulast%3DThomas%26aufirst%3DC.%2BJ.%26aulast%3DRosenwald%26aufirst%3DA.%26aulast%3DOtt%26aufirst%3DG.%26aulast%3DMuller-Hermelink%26aufirst%3DH.%2BK.%26aulast%3DGascoyne%26aufirst%3DR.%2BD.%26aulast%3DConnors%26aufirst%3DJ.%2BM.%26aulast%3DJohnson%26aufirst%3DN.%2BA.%26aulast%3DRimsza%26aufirst%3DL.%2BM.%26aulast%3DCampo%26aufirst%3DE.%26aulast%3DJaffe%26aufirst%3DE.%2BS.%26aulast%3DWilson%26aufirst%3DW.%2BH.%26aulast%3DDelabie%26aufirst%3DJ.%26aulast%3DSmeland%26aufirst%3DE.%2BB.%26aulast%3DFisher%26aufirst%3DR.%2BI.%26aulast%3DBraziel%26aufirst%3DR.%2BM.%26aulast%3DTubbs%26aufirst%3DR.%2BR.%26aulast%3DCook%26aufirst%3DJ.%2BR.%26aulast%3DWeisenburger%26aufirst%3DD.%2BD.%26aulast%3DChan%26aufirst%3DW.%2BC.%26aulast%3DPierce%26aufirst%3DS.%2BK.%26aulast%3DStaudt%26aufirst%3DL.%2BM.%26atitle%3DChronic%2520Active%2520B-Cell-Receptor%2520Signalling%2520in%2520Diffuse%2520Large%2520B-Cell%2520Lymphoma%26jtitle%3DNature%26date%3D2010%26volume%3D463%26spage%3D88%26epage%3D92%26doi%3D10.1038%2Fnature08638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Caro, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kishan, A. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norberg, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanley, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapuy, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ficarro, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polak, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tondera, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gounarides, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marto, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shipp, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danial, N. N.</span></span> <span> </span><span class="NLM_article-title">Metabolic Signatures Uncover Distinct Targets in Molecular Subsets of Diffuse Large B Cell Lymphoma</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">547</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2012.08.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1016%2Fj.ccr.2012.08.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=23079663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFWitbbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=547&author=P.+Caroauthor=A.+U.+Kishanauthor=E.+Norbergauthor=I.+A.+Stanleyauthor=B.+Chapuyauthor=S.+B.+Ficarroauthor=K.+Polakauthor=D.+Tonderaauthor=J.+Gounaridesauthor=H.+Yinauthor=F.+Zhouauthor=M.+R.+Greenauthor=L.+Chenauthor=S.+Montiauthor=J.+A.+Martoauthor=M.+A.+Shippauthor=N.+N.+Danial&title=Metabolic+Signatures+Uncover+Distinct+Targets+in+Molecular+Subsets+of+Diffuse+Large+B+Cell+Lymphoma&doi=10.1016%2Fj.ccr.2012.08.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic Signatures Uncover Distinct Targets in Molecular Subsets of Diffuse Large B Cell Lymphoma</span></div><div class="casAuthors">Caro, Pilar; Kishan, Amar U.; Norberg, Erik; Stanley, Illana A.; Chapuy, Bjoern; Ficarro, Scott B.; Polak, Klaudia; Tondera, Daniel; Gounarides, John; Yin, Hong; Zhou, Feng; Green, Michael R.; Chen, Linfeng; Monti, Stefano; Marto, Jarrod A.; Shipp, Margaret A.; Danial, Nika N.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">547-560</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Mol. signatures have identified several subsets of diffuse large B cell lymphoma (DLBCL) and rational targets within the B cell receptor (BCR) signaling axis.  The OxPhos-DLBCL subset, which harbors the signature of genes involved in mitochondrial metab., is insensitive to inhibition of BCR survival signaling but is functionally undefined.  We show that, compared with BCR-DLBCLs, OxPhos-DLBCLs display enhanced mitochondrial energy transduction, greater incorporation of nutrient-derived carbons into the tricarboxylic acid cycle, and increased glutathione levels.  Moreover, perturbation of the fatty acid oxidn. program and glutathione synthesis proved selectively toxic to this tumor subset.  Our anal. provides evidence for distinct metabolic fingerprints and assocd. survival mechanisms in DLBCL and may have therapeutic implications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFccRUow25JbVg90H21EOLACvtfcHk0liXj7p8y-ZQ9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFWitbbO&md5=cc9e0ced5202e9e61ec7ee3baf4d7306</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2012.08.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2012.08.014%26sid%3Dliteratum%253Aachs%26aulast%3DCaro%26aufirst%3DP.%26aulast%3DKishan%26aufirst%3DA.%2BU.%26aulast%3DNorberg%26aufirst%3DE.%26aulast%3DStanley%26aufirst%3DI.%2BA.%26aulast%3DChapuy%26aufirst%3DB.%26aulast%3DFicarro%26aufirst%3DS.%2BB.%26aulast%3DPolak%26aufirst%3DK.%26aulast%3DTondera%26aufirst%3DD.%26aulast%3DGounarides%26aufirst%3DJ.%26aulast%3DYin%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DF.%26aulast%3DGreen%26aufirst%3DM.%2BR.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DMonti%26aufirst%3DS.%26aulast%3DMarto%26aufirst%3DJ.%2BA.%26aulast%3DShipp%26aufirst%3DM.%2BA.%26aulast%3DDanial%26aufirst%3DN.%2BN.%26atitle%3DMetabolic%2520Signatures%2520Uncover%2520Distinct%2520Targets%2520in%2520Molecular%2520Subsets%2520of%2520Diffuse%2520Large%2520B%2520Cell%2520Lymphoma%26jtitle%3DCancer%2520Cell%26date%3D2012%26volume%3D22%26spage%3D547%26doi%3D10.1016%2Fj.ccr.2012.08.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jerne, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nordin, A. A.</span></span> <span> </span><span class="NLM_article-title">Plaque Formation in Agar by Single Antibody-Producing Cells</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1963</span>,  <span class="NLM_volume"><i>140</i></span>,  <span class="NLM_fpage">405</span>, <span class="refDoi"> DOI: 10.1126/science.140.3565.405</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1126%2Fscience.140.3565.405" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=13957684" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=1963&pages=405&author=N.+K.+Jerneauthor=A.+A.+Nordin&title=Plaque+Formation+in+Agar+by+Single+Antibody-Producing+Cells&doi=10.1126%2Fscience.140.3565.405"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1126%2Fscience.140.3565.405&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.140.3565.405%26sid%3Dliteratum%253Aachs%26aulast%3DJerne%26aufirst%3DN.%2BK.%26aulast%3DNordin%26aufirst%3DA.%2BA.%26atitle%3DPlaque%2520Formation%2520in%2520Agar%2520by%2520Single%2520Antibody-Producing%2520Cells%26jtitle%3DScience%26date%3D1963%26volume%3D140%26spage%3D405%26doi%3D10.1126%2Fscience.140.3565.405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ladics, G. S.</span></span> <span> </span><span class="NLM_article-title">Primary Immune Response to Sheep Red Blood Cells (SRBC) as the Conventional T-Cell Dependent Antibody Response (TDAR) Test</span>. <i>J. Immunot.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">149</span>, <span class="refDoi"> DOI: 10.1080/15476910701337357</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=10.1080%2F15476910701337357" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=18958723" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2007&pages=149&author=G.+S.+Ladics&title=Primary+Immune+Response+to+Sheep+Red+Blood+Cells+%28SRBC%29+as+the+Conventional+T-Cell+Dependent+Antibody+Response+%28TDAR%29+Test&doi=10.1080%2F15476910701337357"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1080%2F15476910701337357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F15476910701337357%26sid%3Dliteratum%253Aachs%26aulast%3DLadics%26aufirst%3DG.%2BS.%26atitle%3DPrimary%2520Immune%2520Response%2520to%2520Sheep%2520Red%2520Blood%2520Cells%2520%2528SRBC%2529%2520as%2520the%2520Conventional%2520T-Cell%2520Dependent%2520Antibody%2520Response%2520%2528TDAR%2529%2520Test%26jtitle%3DJ.%2520Immunot.%26date%3D2007%26volume%3D4%26spage%3D149%26doi%3D10.1080%2F15476910701337357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Finlay, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lloyd, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaccaro, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kover, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhave, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prol, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huynh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhandaru, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caringal, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimarco, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harper, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conder, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levesque, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atwal, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wexler, R.</span></span> <span> </span><span class="NLM_article-title">Discovery of ((S)-5-(Methoxymethyl)-7-(1-Methyl-1 H -Indol-2-Yl)-2- (Trifluoromethyl)-4,7-Dihydropyrazolo[1,5- a ]Pyrimidin-6-Yl)((S)-2-(3- Methylisoxazol-5-Yl)Pyrrolidin-1-Yl)Methanone as a Potent and Selective I Kur Inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">3036</span>, <span class="refDoi"> DOI: 10.1021/jm201386u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201386u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs1OisLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=3036&author=H.+J.+Finlayauthor=J.+Lloydauthor=W.+Vaccaroauthor=A.+Koverauthor=L.+Yanauthor=G.+Bhaveauthor=J.+Prolauthor=T.+Huynhauthor=R.+Bhandaruauthor=Y.+Caringalauthor=J.+Dimarcoauthor=J.+Ganauthor=T.+Harperauthor=C.+Huangauthor=M.+L.+Conderauthor=H.+Sunauthor=P.+Levesqueauthor=M.+Blanarauthor=K.+Atwalauthor=R.+Wexler&title=Discovery+of+%28%28S%29-5-%28Methoxymethyl%29-7-%281-Methyl-1+H+-Indol-2-Yl%29-2-+%28Trifluoromethyl%29-4%2C7-Dihydropyrazolo%5B1%2C5-+a+%5DPyrimidin-6-Yl%29%28%28S%29-2-%283-+Methylisoxazol-5-Yl%29Pyrrolidin-1-Yl%29Methanone+as+a+Potent+and+Selective+I+Kur+Inhibitor&doi=10.1021%2Fjm201386u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of ((S)-5-(methoxymethyl)-7-(1-methyl-1H-indol-2-yl)-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-a]pyrimidin-6-yl)((S)-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone As a Potent and Selective IKur Inhibitor</span></div><div class="casAuthors">Finlay, Heather J.; Lloyd, John; Vaccaro, Wayne; Kover, Alexander; Yan, Lin; Bhave, Gauri; Prol, Joseph; Huynh, Tram; Bhandaru, Rao; Caringal, Yolanda; DiMarco, John; Gan, Jinping; Harper, Tim; Huang, Christine; Conder, Mary Lee; Sun, Huabin; Levesque, Paul; Blanar, Michael; Atwal, Karnail; Wexler, Ruth</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3036-3048</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Previously disclosed dihydropyrazolopyrimidines are potent and selective blockers of IKur current.  A potential liability with this chemotype is the formation of a reactive metabolite which demonstrated covalent binding to protein in vitro.  When substituted at the 2 or 3 position, this template yielded potent IKur inhibitors, with selectivity over hERG which did not form reactive metabolites.  Subsequent optimization for potency and PK properties lead to the discovery of ((S)-5-(methoxymethyl)-7-(1-methyl-1H-indol-2-yl)-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-a]pyrimidin-6-yl)((S)-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone I, with an acceptable PK profile in preclin. species and potent efficacy in the preclin. rabbit atrial effective refractory period (AERP) model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBQ3O-MOGeKbVg90H21EOLACvtfcHk0lghAanZUe1pBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs1OisLY%253D&md5=6c70b62774028a29fb53a65e987e50fe</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm201386u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201386u%26sid%3Dliteratum%253Aachs%26aulast%3DFinlay%26aufirst%3DH.%2BJ.%26aulast%3DLloyd%26aufirst%3DJ.%26aulast%3DVaccaro%26aufirst%3DW.%26aulast%3DKover%26aufirst%3DA.%26aulast%3DYan%26aufirst%3DL.%26aulast%3DBhave%26aufirst%3DG.%26aulast%3DProl%26aufirst%3DJ.%26aulast%3DHuynh%26aufirst%3DT.%26aulast%3DBhandaru%26aufirst%3DR.%26aulast%3DCaringal%26aufirst%3DY.%26aulast%3DDimarco%26aufirst%3DJ.%26aulast%3DGan%26aufirst%3DJ.%26aulast%3DHarper%26aufirst%3DT.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DConder%26aufirst%3DM.%2BL.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DLevesque%26aufirst%3DP.%26aulast%3DBlanar%26aufirst%3DM.%26aulast%3DAtwal%26aufirst%3DK.%26aulast%3DWexler%26aufirst%3DR.%26atitle%3DDiscovery%2520of%2520%2528%2528S%2529-5-%2528Methoxymethyl%2529-7-%25281-Methyl-1%2520H%2520-Indol-2-Yl%2529-2-%2520%2528Trifluoromethyl%2529-4%252C7-Dihydropyrazolo%255B1%252C5-%2520a%2520%255DPyrimidin-6-Yl%2529%2528%2528S%2529-2-%25283-%2520Methylisoxazol-5-Yl%2529Pyrrolidin-1-Yl%2529Methanone%2520as%2520a%2520Potent%2520and%2520Selective%2520I%2520Kur%2520Inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D3036%26doi%3D10.1021%2Fjm201386u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i45"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01246">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_81054"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c01246?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01246</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Selectivity data for <b>MLT-985</b>, detailed metabolism studies for <b>MLT-231</b> and compound <b>4</b>, and <sup>1</sup>H and <sup>13</sup>C data and HPLC–MS details for final compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01246/suppl_file/jm0c01246_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and biochemical potency data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01246/suppl_file/jm0c01246_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01246/suppl_file/jm0c01246_si_001.pdf">jm0c01246_si_001.pdf (595.55 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01246/suppl_file/jm0c01246_si_002.csv">jm0c01246_si_002.csv (0.87 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c01246&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-23%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c01246%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c01246" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799449cea951964","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
